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ABSTRACT 
 
In the UK substantial numbers of new HIV diagnoses are within migrant African 
communities.  A continuing feature of HIV in this population is the late presentation to HIV 
services. This dissertation sets out to explore HIV testing among Africans in the UK, the 
factors associated with late presentation to HIV services, and the extent of HIV 
acquisition within the UK in African communities. The main focus of the thesis is the 
‘study of newly diagnosed HIV among Africans in London’ (the SONHIA study), 
which combined qualitative and quantitative methods in a multi-centre study. 
The thesis begins with the work undertaken in preparation for SONHIA. It presents a 
literature review to provide epidemiological, cultural and historical background. Next is 
an analysis of the 2nd National Survey of Sexual Attitudes and Lifestyles to explore the 
factors associated with HIV testing among black Africans in Britain. Finally, the 
findings from in-depth interviews with key informants to identify the issues affecting 
utilisation of HIV services for Africans in Britain are presented. 
The SONHIA study consisted of survey of 269 Africans newly diagnosed with HIV. All 
respondents self-completed a questionnaire linked to clinical records, and 26 in-depth 
interviews with a purposively selected sub-sample were performed. The findings show 
that Africans are accessing services but clinicians are failing to use these opportunities 
for preventive and diagnostic purposes with regards to HIV infection. HIV presentation 
patterns appear governed by factors linked to the characteristics of, and response to, the 
HIV epidemic operating within people’s sociocultural networks. UK acquisition of HIV 
in this population appears substantially higher than acknowledged by national 
surveillance data, with a quarter to a third of HIV possibly acquired in the UK.  
The qualitative findings provide contextual understanding of the factors contributing to 
late presentation. They highlight the central role of HIV-related stigma and 
discrimination in influencing HIV testing behaviours. Failings within the health care 
system offer insight as how clinicians can better address HIV in the future. 
The key findings are summarized and contextualised with the literature and the current 
socio-political climate. The study’s limitations are addressed, and the thesis concludes 
with the public health and policy implications of the study.  
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Chapter 1: Introduction, Aims and Study 
Outline 
 
1.0  Introduction 
The first cases of a new acquired immunodeficiency syndrome (AIDS) were recognised 
in 1981, heralding the emergence of the human immunodeficiency virus (HIV) 
pandemic that continues to affect the lives of tens of millions of people worldwide, 
especially in sub-Saharan Africa. 
When this work commenced concern was beginning to be expressed about the numbers 
of Africans presenting with advanced disease to services for treatment of HIV in the 
United Kingdom (UK), and the consequent impact late presentation had on the potential 
for onward disease transmission.  This dissertation sets out to explore HIV testing 
among black Africans in the UK, the factors associated with late presentation to HIV 
services, and the extent of HIV acquisition within the UK in black African 
communities.  
This opening chapter provides an overview of the emergence of HIV, its history and 
epidemiology, and the determinants of HIV spread. It concludes with the aims, 
justification, and an outline of the programme of work presented within this thesis. 
1.1  The emergence of an epidemic  
1.1.1    Europe and North America 
In 1981 an unusual cluster of Pneumocystis jirovecii pneumonia (PCP) and Kaposi’s 
sarcoma (KS) among previously healthy men who had sex with men (MSM) in New 
York, California and London alerted the world to the presence of a new immune 
deficiency syndrome (Gottlieb et al., 1981; du Bois, Branthwaite, Mikhail, & Batten,  
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1981). Both of these conditions were known to occur only in severely 
immunocompromised patients, and none of the men had known cause of 
immunodeficiency.  
Initially referred to as gay related immune deficiency (GRID), the clustering in 
homosexual men and the association with high numbers of sexual partners and previous 
sexually transmitted infections, alerted epidemiologists to the possibility of a sexually 
transmitted agent being responsible (Jaffe et al., 1983; Centers for Disease Control and 
Prevention, 1982a).  However others believed it may reflect exposure to some substance 
(rather than an infectious agent) that was associated with a ‘particular type of style of 
life’ (Marmor et al., 1982; Centers for Disease Control and Prevention, 1982a). Possible 
agents at this time included cytomegalovirus, inhaled nitrates, and an as yet 
unrecognised agent in semen (Gottlieb et al., 1981; Marmor et al., 1982).  
It soon became apparent that groups other than homosexual men were also at risk, and 
by 1982 the term acquired immune deficiency syndrome (AIDS) had replaced GRID 
(Centers for Disease Control and Prevention, 1982b). The evidence swung in favour of 
an unrecognised infectious agent being responsible for AIDS as groups not associated 
with a homosexual lifestyle (haemophiliacs, injecting drug users, and heterosexual 
Haitians) were also affected (Centers for Disease Control and Prevention, 1982b). 
Accounts of cases in the heterosexual sexual partners of injecting drug users and 
haemophiliacs were also reported (Masur et al., 1982; Kreiss, Kitchen, Prince, Kasper, 
& Essex, 1985). Importantly index cases were often asymptomatic, suggesting possible 
transmission without recognisable illness. 
Surveillance and epidemiological studies indicated that the major modes of transmission 
of HIV were via sexual intercourse (anal or vaginal), needle-sharing, transfusion of 
contaminated blood or blood products (e.g. factor VIII), and vertical transmission from  
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mother to foetus (Curran et al., 1985; Friedland & Klein, 1987). Breast milk was also 
recognised as a potential vector early in the epidemic (Lepage et al., 1987; Ziegler, 
Cooper, Johnson, & Gold, 1985). Fortunately transmission to household contacts, other 
than via sexual intercourse, was not found to occur (Friedland et al., 1986). 
In 1983 a retrovirus was established as the causative agent for AIDS (Barre-Sinoussi et 
al., 1983; Gallo et al., 1984), and in 1986 international agreement was reached that the 
virus be referred to as human immunodeficiency virus (HIV) (Coffin et al., 1986).  
Cases rapidly increased on both sides of the Atlantic and within 10 years of first 
identifying the clusters of PCP and KS, 22,423 new diagnoses of HIV, 7822 
notifications of AIDS and 5647 HIV related deaths had been reported in the UK (Health 
Protection Agency Centre for Infections, 2008). 
1.1.2    Sub-Saharan Africa  
The first descriptions of AIDS in African patients were reported in France and Belgium 
in 1983 (Clumeck, Mascart-Lemone, de Maubeuge, Brenez, & Marcelis, 1983; 
Clumeck et al., 1984; Brunet et al., 1983). Immunologically these cases were identical 
to those in the United States and London.  Clinically they resembled Haitian AIDS 
cases with a predominance of gastrointestinal symptoms, Cryptococcosis, and 
mycobacterial infections (whilst KS and PCP accounted for the majority of AIDS cases 
in MSM). Epidemiologically these cases arose in male and female migrants from 
Central Africa (Zaire (now Democratic Republic of Congo (DRC)), Chad and Rwanda) 
with no history of homosexuality or injecting drug use. 
These observations led to investigations in Central Africa, which rapidly identified large 
numbers of AIDS patients with similar clinical and immunological features (Melbye et 
al., 1986; Piot et al., 1984; Van de Perre et al., 1984). AIDS cases in Africa were  
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equally distributed between men and women, and most prevalent in people in the 
sexually active age range (20-49 years); This later finding suggesting that non-sexual 
forms of parental transmission such as use of non-sterilised needles or insect vectors 
were unlikely. In addition, clusters linked by frequent heterosexual contact were 
identified with no reports of sex between men or injecting drug use. The case 
distribution supported heterosexual transmission as the principal mode of acquisition.  
Meanwhile in the Rakai district of Uganda there were also reports of an 
immunodeficiency syndrome referred to as ‘Slim disease’ (as the major symptoms were 
weight loss and diarrhoea). In 1985 HIV (then known as human T-lymphotrophic virus 
type III) was found to be associated with Slim disease, thus establishing a definitive link 
between the simultaneous epidemics occurring in African heterosexuals and in MSM in 
Europe and North America (Serwadda et al., 1985). Subsequent serological studies in 
Uganda demonstrated almost complete absence of HIV in non-sexually active persons, 
and again demonstrated that non-sexual household contacts of infected persons were not 
at risk of infection (Carswell, 1987; Sewankambo et al., 1987). 
1.1.2.1  Spread of infection 
It is now believed that the first HIV/AIDS epidemic occurred in Kinshasa in the 1970s 
(Quinn, Mann, Curran, & Piot, 1986).  One theory is that an infected individual brought 
HIV into the Congolese capital from neighbouring Cameroon, and upon entering an 
urban sexual network it was able to establish itself and spread. Cameroon is assumed to 
be the country of origin of HIV as this is where the chimpanzee subspecies Pan 
troglodytes troglodytes, the source of HIV-1, is found (Gao et al., 1999). 
HIV spread rapidly to neighbouring Central and Eastern African countries (see figure 
1.1).  Truck drivers and other migrant groups (soldiers, traders and miners) engaging  
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with sex workers facilitated the initial spread of HIV along transport and trade routes 
(Carswell, Lloyd, & Howells, 1989; Kreiss et al., 1986; Serwadda et al., 1985).  The 
lack of circumcision, limited use of condoms,  and a high prevalence of sexually 
transmitted infections (STIs) also contributed to the accelerated spread throughout the 
region (Mann et al., 1987; Quinn et al., 1986; Weiss, Quigley, & Hayes, 2000). 
Sex workers and their clients in particular were identified from the onset of the 
epidemic as a high risk group important in sustaining the spread of infection (Van de 
Perre et al., 1985; Vittecoq et al., 1987).  In 1986 between 27 and 88% of female sex 
workers in East Africa were HIV positive (Van de Perre et al., 1985; Kreiss et al., 
1986). Dissemination throughout the sex worker population was rapid, seroprevalence 
increasing from 4% to 61% over a period of 4 years in Nairobi (Piot et al., 1987). 
Condoms were not widely used by African sex workers in the 1980s and this is thought 
to have contributed to the rapid spread of infection (Mann et al., 1987). 
 
Figure 1.1 The spread of HIV in Africa 
Adult HIV prevalence (%) 
20%-30%   10%-20%     5%-10% 
1%  -  5%    0%-1%    Data  unavailable 
 
Source: UNAIDS (2004) report on global AIDS epidemic. Geneva 
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The early 1980s saw HIV spread further into Equatorial and Western African nations. 
As in Central and Eastern Africa sex work was a major driver in the early phase of the 
epidemic in West Africa (Lowndes et al., 2002). Southern Africa was affected 
comparatively late by HIV but the virus spread rapidly to epidemic levels throughout 
the general population, such that it is now the region most affected. Southern Africa 
accounted for a third of all HIV diagnoses and AIDS related deaths globally in 2007, 
and eight countries in the region
1 currently have a national adult HIV prevalence in 
excess of 15% (UNAIDS & World Health Organization, 2008). 
Initially HIV was equally distributed between the sexes in Africa, however women now 
account for 61% of all adult infections (UNAIDS & World Health Organization, 2007). 
Consequently Africa has also experienced large numbers of infections acquired 
vertically and in 2007 2.2 million children were estimated to living with HIV in sub 
Saharan Africa (UNAIDS et al., 2007). The other consequence of a primarily 
heterosexual epidemic, in which effective medication has largely been unavailable, has 
been the number of children orphaned; by 2004 12 million children in Africa had lost 
one or both parents to HIV (UNAIDS, 2004). 
1.2   The origin of HIV 
Human immunodeficiency virus is now firmly recognised as the aetiological agent of 
AIDS. There are two types of HIV: HIV-1 and HIV-2.  HIV-1 is the predominant virus 
worldwide, with HIV-2 being relatively concentrated in West Africa.  Whilst both cause 
clinically indistinguishable AIDS, HIV-2 is less infectious and clinical progression is 
slower  (Marlink et al., 1994). HIV is thought to be a descendant of simian 
immunodeficiency virus (SIV) having crossed over from chimpanzees (in the case of 
                                                 
1 Botswana, Lesthoto, Mozambique, Namibia, South Africa, Swaziland, Zambia & Zimbabwe.  
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HIV-1) and sooty mangabeys (HIV-2) (Sharp, Bailes, Stevenson, Emerman, & Hahn, 
1996; Gao et al., 1999). Crossover for HIV-1 M group, the main virus group, probably 
occurred sometime in the 1930s (Korber et al., 2000; Zhu et al., 1998).  
HIV is a lentivirus (a member of the retrovirus family) characterised by a long 
incubation period and persistent infection. It slowly and progressively attacks the 
immune system by incorporating itself into the DNA of host cells via the glycoprotein 
CD4 receptor (Stebbing, Gazzard, & Douek, 2004). CD4 receptors are predominantly 
found on the T-helper lymphocytes. T-helper cells help orchestrate the immune 
response, especially towards viral, fungal and protozoal infections. The destruction of 
CD4 positive cells is the major cause of immunodeficiency observed with HIV 
infection.  
HIV is transmitted by sexual contact, by blood and blood products, and from mother to 
child either during pregnancy or birth, or via breast milk. 
1.2.1    AIDS case definition 
The definition of AIDS has changed over time as knowledge about the syndrome has 
increased.  In 1982 the Centers for Disease Control (CDC) in Atlanta defined a case of 
AIDS as a disease ‘at least moderately predictive of defect of cell-mediated immunity, 
occurring in a person with no known cause for diminished resistance to that disease. 
Such diseases include Kaposi’s sarcoma, Pneumocystis carinii pneumonia, and serious 
opportunistic infections’ (Centers for Disease Control and Prevention, 1982b). The 
definition was revised in 1985 following the development of a laboratory test for HIV 
and again in 1987. The current definition used throughout Europe is the 1993 expanded 
European AIDS case definition (Ancelle-Park, 1993). This includes all HIV-infected 
persons who fulfil the clinical conditions listed in box 1.1 below.  
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The CDC use a slightly different definition that includes all HIV-infected persons who 
meet the conditions in box 1.1 and ‘all HIV-infected persons who have less than 200 
CD4+ T-lymphocytes/µL, or a CD4+ T-lymphocyte percentage of total lymphocytes of 
less than 14’ irrespective of clinical manifestations (Centers for Disease Control and 
Prevention, 1992).  European experts decided against inclusion of a criterion based on 
CD4 count alone as there was concern about the completeness of AIDS surveillance 
based solely on the degree of immunosuppression, potential negative psychological 
effects on symptom-free HIV infected patients, and the fact that in Europe access to 
medical care and social benefits is not conditional upon a person meeting the AIDS 
definition (Ancelle-Park, 1993). 
 
Box 1.1 AIDS Defining conditions 
Candidiasis, oesophageal 
Cervical cancer, invasive 
Coccidiodomycosis, disseminated 
Cryptococcosis 
Cryptosporidiosis (>1 month) 
Cytomegalovirus disease or retinitis  
     (other than liver, spleen or lymph  
     nodes) 
Encephalopathy, HIV related 
Herpes simplex (>1 month) 
Histoplasmosis, disseminated or  
     extrapulmonary 
Isosporiasis (>1 month) 
Kaposi’s sarcoma 
Lymphoma, Burkitts, immunoblastic or    
     equivalent, or brain 
Mycobacterium avium complex or 
Mycobacterium,  
     disseminated/extrapulmonary 
Mycobacterium tuberculosis 
Pneumocystis carinii (or jiroveci) 
pneumonia 
Pneumonia, recurrent bacterial 
Progressive multifocal  
     leukoencephalopathy 
Salmonella septicaemia, recurrent 
Toxoplasmosis of brain 
Wasting syndrome
 
AIDS represents the end stage of a continuous, progressive, pathogenic process.  In 
clinical practice symptoms, together with measures of immune function, particularly 
CD4 cell levels, HIV viral load, and patient wishes, are used to guide treatment of HIV-
infected persons.  
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As well as redefining AIDS, the CDC 1993 Revised classification system categorised 
people on the basis of clinical conditions associated with HIV infection and CD4+ T- 
lymphocyte counts. The system is based on three ranges of CD4+ T- lymphocyte counts 
and three clinical categories and is represented by a matrix of nine mutually exclusive 
categories (Table 1.1) (Centers for Disease Control and Prevention, 1992). This 
nomenclature has been adopted to define clinical status throughout this document. The 
1993 expanded European AIDS case definition (box 1.1) has been used in classifying 
AIDS cases, but for the purposes of this work late presentation is defined solely 
according to CD4 criteria at the time of initial HIV diagnosis (see chapter 5). 
 
Table 1.1 Summary of the 1993 classification of the clinical manifestations of HIV 
Clinical Categories  CD4 categories 
  ≥500 cells/µL  200-499 cells/µL  <200 cells/µL 
Asymptomatic, 
acute (primary) 
HIV or PGL
1 
(A) 
 
A1 
 
A2 
 
A3 
Symptomatic HIV
2 
(B) 
 
B1 
 
B2 
 
B3 
AIDS defining 
conditions
3 
(C) 
 
C1 
 
C2 
 
C3 
1 PGL = persistent generalised lymphadenopathy. Conditions listed in categories B & C must not have 
occurred 
2 Symptomatic patients with conditions attributed to HIV or indicative of cell-mediated immunity defect 
not listed in category C. Includes: recurrent thrush (oral and vulvovaginal), cervical dysplasia, fever or 
diarrhoea lasting more than one month, oral hairy leukoplakia, herpes zoster greater than 1 episode or 
more than one dermatome, idiopathic thrombocytopenia, peripheral neuropathy. 
3 AIDS defining conditions (see box 1.1). For classification purposes once a category C condition has 
occurred the person remains in category C. 
 
 
1.2.2    Natural history of HIV infection 
After acquisition of HIV a flu-like syndrome may develop within days to weeks, 
unfortunately this is rarely recognised as primary HIV infection even if health care is 
sought (Sudarshi et al., 2008). Following primary HIV infection most infected persons  
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enter a period of asymptomatic infection. Untreated the duration of asymptomatic HIV 
infection can vary substantially, for example 5% will develop AIDS within 3 years of 
infection (Munoz & Xu, 1996; Phair et al., 1992) but 12% will remain AIDS free for 
greater than 20 years (Sheppard, Lang, Ascher, Vittinghoff, & Winkelstein, 1993; 
Munoz et al., 1996). The median time from seroconversion to AIDS, without effective 
medication, is approximately 10 years (UK Register of HIV Seroconverters Steering 
Committee, 1998; Koblin et al., 1999; Morgan et al., 2002). In Europe AIDS is defined 
according to the 1993 revised European definition (Ancelle-Park, 1993; European 
Centre for the Epidemiological Monitoring of AIDS, 1993). It differs from the 
definition used in the USA in that it does not include a CD4 lymphocyte count criterion 
(Centers for Disease Control and Prevention, 1992). Without access to antiretroviral 
medication  survival following an AIDS defining illness is usually less than 12 months 
(Martin, Cox, & Beck, 1996; Morgan et al., 2002).  
Despite clinical latency viral replication is highly dynamic and continuous with 
approximately 10
10 virons produced per day (Ho et al., 1995), progressively reducing T-
helper cells (Holodniy, 1999). There is a strong association between HIV viral load 
(measured as the concentration of HIV-1 RNA in plasma) and the rate of CD4 decline 
(Mellors et al., 1997). Clinically the combination of viral load and CD4 count are used 
to provide prognostic indicators to guide management decisions. Transmission of HIV 
can occur at any stage of infection although it also appears to be strongly correlated 
with the viral load (Quinn et al., 2000; Connor et al., 1994; Jackson et al., 2003). 
The immediate risk of HIV related pathology, and time since acquisition, is associated 
with an individual’s CD4 count (Phillips et al., 1991; Fahey et al., 1990; Satten & 
Longini, 1996), hence it is used as a surrogate marker in monitoring HIV infection.  A 
CD4 count below 200 cells/µL
 represents advanced HIV disease, hence it’s inclusion as  
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an AIDS defining condition in the United States (Centers for Disease Control and 
Prevention, 1992). 
1.2.3   Antiretroviral therapy 
The first antiretroviral medication, zidovudine or AZT (a nucleoside analogue), was 
released in 1985 but randomised controlled trails showed no long-term benefit in 
survival with either mono, or subsequently dual, nucleoside analogue therapy (Ioannidis 
et al., 1995; Delta Coordinating Committee, 1996). It was not until the approval of 
protease inhibitors in 1995 and the advent of triple combination therapy that significant 
improvements in the health of HIV infected people could be demonstrated (Hammer et 
al., 1997).  
Highly active antiretroviral therapy (HAART) has been responsible for marked declines 
in HIV related morbidity and mortality (Palella, Jr. et al., 1998; Porter et al., 2003; 
Mocroft et al., 2003; Sterne et al., 2005). Whilst a reduction in viral load occurs almost 
immediately on initiation of HAART, immunological and clinical benefits can take 
considerably longer depending on the baseline CD4 count, viral load, and presence of 
co morbidities (Lepri et al., 2001; May et al., 2007; Gazzard, 2008). Delay of initiation 
of HAART until the CD4 count is below 200 cells/µL is associated with a poorer 
virological and clinical response than when therapy is commenced with a CD4>350 
cells/µL (Gazzard, 2008; May et al., 2007).  
1.2.4   AIDS and HAART 
The incidence of AIDS cases has fallen markedly across Europe since the advent of 
HAART (Mocroft et al., 2003; Sterne et al., 2005; Palella, Jr. et al., 1998). 
Unfortunately for many HIV infected people the benefits of HAART remain elusive, 
either because they have no means of accessing therapy or because they are unaware  
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that they are HIV infected. In Europe the majority of people now developing AIDS 
already have advanced disease at the time they present to HIV services (Hamers & 
Downs, 2004). In 2002 72% of AIDS cases among heterosexually infected persons 
occurred within six months of initial HIV diagnosis (Hamers et al., 2004). 
1.2.5    HIV testing and national surveillance. 
An enzyme-linked immunosorbent assay (ELISA) for non-neutralising HIV antibodies 
was developed in 1984 and a commercial kit became available in 1985 (Weiss et al., 
1985), enabling widespread HIV testing as a diagnostic and screening tool.  HIV testing 
was introduced in Genitourinary Medicine (GUM) Clinics in the UK in 1985.   
Surveillance systems for HIV/AIDS were established nationally and internationally.  In 
the UK in 1982 a system for voluntary reporting of AIDS cases by clinicians was 
established at the Communicable Disease Surveillance Centre, Colindale – now known 
as the Health Protection Agency (HPA). The World Health Organisation set up a global 
network for the control and prevention of AIDS in 1986, and in 1996 the Joint United 
Nations Programme on HIV/AIDS (UNAIDS) became operational (World Health 
Organization, 1986) 
In addition to the voluntary reporting of AIDS cases the HPA now monitors (Health 
Protection Agency, 2009):  
1.  HIV prevalence via unlinked anonymous HIV testing in pregnant women, 
injecting drug users and GUM clinic attendees;  
2.  Accessing of HIV care via the survey of prevalent HIV infections diagnosed 
(SOPHID);   
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3.  New HIV diagnoses via the voluntary case reporting of HIV/AIDS from 
laboratory reports of newly diagnosed HIV infections by microbiologists and 
HIV/AIDS diagnoses by clinicians;  
4.  HIV incidence using the serological testing algorithm for recent HIV 
seroconversion (STARHS) – currently this is restricted to testing samples from 
MSM;  
5.  HIV resistance based upon genotypic reports received by the Medical Research 
Council held UK HIV Drug Resistance Database;  
6.  The National CD4 Surveillance scheme which monitors trends in 
immunosuppression associated with HIV infection by collecting data on CD4 cell 
counts performed by laboratories in England and Wales. 
National surveillance of country of acquisition is based on data collected in the 
voluntary case reporting by clinicians of new diagnoses, with a research 
nurse/counsellor following up incomplete data (Dougan, Gilbart, Sinka, & Evans, 
2005). Currently where region of acquisition is uncertain, for example when an 
individual may have had sex in both the UK and Africa, the region with the higher 
prevalence will be assumed to be the region of acquisition. 
1.3   Epidemiology of HIV 
1.3.1    Current Epidemiology of HIV  
Globally 33 million people were estimated to be living with HIV in 2007, 67% (22.1 
million) of whom reside in sub-Saharan Africa (UNAIDS, 2008). Many African 
countries experience generalised epidemics (UNAIDS, 2006). This means that HIV is 
spreading throughout the general population rather than being confined to high-risk 
groups such as sex workers or their clients. In sub-Saharan Africa in 2006, an estimated  
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2.8 million people became infected with HIV and 2.1 million adults and children died of 
AIDS (UNAIDS, 2006). The majority of adult HIV infections in this region are 
acquired heterosexually. 
In Western Europe there are over half a million persons living with HIV (UNAIDS et 
al., 2007). The numbers of newly diagnosed individuals continues to rise across Europe. 
Originally the primary mode of transmission was sex between men, however since 2000 
heterosexual contact has become the dominant mode of transmission in those newly 
diagnosed with HIV in Europe (UNAIDS, 2004). A substantial proportion of these new 
diagnoses are migrants, in particular people from sub-Saharan Africa (Hamers et al., 
2004; UNAIDS et al., 2007). 
1.3.1.1  Epidemiology of HIV in the UK 
At the time this study commenced 53,000 people were estimated to be living with HIV 
in the UK (The UK Collaborative Group for HIV and STI Surveillance, 2004) with an 
estimated 27% of prevalent infections being undiagnosed. In 2003 58% (3801/6606) of 
new HIV diagnoses were believed to be acquired heterosexually, 26% (1735/6606) via 
sex between men, 2% through injecting drug use, and 2% via vertical (mother to child) 
transmission (Health Protection Agency, 2003). For the first time in 2002 more people 
were estimated to be living in the UK with heterosexually acquired HIV (47.5%) than 
with HIV acquired via sex between men (45.7%) (Health Protection Agency, 2003). In 
2003 947 people developed AIDS for the first time, and 575 died due to HIV related 
illnesses (Ribeiro, 2009). 
The majority (74%) of heterosexually acquired HIV infections in the UK were 
described by the HPA as amongst people who were probably infected in sub-Saharan 
Africa (Health Protection Agency, 2003). In 2002 African born men and women were  
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estimated to account for 69% (16200/26000) of prevalent infections in heterosexuals, 
with an estimated 31% (4800) of infections undiagnosed (undiagnosed HIV estimated at 
39.7% in African men and 25.3% in African women) (Health Protection Agency, 2003).  
In 2002 the prevalence of previously undiagnosed HIV infection
2 in genitourinary 
medicine (GUM) clinic attendees among heterosexuals was 0.8% in London and 0.3% 
outside London. The ratio of undiagnosed HIV infection in UK born heterosexuals to 
sub-Saharan African born was 1:11 inside London and 1:79 outside London (Health 
Protection Agency, 2003). The prevalence of previously undiagnosed HIV infection 
outside London more than tripled between 1997 and 2002. Since most of this is in sub-
Saharan Africans it is thought to be related to dispersal of migrant populations from 
high HIV prevalence countries to areas outside London (Health Protection Agency, 
2003). 
Whilst the prevalence of previously undiagnosed infection among UK-born 
heterosexuals provides an indication of HIV transmission among heterosexuals in the 
UK, the high prevalence seen in African born heterosexuals is believed to primarily 
reflect the high levels of HIV infection in the home countries of these migrant 
populations (Health Protection Agency, 2003). However a 1997 study of diagnosed HIV 
infection in south London estimated that up to 5% of heterosexually acquired HIV 
infections among Africans had been acquired within the UK (Paine et al., 1997). A 
further 12% were either probably or likely to have been infected in the UK.  National 
surveillance data up to 2001 suggests that 3.0% of HIV infections amongst black 
Africans diagnosed in the UK were acquired in the UK, but there is acknowledgement 
                                                 
2 Previously undiagnosed infection includes those who were diagnosed at a clinic visit as well as those 
who remain undiagnosed, but it excludes those who had an HIV infection diagnosed previously.  
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that this figure is likely to be an underestimate (Sinka, Mortimer, Evans, & Morgan, 
2003).  
Of course not all HIV infections in African communities within the UK are 
heterosexually acquired. SOPHID data, which collects data on those individuals with 
diagnosed HIV infection accessing care in England, Wales and Northern Ireland, show 
that 12,688 black Africans accessed HIV care in 2003: Of these 11,068 (87%) were 
infected heterosexually; 226 (1.8%) through sex between men; 31 (0.2%) through 
injecting drug use; 940 (7.4%) via vertical transmission; 61 (0.5%) via blood products; 
and 362 (3%) by other/unreported means (The UK Collaborative Group for HIV and 
STI Surveillance, 2004).  
Similarly ‘Black Africans’ do not represent all Africans. In 2001 only 37% of all 
African-born UK residents were Black (table 2.1), this is predominantly due to the large 
migrant communities of white South Africans and Zimbabweans, Asians migrating 
from Kenya, and Arabic communities from North Africa (Department of National 
Statistics, 2003).  In 2003, of those with reported ethnic group, black Africans 
comprised 70.3% of individuals with heterosexually acquired HIV accessing care in the 
UK (The UK Collaborative Group for HIV and STI Surveillance, 2004).  
The association between country of birth and ethnicity is important as many 
assumptions about HIV risk are based on ethnicity. Many non-black African individuals 
come from countries of high HIV prevalence where HIV transmission between different 
ethnic groups could be occurring. Conversely, 34% of the black African population in 
England and Wales were born in the UK (Department of National Statistics, 2003); risk, 
knowledge and beliefs about HIV for this group are probably more likely to reflect 
those of the general British population.   
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As the prevalent pool of HIV infection increases in overseas-born communities within 
Britain, so will the potential for transmission within these communities, and also from 
them to UK born communities.  This is because people with HIV will have sexual 
relationships with other people within the UK, some of who may already have HIV but 
some of who may not.  If there are more people with HIV then there are likely to be 
more sexual encounters involving someone who has HIV, and hence an opportunity for 
HIV transmission if there is discordance in the HIV status between the parties. 
In the UK 3.6% (788,841/21,660,475) of households have different ethnic identities 
within partnerships (Department of National Statistics, 2003).  The issue of country of 
birth and ethnicity is of particular interest as much HIV surveillance data are unable to 
provide an in-depth profile of high-risk populations within Britain. 
1.3.1.2   The UK African HIV epidemic 
Due to its historical links with Southern and Eastern Africa, the region of the world 
most affected by HIV, the UK has been particularly affected by the African HIV 
epidemic.  In the UK an estimated 77,400 people are currently living with HIV (Health 
Protection Agency, 2008a). As in the rest of Europe, infections acquired through 
heterosexual transmission have progressively increased over the past decade, to the 
extent that since 1999 the number of HIV diagnoses attributable to heterosexual 
acquisition has exceeded that from sex between men (see figure 1.2) (Health Protection 
Agency, 2008a). In 2007, 55% (4260/7734) of new HIV diagnoses were thought to be 
acquired heterosexually (Health Protection Agency, 2008a).   
  32
UK Collaborative Group for HIV and STI Surveillance
0
500
1000
1500
2000
2500
3000
3500
4000
1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
Year
N
u
m
b
e
r
 
o
f
 
d
i
a
g
n
o
s
e
s
Sex between men
Heterosexual men and women
Injecting drug user
Mother to infant
Blood/tissue
Other/undetermined
11
1 Numbers will rise, for recent years, as further reports are received.
Data Source: HIV/AIDS reports. Reports received by the end of June 2004.
 
Source: UK Collaborative Group for HIV and STI Surveillance, 2005. 
 
The majority (67%) of heterosexually acquired HIV infections in the UK are amongst 
people of black-African ethnicity, and most were probably infected in sub-Saharan 
Africa, (figure 1.3) (Health Protection Agency, 2008a). Black-Africans form the second 
largest social group affected by HIV in the UK, with 18,719 15 to 59 year old black 
Africans living with diagnosed HIV(Health Protection Agency, 2008c). It is estimated 
that 30.1% of people with heterosexually acquired HIV in the UK are unaware of their 
HIV seropositivity (Health Protection Agency, 2008a).  
 
Figure 1.2 Exposure category of HIV-infected individuals by year of diagnoses, UK, 1994-2003  
  33
0
500
1000
1500
2000
2500
3000
3500
4000
4500
1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
Year of diagnosis 
N
u
m
b
e
r
 
o
f
 
d
i
a
g
n
o
s
e
s
in Africa
abroad (not Africa)
in the UK
high risk partner*
undetermined
Heterosexual subcategories
Sex between men
Numbers for 2003 will increase as further reports are received and follow up continues
* High risk partner includes people infected through sex between men, injecting drug use or receipt of blood or blood products  
 
Source: UK Collaborative Group for HIV and STI Surveillance, 2005. 
 
Late diagnosis of HIV disease, defined as a CD4 count below 200 cells/μl, increases the 
risk of death within one year of diagnosis 8 to 10 fold (p<0.01), compared to those 
diagnosed with a CD4 greater than 200 cells/μl (Chadborn et al., 2005; Chadborn, 
Delpech, Sabin, Sinka, & Evans, 2006). In the UK African men and women with 
heterosexually acquired HIV are more likely to be diagnosed late than men acquiring 
HIV through sex between men (Health Protection Agency, 2008c). In 2007 42% of all 
new HIV diagnoses among black Africans were with advanced, or late stage, disease 
(Health Protection Agency, 2008c). For heterosexuals earlier HIV diagnosis could 
reduce short-term (within a year of diagnosis) mortality by 56% and all mortality by 
32% (Chadborn et al., 2006).  
Year of diagnosis
Numbers for 2003 will increase as further reports are received. 
*High risk partner includes sex between men, injecting drug use or receipt of blood or blood products.
Figure 1.3 UK HIV diagnoses by the two main routes of transmission 1985-2003 
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Africans in the UK have the same rates of disease progression as non-Africans once 
they begin HAART (Del Amo et al., 1998), yet no national reduction in AIDS 
diagnoses has yet been seen within the African community in the UK (Sinka et al., 
2003).  This is due to the continuing late presentation to HIV services and the increasing 
prevalence of HIV within these communities due to increased life expectancy and 
ongoing immigration (The UK Collaborative Group for HIV and STI Surveillance, 
2007). Late diagnosis not only denies an individual optimum therapy options, but also 
reflects missed opportunities to limit onward transmission. 
Why Africans in the UK continue to present late to HIV services in the era of HAART 
is poorly understood due to a relative lack of research. 
1.4 Access  to  care   
1.4.1    Why it is important epidemiologically 
In populations the incidence and prevalence of sexually transmitted infections (STIs), 
including HIV, are determined by patterns of sexual behaviour; the efficiency of 
transmission of an organism; the duration of infectiousness of infected individuals; the 
effectiveness of control programmes to limit spread; and the current burden of infection 
in the population. The case reproduction number (Ro) is the average number of 
secondary cases from a single case in a totally susceptible population (Aral, 2002). 
When Ro is greater or equal to one the organism will be sustained in the population 
(Garnett, 2002).   
A simple model for the case reproduction number for STIs is: Ro=βcD. Where β is the 
probability of transmission per partnership (infectivity); c is the rate of contact between 
infected and susceptible individuals; and D is the duration of infectivity. The simplicity 
of the model belies the complexity of the components and the interrelationships  
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between them. By identifying the parameters of the individual components below it is 
possible to demonstrate how the accessing of appropriate healthcare is fundamental to 
HIV prevention strategies.  
1.4.2   Efficiency of transmission (β) 
The efficiency of transmission or the infectivity (β) of HIV is influenced by viral load, 
the use of condoms, the presence of other STIs (in particular genital ulcer disease), and 
circumcision. Of these HIV viral load is probably the dominant variable affecting 
infectivity when mode of transmission is unprotected sexual intercourse, vertical 
transmission, or contaminated blood or needles (Quinn et al., 2000; Dickover et al., 
1996; Thea et al., 1997; Cardo et al., 1997). 
HIV viral load varies over the course of HIV infection. It is highest at seroconversion, 
lowest during the asymptomatic phase, and rises again during symptomatic disease or 
with concomitant infections (Coombs et al., 1989; Ho, Moudgil, & Alam, 1989; 
Michael, Vahey, Burke, & Redfield, 1992; Burke, Fowler, Redfield, Dilworth, & Oster, 
1990). Models also suggest that the infectivity/risk of transmission is linked to stage of 
infection, with heterosexual transmission per coital act following a U-shaped curve, 
again highest at seroconversion, lower during latency and increasing with advancing 
disease (Shiboski & Padian, 1998; Anderson & May, 1988; de Vincenzi, 1994; 
Leynaert, Downs, & de Vincenzi, 1998).  In 2000 Quinn et al. demonstrated that the 
chief predictor of the risk of heterosexual HIV transmission is viral load (Quinn et al., 
2000).  
Whilst it could seem plausible that widespread use of highly active antiretroviral 
therapy (HAART) may reduce the risk of onward sexual transmission via reduction in 
viral load, the population level effects of HAART are yet to be seen.  The viral load  
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benefits may be offset by the increased HIV prevalence (due to increased survival), 
increased unsafe sex (due to reduced risk perception), and selective pressure for 
resistant viruses (Johnson, 2001). Additionally, there is typically lack of treatment 
amongst the most infectious fraction  - those recently infected (Sudarshi et al., 2008), 
and those not on treatment because they remain undiagnosed or are as yet ineligible for 
treatment (for clinical or legal reasons). 
Condom effectiveness in reducing heterosexual HIV transmission is approximately 80% 
(Weller, 2001). ‘Safe sex’ is now synonymous with condom use during sex, however 
uptake of consistent condom use can be problematic (Wald et al., 2001). A meta-
analysis has shown that people who know they are HIV positive or in a sero-discordant 
relationship (where one person is HIV positive and the other HIV negative) are less 
likely have unprotected sex and are more likely to use a condom consistently, than 
people untested; Unfortunately people testing HIV negative did not show improved 
condom usage despite counselling and testing for HIV (Weinhardt, Carey, Johnson, & 
Bickham, 1999). Promotion of condoms as effective protection against HIV may again 
be partly offset by reduced risk perception and subsequent compensatory behaviour 
change (Richens, Imrie, & Copas, 2000). 
Co-infection with other STIs, especially herpes simplex virus 2 (HSV-2), is also 
associated with increased transmission of HIV (Weiss et al., 2001; Cohen, 1998). 
Treatment of STIs can decrease shedding of HIV (Cohen et al., 1997), and  one major 
study found STI control an  effective means of reducing HIV incidence (Grosskurth et 
al., 1995), but another did not (Wawer et al., 1999). The ability of STI control to reduce 
HIV incidence may relate to what phase the epidemic is in; with evidence of its benefit 
in emerging epidemics but not in mature epidemics (Gray, 2001; Sangani, Rutherford,  
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& Wilkinson, 2004). Antiviral agents against HSV-2 are currently being evaluated as a 
means of HIV control. 
Male circumcision is also associated with reduced heterosexual acquisition of HIV 
infection, (Gray et al., 2000). The preputial mucosa, located on the foreskin, appears to 
be an important target tissue for HIV due to its high density of readily accessible 
Langerhans cells (immune cells that are primary targets for HIV) (Patterson et al., 
2002). The effect of circumcision appears to be modified by the age at circumcision, the 
degree of circumcision, and the background prevalence of HIV and STDs (Hayes, 
2001).  Circumcision does not appear to effect acquisition of other STIs (Gray et al., 
2004). As with HAART and condoms the population level effects of circumcision 
remain to be seen. The reduction of infectivity by circumcision may result in 
behavioural changes that impact on duration of infectiousness and the contact rate 
between infected and susceptible individuals. It is currently unknown whether 
circumcising men in the UK will reduce heterosexual or homosexual HIV transmission. 
1.4.3  Rate contact between infected and susceptible 
individuals (c) 
The numbers and patterns of sexual contacts in the general population, and within high-
risk (or core) groups, are a crucial determinant of HIV transmission.  There remains 
debate as to the relative importance of the behaviours of the general population 
compared to those of ‘core groups’ (persons with large numbers of sexual partners who 
are interconnected with each other through sex links) (Aral, 2002). The infectivity (β) 
and duration of infectiousness (D) may influence the importance of one over the other, 
as may the phase of the epidemic.   
A consensus definition as to who or what is a ‘core group’ does not exist; most 
definitions and research focus on categorically defined populations such as ‘gay men’ or  
  38
‘sex workers’.  Whilst black African migrants in the UK may not have ‘large numbers 
of sexual partners’ they are ‘interconnected with each other through sex links’ and have 
a high HIV prevalence relative to the general population (The UK Collaborative Group 
for HIV and STI Surveillance, 2004), thus they can be regarded as a ‘core group’. 
Mathematical models suggest that for infections of low infectivity and long duration, as 
with HIV, the sexual behaviour patterns of the general population may be more 
important than that of core groups (Garnett, 2002). When STIs including HIV are 
concentrated within core groups relative to the general population, as in initial growth 
and late low endemic phases, the behaviours of core group members assume more 
importance in determining the spread of infection (Wasserheit & Aral, 1996).  
Whether focusing on the general population or core groups the frequency of 
concurrency (sexual partnerships overlapping in time), the gap between sexual 
partnerships (time duration between the end of one sex partnership and the beginning of 
the next), and the pattern of sexual mixing, all influence the rate of contact between 
infected and susceptible persons (Service & Blower, 1996; Garnett & Johnson, 1997; 
Aral, 2002).  
Concurrency may be more important in the early phases of an epidemic, and in 
disseminating high infectivity – short duration infections (Garnett, 2002).  HIV is 
regarded as a low infectivity - long duration infection, but the period of maximum HIV 
infectivity (seroconversion) is short.   Modifying the duration of gaps between sexual 
partnerships may also be important, especially given the huge numbers of the 
population who practice serial monogamy (Johnson et al., 2001). Data from a national 
probability survey in 2000 reports that black African men in Great Britain were 
significantly more likely to have concurrent partnership over the past year compared to 
white men (34.5% vs. 13.9%) (Fenton et al., 2005).  
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Sexual mixing patterns also influence the spread of HIV through populations (Doherty, 
2001; Service et al., 1996).  The degree of mixing between people of similar (or 
dissimilar) sexual activity and health seeking behaviours, and between populations with 
high or low STI (including HIV) prevalence, all impact on the rate of contact between 
infected and susceptible individuals (Aral, 2002).  Another important component 
influencing rate of contact is the size of sexual networks, especially those involving core 
groups (Garnett, 2001).  Both the absolute and relative size, and the absolute and 
relative contact, between core groups and the general population are thought to be 
important (Aral, 2000; Laumann & Youm, 1999), although the impact of these 
parameters on HIV transmission has yet to be tested.  
Like the general population core groups are not static entities. There is often high 
population turnover with new individuals entering and others leaving. Size, distribution 
and functioning of core groups can rapidly change; both the rate and type of change 
influencing the rate of contact between infected and susceptible individuals (Aral, 
2002). Africans in the UK are a mobile population with many persons in transit between 
Africa and the UK at any point in time (Fenton, Chinouya, Davidson, & Copas, 2001; 
Migration Statistics Unit, 2004). Whilst concentrated in London, African migrants 
seeking asylum are currently experiencing dispersal throughout the country.  Migratory 
influxes are reflected in HIV diagnoses in the UK (Sinka et al., 2003; Forsyth, Burns, & 
French, 2005). How these population dynamics impact on HIV transmission remain 
unexplored however. 
Reducing or influencing partner change requires, amongst other things, concerted 
education at both individual and population level.  The process of voluntary counselling 
and testing (VCT) when undergoing an HIV test has been shown to be effective in 
reducing unsafe sex for those testing HIV positive but not in reducing number of sexual  
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partners (Weinhardt et al., 1999).  Whether sexual networks or timing of sexual 
partnerships changed in response to VCT was not assessed in the meta-analysis. There 
was however an overall reduction in STI incidence in those testing HIV positive. The 
reduction in HIV prevalence seen in Uganda is largely attributed to a reduction in casual 
sex, achieved through intensive publicly available information about HIV/AIDS 
(Asiimwe-Okiror et al., 1997; Stoneburner & Low-Beer, 2004). Currently in the UK 
health education is primarily available through the accessing of health and community 
services including schools, and targeted interventions.  
1.4.4   Duration of infectiousness (D) 
As HIV cannot yet be cured accessing HIV services may not reduce duration of 
infection, but should (in fact) increase people’s life expectancy.  However accessing 
HIV services may reduce the duration of high infectivity via access to antiretroviral 
medication and through diagnosis and treatment of concomitant infections. Delays in 
time to diagnosis (time between accessing health services and diagnosis of HIV), 
treatment delay (time between diagnosis and receipt of antiretroviral medication), and 
the time to effective suppression of virus, can all prolong the duration of infectiousness.  
There is no evidence to suggest delays in treatment or viral suppression exist 
differentially for Africans resident in the UK compared to the non-African population, 
the exception being for those ineligible for free National Health Service (NHS) 
treatment of their HIV.  However as mentioned previously, Africans are diagnosed at 
later stages of HIV infection than non-Africans. It is unknown if this reflects diagnostic 
delays or differential accessing of health services; either way late diagnosis likely 
increases the duration of high infectivity. 
Immigrant populations may lack adequate access to preventive and health care services, 
may have lower levels of condom use, and subsequently have longer duration of  
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sexually transmitted infections (Aral, 2002; McLeish, 2002; Fenton, Chinouya, 
Davidson, & Copas, 2002). Dispersal of asylum seekers may contribute to diagnostic 
and treatment delay as migrants will be seeking health care in regions with lower HIV 
prevalence and clinicians could be expected to be less familiar with HIV and its 
presentations and management (Creighton, Sethi, Edwards, & Miller, 2004). 
Reducing the duration of the period where an individual is HIV positive but unaware of 
their serostatus is a key component of HIV prevention interventions. This is in part to 
ensure timely access to medication to optimise health outcomes, and in part to reduce 
transmission opportunities for HIV via: reduction of the duration of high infectiousness 
(D) with medication; by treating concomitant infections, suppression of virus to low or 
undetectable levels with HAART, and by preventing progression to late stage disease – 
all impacting on efficacy of transmission/infectivity (β); and via uptake of safer sex 
strategies including condom use, and reducing partner change (c). 
1.4.5   The impact of delayed access to HIV services. 
Delayed access to HIV services may influence β, c and D for the reasons mentioned 
above, delayed access also impacts on the individual seeking care, their sexual contacts 
and partners, and the population generally.  
On an individual level an inability to access HIV services leaves people at risk of 
serious morbidity and death, as well as increasing their duration of high infectivity (and 
with it the potential for onward transmission to partners and offspring).  In the UK 
short-term mortality for those diagnosed with late disease is approximately ten times 
that of people diagnosed with less advanced disease (Chadborn et al., 2005). In Spain 
between 1995 and 2000, AIDS diagnoses declined by 36% among those diagnosed late 
in the course of their disease, compared with a decline of 67% for those previously  
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aware of their diagnosis (p<0.01); the median CD4 count at AIDS diagnosis was 
significantly lower (50 versus 81; p<0.0001) among late testers than all other cases; and 
12.5% of late testers died within three months of diagnosis (Castilla et al., 2002).  
Estimation of the public health impact of delayed access to HIV care should take into 
account the potential for onward transmission of infection; late identification and 
management of infected contacts; increasing treatment costs associated with expensive 
therapies and hospitalisation; and, of course, avoidable morbidity and mortality. Few 
studies have been done to qualify the economic impact and this remains an area for 
future research. 
People with undiagnosed advanced HIV disease are likely to suffer symptomatic disease 
necessitating general practitioner (GP) or hospital visits, yet studies have shown these 
opportunities to initiate discussion about HIV and testing are being missed (Madge, 
Olaitan, Mocroft, Phillips, & Johnson, 1997; Burns et al., 2004a). When HIV is not 
readily identified as the underlying pathologic process significant health and personal 
resources can be unnecessarily spent. An inability to establish the underlying disease 
process could also undermine confidence in the health care system generally. 
Undiagnosed HIV positive individuals are likely to continue the chain of transmission 
to new partners, and diagnosis at a later date, for example during a new relationship or 
due to complications, could have considerable clinical and psychosocial consequences. 
In 2001 the Department of Health estimated the economic cost of treating each new 
HIV infection at between £135,000 and £181,000; and the monetary value of preventing 
a single onward transmission at between 0.5 and 1 million pounds sterling due to 
individual health benefits and treatment costs (Department of Health, 2001). Reference 
as to how these figures were obtained is not provided. A Canadian study found that 
direct costs (i.e. medication, investigations, inpatient, outpatient, and home care) were  
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twice as high for late presenters ($18448 vs. $8455), due predominantly to the HIV 
related hospital care costs which were 15 times higher (Krentz, Auld, & Gill, 2004).  
Few other studies have been done to quantify the economic impact of delayed access and 
this remains an area for future research.  
1.5 Rationale  for  interest 
From a public health perspective, improving access to and utilisation of HIV treatment 
and prevention services are key primary and secondary HIV prevention strategies for 
African communities by:   
1.5.1    Improving clinical outcomes 
Proportionately more HIV positive Africans in London presented late to HIV services in 
1998/99 than they did between 1982-1995 (Del Amo et al., 1998; Burns, Fakoya, 
Copas, & French, 2001). In 1998/99 35% of Africans had an AIDS defining illness 
within one month of diagnosis of their HIV infection compared with 13% of non-
Africans (Burns et al., 2001).  
Starting therapy with a CD4 count below 200 cells/µL
 is associated with a substantially 
greater risk of disease progression and death; this risk persisting for a significant period 
after treatment is started (May et al., 2007).
  Better survival from AIDS diagnosis has 
also been associated with a longer awareness of HIV diagnosis prior to AIDS diagnosis 
(Easterbrook et al., 2000).
 Early diagnosis of HIV infection enables timely access to 
effective treatment and care, and optimises clinical outcomes.  
1.5.2   Reducing onward disease transmission 
Earlier diagnosis of one’s HIV infection facilitates the uptake of individual prevention 
strategies to reduce onward transmission of infection (Weinhardt et al., 1999; Crepaz et  
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al., 2006). After adjusting for population differences between groups, the sexual 
transmission of HIV is estimated to be 3.5 times higher in groups unaware of their HIV 
infection than in groups who are aware (Marks, Crepaz, & Janssen, 2006).  
The continued in-migration and establishment of African communities in the UK 
(Home Office, 2008) has raised concerns about the potential for HIV transmission and 
acquisition among individuals resident within the UK. Current surveillance systems are 
limited in providing any detailed understanding of the contribution UK HIV acquisition 
has to the increasing reported HIV infections in this population.  
The relatively high HIV prevalence within African communities in the UK compared to 
the non African communities (Health Protection Agency, 2003; Sadler et al., 2007) and 
the known assortative (like-with-like) sexual mixing patterns (Barlow, Daker-White, & 
Band, 1997; Ford, Sohn, & Lepkowski, 2002) means there is substantially higher risk of 
HIV exposure for an African resident in the UK than a non-African resident.  This 
coupled with high proportions of undiagnosed infection and high viral loads as a 
consequent of late presentation to HIV services (Burns et al., 2001; Health Protection 
Agency, 2003), increases the potential for onward sexual transmission within the UK. 
Our poor understanding of the factors that influence the uptake of HIV testing and 
treatment services by Africans in the UK limits our ability to develop effective HIV 
prevention programmes. 
1.6  Aims and objectives 
This thesis presents a programme of research designed to explore the factors 
contributing to the continuing late diagnosis of HIV among Africans living in London. 
The main focus of the thesis is the ‘study of newly diagnosed HIV among Africans in 
London’ (the SONHIA study), which combined qualitative and quantitative methods in  
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a multi-centre study, to describe and explain the health beliefs, heath care utilisation and 
clinical presentation patterns of newly diagnosed HIV positive Africans.  It also 
explores UK acquisition of HIV in this population.  
Specific objectives are:   
1.  To describe the uptake of HIV testing and the factors associated with HIV testing 
in Africans in Britain. 
2.  To describe the demographic characteristics, migration history, HIV/sexual health 
history, and patterns of service utilisation and levels of psychosocial support in 
newly diagnosed HIV positive Africans.  
3.  To determine the extent to which acquisition of HIV infection may have occurred 
within the UK through ascertainment of migration history, HIV/sexual health 
history, and sexual partnership history.  
4.  To determine if there are opportunities for earlier diagnosis of HIV disease within 
the UK.  
5.  To determine the demographic, behavioural and social factors independently 
associated with delayed presentation (CD4<200 cells /цL) to treatment services 
6.  To explore qualitatively, the contextual, social and economic factors, which 
influence timely access to and uptake of HIV prevention and treatment services 
among newly diagnosed HIV positive Africans.  
 
 
  
  46
1. 7   Study outline 
The thesis is divided into 10 chapters.  
Chapter 1, an introductory chapter, provides an overview of the history and 
epidemiology of HIV, the determinants of HIV spread, and the rationale for this work. 
Chapter 2 presents a literature review to provide epidemiological, cultural and historical 
background. It reviews African migration to the UK and what we already know about 
why some communities access care late.  It explores the interaction between ethnicity, 
inequality and health, and the concept of ‘normalisation’ of HIV.  
Chapter 3 is an analysis of the 2
nd British National Survey of Sexual Attitudes and 
Lifestyles to explore the factors associated with HIV testing among black Africans in 
Britain.  
Chapter 4 presents the findings from in depth interviews with key informants to identify 
the key issues affecting utilisation of HIV services for Africans in Britain.  
Chapter 5 presents the study of newly diagnosed HIV infection among Africans in 
London (SONHIA). It describes the methodologies employed, the development and 
validation of the study instruments (questionnaire, clinical data form and topic guide), 
and the principles behind the study design. The chapter concludes with the challenges of 
implementation of this study, and the strategies to address them. The results are 
presented over the following three chapters. 
Chapter 6 details the response rate to the survey, and provides a descriptive overview of 
the study population. It uses the survey data to identify missed opportunities for earlier 
HIV diagnosis in Africans in the UK.   
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Chapter 7 uses survey data to identify factors associated with late presentation to HIV 
services.  
Chapter 8 explores the extent to which HIV acquisition in UK resident Africans may 
have occurred in the UK rather than abroad. 
Chapter 9 presents the qualitative findings thematically to enable contextual 
understanding of the factors contributing to late presentation. 
Chapter 10. The final chapter contextualises the findings with the literature and current 
socio-political climate. It addresses the study’s limitations and concludes with the 
public health and policy implications of the study.  
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Chapter 2: Background  
 
Abstract 
In the UK substantial numbers of new HIV diagnoses are within migrant 
African communities.  Current surveillance shows that despite health 
promotion efforts and advances in therapy these communities are 
accessing HIV care late. This literature review explores the issues 
influencing the access and uptake of HIV care by migrant Africans in 
Britain. Using Kleinman’s model of health care systems (Kleinman, 
1980) as a theoretical framework the importance of placing health within 
it’s broader context is demonstrated. 
The findings within this chapter are published in Psychology, Health & 
Medicine (2006); Access to HIV care among migrant Africans in 
Britain. What are the issues? F. Burns & K.A. Fenton. v.11:pp.117-125. 
 
2.0 Introduction   
This thesis aims to describe the health beliefs, heath care utilisation and clinical 
presentation patterns of newly diagnosed HIV positive Africans in London.  This 
chapter reviews what is currently known regarding HIV epidemiology, HIV testing and 
health access for African communities in the UK. An overview of relevant demographic 
patterns, migration to the UK by African communities, and current policy regarding 
access to care for asylum seekers and refugees is also provided.  
2.0.1   Literature review strategy 
The following sources of information were utilised between September 2002 and 
December 2004. 
1.  PubMed using the terms UK and Africa* limited to AIDS, English language, 
humans and adults (386 articles identified of which 36 were relevant)  
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2.  Internet search engine (Google Scholar) to identify relevant papers, reports and 
policy documents.  Search terms included Africa*, UK, HIV, health care access, 
immigration and emigration. 
3.  Selected journals (AIDS, British Medical Journal, Sexually Transmitted Infections 
and International Journal of STIs and AIDS) were reviewed by hand or online.  
4.  Websites of relevant organisations such as the Home Office, African HIV Policy 
Network (AHPN), Sigma and National AIDS Trust (NAT) were explored.  
5.  The abstracts of relevant conferences were reviewed by checking available 
abstract books of scientific or medical events. Additionally, all references cited in 
included papers were checked and included if pertinent. 
2.1   Migration & the population of Great Britain 
The population of Great Britain
3 (GB) is estimated to be 57.6 million - 49.6 million in 
England; 2.9 million in Wales; and 5.1 million in Scotland.  Overall 91.9% of the 
British population classify themselves as being white, of whom 96% are defined as 
‘white British’ (Department of National Statistics, 2003). The population of GB is 
steadily increasing due to both natural change (births outnumbering deaths) and net 
migration. Since 1998, migration has accounted for a greater proportion of population 
change than natural change (Migration Statistics Unit, 2004).  In 2001, 8.3% (4.9 
million) of the total UK population was born abroad; this is almost double the 
proportion in 1951 (4.2%). The overseas-born population had a greater increase 
between 1991 and 2001 than in any other post-war decade (Migration Statistics Unit, 
2004).  Migrants from relatively developed OECD (organisation for economic co-
                                                 
3 Great Britain is comprised of the countries of Scotland, Wales and England; it is part of the United 
Kingdom of Great Britain and Northern Ireland.  
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operation and development) countries account for the surge over this decade, with 85% 
of migrants coming from the old commonwealth, Europe and the United States.  Whilst 
two fifths of black Africans resident in the UK entered the country post 1990 (2003), 
there was no upward trend in net immigration from the new Commonwealth
4, including 
Africa, over this period (Hatton, 2005). 
Although country of birth and ethnicity are not so closely linked in the overseas-born 
population within the UK, the rise in international immigration has corresponded with 
the ethnic minority population increasing from 3.1 million (5.5% total population) to 4.6 
million (8.1% total population) over the past decade (Migration Statistics Unit, 2004). 
London has greater ethnic diversity than the rest of Great Britain; 28.8% of Londoners 
identify themselves as ‘non-White’. In 2001 78.2% of all black Africans resided in 
London and black Africans comprised 5.3% of the population (Department of National 
Statistics, 2003). 
2.1.1    International migration 
An international migrant is defined as someone who changes his or her country of usual 
residence for a period of at least a year, so that the country of destination effectively 
becomes the country of usual residence (Migration Statistics Unit, 2004).  The 
Government Actuary’s department project a long-term annual net inflow into the UK of 
130,000 persons per year. 
The past decade has seen marked changes in the country of origin of migrants to the UK 
(figure 2.1) with proportionately more persons arriving from the new commonwealth 
                                                 
4 The old commonwealth countries constitute Australia, Canada, New Zealand and South Africa. 
New commonwealth is defined as all other commonwealth countries, British dependent territories and 
British Overseas citizens. Excludes Hong Kong. This includes all African commonwealth countries 
except South Africa – Botswana, Cameroon, The Gambia, Ghana, Kenya, Lesotho, Malawi, 
Mozambique, Namibia, Sierra Leone, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe.   
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and countries outside the EU
5. England, and London in particular, receive the majority 
of net international migration to the UK (Migration Statistics Unit, 2004). Large 
numbers of Pakistani and Indian subcontinent migrants have also settled in the West 
Midlands, Bradford, and Greater Manchester (2003). 
 
Figure 2.1 Total international migration by country of birth; United Kingdom 1993-2002 
 
 
Source: Migration Statistics Unit 2004 
 
 
The relatively high migration inflow to the UK (and Europe generally) in recent decades 
has met with increasing restrictions on immigration.  These measures include visa 
requirements to enter the country and tightening of criteria for asylum. As global 
movement of people generally is expected to continue to increase, the increased barriers 
to immigration are expected to increase significantly the numbers and the proportions of 
illegal and marginalised migrants (UNAIDS, International organisation for migration, & 
Duckett, 2001). 
                                                 
5 European union as defined in 2002, i.e. Austria, Belgium Denmark, Finland, France, Germany, Greece, 
Italy, Luxembourg, Netherlands, Portugal, Spain, Sweden and the Irish Republic.  
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2.1.2    Internal migration 
Traditionally migrants have been geographically concentrated in London and the 
Southeast of England. Internal migration, which is migration within the borders of the 
UK, has not historically been a feature of overseas-born migrant communities. In 2000 
the National Asylum Support Service (NASS), whose role is to provide accommodation 
and subsistence for asylum seekers, started a policy of asylum seeker dispersal in order 
to spread the cost of care throughout the UK (UK Parliament, 2002). This policy has 
resulted in individuals residing in regions with limited experience with asylum seekers, 
and outside of established community support networks.  
2.1.3    African migration to the UK 
Large-scale migration from Africa to the UK began following the Second World War. 
However the Commonwealth Immigrants Act of 1962 denied many migrants full social 
and political rights, and the Immigration Act of 1972 further limited immigration from 
former British colonies (2003). Until the 1990s migration from Africa was often 
motivated by ‘pull’ factors, in particular the seeking of higher education or employment 
opportunities.  More recently however the motivations behind migration have shifted to 
reflect more ‘push’ factors as people attempt to escape political and economic upheavals 
(Bingham, 2002; Maharaj, Warwick, & Whitty, 1996). This is reflected in migrants 
accepting lower skilled jobs despite coming from the more skilled or educated classes in 
their home countries (Fakhouri et al., 1996; Chimanikire, 2003).  
Migration out of Africa often reflects historical ties, with global flows mainly to ex-
colonial states: South Africans, Kenyans, Nigerians, Ghanaians, Ugandans, and 
Zimbabweans have migrated to the UK (table 2.1 and figure 2.2), Central and West 
Africans to France, and the Congolese to Belgium (Chimanikire, 2003; Bingham, 2002). 
Recently there have been noticeable influxes of populations to the UK associated with  
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conflicts in African countries such as Eritrea, Somalia, and Zimbabwe (figure 2.3) (UK 
Parliament, 2002), these influxes are reflected in those accessing HIV services (Forsyth 
et al., 2005; Sinka et al., 2003). Despite the increase in those seeking asylum, chain 
migration, the process in which family formation drives migration, continues to account 
for the majority of migrants from Africa who settle in the UK. 
 
Table 2.1 Ethnicity of English and Welsh residents born in Africa 
 Ethnic  Group   
Country of birth  White  Black 
African 
Indian Other  Total 
Kenya 16,565 
(13%) 
13,421 
(11%) 
82,727 
(65%) 
14,609 
(11%) 
127,322 
 
Nigeria 5,895 
(7%) 
76,291 
(88%) 
295 
(1%) 
4,477 
(4%) 
86,958 
South Africa  119,129 
(90%) 
4,218 
(3%) 
3,622 
(3%) 
5,332 
(4%) 
132,301 
Zimbabwe 24,664 
(52%) 
17,852 
(38%) 
1,081 
(2%) 
3,561 
(8%) 
47,158 
North Africa  34,997 
(51%) 
9,527 
(14%) 
593 
0.9%) 
23,598 
(34%) 
68,715 
Central & Western Africa 
(other than Nigeria) 
7251 
(7%) 
89,980 
(81%) 
6,119 
(6%) 
7,253 
(7%) 
110,603 
South & Eastern Africa 
(other than Kenya, South 
Africa, and Zimbabwe) 
31,606 
(13%) 
88,757 
(38%) 
73,173 
(31%) 
42,348 
(18%) 
235,884 
Total 240,107 
(29.7%) 
300,046 
(37.1%) 
167,610 
(20.7%) 
101,178 
(12.5%) 
808,941 
(100%) 
Source: Table S102. Census 2001. 
 
 
In 2003, 45,835 Africans were granted settlement in the UK, including 7,530 recognised 
refugees and persons granted exceptional leave to remain (ELR)
6; 71,350 Africans were 
granted extension of leave to remain; and 18,825 applications were refused asylum after 
full consideration, although many of these would go for appeal.  Ten percent of all 
asylum applicants in 2003 were Somalian and 7% were Zimbabwean (figure 2.3). The 
                                                 
6 In April 2003, exceptional leave to remain in the UK was replaced by Humanitarian Protection and 
Discretionary Leave. Humanitarian Protection is a grant of limited leave made to someone who hasn't 
been granted asylum but who, subject to certain exclusion provisions, has been able to demonstrate a need 
for protection in the UK. A person who is not able to demonstrate a need for protection under either the 
asylum or Humanitarian Protection provisions may qualify for a grant of Discretionary Leave (Home 
Office, 2005).   
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black African population in Britain increased by 37% over the 1990’s  (Migration 
Statistics Unit, 2004). 
 
 
 
Figure 2.2 Grants of settlement to African nationals, 1993 to 2003 
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Data provided for the five African countries receiving the majority of settlement grants in the UK.  Total 
grants of settlement to all African nationals over this period ranged between 10,900 (in 1993) to 44,845 
(in 2000). 
Source: National Statistics, November 2004.  
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Figure 2.3 Applications received for asylum in the UK from African nationals, excluding 
dependants, by nationality, 1995 to 2003 
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Data provided for the four African countries making the majority of asylum applications over this period. 
Total applications from African countries over this period ranged between 9,515 (in 1996) and 29,390 (in 
2002). 
Source: National Statistics, November 2004. 
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The former British colonies, in particular Uganda, Zimbabwe, Malawi, Zambia and 
South Africa, have been particularly affected by the HIV epidemic (UNAIDS, 2004). It 
is not surprising that the UK is now seeing significant levels of HIV infection among its 
African migrants (The UK Collaborative Group for HIV and STI Surveillance, 2004). 
Migrant Africans comprise a heterogeneous aggregation of population sub-groups, 
which vary geographically, temporally, socio-economically, and culturally. There is 
much diversity within the African communities resident in the UK and reducing all 
these communities into one broad category, whilst necessary for research purposes, will 
undoubtedly obscure important differences. 
2.2  Migration and HIV infection 
Two thirds of all heterosexually acquired HIV in Europe (see chapter 1) is diagnosed 
among migrants from high prevalence countries (2004). The UK heterosexual HIV 
epidemic reflects historical and recent migratory patterns, and to a lesser extent, 
ongoing transmission of HIV infection within the UK (Sinka et al., 2003). The majority 
of HIV infections among Africans in the UK have occurred among those from, or 
having partnerships with, individuals from high HIV-prevalence countries outside of the 
UK. As such, a significant proportion of these infections are assumed to have been 
acquired before migration to the UK (Health Protection Agency, 2003).  
However, migration differentially favours those who are younger, economically 
productive and healthier and therefore more likely to be sexually active with 
reproductive ambitions (de Putter, 1998). Migration is also often associated with the 
rupture and re-establishment of sexual relationships, particularly as many individuals 
initially migrate without their primary partners. Migration has been identified as a 
critical factor in high-risk sexual behaviour independent of marital and cohabitation  
  57
status, social milieu, or awareness of AIDS (Brockerhoff & Biddlecom, 1999). This is 
thought to be in part due to the concept of the migrant, particularly the voluntary 
migrant, as a ‘risk-taker’. Migrants are individuals who gamble that a different 
environment will be beneficial. This risk-taking may permeate into the choices they 
make in their private life (UNAIDS et al., 2001). The non-voluntary migrant is usually 
fleeing social and political upheaval, conditions known to facilitate HIV transmission 
via the breakdown in infrastructure (including health services), poverty, rape, and 
rupture of family units (Haour-Knipe, 2000).  
2.3 Access  to  care   
The term “access to services” incorporates a variety of concepts including whether and 
how patients attend services, whether they do so at the optimal time, and which services 
they attend.  Access is influenced by patients’ health seeking behaviour, as well as the 
availability of appointments, convenience, and visibility of services.  Access is likely to 
differ between individuals, patient groups, and in different localities.   
Studies from the USA identify lack of knowledge, stigma towards HIV, denial, lack of 
employment opportunities or supportive working environments, distance to medical 
facilities and inadequately trained, or mistrust of, medical professionals as significant 
barriers to accessing HIV care (Heckman T et al., 1998; Raveis, Siegel, & Gorey, 2003). 
However as socio-demographic characteristics are very different in the USA we cannot 
assume that the same issues and processes are automatically applicable to the UK. 
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2.4  Ethnicity, inequality and health 
‘Not only are [migrants] exposed to poor working and living conditions, 
which are per se determinants of poor health, but they also have reduced 
access to health care for a number of political, administrative and 
cultural reasons which are not necessarily present for the native 
population, and which vary in different societies and for different 
groups. Language, different concepts of health and disease, or the 
presence of racism are examples of such selective barriers.’  
(Bollini & Siem, 1995) 
 
The high concentration of migrant and ethnic groups in lower social strata play an 
important role in determining poor health outcomes, but reducing health problems for 
these groups to one of social class does not give justice to the complexity of issues 
(Nazroo & Davey Smith, 2001). Different barriers to health care exist for these groups 
than for natives from the same social class; for example different entitlements according 
to their legal status, and real or perceived racism and discrimination will create 
additional barriers in the utilisation of health care services (Donovan, 1984). Of course 
migrants are not homogeneous – different subgroups may experience different health 
outcomes (according to position in society, religion, level of integration, racism, etc) - 
but the general trend to poor health outcomes for migrants holds true in most parts of 
world.  The term ‘ethnic distance’ is used to illustrate the elements of cultural 
differences that influence risk inherent in migration (Tan, 1998). The ethnic distance for 
a woman from a small village in Africa with no knowledge of English seeking asylum 
in Britain will be much greater than for a businessman from that same country 
transferring his job to Britain – even if they are from the same country and migrate at 
the same time (Tan, 1998).   
  59
2.4.1   Health care systems & health service research 
Kleinman (1980) defines health care systems as socially organised responses to disease 
that constitute a special cultural system. It is a concept as opposed to an entity, and is 
derived by understanding how people think about health care, as well as how they act in 
it and use its components (Kleinman, 1980). Health care systems include people’s 
beliefs and patterns of behaviour, which are governed by cultural rules. Many factors, 
including the health problem itself, treatment options, social institutions, economic, 
political, environmental and historical constraints, influence these beliefs and 
behaviours.  
Traditionally health service research has been quantitative and focused on the use of 
health services.  This has allowed for measurement of health seeking behaviour but has 
failed to answer the ‘how or why’ questions relating to health care access.  Health 
seeking behaviour is but one component of the health care system. Similarly limiting 
are the models of behaviour change traditionally used in health care research, be it the 
health belief model, the theory of reasoned action, or social learning theory.  In these 
models the onus of health is predominantly placed on the individual but they largely fail 
to account for the external influences of the social, political or ecological environment.  
The configuration of health care systems is shaped by internal factors, and factors 
external to it, that is political, economic, social structural, historical and environmental 
determinants.  Kleinman’s model sees the internal factors as comprising of the popular, 
professional and folk sectors (Kleinman, 1980). People beliefs comprise part of the 
popular sphere of health care.  This is the area in which illness is first defined and 
health care activities initiated.  It is the most immediate determinant of care as people 
generally decide when and whom to consult, whether or not to comply, whether care is 
effective, and whether they are satisfied with its quality. Within Britain the professional  
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sector is essentially modern scientific medicine. The differences in cognitive and 
communicative processes or treatment styles within the professional sector are 
important factors in determining differences and acceptability in clinical care.  The folk 
sector of health care is the non-professional, non-bureaucratic, specialists, for example 
herbalists.  It incorporates both sacred and secular traditions. In Britain all three sectors 
(popular, professional and folk) are operating, whilst in some more rural African 
societies the folk and the popular sector are likely to constitute the majority of the health 
care system.   
Most researchers study isolated components of health care systems without exploring 
the linkages between the components or the system as a whole.  Freidson argued that to 
understand any single component one needs to locate it within its social context and see 
how it functions within that setting.  The system is formed and guided by the 
interrelationships between the components (Freidson, 1970). Such a holistic approach is 
required to understand the influences affecting access to HIV care for migrant Africans 
in Britain. 
2.4.2   Access to HIV services and African communities in 
Britain 
For an individual to consider accessing HIV care, they first need to appreciate either a 
transmission risk or a change in health status. It is not yet known how the non-specific 
symptoms of HIV are perceived, recognised or related to decisions to seek help among 
Africans in Britain. For Africans in the UK negotiating a pathway to sexual health 
services can be a complex process involving a lay referral system of friends and social 
kin (Chinouya, 2001).  
Risk (perception) awareness is likely to differ according to home-country experience.  
For example, the perceived or actual ability to modify risk of HIV  
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transmission/exposure or outcome following diagnosis will be influenced by, amongst 
other things, gender politics and accessibility of ART in their countries of origin. For 
many Africans it is likely that the perception of modifying either HIV risk or outcome is 
extremely low. Studies have demonstrated that a substantial proportion of London’s 
population remain unaware of many of the benefits of testing in terms of pregnancy or 
the availability of medicines to treat HIV (Burns et al., 2004b; Ndofor-Tah et al., 2000).  
A lack of perceived risk of HIV, or lack of perceived benefit in knowledge of HIV 
status and potential interventions, may contribute to poor accessing of HIV care in 
Britain. It may also reflect ‘structural forces’ whereby the degree to which patients are 
able to access services is significantly limited by forces quite beyond their control 
(Farmer, 1997). These structural and social forces include poverty, gender and 
economic inequality, political violence, racism and institutional barriers.  
2.4.3   Institutional barriers 
One such institutional barrier may be confusion over eligibility for NHS care. Currently 
the Department of Health has different criteria for entitlement to primary and secondary 
care.  Whilst any person living here lawfully and on a settled basis is regarded as 
resident in the UK and therefore entitled to free primary medical services, hospital care 
is provided free only to people who fulfill certain criteria. Persons who are intending to 
seek asylum or refugee status within the UK but who have not yet submitted an 
application to the Home Office are not eligible for NHS treatment; nor are illegal 
immigrants, or visitors and students (on a course less than six months) from countries 
without a reciprocal agreement.  No African country has a reciprocal agreement 
entitling its citizens to free NHS treatment (Department of Health, 2004a). Exceptions, 
in which free care is available to all, are: treatment given only in an accident & 
emergency department; treatment for certain infectious diseases (excluding HIV/AIDS  
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where it is only the first diagnosis and connected counselling sessions that are free of 
charge); compulsory psychiatric treatment; and family planning services (Department of 
Health, 2004a). To add to the complexity there are proposals to exclude overseas 
visitors from eligibility to free NHS primary medical service (Department of Health, 
2004b), designed to align primary care with hospital care. 
The Venereal Diseases (VD) regulations (NHS Venereal Diseases Regulations 1974, 
NHS Trusts (Venereal Diseases) Directions 1991, and NHS Trusts & Primary Care 
Trusts (Sexually Transmitted Diseases) Directions 2000) however guarantee any 
individual anonymous free open access medical services for the management of STIs; 
HIV testing is also freely available to all (Department of Health, 2000). Different GUM 
clinics interpret the Venereal Disease regulations differently. As HIV treatment 
prescribing is often done under the auspices of GUM clinics, and patients can remain 
anonymous, there may be no way of checking eligibility to HIV treatment and many 
clinics choose not to ask about eligibility.  However, if patients are admitted or referred 
to hospital services they may be expected to pay. In summary, all individuals within the 
UK are entitled to free HIV testing, but HIV treatment may only be available to eligible 
individuals.   
Research suggests that the quality of consultation is less adequate for ethnic minority 
people than that for white people (Burns et al., 2004a; Nazroo, 1997).  Whilst patients 
intention to test, or uptake if offered an HIV test, did not vary according to ethnicity in a 
previous study it was demonstrated that non-white patients were less likely to be offered an 
HIV test during a GUM clinic consultation (Burns et al., 2004a). Factors that may 
contribute to the disparity include the clinician’s perception of the patient’s health 
issues, prejudice (both on a personal and institutional level), language barriers, and time 
constraints of staff.   
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The length of residence in Britain will influence the above factors.  It is likely that 
increasing time in Britain correlates with increased knowledge of the health services and 
how to access them, however this may be offset by heightened awareness of HIV and its 
treatment options in more recent migrants.   
2.4.4   Education and social exclusion  
Despite having higher education levels relative to the indigenous population (Fakhouri 
et al., 1996), migrant Africans in the UK experience high levels of social and economic 
deprivation with high unemployment and poor housing (Mason 2000) (UK 
Government, 1992).  Financial, housing or childcare issues may take precedence over 
accessing health care (Anderson & Doyal, 2004). 
The immigration process is one of the first exposures many migrant Africans have to 
UK government agencies. This process can take years and may be perceived as hostile, 
racist and disempowering to the communities involved. The increase in in-migration, 
and asylum seeking in particular, has met with hostility from sections of the general 
public and tabloid press (Browne, 2003). The hostility expressed in public discourse has 
been mirrored in the politicisation of the immigration issue; immigration has become a 
politically sensitive topic and was one of the key general election issues in Britain in 
2005. The tightening of measures in the asylum decision-making process meant that 
83% of initial asylum decisions in 2003 were refusals (National Statistics, 2004).   The 
hostility the lay public, some sectors of the media, and the home office currently feel 
towards immigrants as a whole, and those who require state support in particular, may 
make people unwilling to come forward for diagnosis and treatment.    
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2.4.5   Heterosexual issues  
Addressing the issues of a predominantly heterosexual epidemic are complicated by the 
fact that much of the sexual liaisons responsible for HIV transmission are occurring 
within the context of marriage, a climate of gender inequality, and are underpinned by 
reproductive drive. Perceptions of HIV risk may be influenced by marriage, an 
institution associated with expectations of trust and monogamy. Condom use, as a safer 
sex measure, may only be considered necessary in the early stages of relationships or 
for unmarried people; use also lessens when there is a desire to conceive (Elam, Fenton, 
Johnson, Nazroo, & Ritchie, 1998). Gender inequalities can influence the uptake of 
safer sex measures, such as condoms, and the accessing of HIV testing opportunities, 
decisions both often controlled by men (Maman, Mbwambo, Hogan, Kilonzo, & Sweat, 
2001; Chinouya, Ssanyu-Sseruma, & Kwok, 2003).  Similarly the fear of rejection, 
violence, or both may dissuade women from HIV testing or in disclosing their HIV 
status to partners (Maman et al., 2001; Gielen, O'Campo, Faden, & Eke, 1997; 
Anderson et al., 2004). 
HIV testing programmes need to account not only for transmission risk between 
partners but also that associated with mother-to child, or vertical, transmission. The 
efficacy of zidovudine in reducing vertical transmission by two thirds (in the absence of 
breast feeding), was established by the multicentre AIDS clinical trials group 076 in 
1994 (Connor et al., 1994); and universal antenatal HIV testing  was introduced in the 
UK in 1999 (NHS Executive, 1999). Whilst largely successful in helping to reduce the 
undiagnosed fraction of HIV infection among African women attending these services 
(The UK Collaborative Group for HIV and STI Surveillance, 2004), its effectiveness in 
reducing undiagnosed HIV within the wider community has not been assessed.  
  65
2.4.6   Stigma 
HIV is greatly stigmatised in African communities (Goldin, 1994; Dodds et al., 2004; 
Anderson et al., 2004). Stigma can be viewed as an attribute that makes an individual 
both different and less desirable, than others (Goffman, 1963).  In effect, stigma reduces 
in our minds a whole person to a tainted and discounted one. This attitude or belief is 
not always imposed upon the stigmatised individual; they themselves may hold the 
same beliefs about identity. Individuals with a ‘spoiled identity’ may seek to avoid the 
consequences of others reactions by trying to conceal their stigmatising condition – thus 
perpetuating an illusion of normality whilst simultaneously compounding their sense of 
social isolation (Goffman, 1963).  
Stigma however is not merely an act of exclusion between individuals it also a process 
with social, economic and political functions which serve to maintain power inequalities 
(Parker & Aggleton, 2003). HIV-related stigma is heavily related to other forms of 
discrimination such as racism, sexism, homophobia and xenophobia (de Bruyn, 2002; 
Dodds et al., 2004); compounding the vulnerability of the individual and the 
communities involved. These power inequalities in turn augment the HIV epidemic.  
For example, one-reason women are more vulnerable to HIV is that as they are often 
unable to protect themselves because of cultural norms in the negotiation of sex; 
similarly the negotiation of health care by migrants may be impeded due to laws and 
policies. The stigma and discrimination associated with HIV make people reluctant to 
test for the infection; and those with diagnosed HIV infection may be reluctant to access 
services due to real or anticipated prejudicial behaviour from healthcare providers (de 
Bruyn, 2002). 
Fear of discrimination has a profound effect on people with HIV even if only a minority 
of the population acts on its prejudices (de Bruyn, 2002).  HIV education campaigns  
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directed at specific populations are unlikely to be supported by the target population 
because of the adverse reaction they expect from others (Terrence Higgins Trust, 2001). 
Exactly why HIV remains so stigmatised in African communities is not fully 
understood, but may in part reflect the continuing poor prognosis of HIV in much of 
Africa due to lack of widely available affordable and effective treatment options. For 
many Africans there is a stigmatising and immediate connection between HIV/AIDS 
and death. This can manifest in a ritualised ‘social death’ for those who choose to 
disclose their HIV diagnosis (Dodds et al., 2004).   
It is in the social context of this perceived racism, secrecy, financial and economic 
insecurity and uncertainty over immigration status that many migrant Africans have to 
consider HIV (McMunn, Mwanje, & Pozniak, 1997).     
2.4.7   Mistrust 
Historically medical science/ public health was often used as a means for social control 
in Africa (Comaroff & Comaroff, 1992). More recent experiments such as the Tuskegee 
Syphilis Study in the USA would further erode any faith in western biomedicine 
(Kampmeier, 1972). Distrust of the medical profession by the black community is 
evident in the conspiracy views expressed by many (Klonoff & Landrine, 1999). The 
origin of HIV/AIDS is perceived by some to be a man made virus developed to wipe 
out black people, others express a belief that they are being experimented upon with 
HAART, whilst others believe they receive either inferior or detrimental care (Erwin & 
Peters, 1999; Klonoff et al., 1999).  The medicalisation of sex inherent in HIV 
prevention could be seen as an expression of ‘internal colonialism’ (O'Neil, 1986).   
Rejection of HIV care in this circumstance becomes a political act, a gesture of 
rebellion.   
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The mistrust of the ‘professional sector’ may mean the ‘folk sector’ is utilised in 
preference or in addition to biomedicine.  Traditional therapies are widely used in 
Africa (Njanji, 1999) although their influence within the UK has not been studied.   
Utilising traditional forms of health care is also a means of retaining a sense of cultural 
identity for displaced communities.    
2.4.8   Religion 
Faith and traditional sacred beliefs are important to many Africans (Tiendrebeogo & 
Buykx, 2004). In the 2001 census, 68.8% of black Africans identified as Christian and 
20% as Muslim (Department of National Statistics, 2003). Religious faith appears 
especially important for Africans, in particular African women, living with diagnosed 
HIV infection (Anderson et al., 2004; Chinouya & Davidson, 2003). The interaction 
between faith, health and HIV can manifest itself in different ways: for most the church 
provides a means of spiritual, emotional and practical support; for a few the direct 
healing potential of religious faith is important; whilst for others the church is a place 
where an HIV identity can be forgotten (Chinouya et al., 2003; Erwin et al., 1999; 
Anderson et al., 2004).  HIV is apparently almost never discussed at church (Chinouya 
et al., 2003; Erwin et al., 1999; Anderson et al., 2004). 
The more evangelical sects have been known to actively discourage people from taking 
antiretroviral medication, preaching that faith alone could cure HIV (Anderson et al., 
2004; Erwin et al., 1999); the need for medication being a reflection of inadequate 
prayer or belief. The extent of these beliefs and impact on adherence to medication is 
not yet known. 
The issues of sexuality, gender and HIV/AIDS have often found themselves juxtaposed 
to those of diametrically opposed religious doctrines and morality (Tiendrebeogo et al.,  
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2004). For example condom promotion has faced considerable opposition from certain 
religious groups who are unable to disentangle HIV prevention from family planning; 
Historical religious interpretations of leprosy or skin-diseases as the entry of evil spirits, 
have reinforced the stigma and discrimination attached to HIV, which often manifests 
itself with skin complaints (Tiendrebeogo et al., 2004); And religious leaders have also 
expressed judgemental attitudes toward people living with HIV, with HIV considered a 
‘curse from God’ for sins such as homosexuality or promiscuity. In these ways religion 
may have contributed to the stigmatisation of HIV (Tiendrebeogo et al., 2004).  Despite 
this people with HIV obviously seek solace in their personal faith and there is 
increasing acknowledgement of the role the church/mosque could play in facilitating an 
environment of acceptance and understanding for people with HIV. 
  The influence of religion will differ widely between communities however it is 
important to be aware of its integral role within the healthcare system.   
2.4.9   Dispersal 
Government implementation of asylum seeker dispersal (see 2.1.2 Internal migration 
above)(UK Parliament, 2002) may impact on HIV presentation and prevention 
measures.  By moving people outside of their communities, access to quality, culturally 
appropriate health promotion activities and services may be compromised.  There is the 
potential to isolate HIV positive Africans in centres less aware about HIV and without 
readily accessible specialist services, exacerbated by the fact that dispersal often occurs 
at short notice and without appropriate transfer of medical details (Creighton et al., 
2004). Dispersal may further delay presentation and hence facilitate HIV spread (see 
2.4.4 above).  
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Whether regional differences in clinical attitudes and knowledge of HIV infection exist 
has not been assessed. However one study with GPs in the north of England found that 
none of them were aware that antiretroviral medication could reduce vertical 
transmission of HIV (Kellock & Rogstad, 1998).  
Currently very little information is known about the influence factors such as support of 
family and friends play in HIV presentation and accessing of services, especially within 
marginalized groups.  
2.5  African communities & HIV testing 
Despite advances in therapies and health promotion efforts Africans continue to present 
late to HIV services. Africans are more likely to have an AIDS defining illness within 
one month of diagnosis of their HIV infection compared with non-Africans (Burns et 
al., 2001); and 87% of AIDS diagnoses in black Africans are made within 3 months of 
HIV diagnosis (Sinka et al., 2003). 
Erwin (1999), working with HIV positive Africans in London, found that Africans were 
reluctant to present themselves to health services until ill-health made it unavoidable 
due to fears around disclosure to immigration services, mistrust of the medical 
profession, and perceived discrimination (Erwin et al., 1999).  Given the social context 
of the lives of many migrant Africans in Britain it is not surprising that this sentiment is 
expressed.   
In many migrant communities and Britain generally, HIV testing is still viewed 
predominantly as a diagnostic rather than a screening/ prevention tool, which may 
inadvertently discourage people who view themselves as low risk to test earlier 
(Danziger, 1998). Little is known about HIV testing behaviours among migrant 
Africans. In 2000 a community-based survey of sexual attitudes and lifestyles among  
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746 Africans in London, found that 34% had ever tested for HIV. HIV testing was 
significantly associated with having previously been diagnosed with a sexually 
transmitted infections, and in men, perceived HIV risk (Fenton et al., 2002). This high 
proportion having ever had an HIV test suggests there is awareness of HIV within the 
black African community. However compared with non-Africans, Africans are more 
likely to HIV test because of a preceding event suggesting the possibility of HIV 
infection (Burns et al., 2001). This includes the development of AIDS or a positive 
diagnosis in a symptomatic child. Africans are also more likely to be diagnosed via 
antenatal screening.
   
Despite the apparent awareness of HIV as a health issue for their communities black 
Africans appear less likely to have suspected that they were HIV positive prior to 
diagnosis than non-Africans (Erwin, Morgan, Britten, Gray, & Peters, 2002; Anderson 
et al., 2004; Erwin et al., 1999); this may relate to perceptions that HIV is a disease of 
people with multiple partners  and its association with profound ill health (Anderson et 
al., 2004). If Africans did suspect they may be HIV positive they were more likely to 
wait more than one year before testing (Erwin et al., 2002). Knowledge of where to test, 
concern over entitlement to care, discrimination and confidentiality were all identified 
as significant factors delaying access to services for people within the African 
community; 14% reported concerns about immigration and notification to the 
authorities (Erwin et al., 2002; Erwin et al., 1999).
    Whilst these fears create barriers to 
accessing services recent work suggests that once within the health care system HIV 
services are very highly rated by African patients and are regarded as safe environments 
(Anderson et al., 2004).  
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2.5.1   HIV testing: barrier to care? 
In the pre-HAART era a diagnosis of HIV infection was often accompanied by stigma 
and discrimination, with very little to offer in the way of effective medication. Civil 
libertarians and gay rights advocates feared that HIV may become defined as a 
‘dangerous disease’ with registries of infected persons, and the possibility of 
behavioural restrictions, and even quarantine, imposed on those infected (Bayer, 1991).   
There was broad consensus that people should only be tested with informed, voluntary 
and specific consent; this differs from other blood tests, which are usually obtained with 
the ‘presumed consent’ of the patient. As a result pre and post-test counselling usually 
accompany HIV testing. This process of managing HIV differently to other chronic and 
infectious health conditions became known as HIV exceptionalism (Bayer, 1991).  
Because of the social, financial and medical implications of an HIV diagnosis the 
General Medical Council advises that pre-test discussion is necessary before performing 
an HIV test except in exceptional circumstances (General Medical Council, 1997).The 
Department of Health issued guidelines for the pre-test discussion on HIV testing in 
1996 (Department of Health, 1996). Although the guidelines specified that HIV testing 
should be part of mainstream clinical care, they also stipulated that a health care worker 
(HCW) conducting pre-test discussion should: 
‘… ensure they are aware of current developments in the management of 
HIV and AIDS. Health care workers who do not feel able to conduct 
pre-test discussion should refer the individual seeking an HIV test to 
another trained health care worker.’  
(Department of Health, 1996) 
 
In the guidelines this paragraph was followed by a list of publications that would 
facilitate training in pre-test discussion, hence creating an assumption that to offer an 
HIV test a health care worker should be specifically trained.   
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The guidelines identify five main components of the pre-test discussion: 
1.  Ensuring the individual understands the natures of HIV infection (including 
difference between HIV and AIDS); provision of information about HIV 
transmission and risk reduction (including the modes of transmission, methods 
to reduce risk, and written material available to support risk reduction). 
2.  Personalised discussion of risk activities, including date of last risk activity and 
perception of need for test. 
3.  Discussion of the pros and cons to the individual, their family and associates of 
having a test and knowing the result. 
4.  Provision of details about the test and how the result will be provided. 
5.  Obtaining an informed decision about whether or not to proceed with the test. 
The exception to this practice of detailed pre-test discussion is HIV testing that occurs 
as part of the screening of all blood donations.  In recognition of the time constraints 
involved only written information is made available.  The risk assessment and the need 
for a test (stage 2 above) occurs when potential donors are sent information to allow 
them to exclude themselves if they fall within several higher risk categories; written 
information on HIV/AIDS is provided in the form of a leaflet; and stages 4 and 5 (test 
details and informed consent) are established by asking potential donors if they have 
read and understood the leaflet (Department of Health, 1996). 
The average time for pre-test voluntary counselling in the UK in the early 1990’s was 
21 minutes, with 18% of people requiring two visits (Department of Health, 1996). To 
have the time and knowledge to address all the specified components of a pre-test 
discussion a health care worker would probably need to be specifically working in the 
field of HIV. In the 1980s and 1990s the majority of HIV care in the UK, including  
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counselling and testing, was restricted to specialist settings with general practitioners 
(GP’s) typically not involved nor often notified of the diagnosis. 
This emphasis on voluntary counselling and testing (VCT) may in itself be a barrier to 
HIV testing. Outside of antenatal HIV testing, HIV testing in Britain predominantly 
occurs within genitourinary medicine (GUM) clinic settings (Rogstad, 2004; 
Department of Health, 1996). A study with GPs following attendance at a STI study day 
found that there was significant anxiety associated with broaching the subject of HIV 
testing. The anxiety was significantly more pronounced when the GP was asked to 
consider HIV testing to an at-risk heterosexual compared to homosexual men or 
intravenous drug users. The GPs were also likely to actively discourage testing in 
individuals they considered low risk.  Only 14.6% (7/48) of the GPs would ‘usually 
discuss’ HIV testing with at-risk heterosexuals, and the majority were reluctant to offer 
an HIV test themselves and preferred instead to recommend attendance at a sexual 
health clinic (Kellock et al., 1998).  Qualitative research with GPs is required to 
establish whether these findings are associated with the emphasis on VCT. 
Even within GUM clinics the principal barrier to HIV testing was identified as lack of 
time, especially of health advisors (British Co-operative Clinical Group, 2000). Whilst 
not specifically mentioning VCT as a barrier the majority of clinics used health advisors 
to conduct the pre-test counselling for 75-100% of patients having an HIV test. 
Clinicians, including GPs, often request investigations that have social, financial and 
medical implications, for example X-rays to diagnose lung cancer or sputum analysis 
for tuberculosis. Similarly all clinicians are trained in delivering bad news.  Admittedly 
HIV/AIDS is a relatively new infectious disease and many older clinicians may not 
have received formal training on this condition at medical school, however the focus of  
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extensive pre-test discussion may be contributing to the anxiety the GPs expressed 
when asked to consider discussing HIV with patients. 
 For most other disease processes, including chronic and terminal illnesses, clinicians 
would try to establish a diagnosis first and then refer to specialist services. It is 
inevitable that the process of onward referral creates a barrier to HIV testing. Referral to 
a GUM clinic may be a particular barrier for African communities given the stigma 
associated with HIV, the barriers to accessing services generally inherent for migrant 
communities, and the fact that GUM clinics are an unfamiliar service to most Africans.  
In African communities within Britain HIV remains highly stigmatised (Goldin, 1994; 
Dodds et al., 2004; Anderson et al., 2004). Fear of stigma and discrimination has been 
identified as a barrier to Africans presenting for an HIV test (Erwin et al., 2002). Stigma 
also acts by creating a sense of ‘otherness’ (Busza, 1999), that is only certain types of 
people get certain conditions. Erwin identified that Africans in particular may not 
identify as being at risk of HIV (Erwin et al., 2002).  In a national survey on HIV testing 
in GUM clinics the majority of patients at high-risk of HIV actually requested an HIV 
test, the exception to this were heterosexuals from sub-Saharan Africa (British Co-
operative Clinical Group, 2000).  In this context it becomes more important that health 
care professionals ensure institutional barriers to the accessing of HIV testing and care 
are kept to a bare minimum. Normalisation of HIV testing is one means by which this 
issue can begin to be addressed. 
2.5.2   Normalisation of HIV 
HIV exceptionalism arose largely because of fears about stigmatisation and 
discrimination in an era when diagnosis of HIV had little impact on prognosis. The 
activism that led to its exceptional status can also be credited with encouraging greater  
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respect for autonomy, informed consent, and confidentiality within medical 
establishments (De Cock & Johnson, 1998). 
Normalisation refers to the process of treating HIV more like other infectious diseases 
for which early diagnosis is essential for appropriate therapeutic and preventive 
measures (De Cock et al., 1998). It encapsulates the notion that all doctors should be 
confident and competent at HIV testing and diagnosis. It should still incorporate the 
need for confidentiality and informed consent.  
The national strategy for sexual health and HIV (Department of Health, 2001) set 
specific targets to improve HIV testing uptake and reduce undiagnosed HIV infection. 
‘By the end of 2004 all GUM clinic attendees should be offered an HIV test’ with a 
view to increasing uptake of the test to 40% (70% by 2007), and reducing by 50% the 
number of previously undiagnosed HIV infected people attending GUM clinics by 2007 
(Department of Health, 2001). The strategy also draws attention to health inequalities 
noting that sexual ill health is not equally distributed among the population and black 
and minority ethnic groups are acknowledged as bearing some of the highest burdens of 
sexual ill health and HIV in particular. Similarly it highlights that service provision, 
including HIV prevention services, is inequitable across the country. New models of 
working are envisaged which increase the role of GPs.  HIV testing and counselling is 
considered a level one service that should be available through primary care. The 
strategy does not stipulate how these changes are to be achieved and no financial 
incentives to ensure they occur are provided. However the strategy does mark an 
important cultural shift towards normalising the provision of HIV testing. 
An audit at the Mortimer Market Centre, a large central London sexual health clinic, in 
2001 showed that, despite a universal offering policy, only 47% of new attendees had 
an HIV test (Arthur, Burns, Mercer, & Mercey, 2002). Since then this clinic has  
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attempted to further normalise the process of HIV testing. A pre test discussion still 
occurs but there has been a move away from in-depth counselling. In a more recent 
audit at the same clinic, 98% of 2368 new attendees over a three-month period were 
offered an HIV test (Arthur, 2005).  Every one of these patients was made explicitly 
aware of HIV testing.  Patients identified as high-risk were offered detailed VCT 
however this was not a prerequisite for testing.  77% of all patients had a HIV test.  
These results occurred in the context of a busy GUM service where most appointment 
slots are for 15 minutes. 
Unsurprisingly a direct offer of an HIV test significantly increases uptake of HIV 
testing. However the method by which this offer is delivered, be it minimal or 
comprehensive discussion about all blood tests, or minimal or comprehensive HIV 
specific discussion, does not appear to influence uptake of the test or the anxiety 
associated with the test, at least in the antenatal setting (Simpson et al., 1998). HIV 
specific knowledge was significantly increased followed comprehensive discussion. 
Universal offering of HIV testing, sometimes referred to as an opt-out policy, should 
now be routine practice in most GUM clinics and antenatal settings (NHS Executive, 
1999; Department of Health, 2001). Compulsory HIV testing also occurs with all blood 
donations. These policies represent significant progress in ‘normalising’ HIV testing 
within these particular services.  The benefits of these changes however are limited to 
those individuals who access these specialist services. Whilst we know that the majority 
of Africans in the UK are registered with a GP (McMunn, Mwanje, Paine, & Pozniak, 
1998), the proportion of the UK African population who access GUM services is not 
currently known. Most Africans would not be eligible for blood donation as they are 
identified as a higher risk population (NHS Blood and Transplant, 2009).  It remains to  
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be seen if the national strategy for sexual health and HIV is able to motivate change in 
primary care services towards HIV testing.  
2.6 Conclusion 
The findings of this literature review reflect the complex interplay of factors influencing 
HIV testing. Migrant Africans are comprised of diverse and possibly fragmented 
populations. Whilst the interplay of external and internal factors, that determines health 
and health-seeking behaviour, operates for all migrant Africans the weight of various 
issues will be influenced by personal circumstances. 
In order to tackle the problems of HIV for migrant Africans, it is necessary to address 
both the internal and external factors influencing health care access, be they social, 
political or cultural.  The complexity of the forces and interrelationships impacting on 
the ‘healthcare system’ means time; financial commitment; and a multi-sectorial 
approach will be necessary.  The Social Exclusion Unit, designed to use joined-up-
government to tackle social problems (Social Exclusion Unit, 1999), may provide a 
suitable starting point for initiating non-health care sector, holistic systems 
modification.  
Efforts aimed at reducing undiagnosed HIV infection through the promotion of HIV 
testing remain a key component of primary and secondary HIV prevention strategies.  
Currently HIV testing, which effectively is the gateway to accessing HIV services, 
resides almost exclusively within the domain of the specialist professional sector.     
Adopting more innovative approaches to testing that encourage overlap with the popular 
and folk sectors may improve acceptability and help reduce the stigma attached to HIV. 
This could include adoption of community-based voluntary counselling and testing like 
that successfully implemented in Kenya (The Voluntary HIV Counselling and Testing  
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Efficacy Study Group, 2000).  In this model lay people are trained as counsellors and 
rapid HIV assays are performed in community settings.  In so doing accessing HIV 
services may gain the implicit approval of the milieu in which it is placed. 
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Chapter 3:HIV testing among Africans in 
Britain 
 
Abstract 
Objective:  To describe the factors associated with HIV testing amongst 
heterosexual black Africans aged 16-44 years living in Britain. 
Design: Data from the main and ethnic minority boost samples of the 
second British National Survey of Sexual Attitudes and Lifestyles (Natsal 
2000), a stratified national probability sample survey conducted between 
1999-2001, were analysed. Multivariate analysis was performed using 
complex survey functions to account for the clustered, stratified and 
differential selection probabilities inherent within the survey.  
Results:  A total of 385 (216 women and 169 men) black African 
respondents were included in the study. 44.0% women and 36.4% men 
reported ever having had an HIV test. In univariate analysis, HIV testing 
was associated with being born abroad (OR 3.63), having a new partner(s) 
from abroad in past five years (OR 2.88), and attending a GUM clinic (OR 
3.27), among men; and higher educational attainment (OR 3.50), perception 
of ‘not very much’ personal risk of HIV (OR 2.75), and attending a GUM 
clinic (OR 2.91) among women. After adjusting for potential confounders, 
an increased likelihood of HIV testing was associated with being in the UK 
less than 5 years relative to being UK born (adj. OR 9.49), and ever 
attending a GUM clinic (adj. OR 5.53), for men; and educational attainment  
(adj. OR 4.13), and low perception of HIV risk (adj. OR  2.77) for women.  
Conclusions: Black Africans appear to have relatively high rates of HIV 
testing compared to the general UK population reflecting, at least partially, 
awareness of risk behaviours and potential exposure to HIV. Nevertheless, 
there remains substantial potential for health gain and innovative approaches 
are required to further increase timely HIV testing. 
The findings within this chapter are published in: Sexually Transmitted 
Infections (2005); Factors associated with HIV testing amongst black 
Africans in Britain. F. Burns et al., v.81:pp 494-500. 
 
3.0 Introduction 
Reducing the level of undiagnosed HIV infection through the promotion of HIV testing 
is an important component of primary and secondary HIV prevention strategies 
(Department of Health, 2001). To date, there have been no population-based studies of 
HIV testing behaviours of black Africans in Britain.   
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The first national probability sample survey of sexual attitudes and lifestyles (Natsal) 
conducted in 1990/91 was designed to identify demographic and sexual behaviour 
characteristics that would help with understanding the reproductive and sexual health 
needs, as well as transmission patterns of HIV and other STIs, in Britain (Johnson, 
Wadsworth, Wellings, & Field, 1994). The second national survey of sexual attitudes 
and lifestyles (Natsal 2000) was designed to examine the changes over time and provide 
up-to-date estimates of sexual behaviour in Britain, as well as provide a boost sample of 
people from four ethnic minority groups (black Caribbean, black African, Indian and 
Pakistani) to allow exploration of ethnic variations in behavioural risk and outcomes.  
This chapter explores uptake of HIV testing by black Africans in Britain. 
3.0.1   Aims and objectives 
To describe the factors associated with HIV testing among heterosexual Africans aged 
16-44 years living in Britain. Specific objectives were to: 
1.  Describe the socio-demographic and sexual behavioural risk factors, and health 
service utilisation history associated with HIV testing among Africans in Natsal 
2000 
2.  Determine the factors associated with the uptake of HIV testing. 
3.  Describe the association between reason for having an HIV test and where tested 
among Africans. 
3.1 Methods 
3.1.1   Natsal  2000 
Data for this study came from the Natsal 2000 survey. Natsal 2000 is a stratified 
probability sample survey of sexual attitudes and lifestyles among 11,161 British  
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residents aged 16-44 years undertaken between 1999 and 2001. In order to increase the 
number of respondents from Britain’s largest ethnic minorities further sampling of 949 
black African, black Caribbean, Pakistani and Indian adults were interviewed as part of 
the ethnic minority boost (EMB) sample over a 9-month period at the end of the main 
survey.  
The project was funded by the Medical Research Council and the Department of Health, 
and run collaboratively between the London School of Hygiene and Tropical Medicine, 
the National Centre for Social Research, and the Royal Free and University College 
Medical School.
7 
3.1.2   Sampling frame 
The core sample involved a multi-stage stratified probability design. Postcode sectors 
were selected as the primary sampling units (PSUs). Prior to selection PSUs with fewer 
than a 1000 addresses were combined with neighbouring sectors to avoid tight 
clustering of sampling addresses. Using data from the 1991 census the PSUs were also 
stratified according to region, population density, age of population, and socio-
economic status. 466 sectors were then selected systematically. The second stage 
involved selection of addresses within the PSUs from the small user postcode address 
file (PAF), and finally one eligible adult was randomly selected. Addresses in London 
were over-sampled as Natsal showed the prevalence of many HIV risk behaviours, such 
as homosexuality and intravenous drug, was higher in London than elsewhere in 
Britain.(Erens et al., 2001) 
The ‘boost’ sampling frame was also multi-stage and very similar to the core sample. 
The first stage involved randomly selecting postcode sectors; secondly, addresses within 
                                                 
7 Ethical approval for Natsal 2000 was obtained from the North Thames Region Multicentre Research 
Ethics Committee and local research ethics committees throughout Britain.  
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these sectors were randomly selected using the PAF; and thirdly, one adult was 
randomly selected.  Prior to selection of PSUs for the boost sample, all postcode sectors 
were assigned to one of three strata based on the proportion of residents of ethnic 
minority origin determined by 1991 census data.  The number of sectors selected for the 
boost sample, and the screening method, varied by stratum. In the stratum with highest 
density (>12%) 72 sectors were selected and full household screening occurred. 
Interviewers contacted every address to determine whether there were eligible residents. 
In the second stratum 78 sectors were selected and focused enumeration was used to 
screen and identify eligible residents. Focused enumeration is a cost-effective method 
for screening large numbers of addresses; sampled addresses were asked to identify 
members of ethnic minority groups in adjacent addresses, if any adjacent addresses 
were identified as including residents of the relevant ethnic groups the interviewers also 
visited those properties. Respondents living in the stratum of lowest density (<6%) were 
obtained in the main Natsal 2000 sample. Only addresses with at least one adult from 
the target ethnic minority groups were eligible for inclusion in the survey (Erens et al., 
2001).  
To obtain the total ethnic minority sample respondents from eligible groups identified in 
the core sample were included with those from the boost sample. 
3.1.3   Data collection 
A combination of interviewer administered computer-assisted personal interviews 
(CAPI), and self-completed computer-assisted self-interviews (CASI) were conducted.  
All respondents undertook the CAPI but only those meeting certain criteria were offered 
the CASI.  People with no sexual experience of any kind, and 16 to 17 year olds with no 
heterosexual intercourse or homosexual experience, were not eligible for the CASI 
module. The CASI component allowed respondents to key in responses to more  
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sensitive questions directly on to a laptop computer. The questionnaire used for the 
ethnic minority boost sample was the same as that for the general population sample, 
with additional questions on country of origin and languages spoken. Questionnaires 
were available in Urdu and Punjabi for the boost sample, and trained interviewers fluent 
in these languages as well as English were used. Chlamydia-testing was excluded from 
the EMB component (Erens et al., 2001). 
3.1.4   Present Study 
Inclusion in the current study was limited to heterosexual Africans.  For the purposes of 
this study black African was defined by self-classification as black or mixed ethnic 
group with a black African cultural background.  A heterosexual was defined as any 
person who had ever had heterosexual intercourse and had no homosexual experience in 
the past five years.  The study was limited to heterosexuals as people with homosexual 
or bisexual experience were likely to differ in terms of sexual attitudes, practices and 
awareness from those who were solely heterosexual. The small numbers of bisexual and 
homosexual Africans prevented separate analysis for these groups.  People who had 
never had sexual intercourse were excluded, as it was unlikely that they would be 
testing for HIV infection. 
3.1.5   Data Preparation and software 
The Natsal 2000 investigators performed initial data editing, coding and consistency 
checks.  Further checking was performed following reduction of the full data set to 
those meeting the eligibility criteria for this study. All the analysis for this study was 
conducted by myself and performed using STATA 8.0.  
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3.1.5.1  Rationale for using specialist survey commands 
Survey commands were used in all analyses unless otherwise specified to account for 
the clustered, stratified and differential selection probabilities inherent within the Natsal 
2000 design. For example, individuals in the same strata, or cluster, are more likely to 
be similar to each other than to individuals in other clusters, resulting in inaccurate 
estimates of effect if not accounted for.  Thus stratification and over-sampling in the 
study design need to be incorporated into all analysis. Individuals in single-occupancy 
dwellings were more likely to be selected than those in multi-occupancy dwellings, 
those living in London were more likely to be sampled compared to the rest of Britain, 
and the probability of selection into the boost sample depended on the proportion of 
residents of ethnic minority origin in both the household and strata.  To adjust for these 
differential selection probabilities both within and between the core and ethnic boost, 
the data was weighted proportional to the number of eligible residents per household, 
the number of eligible ethnic minority adults by household and strata, and by region. 
Finally to correct for differences in gender, age group and government office region 
between the achieved sample and population estimates, a non-response/post-
stratification weight was applied. Weighting thus helps ensure the sample is broadly 
representative of Africans living in standard residential type accommodation in Britain.
8  
3.1.6   Data Analysis Strategy   
The conceptual framework for analysis used ‘ever had an HIV test’ as the outcome of 
interest.  The outcome excluded those people who had a test for HIV as part of blood 
donation.  This was to ensure HIV testing was part of an active decision making process 
                                                 
8 The weighting was set by the National Centre for Social Research.  
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as many people donating blood are unaware that HIV tests are conducted routinely on 
all blood donations.   
The choice of explanatory variables was limited by the Natsal 2000 data set.  For 
example accessing of  general practitioner (GP) care would have been included if such 
information had been collected in the Natsal 2000 survey.  The explanatory variables 
were grouped into distal (socio-demographics) and more immediate factors (indicators 
of sexual risk and general health). The more distal factors may affect more immediate 
factors but also may affect HIV testing independently.  
3.1.6.1  Data editing and reduction 
Individuals with missing data for HIV testing were excluded from analysis.   All other 
unavailable data was coded as missing.  Data on HIV testing was not available for 10 
(3.6%) African men and 20 (10.4%) African women. Missing data for the explanatory 
variables was less than 3% in all cases except concurrency, which was 10% for men and 
7% for women. 
Continuous variables such as age were categorised into groups that would have 
statistical efficacy whilst maintaining relevance.  Similarly explanatory variables were 
re-categorised if numbers were too small for analysis and merger of categories was not 
felt to lead to loss of information. The binary measure of perception of health was 
dropped as insufficient numbers of respondents perceived their health as poor (5 men 
and 6 women). 
3.1.6.2 Statistical  analysis 
As gender differences in sexual practices, awareness and attitudes were likely to exist, 
men and women were analysed separately. Univariate analysis was conducted by 
weighted cross-tabulations and calculating the odds ratio (OR).  Chi-squared tests of  
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association and corresponding p values were calculated to give a measure of the 
strength of association unless numbers were small, when Fisher’s exact test was used. 
As the analysis took into account clustering and weighting, classical methods and 
maximum likelihood theory were unable to be used. Logistic regression was used for 
both univariate and multivariate analysis to obtain crude and adjusted odds ratios 
(AOR). Significance was determined using Wald and adjusted Wald tests.  A 
significance level of 0.05 was used, although those below 0.1 (in either the male or 
female analysis) were retained for multivariate analysis.  
All the variables in the distal determinant group that satisfied inclusion criteria were 
fitted into a multivariate logistic model.  Backward elimination was used to exclude 
variables not contributing significantly to the model (p>0.1) or altering the OR for 
variables already in the model. For the final model the more immediate factors were 
added to the model with backward elimination at each stage being used to obtain the 
most parsimonious model.  The more immediate factors were added in a step-wise 
fashion with those related to high risk sexual practices added first, followed by 
perception of HIV risk, GUM clinic attendance, health care and finally health 
perception (see Figure 3.1 below). 
Figure 3.1 Schematic representation of derivation of final multivariate model 
 
Distal  determinants       Model  1   
Model 1 + high risk sexual practices       Model 2 
Model 2 + perception of HIV risk        Model 3 
Model 3 + GUM clinic attendance        Model 4 
Model 4 + health care use          Model 5 
Model 5 + health perception            Model 6=final model.  
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3.1.7   Confounders and effect modifiers 
Age was assumed to be an a priori confounder and was retained in the model regardless 
of significance levels. All other variables were treated as potential confounders and 
mediators. At each stage of analysis it was assessed whether the OR for the distal 
determinants changed, which would imply the new variables were acting as mediators. 
If the OR for the newly added variables changed, either from the crude OR or when 
added to the model, this would suggest confounding by the variables already in the 
model.  Effect modification was investigated once the final model had been determined.  
To ensure adequate numbers for statistical purposes each parameter in the final model 
was recoded into a binary variable. Possible interactions were tested using adjusted 
Wald tests. 
3.2 Results 
One hundred and sixty nine heterosexual black African men and 216 black African 
women were interviewed for Natsal 2000. The majority of respondents came from 
former British colonies (table 3.1), especially Nigeria (35%) and Ghana (22%).  
Table 3.1 Country of origin of study respondents 
 
Country of origin 
 
n 
 
% 
 
    
       Nigeria  134  34.8 
       Ghana  84  21.8 
       Somalia  15  3.9 
       Uganda  14  3.6 
       Zimbabwe  13  3.4 
       Kenya  9  2.3 
       South Africa  8  2.1 
       Sierra Leone  8  2.1 
       Other/not answered  100  26.0 
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Table 3.2 summarises the demographic and behavioural characteristics of respondents. 
There were significant differences in the socio-demographic characteristics of men and 
women. Women tended to be older, less likely to have higher education, of lower social 
class
9, and more likely to be married or previously married, than men. Men were more 
likely to report high-risk sexual practices (number of partners in past five years, new 
partner from abroad in past five years, early age at first sex, and concurrent partnerships 
in past five years) than women. Approximately 17.5% of men and women had ever 
being diagnosed with a sexually transmitted infection, and 23.6% of men and 17.9% 
(p=0.36) of women reported ever attending a GUM clinic. Self-perception of HIV risk 
differed (p=0.10) between men and women. 71.0% of women perceived themselves at 
no risk of HIV compared to 48.9% of men; and 8.5% of men and 7.6% of women 
perceived themselves at ‘quite a lot’ or ‘great’ risk of HIV. Men and women appeared 
equally likely to use tertiary NHS health services (other than antenatal services) in the 
previous year with 71.5% and 61.4% (p=0.184) using services respectively.  
Overall, 36.4% (95%CI 26.5-47.6) black African men and 44.0%(95%CI 34.6-53.9) 
black African women reported having ever tested for HIV. Differences in the reasons 
for and site of HIV testing were observed by gender (p<0.001) (Table 3.3). 34.3% of 
men who tested had their last HIV test in a GUM clinic, and a further 25.8% in a GP 
surgery. The majority (54.6%) of men who tested had their last HIV test as part of a 
general health check-up. In contrast, 35.9% of women who tested listed ‘elsewhere’ as 
the site of their last HIV test. A further 22.7% tested at a GP surgery and 21.1% at 
family planning clinics (FPC). The majority of women (62.7%) tested due to pregnancy. 
Testing as part of a general health check-up tended to occur in GUM clinics (41.9%) for 
                                                 
9 Registrar Generals grading system of social class: I professional/managerial, II managerial/technical, III 
skilled non-manual and manual, IV partly skilled, V unskilled. ‘Unclassifiable’ includes caring for home, 
military, in education, or not employed.  
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men, and in GP surgeries (39.6%) for women (data not shown).  HIV testing for 
pregnancy occurred mainly ‘elsewhere’ for women possibly reflecting testing in 
antenatal clinics. 25.8% of pregnancy motivated tests apparently occurred in FPCs (data 
not shown).  
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Table 3.2 Characteristics of study respondents  
 
Characteristic 
Men 
(Base 
1 169UW  57WT) 
Women 
(Base
1216UW   54WT) 
 
 %  %  p-value
2 
Age (years): 
         16-24          
         25-34 
         35-44 
 
23.3 (15.4-33.6) 
35.5 (25.8-46.7) 
41.2 (30.7-52.5) 
 
9.6 (6.4-15.2) 
43.6 (34.1-53.6) 
46.5 
0.049 
Education: 
         Degree 
         Higher education (<degree) 
         GCSE/O-level/Other/none 
 
50.0 (39.0-60.9) 
28.1 (19.8-38.2) 
21.9 (14.3-32.1) 
 
31.3 (23.3-40.7) 
27.5 (20.9-35.3) 
41.2 (32.1-50.9) 
0.006 
Social class 
          I or II 
          III (manual or non-manual) 
          IV or V 
          Unclassified 
 
43.3 (32.5-54.8) 
28.6 (21.1-37.5) 
15.6 (9.3-25.0) 
12.5 (8.1-18.8) 
 
22.0 (15.6-30.0) 
36.1 (28.0-45.1) 
20.1 (14.1-27.9) 
21.8 (14.3-31.8) 
0.007 
Index of multiple deprivation 
          1
st -4
th  
          5
th (most deprived) 
 
35.9 (24.4-49.3) 
64.1 (50.7-75.6) 
 
41.6 (31.4-52.6) 
58.4 (47.4-68.6) 
0.446 
Marital status 
          Married  
          Cohabiting 
          Previously married 
          Single, never married 
 
41.2 (30.5-52.7) 
13.0 (6.5-24.3) 
6.9 (3.8-12.2) 
38.9 (29.1-49.8) 
 
49.9 (39.8-60.1) 
7.8 (4.4-13.4) 
19.1 (12.4-28.2) 
23.3 (17.0-31.0) 
0.007 
Religion 
         Christian – non RC 
         Roman catholic 
         Other /none 
 
49.9 (39.2-60.7) 
16.1 (9.2-26.7) 
34.0 (24.8-44.5) 
 
59.1 (49.7-67.9) 
15.1 (10.6-21.0) 
25.8 (17.5-36.3) 
0.410 
Region of residence 
         Greater London  
         Elsewhere in Britain 
 
73.4 (62.5-82.0) 
26.6 (18.0-37.6) 
 
87.4 (76.1-93.8) 
12.6 (6.2-23.9) 
0.081 
Time spent in UK 
         Born in UK 
         Born abroad 
 
27.4 (9.9-40.4) 
72.6 (62.6-80.8) 
 
26.0 (19.4-34.0) 
74.0 (66.0-80.6) 
0.826 
Time in UK if migrant (years, median, range)  9.5 (0-37)  10.0 (0-35)  0.442 
Region of birth 
         Europe 
         Central/East Africa 
         West Africa 
         Other 
 
29.1 (20.7-39.1) 
17.9 (11.8-26.2) 
44.6 (33.9-55.8) 
8.4 (3.4-19.4) 
 
27.3 (20.4-35.4) 
29.2 (20.4-39.9) 
39.9(31.2-35.3) 
3.6 (1.7-7.5) 
0.147 
Previous STI diagnosis  17.5 (11.3-26.1)  17.7 (11.0-27.4)  0.158 
Sex
4 in past year without a condom 
        No 
        Yes 
        Not answered correctly 
 
26.0 (18.0-36.2) 
63.9 (52.7-73.8) 
10.0 (4.6-20.7) 
 
23.5 (16.6-32.2) 
61.3 (51.3-70.4) 
15.2 (8.1-26.7) 
0.619 
Number of partners in past 5 yrs  
         0-1 
         2-5 
         6+ 
         Median (range) 
 
28.4 (19.9-38.8) 
48.0 (37.9-58.3) 
23.6 (16.6-32.5) 
3 (0-130) 
 
75.4 (66.3-82.7) 
22.6 (15.6-31.5) 
2.1 (0.8-5.6) 
1 (0-11) 
<0.001 
 New partner from abroad in past 5 years  37.9 (28.2-48.8)  6.4 (3.6-11.2)  <0.001 
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Table 3.1 continued 
 
Characteristic 
Men 
(Base 
1 169UW  57WT) 
Women 
(Base
1216UW  54WT) 
 
  % %  p-value
2 
Age at first sex
3 (years) 
        16+  
        <16 
 
67.5 (57.0-76.5) 
32.5 (23.5-43.0) 
 
88.3 (81.1-92.9) 
11.7 (7.1-18.9) 
<0.001 
Ever paid for sex
3 14.9  (9.7-22.2)  NA  --- 
Had concurrent partnerships in past five 
years 
 
35.6 (24.8-48.1) 
 
7.0 (4.1-11.7) 
 
<0.001 
Perception of HIV risk for self 
          Not at all 
          Not very much  
          Quite a lot or Great 
 
48.9 (37.6-60.4) 
42.5 (31.5-54.4) 
8.5 (4.1-16.8) 
 
71.0 (62.6-78.2) 
23.6 (16.9-31.9) 
5.4 (3.0-9.6) 
0.010 
Ever attended GUM clinic   23.6 (15.8-33.6)  17.9 (11.8-26.3)  0.360 
Antenatal care (past 5 yrs)  NA  57.5 (48.3-66.2)  --- 
User of tertiary NHS services
4   71.5 (60.0-80.7)  61.4 (52.2-69.9)  0.184 
EVER HAD AN HIV TEST  36.4 (26.5-47.6)  44.0 (34.6-53.9)  0.303 
1 Base varies due to item non-response  Wt =Weighted and UW= Unweighted Bases    
2 Comparing men and women   
3 Anal or vaginal intercourse      
4 In past year other than antenatal service 
 
Table 3.3 Where and why had last HIV test; proportions by gender  
 
Characteristic 
Male 
%
1 
(Base 53UW, 
20WT ) 
Female 
%
1 
(Base 94UW, 
21WT) 
p-
Value 
Where had last HIV test     0.076 
       GP surgery  25.8  22.7   
       GUM clinic  34.3  17.0   
       NHS Family planning clinic  11.1  21.1   
       Privately  12.8  3.3   
       Elsewhere  15.9  35.9   
              
Why had last HIV test     <0.001 
       Pregnancy related  14.0  62.7   
       Part of insurance, travel or mortgage  
        requirements 
13.2 6.5   
       Part of general health check  54.6  16.8   
       Concerned about risk of HIV/AIDS to  
       self or partner 
4.6 9.6   
       Other reason  13.7  4.4   
     
1 Weighted percentages   Wt =Weighted and UW= Unweighted Bases 
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Table 3.4 shows the frequency, odds ratio and adjusted odds ratio of factors associated 
with HIV testing. No significant associations were found between HIV testing and age, 
social class, index of multiple deprivation
10, marital status, religion, or region of 
residence. Among black African men, being born abroad was significantly associated 
with higher odds of HIV testing than UK born men (OR 3.63 95%CI 1.12-11.7) (data 
not shown). Men who had new partner(s) from abroad (including those who had sex in 
Britain with partners from abroad, and those who had sex abroad) in past five years 
were more likely to have tested for HIV than men who had not (OR 2.88 95%CI 1.03-
8.05), as were men who reported attending a GUM clinic compared to men who did not 
(OR 3.27 95%CI 1.20-8.90). In multivariate analysis, time spent in the UK (men in UK 
five or more years adj. OR 5.10 95%CI 1.40-18.86; men in UK less than 5years adj. OR 
9.49 95%CI 2.30-39.14) and attending a GUM clinic (AOR 5.53 95%CI 1.98-15.42) 
remained independently associated with higher odds of HIV testing in men. No 
evidence of any interactions was found in the final model. 
In univariate analysis black African women with higher education but less than a degree 
were more likely to test for HIV than women with a degree (OR 3.50 95%CI 1.29-9.51) 
(Table 3.4). Women who perceived themselves at ‘not very much’ risk were more likely 
to have tested for HIV compared to women perceiving themselves at no risk (OR 2.75, 
95% CI 1.06-7.13) and attending a GUM clinic meant women were more likely to have 
tested compared to those who had not attended (OR 2.91 95%CI 1.10-7.72).  No high-
risk sexual practices were significantly associated with HIV testing in women. 
Antenatal care in the past five years was not significantly associated with HIV testing 
(OR 1.25 95%CI 0.59-2.65). 
                                                 
10 A ward level measure developed by the Department of Environment, Transport and the Regions, 
dependent on six factors: income, employment, health & disability, education, housing, and geographical 
area. The index consists of five levels, the higher the score the more deprived.  
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Table 3.4 The frequency and odds ratios (95% confidence limits) of factors associated with HIV testing in black African men & women.  
  Men 
(Base 159UW 55WT) 
Women 
(Base 196UW 48WT) 
  % Crude  OR 
 (95%CI) 
Adjusted OR  
(95%CI) 
% Crude  OR 
(95%CI) 
Adjusted OR 
 (95%CI) 
Age (years): 
         16-24 
         25-34 
         35-44 
 
22.8 (8.3-49.2) 
39.8 (22.5-60.1) 
40.8 (25.1-58.7) 
P=0.472 
1.00 
2.24 (0.49-10.26) 
2.34 (0.58-9.36) 
P=188 
1.00 
4.04 (0.90-18.08) 
2.27 (0.57-9.08) 
 
34.1 (16.4-57.7) 
41.1 (27.1-56.6) 
48.8 (35.7-62.2) 
P=0.491 
1.00 
1.35 (0.43-4.26) 
1.85 (0.61-5.55) 
P=0.675 
1.00 
1.05 (0.32-3.47) 
1.52 (0.44-5.20) 
Education: 
         Degree 
         Higher education (<degree) 
         GCSE/O-level/Other/none 
 
28.0 (15.1-46.0) 
43.7 (27.5-61.3) 
47.0 (26.8-68.2) 
P=0.317 
1.00 
1.99 (0.68-5.84) 
2.28 (0.69-7.53) 
  
39.2 (22.5-58.9) 
69.3 (53.3-81.7) 
28.8 (17.5-43.4) 
P=0.003 
1.00 
3.50 (1.29-9.51) 
0.63 (0.22-1.78) 
P=0.001 
1.00 
4.13 (1.43-11.88) 
0.72 (0.27-1.93) 
Social class 
          I or II 
          III (manual or non-manual) 
          IV or V 
          Unclassified 
 
27.7 (13.1-49.3) 
51.5 (34.0-68.6) 
56.9 (30.9-79.6) 
18.3 (7.7-37.7) 
P=0.045 
1.00 
2.77 (0.83-9.16) 
3.45 (0.83-14.27) 
0.59 (0.15-2.31) 
 
 
 
37.3 (22.2-55.5) 
55.7 (40.2-70.2) 
40.7 (23.4-60.7) 
35.6 (17.2-59.5) 
P=0.347 
1.00 
2.11 (0.84-5.61) 
1.15 (0.36-3.71) 
0.93 (0.28-3.04) 
 
Index of multiple deprivation 
          1
st -4
th  
          5
th (most deprived) 
 
30.9 (14.8-53.7) 
39.6 (28.3-52.2) 
P=0.484 
1.00 
1.46 (0.50-4.29) 
  
42.8 (26.8-60.5) 
44.8 (34.8-55.2) 
P=0.838 
1.00 
1.08 (0.50-2.32) 
 
Marital status 
          Married  
          Cohabiting 
          Previously married 
          Single, never married 
 
43.9 (27.2-62.1) 
58.5 (24.7-85.9) 
23.0 (9.0-47.3) 
22.7 (12.0-38.8) 
P=0.117 
1.00 
1.81 (0.36-9.10) 
0.38 (0.10-1.44) 
0.38 (0.17-1.12) 
  
43.1 (28.9-58.6) 
42.7 (18.2-71.5) 
57.1 (40.8-72.0) 
35.1 (23.5-49.6) 
P=0.259 
1.00 
0.98 (0.28-3.44) 
1.76 (0.75-4.12) 
0.73 (0.31-1.68) 
 
 
Religion 
         Christian – non RC 
         Roman catholic 
         Other /none 
 
31.6 (19.0-47.8) 
48.9 (20.0-78.5) 
37.5 (21.9-56.3) 
P=0.623 
1.00 
2.07 (0.46-9.37) 
1.30 (0.47-3.61) 
  
44.1 (32.1-56.8) 
61.7 (42.3-78.0) 
32.7 (15.7-56.6) 
P=0.141 
1.00 
2.04 (0.80-5.24) 
0.62 (0.20-1.89) 
 
Region of residence 
         Elsewhere in Britain  
         Greater London 
 
41.5 (16.9-71.3) 
34.5 (25.4-45.0) 
P=0.657 
1.00 
0.74 (0.20-2.80) 
  
34.1 (8.1-75.2) 
45.5 (36.3-55.1) 
P=0.601 
1.00 
1.61 (0.26-9.84) 
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Men 
(Base 159UW 55WT) 
 
Women 
(Base 196UW 48WT) 
  % Crude  OR 
 (95%CI) 
Adjusted OR  
(95%CI) 
% Crude  OR 
(95%CI) 
Adjusted OR 
 (95%CI) 
Time spent in UK 
         Born in UK 
         5+ years 
          <5 years 
 
17.5 (7.2-36.8) 
40.8 (27.1-56.1) 
50.4 (23.9-76.7) 
P=0.096 
1.00 
3.25 (0.99-10.70) 
4.78 (0.98-23.32) 
P=0.008 
1.00 
5.1 (1.40-18.86) 
9.49 (2.30-39.14) 
 
40.8 (25.3-58.5) 
43.8 (31.2-57.2) 
50.5 (29.4-71.4) 
P=0.801 
1.00 
1.12 (0.47-2.72) 
1.48 (0.45-4.82) 
 
 
Region of birth 
         Europe 
         Central/East Africa 
         West Africa 
         Other 
 
20.9 (9.7-39.5) 
38.7 (21.5-59.3) 
43.8 (27.1-62.1) 
47.3 (10.8-86.9) 
P=0.192 
1.00 
2.38 (0.70-8.16) 
2.94 (0.89-9.78) 
3.38 (0.39-29.45) 
  
40.4 (25.0-57.9) 
35.2 (20.2-53.8) 
46.9 (30.5-64.0) 
43.7 (13.8-78.9) 
P=0.821 
1.00 
0.80 (0.29-2.18) 
1.30 (0.46-3.67) 
1.14 (0.23-5.65) 
 
Antenatal care (past five yrs) 
          No 
          Yes 
 
NA 
NA 
 
NA 
NA 
 
 
 
40.8 (29.3-53.4) 
46.2 (32.3-60.7) 
P=0.559 
1.00 
1.25 (0.59-2.65) 
 
User of tertiary NHS services
1     
           No 
           Yes 
 
48.6 (24.3-73.6) 
31.8 (22.0-43.6) 
P=0.249 
1.00 
0.49 (0.15-1.66) 
  
34.7 (21.2-51.2) 
49.5 (38.5-60.6) 
P=0.121 
1.00 
1.87 (0.85-4.02) 
 
Ever attended GUM clinic  
           No 
           Yes 
 
29.7 (18.8-43.4) 
58.0 (38.9-74.9) 
P=0.021 
1.00 
3.27 (1.20-8.90) 
P=0.001 
1.00 
5.53 (1.98-15.42) 
 
38.9 (28.7-50.1) 
64.9 (43.3-81.8) 
P=0.032 
1.00 
2.91 (1.10-7.72) 
 
Previous STI diagnosis 
        No 
        Yes 
 
33.9 (22.7-47.2) 
48.4 (28.2-69.1) 
P=0.261 
1.00 
1.83 (0.63-5.29) 
  
37.4 (25.7-50.7) 
53.5 (28.8-76.6) 
P=0.267 
1.00 
1.93(0.60-6.17) 
 
Sex
2 in past year without a condom 
        No 
        Yes 
        Not answered correctly 
 
31.9 (14.3-56.8) 
37.8 (25.2-52.3) 
38.9 (11.3-76.0) 
P=0.906 
1.00 
1.30 (0.39-4.35) 
1.36 (0.20-9.37) 
 
 
 
44.7 (29.8-60.7) 
46.4 (35.2-62.3) 
32.0 (10.5-65.4) 
P=0.701 
1.00 
1.07 (0.47-2.43) 
0.58 (0.14-2.51) 
 
 
Number of partners in past 5 yrs  
         0-1 
         2-5 
         6+ 
 
32.4 (18.2-50.9) 
41.0 (24.5-59.8) 
32.7 (17.5-52.6) 
P=0.750 
1.00 
1.45 (0.50-4.19) 
1.01 (0.33-4.19) 
  
42.8 (30.7-55.8) 
48.7 (35.2-62.3) 
37.3 (7.5-81.3) 
P=0.792 
1.00 
1.27 (0.60-2.70) 
0.80 (0.10-6.28) 
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  Men 
(Base 159UW 55WT) 
Women 
(Base 196UW 48WT) 
  % Crude  OR 
 (95%CI) 
Adjusted OR  
(95%CI) 
% Crude  OR 
(95%CI) 
Adjusted OR 
 (95%CI) 
New partner from abroad in past 5 
years 
         No 
         Yes 
 
 
27.3 (16.2-42.1) 
52.0 (34.2-69.3) 
 
P=0.044 
1.00 
2.88 (1.03-8.05) 
 
 
 
 
45.1 (34.6-56.4) 
33.1 (13.4-61.1) 
 
P=0.414 
1.00 
0.60 (0.18-2.05) 
 
 
Age at first sex (years) 
        16+ years 
         <16 
 
33.4 (21.3-48.2) 
35.5 (26.9-60.1) 
P=0.401 
1.00 
1.20 (0.41-2.97) 
  
41.2 (31.2-52.0) 
65.6 (41.1-83.9) 
P=0.071 
1.00 
2.72 (0.92-8.10) 
 
Ever paid for sex 
         No 
         Yes 
 
33.2 (22.5-45.9) 
55.3 (32.3-76.2) 
P=0.100 
1.00 
2.49 (0.84-7.41) 
 
 
 
NA 
NA 
 
NA 
NA 
 
 
 Had concurrent partnerships in past 5 
years 
        No 
        Yes 
 
 
38.3 (24.3-54.4) 
30.7 (16.9-49.0) 
 
P=0.517 
1.00 
0.71 (0.26-2.00) 
 
 
 
 
43.6 (32.6-55.2) 
66.6 (36.4-86.4) 
 
P=0.178 
1.00 
2.47 (0.66-9.24) 
 
 
Perception of HIV risk for self 
          Not at all 
          Not very much  
          Quite a lot or Great 
 
36.6 (24.0-51.3) 
33.0 (18.3-51.8) 
52.8 (21.0-82.4) 
P=0.574 
1.00 
0.85 (0.32-2.31) 
1.94 (0.40-9.34) 
  
39.1 (27.5-52.0) 
63.9 (44.9-79.3) 
26.4 (11.1-50.7) 
P=0.036 
1.00 
2.75 (1.06-7.13) 
0.56 (0.17-1.80) 
P=0.026 
1.00 
2.77 (1.00-7.81) 
0.50 (0.17-1.44) 
1 In past year other than antenatal services  
2 Heterosexual anal or vaginal intercourse  
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When incorporated into a multivariate model education level (AOR 4.13 95%CI 1.43-
11.88) and perception of HIV risk (AOR 2.77 95% CI 1.00-7.81) continued to be 
independently associated with HIV testing. No evidence of significant confounding, 
mediation or effect modification was found in the final model. 
3.3 Discussion 
In 2000, Black Africans appear to have relatively high rates of HIV testing potentially 
reflecting awareness of risk behaviours and potential exposure to HIV. Approximately 
40% of black Africans had ever had an HIV test, compared with 12-13% having tested 
in the general UK population once blood donation as the reason for testing was 
excluded (McGarrigle et al., 2005). The inability of this study to demonstrate 
association between HIV testing and self-perception of risk may relate to the study’s 
design. Although no association between testing and risk perception was found it is 
concerning that almost half (48.9%) of the men and 71% of the women perceived 
themselves ‘not at all at risk of HIV’. This may reflect the high proportion of 
respondents from West Africa, an area with lower prevalence of HIV compared to 
Southern and Eastern Africa (UNAIDS, 2004).   
Important heterogeneity in the factors associated with HIV testing existed between 
black African men and women in Britain. Higher odds of HIV testing were associated 
with recent arrival in the UK, and attending a GUM clinic, for men; and higher 
education level, and low perception of HIV risk for women. 
Perhaps surprising is the lack of association between antenatal care in the past five years 
and HIV testing.  Knowledge of the ability to reduce mother-to-child transmission has 
been available since 1994 (Connor et al., 1994) and universal antenatal HIV testing  was 
introduced in the UK in 1999 (NHS Executive, 1999).  This may indicate missed  
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opportunities to uptake HIV testing, however the study lacked power to investigate 
possible interactions fully. A relatively high number of people reported having their last 
HIV test at a NHS family planning clinic (FPC).  This was selected from a range of 
options that consisted of GUM clinic, GP surgery, privately or elsewhere.  In 2000/01 
FPCs did not routinely offer HIV testing and tended to refer people to other services for 
testing.  It may be that people misunderstood this to mean NHS antenatal testing, or 
NHS services generally, including GUM clinics that are not infrequently confused as 
FPCs.  
3.3.1   Comparison with previous research 
The MAYISHA study, a sexual behavioural survey of five African communities in 
London, (Chinouya, Davidson, & Fenton, 2000) found similar rates of HIV testing to 
this study (34% vs. 36% for men; and 30% vs. 44% for women). In MAYISHA, HIV 
testing was associated with a previous STI diagnosis in men and women, and perceived 
risk of acquiring HIV in men.  MAYISHA, which surveyed migrant and not British 
born Africans in social venues, found more people reported a previous STI diagnosis. 
STI rates are known to be higher in migrant populations (Low, Sterne, & Barlow, 2001). 
Fewer men but more women did not consider themselves at risk of HIV in this study. 
The lower risk perception amongst women may reflect the higher proportion of women 
who were either born or spent over five years in Britain and/or the higher proportion 
having had a HIV test and therefore aware of their serostatus. Natsal 2000, which was 
more likely to capture both older and second generation migrants than MAYISHA, 
found men were more likely to test if they were recently arrived in Britain. MAYISHA 
found no association with time in Britain. This may reflect changing attitudes, greater 
visibility and increased treatment awareness of HIV within African countries, especially 
compared to more established African communities within Britain. Perception of HIV  
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risk and education level, factors found to be associated with HIV testing in women in 
this study, could all be influenced by time spent in Britain or age of migration.  The 
small numbers involved meant this study lacked power to investigate possible 
interactions fully. 
3.3.2   Limitations 
This study has some limitations. Natsal 2000 was a cross-sectional survey so causality 
is unable to be determined. The association between GUM attendance and HIV testing 
may reflect individuals accessing these services for the expressed intention of obtaining 
an HIV test, or reflect the offering of an HIV test as a result of their attendance.   
Similarly perception of HIV risk will be influenced by knowledge of their result (HIV 
status) at some point. This may account for the finding of low perception of HIV risk 
being associated with HIV testing for women. Data on those who tested HIV positive is 
not available.  Women perceiving themselves at high risk of HIV appeared less likely to 
test for HIV; given the small sample size in the current study this should be investigated 
further in future studies.  
Survey participants did not include the homeless or those living in institutions such as 
hostels.  A substantial proportion of the African population in Britain may be students, 
refugees, asylum seekers, or living in tied accommodation and thus more likely to be 
housed in institutions or even homeless. 6% of men and 5% of women in the ethnic 
boost sample refused CASI, compared to 1% of the core sample.  The CASI component 
included all the questions on sexual behaviour and HIV testing. These factors may have 
influenced those who felt able to complete the questionnaire. A number of potential 
confounders were not included in the survey questions and therefore unable to be 
included in the analysis for example, GP utilisation, residency status, fears and concerns 
around HIV testing, and perceptions of health services. Finally ‘black Africans’  
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comprise a heterogeneous aggregation of population sub-groups and includes 
individuals both born in the UK and in Africa. The broad ethnicity categorisation may 
obscure important cultural, religious, and temporal diversities that may impact on sexual 
attitudes and lifestyles (Fenton et al., 2002; Fenton et al., 2005).  
3.3.3   Implications for future policy and research 
A high proportion of men had sex with a partner from abroad; most are likely to be with 
people of the same ethnic background as the respondent (Fenton et al., 2001). This 
assortative sexual mixing contributes to perpetuating the cycle of high HIV risk 
amongst Africans in Britain.  Maintaining surveillance within Britain and globally of 
migration patterns, ethnic variations and STI epidemiology is fundamental to planning 
effective health interventions.  
The national strategy for sexual health and HIV sets specific targets to improve HIV 
testing uptake and reduce undiagnosed HIV infection (Department of Health, 2001). 
Results from this study will therefore help identify where HIV testing promotion 
interventions should be targeted. For example the low level of risk-perception in 
African women, suggests a need for enhanced gender specific education programmes. 
This study also provides baseline data to help evaluate the effectiveness of HIV testing 
promotion campaigns and provides a useful adjunct to interpreting data derived from 
other community and clinic based surveys. Encouragingly, black Africans appear to 
have relatively high rates of HIV testing compared to the general population 
(McGarrigle et al., 2005). GUM and antenatal services, where the majority of HIV 
testing in the UK occurs, are also well accessed by this population. These findings 
suggest prior prevention interventions with these communities have been successful. 
Nevertheless, there remains significant potential for health gain as the proportion of  
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undiagnosed HIV infection remains high and diagnoses continue to be made late in this 
group (The United Kingdom Collaborative Group for HIV and STI Surveillance, 2004). 
Innovative approaches are needed to improve opportunities for, and uptake of, HIV 
testing.  
3.3.4   Summary 
This chapter suggests that British black Africans do access health services and have a 
relatively high uptake of HIV testing. However as stated above Africans continue to 
present to HIV services with advanced disease.  Greater understanding of the factors 
associated with when and why Africans access HIV services in the UK is required, and 
this is the focus of the study presented in chapter 4.  
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Chapter 4: Key informant understandings 
of factors contributing to late presentation 
 
Abstract 
Objective: To identify the key issues affecting utilisation of HIV 
services for Africans in Britain.  
Design: Employing purposive sampling techniques, semi-structured 
interviews were conducted with key informants with extensive 
experience working with African communities, HIV and sexual health.  
Results: Eleven interviews were conducted. Respondents felt there was 
high HIV awareness within African communities in Britain but this did 
not translate into perception of individual risk. Home country experience 
and community mobilisation was highly influential on HIV awareness, 
appreciation of risk, and attitudes to health services. All informants 
identified confidentiality, stigma and migration issues as major 
influences on uptake of HIV services. Many institutional barriers to care 
exist; these include lack of cultural understanding, lack of open access or 
community clinics, failure to integrate care with support organisations, 
and the inability of GPs to address HIV effectively. 
Conclusion: Considerable agreement about the major issues influencing 
uptake of HIV services existed amongst the key informants.  Community 
involvement is paramount to effectively tackle health issues for these 
communities and should include input to ensure there is: better cultural 
understanding within the NHS; normalisation of the HIV testing process; 
and a clear message on the effectiveness of therapy. This would enable 
greater openness and visibility; vital to breaking down barriers to care 
and stigma. 
The findings within this chapter are published in AIDS care (2007): Why 
the(y) wait? Key informant understandings of factors contributing to late 
presentation and poor utilisation of HIV health and social services by 
African migrants in Britain. F. Burns et al., v.19: pp 102-8. 
 
4.0 Introduction   
Work presented in chapter 3 shows around 40% of black Africans in Britain having ever 
knowingly tested for HIV, compared to just 13% of the general British population 
(excludes those testing as part of blood donation) (McGarrigle et al., 2005; Burns et al., 
2005). This suggests relatively high awareness of HIV within British African  
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communities however compared to non-Africans HIV positive Africans in the UK 
access HIV services at a later stage of disease (Burns et al., 2001; Del Amo, Goh, & 
Forster, 1996; Sinka et al., 2003). Late diagnosis of HIV disease (CD4<200) 
significantly increases the risk of death within one year of diagnosis (OR 13.9, p<0.01) 
compared to those not diagnosed late (Chadborn, Delpech, Sinka, Rice, & Evans, 2005). 
Whilst the proportion diagnosed late is decreasing amongst men who have sex with 
men, it remains stable at between 40 and 50% among heterosexuals (The UK 
Collaborative Group for HIV and STI Surveillance, 2005). 
Given this significant health inequity in accessing of HIV services it is important to 
identify factors impeding more timely access. Review of the literature can be limited in 
its ability to identify local issues and, due to the inherent time involved in undertaking 
and writing up research, may not address topical issues.  Interviews with local key 
informants could help identify the current key issues influencing service uptake by HIV 
positive Africans living in London. This knowledge would help inform development of 
the questionnaire and topic guide to be used in SONHIA. The interviews would also 
provide an opportunity for exploration of the acceptability and appropriateness of the 
proposed methodology. 
4.0.1     Aim 
To undertake key informant interviews to identify key issues influencing service uptake 
by HIV positive Africans in Britain and to map out the pathways to HIV care for 
African migrants.  
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4.1  Methods 
4.1.1    Sampling frame  
Purposive sampling based around a sampling frame was used to ensure diversity of 
knowledge and experience. The sampling frame was defined according to key 
constituencies in the field of HIV service provision; these comprised of clinicians, 
public health consultants and epidemiologists, policy makers, health service researchers, 
health promotion specialists, and those involved in the voluntary sector. People living 
with HIV were not specifically identified for this study.  Once the key constituencies 
were defined it was possible to identify key organisations within each constituency 
(Table 4.1). By focusing down to the organisational level key people became 
identifiable, as the field of HIV and African communities in the UK is comparatively 
small.   
Table 4.1 Sampling Frame used for identifying key informants 
Key Constituency  Organisation 
Clinical  District general hospital 
Academic teaching hospital 
Public Health/Epidemiology  Health Protection Agency - National  
Health Protection Agency - Local  
Health service access researchers  Universities  
Hospitals/NHS 
Voluntary sector  Terrence Higgins Trust (National HIV NGO) 
African community NGOs 
Health promotion  Terrence Higgins Trust 
Camden & Islington Health Promotion 
Health First 
Policy National  AIDS  Trust 
African HIV Policy Network 
 
4.1.2    Recruitment 
All prospective informants were approached by letter and then phone. If the individual 
agreed an informal face-to-face interview was arranged and conducted at the venue of 
their choice. At least one individual from each constituency was interviewed. In order to  
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reduce selection bias the key informants were also asked if they could recommend 
anyone to speak to.  The HIV status of informants was not ascertained at any time. 
4.1.2    The interviews 
The interviews were interactive and exploratory in form based on a topic guide (Box 4.1 
and appendix 2). The key areas for exploration included: influences on community 
attitudes towards HIV and health care; perception of health services and the barriers to 
accessing care; HIV treatments; and how to improve services and information. 
Informants were also asked to map out the pathways into HIV care.  Clinical practice, 
other than how policy and structure of health services affect it, was not discussed thus 
avoiding potential ethical dilemmas pertaining to individual clinical practice. 
Box 4.1 Topic guide – summary of key areas for investigation 
Key informant particulars 
Community attitudes –  
Influences on learning about and attitudes towards HIV  
Influences on learning about and attitudes towards health care access 
Health Services & service history 
Barriers to health care access 
Successes in improving access to health services 
Map out pathways to HIV care 
HIV treatment options 
  Influence on presentation to services 
  Belief  & utilisation of other forms of therapy 
  Treatment migration as a phenomenon 
Improvements to services & information  
  Effective forms of encouragement and information 
  Who should be targeted 
Research process of proposed study 
  Views on proposed methodology 
4.1.3    Data collection and analysis 
All interviews were electronically recorded where possible.  Recording was not possible 
for four interviews, in these cases extensive field notes were taken during the interview 
and subsequently written up.  The recorded interviews were independently transcribed  
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verbatim. Analysis was undertaken using ‘Framework’(Ritchie & Spencer, 1994). This 
is a method of qualitative data analysis that involves ordering and synthesising verbatim 
data within a thematic matrix. The themes are developed both from the research 
question and from the accounts of the research participants.  ‘Framework’ is seen as 
particularly good for applied health service research (Ritchie et al., 1994). I conducted 
all the interviews, was responsible for identifying a thematic framework (based on the 
recurrent issues which emerged as important to the informants themselves), indexing, 
charting and interpretation of the data.  
4.1.4    Ethical approval  
Ethical approval for this study was obtained from the London Multi-centre research 
ethics committee (MREC 03/2/001) and informed consent obtained from all 
participants. 
4.2 Results 
4.2.1    Overview of sample 
 
Eleven interviews were conducted between July and September 2003. The informants 
had a total of 122 years (average 11 years) experience of working with African 
communities affected by HIV. The key informants included three clinical doctors, one 
public health consultant/epidemiologist, two health service researchers, two health 
promotion specialists, and five individuals who worked in the voluntary sector. Ten of 
the individuals were or had been directly involved in research into HIV within African 
communities in the UK.  Six informants had lived and/or worked in Africa, and five 
were Black Africans. Several individuals were involved in multiple roles such that all  
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constituencies and organisations identified in the sampling frame were represented in 
the sample. Interviews took on average one hour (range 45 to 90 minutes). 
4.2.2   Influences on knowledge and attitudes   
4.2.2.1 The  community 
All informants identified an individual’s national and ethnic identification as a key 
determinant of HIV awareness and that the level of awareness was proportional to the 
HIV prevalence in the country of origin.  This was modified by the extent of political 
will and community mobilisation that was occurring in African countries to highlight 
the problem of HIV.  Ugandans were regarded as a community that acknowledged HIV 
as a major problem and mobilised accordingly, both in Uganda and in the UK.   
Conversely West African communities were identified as not yet acknowledging HIV as 
a major issue and there was a corresponding lack of community mobilisation and 
awareness.  
Compared to non-Africans, UK African communities were thought to have a higher 
degree of HIV awareness.  However, most informants did not think this awareness 
translated into an appreciation of individual HIV risk, and that overall perception of 
personal risk remained low among most Africans resident in the UK. This was 
attributed to a combination of denial and beliefs that sexual practices outside the norm 
were required to enable HIV transmission.   
‘There is dissonance between fact and expectation, …  a separation of 
awareness from risk, and community from self.’  
Health promotion, male 
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4.2.2.2 Stigma 
HIV remains a much-stigmatised disease within African communities in the UK, and all 
informants acknowledged this as a major barrier to accessing HIV testing and other HIV 
services.  Why this continues to exist despite high HIV prevalence in Africa and often 
shared-common experience of the disease was not fully understood. The lack of 
openness about HIV, especially by those in positions of power and influence (for 
example religious leaders and community elders) was identified as a causative factor. 
That HIV is predominantly a sexually transmitted infection, and thus carries 
connotations about personal character, was also identified as an important factor 
increasing HIV-associated stigma. This association impacted on the accessing of 
services. People were fearful of presenting for an HIV test as the testing process itself 
carried an implication of blame; one only testing if they considered themselves 
susceptible because of their behaviour. 
However the perception of HIV as a deadly disease, directly resulting from home 
country experience, was seen as the principal cause of fear and stigma; as one informant 
stated: 
 ‘There is a set of assumptions that an HIV diagnosis is an immediate 
death sentence because that’s the experience that they’ve come from…. 
So there is a vision of what HIV means which I think colours a lot of 
stuff.’ 
 Female clinician  
 
 It was generally felt that there was now less stigma and discrimination attached to HIV 
in Africa.  However many Africans in the UK were not aware of a cultural shift towards 
greater openness and acceptance of HIV in Africa. The HIV-related stigma and fear of 
discrimination coming from within African communities was seen to have impeded  
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development of an effective community response, such as that seen within the gay 
community in the 1980s. 
4.2.2.3 Confidentiality 
Confidentiality was another barrier to accessing care that all informants identified. 
Limited freedom of movement as a consequence of prolonged immigration processes 
amplified individuals’ personal fears about disclosure and their ability to ‘contain’ the 
information about their HIV status from others, particularly people ‘at home’.  An 
example given was the fear that knowledge of HIV status may get back to the home 
country without them having any ability to modify the impact of this news for friends, 
family or acquaintances.  Several informants referred to Africans actively trying to 
avoid ‘burdening’ those back in Africa with knowledge of their HIV status, especially 
given the context of HIV diagnosis and association with death. Due to the isolation 
experienced as a consequence of migration, support networks in Britain tend to be small 
and based on kinship rather than direct or extended family.  The common perception 
was that people would face social isolation, and even violence, if their HIV status were 
disclosed.  
Confidentiality concerns also involved the accessing of particular services being 
associated with being HIV positive:  
‘There were special wards for people everywhere so people started 
fearing to go to any hospital. They would rather go where they don’t 
know them or where there’s no special ward’  
Voluntary sector, female 
 
Several informants believed this attitude was changing and that there was now a greater 
acceptance of the need for specialist services. Nevertheless, most felt UK Africans with 
HIV would prefer their HIV services to be located within a general medical context, to  
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avoid the possibility of indirect disclosure that comes with attending specialist services. 
Similarly there was perceived reluctance of Africans to access HIV services run by 
people from within their own communities due to increased likelihood of indirect 
disclosure. 
Fears around disclosure were intimately linked to the immigration process. Informants 
believed that many people either thought an HIV diagnosis would adversely affect their 
application for permanent residence, or that accessing health services would identify 
them to the immigration services.  Several informants spoke of lay fears of a ‘Big 
Brother’ like computer network operating between government departments that 
routinely exchanged such information. 
4.2.2.4 Cultural  norms 
Experiences people brought with them when they migrate were thought fundamental to 
how they subsequently viewed HIV and UK health services. In many African settings 
health services are accessed only when there is a specific need, and then, only when it is 
perceived to be serious.  As a result the philosophy of health promotion and preventive 
medicine are not well established in most African communities.  
‘As I understand it, in that society you wouldn’t go to hospital unless 
you were ill and therefore I’ve seen people present late, get an HIV 
diagnosis and are really dead pretty quickly afterwards so I think that 
people come with that, that lens, if you like. And so to then come to a 
society where you might just go to hospital feeling completely well and 
walk in and take an HIV test is not necessarily what people think of as 
standard behaviour.’  
Female Clinician 
 
As a result most Africans would be unfamiliar with a sexual health clinic that is ‘open-
access’ from the street, where one might go routinely, and certainly not expect it to be a 
place one would routinely go for an HIV test. Thus they would be unlikely to either  
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identify it as a place to go or know what to expect when they attend. Informants felt that 
many people did not know where to go for an HIV test, how long it would take, or that 
the result would be confidential. Similarly informants believed a high proportion of 
African immigrants did not appreciate that the National Health Service (NHS) is free at 
the point of delivery.   
The importance of the oral tradition within African societies was acknowledged by all 
informants as fundamentally important for imparting of knowledge, forming social 
attitudes, and for perpetuating ignorance around HIV transmission, fear and stigma. The 
informants felt there was a lack of accessible information on health services that 
reinforced the reliance on word-of-mouth, thus hindering individuals from acting 
independently.     
4.2.2.5  Migration 
The difficulties encountered by migrants generally were identified as a key factor 
impacting on HIV service uptake.  Health is only a priority when one is unwell; 
otherwise issues around immigration, housing, employment, and childcare take 
precedence. English being a second language means health messages get lost or 
distorted in translation. Disempowerment experienced by asylum seekers in particular 
was considered as a major factor impacting on health.  Uncertainty about entitlement to 
care under the National Health Service (NHS) was believed to limit utilisation of health 
services and although many people knew about treatments, many believed they would 
not be eligible for them or would have to pay for them. 
Although the migration experience and corresponding economic hardship was seen as a 
unifying factor, there remained significant diversity in the British ‘African community’. 
Informants felt these differences, not only in terms of country of origin but also gender  
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or religion, were not being acknowledged or addressed in services or information 
targeting ‘Africans’. ‘Treatment migration’, where individuals specifically migrate to 
Britain to access HIV services, was acknowledged to occur but was not felt to be 
significant.   
4.2.2.6  Institutional issues  
Informants described numerous structural and cultural institutional barriers to accessing 
health care. They felt the NHS’s institutional culture did little to help ‘break the silence’ 
around HIV in African communities. This was not perceived as institutional racism but 
institutional inertia. Failure of clinicians to understand cultural factors, social exclusion 
or poverty was felt to contribute to making the population of HIV infected Africans in 
Britain ‘invisible’. The lack of advocacy for Africans with HIV in Britain was 
compounded by the adverse advocacy frequently expressed in the media; HIV amongst 
migrants was still perceived by society as something we shouldn’t be spending money 
on. All informants raised the negative impact of the media.  It contributed to sense of 
general mistrust of people and institutions, specifically helped create mistrust of the 
NHS, and generally fuelled fear of stigma and discrimination.   
‘Africans are seen as vectors of infection. Testing in this environment 
just reinforces prejudices’  
Voluntary sector, male 
 
To balance this perspective the informants believed requires money, political will, and 
advocacy, resources that are often lacking for British African communities. 
Structural barriers to health care included appointment systems, which were viewed as 
especially intimidating for people unfamiliar with the system, or with English as a 
second language. Language barriers still exist although this is being addressed with the 
rise in interpreter and advocacy services. Lack of family facilities made access for those  
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with children difficult, as the HIV clinic environment is inappropriate for children. The 
overcrowding of many sexual health clinics amplified the fear of disclosure. 
Many of the informants identified problems within primary care. Many General 
Practitioners (GPs) were perceived to be failing to address HIV with their service users, 
whether this reflected a lack of knowledge or a lack of confidence on the part of GPs 
was unknown. Some felt people had lost trust in their GPs because despite testing HIV 
positive elsewhere the GP asked questions which were perceived to reflect ignorance, 
e.g. ‘how did you get it?’ or failed to even mention HIV. This prevents patients 
disclosing their HIV status to them. Several informants identified GP receptionists as 
being associated with breaches of confidentiality.  
To develop new initiatives to improve access for Africans affected by HIV, staff, time 
and money would be required; as health services were identified as already struggling to 
cope with current workload this was recognised as difficult.  
4.2.2.7 Treatment   
 
Effective treatments for HIV had impacted tremendously on people with diagnosed HIV 
infection; they had lifted morale and enabled patients to plan for the future. However 
the availability of treatment was not yet felt to have influenced attitudes or behaviours 
amongst those people who were not accessing HIV services.  Only one informant felt 
the benefit of effective therapies was feeding back into the community and changing 
people’s perceptions of and reactions to HIV. The uncertainty over entitlement to care 
was felt by some to be a limiting factor in the impact of antiretroviral therapies.  
Belief in and utilisation of other forms of therapies for HIV was thought to occur 
although other than the use of faith none of the informants had knowledge as to how 
common this may be.  Faith was felt to be widely used, as most African societies are  
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faith based; whilst there was acknowledgement that occasionally faith was used in lieu 
of medical interventions this was not felt to be common. 
4.2.3   Pathways to HIV care 
In Britain the majority of HIV testing occurs within open-access sexual health settings 
however informants felt migrant Africans rarely accessed these services directly. 
Instead indirect pathways exist encompassing social contacts, primary care, and hospital 
services. The failure of GPs to address HIV directly often means multiple exposures to 
health services before an HIV test is undertaken.  
‘One of the biggest barriers to HIV testing is how poorly accessible 
health services are in the UK. Its only when you’re very, very sick that 
you’re persistent. So people who access [HIV services] normally will 
have been to four or five different health facilities before they actually 
end up [here] - time and time again that’s what you see.’  
Male Clinician 
 
Entrance into HIV care for migrant Africans was perceived to be predominantly via 
hospital based services, e.g. antenatal and TB services, although social services 
(including the National Asylum Support Service), student health and community based 
organisations also provided important access points (figure 4.1). Services were not 
accessed unless driven by illness, which informants felt to be typically two to three 
years after arrival in the UK.  
4.2.3   Improving access to HIV services 
 4.2.3.1  Community involvement 
As peer-led interventions were perceived as best practice, all informants felt more 
community involvement was fundamental to improving information and services for 
Africans affected by HIV. Community participation was required at all stages of service 
provision from inception to implementation and evaluation.  Greater          
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Figure 4.1 Schematic of Pathways to HIV Care 
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community involvement incorporated the idea of more community clinics and testing 
opportunities. 
Community involvement would enable greater openness and visibility, which was vital 
to breaking down barriers to care and stigma. In particular informants identified a need 
for community leaders (faith leaders, traditional leaders, big business people) to be 
involved. Greater openness would in turn enable more positive advocacy.  It was hoped 
Africans would become more involved with organisations that are already well 
established with political clout (e.g. the Terrence Higgins Trust).   
4.2.3.2 Cultural  understanding of health and disease 
Better training of health professionals around the cultural meanings of health and 
disease was identified as an area that would improve services and help with 
development of appropriate prevention interventions. Clinicians need to understand the 
assumptions made and the impact on the social environment of testing HIV positive.  
‘Some of the literature that comes out I think is not very appropriate, it’s 
very Western medical model, this is HIV and it’s a virus, it doesn’t 
really take into account people’s cultures and understanding about 
illness and what it means’  
Male clinician 
 
The importance of community prescribed norms in influencing behaviours must not be 
overlooked. The difficulty for prevention interventions was in adopting messages that 
actually support African culture and cultural needs, such as reproductive drive.  
4.2.3.3 Gender 
All the informants spoke of the need to engage more with African men.  There is 
evidence that African men access HIV services later than African women (SOPHID, 
2003).  Men lack a ‘front door’ to services (compared to women who access health 
services for pregnancy and childcare issues), are greater risk takers (more sexual  
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partners, more time and social space than women are likely to have), and are less 
willing to seek help unless absolutely necessary. These issues exist for all men however 
the processes involved in migration (see above) have the potential to amplify these 
barriers for African men living in the UK.  Men were also felt to have more difficulty 
accepting their diagnosis. 
4.2.3.4  Broaden health message 
The informants felt HIV information needs to broaden its remit. Currently most HIV 
information for African communities is targeted at those already positive rather than 
focusing on prevention and health promotion. Similarly the messages should 
incorporate all aspects of sexual health. The message of ‘probably acquired in Africa’ 
was felt to be counterproductive to HIV prevention work within Britain. Africans do not 
embrace imagery targeted at Africans per se, as this is perceived to fuel stigma and 
discrimination. Providing different universal messages that include Africans was 
preferred. Health promotion needed to become incorporated into everyday life, as 
people will not attend HIV talks as this implies ‘bad behaviour’.  
However clinicians when working with patients should try to personalise the message, 
i.e. focus on the individual not the population. 
 ‘It’s important for you to use a condom because of this…’  
Health promotion, man 
 
Other ideas included utilising the Internet and provision of information on how to 
access health services outside of health services. Several informants felt that 
acknowledging modes other than sexual transmission would enable more people to 
access HIV services.   
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4.2.3.5   Successful interventions  
Examples of successful interventions involving HIV services were limited.  All 
informants referred to the antenatal HIV testing programme.  Whilst there was 
acknowledgement of the difficulties and controversies associated with diagnosis at this 
time it was felt to have proved successful in reducing vertical transmission of HIV and 
in getting women appropriate care.  The combination of political will and community 
mobilisation was thought crucial to the success of this programme. 
Otherwise informants referred to the increase in community mobilisation generally, this 
incorporated the rise in HIV positive support organisations and trained HIV positive 
speakers doing outreach and general advocacy. ‘Awaredressers’ in Birmingham was 
identified as a successful intervention in which hairdressers are trained in health 
promotion around HIV and sexual health. Optimism was expressed about the integrated 
HIV testing service with Lighthouse Kings where health professionals and community 
organisations worked in unison. Finally the health packs provided by the Refugee 
Council were identified as helping get people into services. 
4.2.4   Views on proposed methodology 
A detailed overview of the proposed methodology for SONHIA was provided to the 
informants for feedback on during the interview. The aims and objectives, recruitment 
process, and utilising dual methodologies were discussed. Few informants had specific 
comments about the proposed methodology for SONHIA. Most anticipated that the 
study population would be reluctant to participate due to the concerns around disclosure 
and mistrust of ‘the system’. The informants felt recruitment to the interviews, and of 
men in particular, would be especially problematic. The proposed ‘token of 
appreciation’ was felt to be important for acknowledging the time involved and in its  
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ability to act as an incentive to facilitate recruitment. They agreed that providing the 
survey in French and English should suffice, the use of interpreters being sufficient for 
those not covered by those languages.  
Several informants recognised that the in-depth interviews to be conducted in SONHIA 
would allow comparison of issues identified by the service users with those of service 
providers, enhancing the applicability of these findings.  
The strongest message was the need for acknowledgment and dissemination of the 
research findings back into the communities affected by the research.   The need for 
participants to see the results of research and how they impact on their community and 
health care experiences was perceived to be currently lacking from most research. 
Community involvement was felt paramount to effectively tackle the health issues for 
this immigrant population. Whilst the involvement of a community advisory group was 
always anticipated, feedback from the interviews reinforced the importance of 
community involvement from inception right through to dissemination of findings. 
Proposed outputs were modified to include more extensive dissemination to the 
communities following these interviews.  
Being a white New Zealander was not seen as barrier to me conducting the research. 
4.3 Discussion 
Considerable agreement about the major issues influencing uptake of HIV services, 
regardless of professional background, existed among these key informants.   
Respondents felt there was high HIV awareness within African communities in the UK 
but this did not translate into perception of individual risk or effective use of services. 
Home country experience and community mobilisation was hugely influential on HIV 
awareness, appreciation of risk, and attitudes to health services. All informants  
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identified stigma, confidentiality and migration issues as major influences on uptake of 
HIV services. Many institutional barriers to care were thought to exist. These include 
lack of cultural understanding amongst staff, lack of open access clinics and child-care 
facilities, failure to integrate care with support organisations, few community clinics, 
and the inability of many GPs to address HIV effectively.  
The issues identified by the key informants support previous work that has been done in 
this area.  UK African communities still need basic information on how and where to 
access appropriate health services, what these services entail, that they are confidential 
and that they are not linked to the Home Office or Immigration Services (Erwin et al., 
1999; Maharaj et al., 1996; Ndofor-Tah et al., 2000). HIV-related stigma and the fear of 
discrimination, which are intimately tied into issues of poverty and migration, continue 
to exert a disproportionate influence on health and health service access (Doyal & 
Anderson, 2005; Erwin et al., 1999).   
Effective antiretroviral regimes have been widely available within the NHS since 1996. 
Despite this, there has been no decline in the proportion of Africans in Britain 
presenting to HIV services with advanced disease (The UK Collaborative Group for 
HIV and STI Surveillance, 2005).  This study suggests poor understanding of the 
benefits of early intervention, fear of the consequences of testing positive in relation to 
immigration, ignorance around entitlement to care and unfamiliarity with the NHS 
combine to hinder service access.  
This study highlights the institutional role played by NHS service structures in 
perpetuating poor access for migrant Africans. Several informants, as well as recent 
literature (Manavi & Welsby, 2005), suggested that the emphasis placed on detailed 
voluntary counselling and testing has created a barrier for many clinicians to offering 
HIV tests.  Clinicians outside sexual health clinics and antenatal settings appear  
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reluctant to offer an HIV test themselves, even when they suspect HIV infection, and 
prefer instead to recommend attendance at a sexual health clinic.   
The process of onward referral inevitably creates a barrier to HIV testing, and 
complicates the pathway into care. Referral to a sexual health clinic in particular, may 
create its own barrier for African communities given the stigma associated with HIV 
and unfamiliarity with sexual health services. The informants all spoke of the indirect 
pathway into HIV care experienced by many Africans.  
Although the sample size of this study was small, utilising purposive sampling 
techniques ensured it encompassed a broad cross-section of experts involved with 
African communities and HIV care in Britain. Even with the diverse sample, there was 
consistency in expert views about what were the key issues, suggesting that some 
degree of ‘saturation’ of view about the problem had been reached. Emergent themes 
such as community involvement could potentially be influenced by the sample selected, 
for example many of the informants were directly involved with community 
organisations. Care was taken to ensure that when views that may reflect a vested 
interest or bias were expressed that these views were either also expressed by other 
informants or were acknowledged as such.  
The lack of service users among the informants is a major limitation of the current 
study. Involvement of service users would enhance the applicability of these findings 
and allow comparison of their identified issues with those of service providers; a study 
of this nature is presented in chapter 9. 
4.3.1    Summary  
Socio-cultural factors are key determinants of the HIV epidemic. For many, migration is 
a difficult uncertain process and HIV in this scenario can have greater social  
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consequences than it does for others in the UK general population. Community 
involvement is paramount to effectively tackle health issues for immigrant populations. 
To address HIV in African communities this should include input to ensure there is 
better cultural understanding within the NHS and other government organisations; 
normalisation of the HIV testing process; and a clear message of the effectiveness of 
therapy. 
This study provides some insight into how people working in the field perceive factors 
impacting on utilisation of HIV services by migrant Africans. These views need to be 
considered in conjunction with those of service users and the rest of this thesis will be a 
presentation and discussion of the Study of newly diagnosed HIV infection among 
Africans in London (the SONHIA study).  
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Chapter 5: Study of newly diagnosed HIV 
infection in Africans in London: 
Methodology 
 
Abstract 
This chapter describes the design of a study to determine and explore the 
factors influencing access and utilisation of HIV treatment services, and 
to determine the extent of UK acquisition of HIV, among Africans 
resident in London. Methodology was to combine quantitative and 
qualitative methods in a multi-centre study of newly diagnosed HIV 
positive Africans.  
A study of newly diagnosed HIV positive Africans attending 15 HIV 
treatment centres across London was conducted between April 2004 and 
February 2006.  The study consisted of two components: i. a quantitative 
cross-sectional survey and ii. in depth interviews with a purposively 
selected sub sample. The survey consisted of a confidential self-
completed questionnaire linked to clinician completed clinical records. 
All HIV positive Africans attending the participating centres i) 
diagnosed HIV positive for the first time within twelve months of 
recruitment and ii) aged 18 years or older were eligible for recruitment 
to this study. For the purposes of this study ‘Africans’ were defined as 
persons born or raised (up to and including 16 years of age) in Africa. 
Whilst uptake amongst those approached was higher than anticipated, 
the referral of eligible patients to the study team for recruitment was 
lower, necessitating extension of the recruitment period. 
Exploring factors associated with late presentation to HIV services and 
UK acquisition of HIV with newly diagnosed HIV positive Africans was 
both feasible and acceptable to staff and study population alike.   
Continual monitoring of study instruments and procedures ensured 
problems were identified early and addressed appropriately. 
 
5.0 Introduction 
The literature review presented in chapter 2, the analysis of factors associated with HIV 
testing among Africans residing in Britain (chapter 3), and the key informant interviews 
(chapter 4) were critical components of the preparatory work towards the study of 
newly diagnosed HIV infection in Africans in London (the SONHIA study). This 
chapter describes the methodology employed, the development and validation of the  
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study instruments (questionnaire, clinical data form and topic guide), and the principles 
behind the study design. The chapter concludes with the challenges of implementation 
of this study, and the strategies to address them. 
5.1   SONHIA 
The study of newly diagnosed HIV positive Africans in London (SONHIA) consisted of 
two inter-linked components implemented over two years: i) A survey of newly 
diagnosed HIV positive Africans presenting to specialist HIV services in London linked 
to clinical data; and ii) A qualitative study amongst a purposively selected sub sample 
of newly diagnosed HIV positive Africans employing in-depth interviewing techniques. 
5.1.1    Why use dual methodologies? 
Quantitative and qualitative approaches differ conceptually and methodologically 
yielding different types of information; it is this very difference that makes them 
complementary. To quantify patients’ experiences of a disease would only tell half the 
story without also identifying the ways in which the disease impacts on their lives, or 
indeed how their lives impacts on the disease.  
Quantitative research focuses on revealing causal relationships through quantification 
and hypothesis testing. Surveys can provide valuable data on the ‘how much’ and 
‘what’ but are limited in their ability to answer complex questions such as exploring the 
‘how’ and ‘why’.  Qualitative research, whilst also examining causation, focuses on 
discovering the nature of phenomena as humanly experienced (Minichiello, Sullivan, 
Greenwood, & Axford, 1999). Particular aspects of culture, such as health seeking 
behaviours, can only be understood by placing them in a broader context. 
By using mixed methodology a more holistic or critical understanding of the issues 
affecting accessing of HIV services is acquired. The quantitative component provides  
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data on distribution and associations with outcomes, whilst the qualitative component 
provides in-depth understanding of meaning and context. Qualitative methods will help 
highlight the contradictions and ambivalence in what may at first seem a simple reality. 
Simply put, the combining of quantitative and qualitative methodologies allows for both 
detailed measurement and explanation. 
Development of the questionnaire, clinical data form and topic guide did not occur until 
completion of all phases of preparatory work; including the key informants interviews, 
analysis of Natsal 2000 dataset and the literature review. This enabled questions to be 
incorporated that explored the major issues identified in the background work. To 
facilitate future comparative analysis questions were taken from other large-scale 
surveys of health service utilisation, and sexual attitudes and lifestyles, e.g. Natsal 2000 
(Erens et al., 2001) and the MAYISHA study (Chinouya, Davidson, Fenton, & on 
behalf of the MAYISHA Team, 2000), whenever possible. The underlying principles 
that informed development of the study instruments are provided in box 5.2 below. 
Box 5.2 
Key principles that informed development  
of the questionnaire and topic guide 
•  Format and content to be acceptable to study population 
•  Ensure ethically and culturally appropriate 
•  Keep questions simple (questionnaire to be self-completed by pen on paper) 
•  To use validated questions whenever possible 
•  To incorporate findings from literature review, Natsal analysis and key 
informant interviews. 
•  Focus limited to study objectives 
•  Facilitate comparison with other large-scale behavioural surveys  
(MAYISHA, Natsal) where possible 
•  Enable in-depth exploration to maximise output potential 
•  Facilitate recruitment by minimising work for clinic staff   
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5.1.2   Developing the quantitative component 
5.1.2.1  Designing the questionnaire 
In order to design the quantitative questionnaire and clinical data form it was important 
to first identify specific survey objectives.   
The measurement objectives of the study were defined as follows: 
1.  To measure the frequency and event experience of HIV testing.  
2.  To measure utilisation of health and social services in the UK prior to HIV 
diagnosis. 
3.  To measure attitudes towards and knowledge of HIV and HIV services, and to 
examine their relationship with behaviour. 
4.  To assess the proportion of HIV infections amongst Africans acquired within the 
UK 
5.  To determine the probability of onward transmission of HIV infection related to 
undiagnosed HIV infection. 
6.  To determine the demographic, social and behavioural characteristics of those who 
present with advanced HIV disease. 
Defining the measurement objectives enabled identification of the research variables 
needed to meet these objectives.  
Research variables 
Utilisation of services: Frequency and cause of use; Perception of health services; 
Knowledge and awareness of sexual health services. 
 Sexual health: Knowledge and awareness of HIV; Attitudes towards HIV; History of 
STIs; Sources of information on HIV; HIV testing.  
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Sexual partners: Numbers and gender of sexual partners in different time intervals; 
Experience of paying or being paid for sex. 
Migration history: Time in the UK; Travel back to Africa; Country of birth and 
adolescence; Residency status.  
Clinical (at diagnosis and 6 months post diagnosis): CD4 count; HIV viral load; AIDS 
defining illnesses; CDC stage; Probable seroconversion; Treatment history. 
Demographic variables for subgroup analysis: gender, age, marital status, education 
level, religion, ethnic identity, area of residence, children, employment, country of birth, 
language, residency status. 
All these variables were captured within the questionnaire. 
5.1.2.2  Method of data collection 
The decision about the methods of data collection revolved around the study population, 
the nature of the information to be collected, cost and practicality. Computer-assisted 
self-interview (CASI) has been shown to aid in the disclosure of sensitive information 
(Johnson et al., 2001) however some concern was expressed by key informants about 
this modality for this particular study population. Computers were identified as a source 
of mistrust by some informants and linked into fears of information sharing and 
disclosure between government agencies. In Natsal 2000 6% of men and 5% of women 
in the ethnic boost sample refused CASI, compared to 1% of the core sample (Erens et 
al., 2001).  There was also no budget for the multiple laptops CASI would require given 
the number of study sites, nor a budget for the staff time that would be required to 
administer the questionnaire in this way. Thus although pen and paper limited the 
nature, breadth and depth of questions, this was the chosen modus operandi. The  
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questionnaire was designed to be self-completed to facilitate disclosure to sensitive 
questions. 
5.1.2.3 Questionnaire  format 
The questionnaire was structured to provide a sequence of questions that would provide 
clarity and facilitate reliable responses. Relatively neutral questions (for example 
requests on demographics and general health) led on to more sensitive ones. The 
questionnaire was presented in a booklet divided into chronological sections designed to 
provide a contextual framework to place events, order thoughts, and aid recall. 
5.1.2.4 Language 
As the questionnaire was designed to be self-completed, it was very important that all 
respondents interpreted terminology the same way.  Thus the self-completion booklet 
was prefaced with a glossary of key terms. To enable cross study comparison the same 
definitions used in the Natsal 2000 survey (Erens et al., 2001) were employed in this 
study. The language used throughout the questionnaire was neutral but formal.  
The questionnaire was made available in both an English and French version.   
HIV/AIDS surveillance data from the Public Health Laboratory Service
11 at the time of 
study development suggested that for the ten most common countries of origin for 
newly diagnosed Africans (accounting for over 75% of newly diagnosed infections), the 
overwhelming majority were from English speaking Commonwealth African countries.  
This reflects our historical ties with the countries of origin and current migratory 
patterns. Most other non-English speaking countries represented within the surveillance 
data were francophone, with Congo being the largest contributor.  
                                                 
11 The Public Health Laboratory Service was the predecessor of the Health Protection Agency. It ceased 
to exist on 1/4/2003.  
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Experience with research among African communities also supported this approach. 
After extensive field-research, the MRC-funded ethnic minority boost for the National 
Survey for Sexual Attitudes and Lifestyles (Natsal 2000) felt that provision for 
languages other than English were not required. Whilst MAYISHA, a study of over 700 
Black Africans from the highest prevalence countries in Britain, utilised English and 
French questionnaires for respondents (Chinouya et al., 2000).  
The SONHIA questionnaire was only available in English and French versions, 
however advocates and translators were used for those participants who spoke other 
languages; the numbers requiring this service being small.  In addition the key worker 
was available to assist with the questionnaire should this have been required.   
5.1.2.5  Reliability and validity 
A study of this nature, although linked to clinical information, essentially relies on self-
reports. Disclosing honest information related to sexual behaviour in the context of HIV 
infection could be problematic for some. Guarantees of confidentiality were given on 
the front cover and throughout the booklet to help maximise veracity. This was 
reinforced by the provision of a sealable envelope to put the completed questionnaire in. 
‘Permissive’ questions, i.e. questions that by their wording imply acceptance of the 
behaviour in question, were sometimes employed to aid disclosure. The questionnaire 
consisted largely of tick boxes to facilitate the answering of sensitive questions. 
  Whenever possible questions were taken from other large-scale surveys of health 
service utilisation, and sexual attitudes and lifestyles, e.g. Natsal 2000 (Erens et al., 
2001) and the MAYISHA study (Chinouya et al., 2000), as these questions had already 
undergone thorough validation and reliability testing. An eligibility criterion from the 
time of initial HIV diagnosis was specifically set up to minimise recall bias. As the  
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study’s principal aim was to understand the factors associated with initiating access to 
HIV care it was important that respondents completed the questionnaire as close as 
possible to their initial diagnosis. 
5.1.2.6  The survey instruments  
The survey instruments (questionnaire and clinical data form (appendices 4 and 5)) were 
designed to obtain data related to patient’s health beliefs and utilisation of health 
services; the demographic, behavioural and social factors associated with delayed 
presentation to treatment services; and the extent to which acquisition of their infection 
may have occurred within the UK. They also obtained information on patient’s 
demographic characteristics, HIV history, sexual health and sexual behaviour, 
antiretroviral drug history, and service access. Finally, the questionnaire was designed 
to assess knowledge, attitudes and beliefs around HIV/AIDS. 
Each confidential self-completed pen and paper questionnaire  (available in English and 
French) was linked to relevant clinical information obtained from the patient’s medical 
notes. Clinical data from the time of diagnosis and six-months post diagnosis was 
collected by members of the research team. Data collected included: CD4 and viral 
load, clinical staging including seroconversion and AIDS defining conditions, exposure 
to antiretroviral medication, viral subtypes and resistance patterns. 
The questionnaire was designed to take between 30 and 60 minutes to complete. All 
participants completing the questionnaire were reimbursed £10 to cover time and travel 
expenses. A list of relevant helplines was provided to each respondent. All respondents 
undertook this component of the study.    
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5.1.2.7 Sample  size 
Previous research suggest that between 35 and 50% of Africans who are diagnosed with 
HIV in London already have advanced disease at the time of diagnosis (Burns et al., 
2001; Gupta, Gilbert, Brady, Livingstone, & Evans, 2000; Saul, Erwin, Bruce, & Peters, 
2000). Along with AIDS, a CD4 count below 200 cells/µL is a marker of advanced HIV 
disease. As CD4 can be viewed as a more solid marker of late presentation given that 
tuberculosis (TB), an AIDS defining illnesses especially prevalent among Africans 
(Sinka et al., 2003), can occur early in the course of HIV infection. Late presentation 
was defined according to CD4 criteria alone. Late presentation (CD4 count below 200 
cells/µL at time of HIV diagnosis) was the principal outcome for the survey. 
It was assumed that a measure of late presentation would have a population prevalence 
of roughly 40%. The aim was to have 80% power to detect significant associations of 
moderate risk, e.g. relative risk (RR) 1.5, necessitating a sample size of 330. Assuming 
a response rate to the questionnaire part of the study of 70% then approximately 470 
eligible patients would be required.  Sample size was calculated using Epi info.  
5.1.3   The qualitative component 
5.1.3.1  Sample design  
The population for this qualitative sub study comprised of English speaking African 
people aged over 18 diagnosed recently with HIV infection. African communities 
contain an aggregation of heterogeneous population sub-groups, which vary 
geographically and over time. For a sample of this kind purposive sampling using quota 
criterion was appropriate to ensure maximum diversity of key socio-demographic 
variables thought to be associated with late presentation.  The quota matrix (appendix 7) 
consisted of primary and secondary criteria. The primary criteria comprised of age,  
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gender and length of residence in the UK.  The secondary criteria consisted of 
partnership status, region of origin (divided according to a low, high or increasing HIV 
prevalence), and recruitment site. The selection criteria were informed by the key 
informants interviews.  
Because of the screening procedure employed it was not possible to link selection 
criteria with clinical stage. The initial plan was for forty purposively selected 
participants were to be interviewed, as this number should allow for data saturation 
(when no new concepts are emerging). The interviews were limited to those proficient 
in English as all interviews were conducted by myself.  
5.1.3.2  Development of the topic guide  
As with the survey instruments the topic guide was not developed until all phases of 
preparatory work were completed; thus enabling inclusion of the key issues that 
emerged.  Refinement of the topic guide (appendix 8) was an ongoing process grounded 
in the information obtained from the interviews themselves.  
The key areas for investigation were: personal circumstances, e.g. partnership status, 
migration history; personal and community attitudes and influences, e.g. stigma, role of 
religion; learning about and the awareness of HIV – both personally and within the 
community; perceptions and experiences of health services; detailed sexual health 
history; awareness and beliefs on HIV treatment options; and means of improvement to 
services and information.  
It was estimated that the interviews would take approximately 90 minutes to complete. 
All participants were reimbursed £20 to cover time and travel expenses. A list of 
relevant helplines was offered to each participant, as was the opportunity to discuss 
further any issues raised with an appropriate trained professional.    
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5.2 Validation 
An African community reference group (ACRG) was set-up to approve, review and 
oversee all stages of the study. The steering committee for the African HIV Research 
Forum (AHRF) was chosen for the role of ACRG. The AHRF is an umbrella 
organisation that’s main aim is to bring together individuals and organisations to focus 
on all aspects of HIV research relating to the various African communities within the 
United Kingdom. The AHRF steering committee is drawn from key stakeholders 
working in community-based organisations, the statutory and voluntary sectors. 
Although individuals changed the steering committee was essentially always comprised 
of people with knowledge and interest in the field of HIV and African communities, 
they were already formally linked and meet regularly. 
Once the Topic Guide and Questionnaire were developed they were presented both to 
the key informants and to members of the ACRG for review.  This was done in order to 
try and ensure that the content, construct and context of the instruments were 
appropriate.  The London Multi-centre research ethics committee (MREC) also 
suggested some minor changes to wording of certain questions and further explanation 
on certain terminologies that were duly incorporated. At this stage the questionnaire and 
topic guide were piloted. 
5.2.1  Piloting of questionnaire  
Piloting was undertaken before embarking upon full-scale recruitment in order to test 
the feasibility of survey procedures and their acceptability to patients. The pilots 
explored patients’ understanding of the questionnaire’s items and constructs and 
involved: i) recruitment of 13 respondents; ii) monitored administration of 
questionnaires (timing, questions asked by respondent); iii) in-depth cognitive  
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interviewing with respondents to explore understanding of key words and constructs; 
and iv) review of questionnaire completion and item non-response rates. 
Two small-scale pilots, including cognitive interviews, were conducted on African 
patients attending the Mortimer Market Centre. The second pilot (n=8) was conducted 
following modification of the questionnaire to incorporate feedback from the initial 
pilot (n=5). All people participating in the pilot were reimbursed £10. Following the 
initial pilot construction and/or terminology of several questions was modified, one 
question was dropped and several open-ended questions were changed to tick boxes 
options. Piloting of the modified questionnaire led to inclusion of more statements about 
confidentiality of the study. The average time to complete the questionnaire was 40 
minutes (range 20 to 65 minutes). 
5.2.2    Feedback from pilots and presentation to ACRG 
Response to the questionnaire from both the pilots and ACRG was overwhelmingly 
positive. The research was seen as worthwhile with ‘relevant’, ‘valid’ and ‘important’ 
being frequently used to describe the aims of the study by both the ACRG and pilot 
participants.   
The questionnaire bordered on being too long however the reimbursement provided 
helped compensate for this. Despite the length and use of jumps the questionnaire was 
‘informative, straightforward and to the point’ and ‘not complicated’. One patient felt 
unable to answer the question about the belief that HIV was created by white people 
because she knew she was going to talk to me after completing the questionnaire and I 
am a white person. Otherwise all patients piloting the questionnaire felt able to answer 
all questions honestly with the stems making the very sensitive questions acceptable. 
Respondents described getting a sense of purpose from the questionnaire.   
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5.2.3   Pilot of in-depth interviews 
A pilot was undertaken to test survey procedures and their acceptability to patients 
before embarking upon full-scale recruitment. The pilot was used to explore patients 
understanding of the items and constructs included in the topic guide. The pilot 
involved: i) recruitment of three respondents; ii) monitored in-depth interview to 
explore understanding of key words and constructs, timing, questions asked by 
respondent; iv) review of topic guide; and v) feedback on interviewing technique by my 
supervisors.   
The pilot interviews were all conducted at Newham University Hospital in a private 
room.  Two women and one man were interviewed, and the interviews lasted between 
60 and 90 minutes.  The interviews were tape-recorded although for the first interview 
the recording mechanism failed.  This was discovered immediately after the interview at 
which stage extensive notes were written.  At completion of the interviews the 
interviewees were all asked how they found the interview, and whether they had 
difficulty with any of the questions.  One of the interviewees had recounted very 
traumatic experiences and had expressed a lot of grief during the interview, despite this 
all said they would be involved in further interviews should these be required and 
expressed a sense of pride that they had in some way contributed to research into HIV 
and African communities. One of the respondents had indefinite rights to remain in the 
UK, one was an asylum seeker and the other was ‘illegal’; yet they felt secure 
discussing immigration issues and being tape-recorded.  It was important to them to 
know that the tape recording could be stopped whilst they answered certain questions 
although none used this option.  The interviewees received £20 for participating in the 
pilots.  
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The tape-recordings/transcripts and field notes of the pilot interviews were all reviewed 
by one of my supervisors.  The content and conduct of the interviews were felt 
appropriate. Guidance on allowing space within an interview and exploring emerging 
themes in more depth was also provided. 
5.3 Study  setting 
The study was undertaken in 15 London HIV treatment centres providing in- or out-
patient services: Archway Sexual Health Clinic, Central Middlesex Hospital, Charing 
Cross Hospital, The Chelsea and Westminster Hospital, Homerton University Hospital, 
the Mortimer Market Centre, the North Middlesex Hospital, Newham University 
Hospital, the Royal London Hospital, St. Bartholomew’s Hospital, St. George’s 
Hospital, St. Mary’s Hospital, University College Hospital, Watford General Hospital, 
and the Victoria Clinic for Sexual Health.  
Initially 11 HIV treatment centres were approached to participate in SONHIA however 
after 10 months of recruitment it was evident that to obtain adequate numbers further 
sites would be needed; at this stage four further sites became involved (table 5.1). 
5.4 Study  population 
All HIV positive Africans attending the participating centres i) diagnosed HIV positive 
for the first time within twelve months of recruitment and ii) aged 18 years or older 
were eligible for recruitment to this study. For the purposes of this study ‘Africans’ 
were defined as persons born or raised (up to and including 16 years of age) in Africa. 
Africans of all racial and ethnic backgrounds were included in the study. Patients 
diagnosed HIV positive for longer than twelve months but transferring to the study 
centres during the recruitment period were not eligible for inclusion.  
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Initially recruitment was restricted to those patients within six months of initial HIV 
diagnosis; this was in order to reduce measurement error associated with recall bias, and 
to limit loss to follow-up. It became apparent that such a short time span missed too 
many eligible patients, in particular pregnant women.  The period of eligibility for 
recruitment was increased to twelve months in May 2005.  The time extension provided 
greater opportunities to approach patients at ‘appropriate’ times without substantially 
altering the potential for recall bias. 
5.4.1   Patient identification and recruitment 
The same recruitment procedure was used for both study components: Each of the 15 
study centres nominated a key worker (for example a research nurse) who was 
responsible for identifying eligible patients.  Key workers identified eligible patients via 
electronic databases and HIV positive case note review. The case notes of all eligible 
patients were then ‘flagged’, thereby alerting the physician for study recruitment at an 
appropriate time.  This ‘appropriate’ time was at the discretion of the attending 
physician. Recruitment could be undertaken by the physician but was usually conducted 
by the key worker. 
At recruitment, patients received information sheets summarising the study and its key 
objectives (appendix 5). Written informed consent was required prior to participation in 
the study (appendix 6). For patients declining to participate in the study collection of 
anonymised minimal information (ethnicity, country of origin, CD4) to enable 
assessment of potential selection and participation biases was desired. Despite an 
appeal, the ethics committee approving this study expressly stipulated that written 
consent must be obtained to collect this data. If consent was not obtained only data on 
gender and age could be collected. Once recruited, the key worker arranged for the 
patient to complete the questionnaire at a convenient time and place.    
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Once the quantitative component was completed patients were also invited to consider 
participation in the interviews and if agreeable provided their contact details. Contact 
was established by telephone and a short screening questionnaire was completed to 
assess eligibility according to the quota system developed. If the respondent was 
eligible arrangements were made to conduct the interview at a mutually convenient time 
and location.  
An opportunity to discuss any sensitive issues raised as a result of participating in the 
interviews or questionnaire (with an appropriate trained professional) was offered to all 
participants. 
5.4.2   Monitoring of recruitment  
Monitoring of recruitment procedures occurred throughout the study period.  All 
eligible patients were recorded onto a clinic log.  The log included data on age, gender 
and date of HIV diagnosis. If a patient failed to be approached within the eligibility 
period this was recorded on the log; as were details and outcome of any approach made 
within the eligibility period. Copies of the clinic logs were collected on a quarterly 
basis. In addition for every respondent approached a response sheet was completed. If 
consent was obtained the response sheets collected data on site of recruitment, age, 
gender, ethnicity, country of birth, time in UK, and CD4 count and CDC stage at HIV 
diagnosis. If consent to supply baseline information by those declining to participate 
was not obtained then only data on clinic site, age and gender was obtained. These 
sheets were collected regularly and provided a means of monitoring whether systematic 
bias was occurring in the recruitment process.  
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I obtained an honorary contract as a clinical researcher at every study site.  This enabled 
me to check data handling methods, review procedures for patient identification, and 
assist the key workers in data collection, flagging notes and recruitment. 
5.5 Ethical  approval 
Agreement to collaborate was granted from the Lead HIV Consultant in all participating 
treatment centres. The questionnaire, topic guide, information sheets, consent forms and 
protocol were granted approval from the London Multicentre Research Ethics 
Committee (MREC/03/2/105). The study was awarded a no local investigator status, 
which meant approval from all the appropriate Local Research Ethics Committees was 
not required although they were all notified about the project. In addition the ACRG 
approved, reviewed and oversaw all stages of the study.  
5.6 Timetable 
The quantitative component was initially designed to run for 18 months, with 
recruitment to the qualitative component to occur in the final 6 months of this 18-month 
period.  In reality the quantitative component ran for 22 months, with recruitment to the 
in-depth interviews occurring over the final 10-month period. The first study sites 
commenced recruitment to SONHIA in April 2004. A rollout of subsequent sites 
followed until March 2005. All sites stopped recruiting on 28 February 2006. 
5.7  The challenges of implementation  
5.7.1   Recruitment   
The principal difficulty with SONHIA was recruitment.  Although intended otherwise 
recruitment was effectively suspended during my maternity leave.  In addition the  
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numbers of Africans diagnosed HIV positive at nearly all the study centres was 
substantially fewer than those anticipated (table 5.1).   
 
Table 5.1 Study sites recruitment tally 
 
Site 
 
Site # 
 
Start date 
 
Anticipated 
Total
1 
Actual 
Total 
eligible 
Approach 
rate 
% 
Uptake rate 
% (of those 
approached) 
Archway Sexual 
Health Clinic 
1 06/05/04  57  (19x3)  43  44.2  63.2 
Charing Cross 
Hospital 
2 22/4/04  76  (19x4)  12  75.0  100 
Chelsea & 
Westminster Hospital 
3 3/8/04  96  (16x6)  78  67.9  43.4 
Homerton University 
Hospital 
4 18/05/04  111  (18.5x6)  72  41.7  90.0 
Mortimer Market 
Centre 
5 7/4/04  140  (20x7)  58  67.2  87.2 
Newham University 
Hospital 
6 01/08/04  160  (16x10)  130  56.9  87.8 
North Middlesex 
Hospital 
7 12/5/04  171  (19x9)  108  25.9  96.4 
Royal London 
Hospital 
8 15/3/05  102  (8.5x12) 38  36.8  92.9 
St. Bartholomew’s 
Hospital 
9 17/03/05  17  (8.5x2)  20  80.0  81.3 
Victoria Clinic  10  01/08/04  32 (16x2)  3  100  100 
University College 
Hospital 
11 01/09/04 30  (15x2)  6  83.3  83.3 
Central Middlesex  12  15/12/04  48 (12x4)  7  85.7  83.3 
Watford General 
Hospital 
13 30/03/05  32  (8x4)  26  57.7  80.0 
St. Georges Hospital  14  18/02/05  28 (9.5x3)  51  35.3  94.4 
St. Mary’s Hospital  15  9/03/05  36 (9x4)  59  40.7  70.8 
1Based on 2002-2003 figures of expected eligible patients per month provided by local lead clinician 
multiplied by number of months in study (ending 31/12/05). 
 
Whilst uptake amongst those approached was higher than anticipated the initial 
approach was lower.  Recruitment opportunities were reduced by the delay inherent in 
obtaining research and development approval and honorary contracts at each site. Table 
5.1 shows the start dates for each study site.   
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To address these difficulties the period for recruitment was extended and new study 
sites included.  In addition the sample size was reduced from 330 to 250 as power 
calculations demonstrated minimal effect on the ability to detect associations of interest 
(table 5.2). MREC was notified of, and approved, these changes. 
 
Table 5.2 Sample size and relative risk 
Ability to detect significant associations
1 with outcome measure: 
Sample size  Late presentation 
200 RR  1.67 
250 RR  1.58 
330 RR  1.5 
1Assuming explanatory factor is binary with a prevalence of 50%, 80% power and significance of 0.05 
 
There was no budget to financially reimburse any of the study sites and involvement in 
the study was undertaken on a basis of goodwill. Protected time for key workers to 
work on SONHIA did not exist at most sites and clinical and other research priorities 
often took precedence. Strategies to support clinic staff, and the key workers, included 
regular newsletters, emails and phone calls. Collaborative meetings enabled key 
workers to be kept up to date, and provided a forum for problem solving. In addition I 
became more directly involved with recruiting at various sites.  Clinic presentations 
were conducted to inform clinic staff about the study, and how they could facilitate 
recruitment.  
5.7.2   Data 
Data related issues arose on several fronts.  Early on several completed anonymous 
questionnaires were posted via Royal Mail but never arrived. As a consequence all 
questionnaires had to be completed on site (given the financial reimbursement), and  
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completed questionnaires and clinical data sheets remain on site to be collected in 
person. 
To facilitate determination of country of HIV acquisition a revised questionnaire that 
incorporated additional variables was distributed in August 2005 (appendix 3). These 
questions included: ‘Does your partner currently live in the UK?’; the start and end 
dates and country of origin of the past two sexual partners; and ‘how many people have 
you had sex with since moving to the UK?’. MREC was notified about, and approved, 
these changes. 
As anticipated those individuals declining to participate also declined to consent to 
baseline data collection. This was principally due to concerns about disclosure; the 
consent form was the only place persons could be identified as it included both name 
and signature. Several persons had been happy to participate until the consent form was 
presented. A request to obtain the same baseline data on those who were eligible but not 
approached (the rate limiting step in recruitment) was approved by MREC (substantial 
amendment 3, December 2005).  
The initial plan was that an interim analysis of the quantitative component would have 
been undertaken prior to the in-depth interviews - thus allowing exploration of factors 
of interest identified in the survey.  This did not occur due to time constraints.   
5.8 Further  work 
Further methodology specific to analysis of the survey is presented along with the 
results in chapters 6 and 7; in particular chapter 6 explores factors associated with 
missed opportunities for earlier HIV diagnosis, and chapter 7 with late presentation.  
The methodology used to determine likely acquisition of HIV in the UK is presented  
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along with the results in chapter 8.  Finally the methodology and findings specific to the 
qualitative component, the in depth interviews, is found in chapter 9. 
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Chapter 6: Survey of newly diagnosed 
HIV positive Africans in London: Results 
 
Abstract 
Objective: To describe the socio-demographic and sexual health profile 
of Africans with newly diagnosed HIV infection living in London. 
Methods: A survey of newly diagnosed HIV positive Africans attending 
15 HIV treatment centres across London was conducted between April 
2004 and February 2006.  The survey consisted of a confidential self-
completed questionnaire linked to clinician completed clinical records. 
Results: 263 questionnaires were completed, representing an uptake rate 
of 79.5% of patients approached. 49.8% (131/263) of participants 
presented with advanced HIV disease (CD4 <200x10
6/l at diagnosis). In 
the year prior to HIV diagnosis 76.4% (181/237) had seen their GP, 
38.3% (98/256) had attended outpatient services, and 15.2% (39/257) 
inpatient services, representing missed opportunities for earlier HIV 
diagnosis. Of those attending GP services the issue of HIV and/or HIV 
testing was raised for 17.6% (31/176).  37.1% (78/210) had a previous 
negative HIV test, 32.5% of these within the UK.  Despite the 
population predominantly coming from countries of high HIV 
prevalence personal appreciation of risk was comparatively low and 
knowledge of benefits of testing lacking.  
Conclusion: Africans are accessing health services but clinicians are 
failing to use these opportunities effectively for preventive and 
diagnostic purposes with regards to HIV infection. Comparatively low 
appreciation of personal risk and lack of perceived ill health within this 
community means clinicians need to be more proactive in addressing 
HIV.  
The findings within this chapter are published in AIDS (2008) Missed 
opportunities for earlier HIV diagnosis within primary and secondary 
health care settings in the UK. F Burns et al., v.22: pp.115-122. 
 
6.0  Introduction  
Africans with HIV infection in the UK access HIV services at a later stage of HIV 
disease than non-Africans (Sinka et al., 2003; Del Amo et al., 1998; Burns et al., 2001), 
this denies them optimal therapeutic options and may hinder prevention efforts.  
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However the extent of missed opportunities within primary and secondary health care
12 
settings for earlier diagnosis within Britain is not known. 
This chapter seeks to describe the characteristics of the study population, identify 
opportunities for earlier HIV diagnosis within primary and secondary care settings in 
the UK, and to identify factors related to these missed opportunities, in Africans with 
newly diagnosed HIV infection. Data management, response rates and item non-
response are discussed, followed by the descriptive analysis.  
6.0.1   Aims and objectives 
This chapter aims to describe the health beliefs, heath care utilisation and clinical 
presentation patterns of newly diagnosed HIV positive Africans in London.  Specific 
objectives are:   
a)  To describe the demographic characteristics, migration history, HIV/sexual 
health history, patterns of service utilisation and levels of psycho-social support 
among this group.  
b)  To determine opportunities for earlier diagnosis of HIV disease within the UK.  
6.1 Methods 
As previously described in chapter 5. 
6.1.1    Data Preparation and software 
Data was entered onto a secure database and systematically checked. Access to the 
database was limited to the research team and password protected. No identifying data, 
such as name or hospital number was entered into the database. The questionnaires and 
                                                 
12 Secondary care: Services provided by medical specialists who generally do not have first contact with 
patients (e.g., cardiologist, urologists, dermatologists). In the UK patients must first seek care from 
primary care providers (General practitioners) and are then referred to secondary and/or tertiary 
providers, as needed.  
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master sheet are stored in a locked cupboard with access limited to the research team. 
Data editing, coding and consistency checks were performed prior to any statistical 
analysis. Analysis was performed using STATA 8.0 (Stata Corporation, College 
Station, Texas, USA) and SPSSv.12.0 (SPSS Inc.). 
6.1.2   Data editing and reduction 
All unavailable data was coded as missing.   
When necessary continuous variables such as age were categorised into groups that 
would have statistical efficacy whilst maintaining relevance.   
6.1.3   Statistical analysis 
Frequency tables and summary statistics with confidence intervals were used to describe 
the sample population in terms of the various demographic, behavioural, and health 
service utilisation information of interest.  
Two-way associations were examined using cross tabulations and χ
2  tests, unless 
numbers were small when Fishers exact test was used.  Logistic regression was used for 
univariate analysis to obtain crude odds ratios (OR) with 95% confidence intervals 
(95%CI).  Significance was set at p<0.05.  
6.2 Results  
6.2.1   Response rate and missing values 
6.2.1.1 Response  rate 
Of 711 potentially eligible patients 109 (15.3%) were lost to follow-up and 17 (2.4%) 
had died before they could be approached regarding the study (figure 6.1).  Sixty 
percent (353/585) of remaining patients were approached. The approach rate varied 
(25.9-100%, p<0.001)) between study sites (table 6.1). The uptake rate was 79.6%  
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(281/353) and 263 questionnaires were available for analysis.  A total of 18 
questionnaires were lost in the postal system and not available for analysis.  
Figure 6.1 Recruitment flow chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Not re attended within the 12-month eligibility period after receiving HIV diagnosis, or if recruited no 
longer attending site for follow-up by six months post diagnosis. 
711 eligible patients identified 
via patient databases 
‘Appropriate time’ to approach 
determined by clinicians 
Notes flagged 
358 Not approached 
(50.4%) 
353 Approached 
(49.6%) 
17 Died 
(17/358 (4.7%)) 
109 Lost to follow up* 
(109/358 (30.4%)) 
72 Declined 
(20.4%) 
281 Accepted 
(79.6%) 
263 Questionnaires 
available for analysis 
2 Died 
(0.7%) 
11 Lost to follow up*  
(4.2%)  
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Table 6.1 Characteristics of those approached and not approached regarding study participation 
  
Characteristic Approached
1 
%  (r/n) 
p-value
2 
Gender   0.165 
       Male  53.1 (139/262)   
       Female  47.7 (214/449)   
     
Age (years):    0.272 
18-24 50.0  (30/60)   
25-34 45.8  (143/312)   
35-44 53.5  (130/243)   
45+ 53.9  (48/89)   
      Median (range)  35.0 (18-64)   
     
Site:   <0.001 
      Archway sexual health clinic  44.2 (19/43)   
      Chelsea & Westminster group
3 69.9  (65/93)   
      Homerton Hospital  41.7 (30/72)   
      MMC & UCH
4 68.8  (44/64)   
      Newham Hospital  56.9 (74/130)   
      North Middlesex Hospital  25.9 (28/108)   
      St. Bartholomew’s & The Royal London  51.7 (30/58)   
      St. Georges Hospital  35.3 (18/51)   
      St. Mary’s Hospital  40.7 (24/59)   
     Watford & Central Middlesex Hospitals  63.6 (21/33)   
     
1 
2 Includes those accepting and declining to participate  
2 Comparing those approached with not approached 
3 Chelsea & Westminster hospital, West London Centre for Sexual Health & the Victoria Clinic for 
Sexual Health 
4 The Mortimer Market Centre & University College Hospital 
 
 
 
Data on country of birth and CD4 at diagnosis was collected on those not approached 
but not for those approached but who declined to participate (see previous chapter, 
section 5.4.1). 
Patients not approached did not differ significantly from those approached in terms of 
gender or age (table 6.1).  Patients that agreed to participate were more likely to come 
from Southern & Eastern Africa (73.0% vs. 57.9%, p<0.001) than patients not 
approached (table 6.2). The median CD4 of those accepting to participate was 182  
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whilst for those not approached it was 260. The patients that were lost to follow up 
before they could be approached did not differ significantly in terms of gender, age, 
region of birth, or CD4 at diagnosis from others not approached (data not shown). The 
proportions of eligible patients approached varied substantially according to site 
attended (table 6.1). 
 
Table 6.2 Characteristics of those accepting to participate and those not approached 
Characteristic   % (r/n)
1 p-value
2 
 Accepting   
to participate
3  Not approached 
 
Region of birth:     0.001 
Central Africa   6.4 (18/281)  8.1 (26/321)   
Southern & Eastern Africa  73.0 (205/281)  57.9 (186/321)   
West Africa  18.1 (51/281)  29.9 (96/321)   
        Other (including North Africa)  2.5 (7/281)  4.1 (13/321)   
       
HIV prevalence in country of birth
4     0.007 
     High (>15%)  44.4 (122/275)  33.1 (106/320)   
     Medium (5-15%)  39.6 (109/275)  42.8 (137/320)   
     Low (<5%)  16.0 (44/275) 24.1  (77/320)   
       
CD4 count at diagnosis (x10
6/l)     <0.001 
      0-49  18.9 (53/281)  9.3 (28/300)   
      50-199  33.8 (95/281) 26.3  (79/300)   
      200-349  23.1 (65/281)  29.0 (87/300)   
      350+  24.2 (68/281)  35.3 (106/300)   
      Median (range)  182 (0-1333)  260 (1-1160)   
       
Late presentation (CD4<200)  52.7 (148/281)  35.7 (107/300)  <0.001 
       
Lost to follow up (excludes those 
known to have died) 
4.2 (11/261)  32.0 (109/341)  <0.001 
      
Died within six months of HIV 
diagnosis 
0.8 (2/252)  6.7 (17/248)  <0.001 
1 Base varies due to missing data 
2 Comparing those approached with not approached 
3 Excludes those approached but declining to participate 
4 According to UNAIDS 2003 data (adults aged 15-45) 
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6.2.1.2 Missing  Data 
The variables: partner currently living in the UK, country of birth of last two sexual 
partners, commencement and termination dates of last two sexual relationships, number 
of (both new and total) sexual partners in UK, and what participants would like more 
information on, were added at a later date (see previous chapter, section 5.7.2) and so 
only available to answer for 80 participants. 
Item non-response was less than 5% except for those variables shown in table 6.3. 
Table 6.3 Questionnaire item non-response  
Variable    Item non-response  
Postcode 11.0% 
Number of sexual partners in UK prior to HIV diagnosis  12.2% 
Condom use in UK prior to HIV diagnosis  8.4% 
Ever been paid for sex  5.3% 
STI diagnosis prior to UK  9.1% 
STI diagnosis in the UK  18.6%
1  
Previous negative HIV test  20.2% 
Number of people participant knew to have HIV prior to their 
diagnosis 
12.2% 
Main source of HIV information prior to diagnosis  18.2% 
Influence of advertising on HIV testing  10.6% 
Perceived time of infection  20.5% 
Perceived reason for HIV infection  24.3% 
Factors that would have made participant test earlier  6.1% 
Accessing of HIV support groups  12.2% 
   
1 Typing error routed participants away from this question – amended half way through recruitment 
period. 
 
 
Questions presented in the form of a Likert scale were more poorly answered than other 
question formats. For the Likert scales exploring beliefs around HIV and HIV services, 
and people’s reactions and attitudes to HIV, missing responses were 4.2-7.2%. Missing 
responses for the Likert scales exploring factors preventing participants testing earlier 
ranged between 14.8-18.6%.  
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6.2.2   Descriptive analysis: 
One hundred and four men and 159 women completed the questionnaire. The median 
time between HIV diagnosis and questionnaire completion was 3.5 months. 83.6% of 
participants came from countries with HIV prevalence greater than 5% (table 6.4), and 
the median time in the UK prior to diagnosis was 3.9 years.  
Table 6.4 Country of birth of study participants (n=263) 
Country of birth  N (%) 
High  (>15%) HIV prevalence countries
1  
     Zimbabwe  68 (25.9) 
     Zambia  27 (10.3) 
     South Africa  23 (8.7) 
     Swaziland  1 (0.4) 
  
Medium (5-15%) HIV prevalence
1  
     Uganda  33 (12.5) 
     Nigeria  20 (7.6) 
     Kenya  12 (4.6) 
     Malawi  8 (3.0) 
     Cameroon  7 (2.7) 
     Congo (Democratic republic of)  6 (2.3) 
     Rwanda  5 (1.9) 
     Burundi  5 (1.9) 
     Cote d’Ivorie  4 (1.5) 
     Tanzania  1 (0.4) 
  
Low (<5%) HIV prevalence
1  
     Ghana  22 (8.4) 
     Ethiopia  5 (1.9) 
     UK  5 (1.9) 
      Somalia
2 5  (1.9) 
     Angola  2 (0.8) 
     Eritrea  1 (0.4) 
     Algeria  1 (0.4) 
     Italy  1 (0.4) 
     Sierra Leone
2 1  (0.4) 
  
1 According to UNAIDS 2003 data (adults aged 15-49) 
2 Data unavailable – assumed to be <5% prevalence  
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Socio-Demographics (table 6.5) 
The median age of respondents was 34 years, 62.5% were women, 98.1% were born in 
Africa, and 93.5% described their ethnicity as black African. Almost half (48.3%) of 
respondents had migrated from Southern or South-eastern Africa, and 17.9% (47/263) 
from West Africa. The majority (92.5%) defined themselves as heterosexual and most 
(66.5%) had children. Respondents were well educated, 43.8% having undertaken 
higher education, however 31.3% were unemployed when completing the survey.  
A substantial minority (21.7%) were dependent on friends or relatives for housing and 
6.1% were homeless living in hostels or bed and breakfasts. 48.1% of respondents had 
secure permanent residency rights within the UK, this included citizenship, indefinite 
leave to remain, and refugee status. A further 33.5% were on time-limited visas, and 
18.5% had uncertain rights to remain in the UK as they were awaiting decisions on 
asylum applications, applying for visas or illegally in the country. 
Several significant differences in the socio-demographic characteristics existed between 
men and women. Men tended to be older (median age 37 vs. 33, p=0.001), more likely 
to define themselves as homosexual or bisexual, more likely to be married, to be in full 
time employment, and of occupational class 1 or 2 (12.9% vs. 4%, p=0.002) than 
women. Women were more likely to be of black ethnicity, to have been previously 
married, to be in full time study, to attend religious services once a week or more 
(60.4% vs. 35.9%, p=0.002) and to report their faith as very important (94.3 vs. 85.4, 
p=0.027) compared to men.  
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Table 6.5 Socio-demographic profile of study participants 
Characteristic %  (r/n)
1 p-
value
2 
 Total  Male  Female   
Gender  100 (263/263)   39.5 (104/263)  60.5 (159/263)  --- 
Age (years):        0.001 
18-24  7.6 (20/263)  2.9 (3/104)  10.8 (17/159)   
25-34  43.0 (113/263)  33.7 (35/104)  48.7 (78/159)   
35-44  35.7 (94/263)  49.0 (51/104)  27.2 (43/159)   
45+  13.7 (36/263)  14.4 (15/104)  13.3 (21/159)   
      Median (range)  34 (18-62)  37 (22-57)  33 (18-62)   
Ethnicity:       --- 
Black African  93.5 (246/263)  88.5 (92/104)  96.9 (154/159)   
Black other (including black 
British and mixed) 
3.4 (9/263)  3.8 (4/104)  3.1 (5/159)   
Other (White, Asian, Arab)   3.0 (8/263)  7.7 (8/104)  0   
Sexuality:       <0.001 
Heterosexual  92.5 (234/253)  84.8 (84/99)  97.4 (150/154)   
Bi or Homosexual  7.5 (19/253)  15.2 (15/99)  2.6 (4/154)   
Education       0.134 
Degree   27.3 (71/260)  35.0 (36/103)  22.3 (35/157)   
Diploma/NVQ or equivalent  16.5 (43/260)  11.7 (12/103)  19.7 (31/157)   
A-levels or equivalent  21.2 (55/260)  22.3 (23/103)  20.4 (32/157)   
GCSE/O-level equivalent  23.5 (61/260)  21.4 (22/103)  24.8 (39/157)   
Other/none  11.5 (30/260)  9.7 (10/103)  12.7 (20/157)   
Marital Status:        0.003 
Married/cohabiting  38.0 (98/258)  46.2 (48/104)  32.5 (50/154)   
Previously married   18.6 (48/258)  8.7 (9/104)  25.3 (39/154)   
Partner but living apart  20.9 (54/258)  25.0 (26/104)  18.2 (28/154)   
Single, never married  22.5 (58/258)  20.2 (21/104)  24.0 (37/154)   
Have children  66.5 (173/260)  62.7 (64/102)  69.0 (109/158)  0.298 
       At least one child born in   
       UK since 1998
4 
13.6 (35/257)  17.0 (17/100)  12.8 (20/156)  0.353 
Region of birth:        0.304 
Central  & Western Africa   23.6 (62/263)  26.9 (28/104)  21.4 (34/159)   
East Africa  25.5 (67/263)  20.2 (21/104)  28.9 (46/159)   
Southern & South-eastern Africa   48.3 (127/263)  49.0 (51/104)  47.8 (76/159)   
       Other (Northern Africa & Europe)  2.7 (7/263)  3.8 (4/104)  1.9 (3/159)   
HIV prevalence
3 of country of birth        0.148 
       High (>15%)  45.2 (119/263)  48.1 (50/104)  43.4 (69/159)   
       Medium (5-15%)  38.4 (101/263)  30.8 (32/104)  43.4 (69/159)   
       Low (<5%)  16.4 (43/263)  21.2 (21/104)  13.2 (21/159)   
Currently:       0.497 
Living in the UK  76.8 (202/263)  81.7 (85/104)  73.6 (117/159)   
Visiting the UK  4.9 (13/263)  3.8 (4/104)  5.7 (9/159)   
        Studying in the UK  12.5 (33/263)  9.6 (10/104)  14.5 (23/159)   
Other (e.g. short term-work contract)  5.7 (15/263)  4.8 (5/104)  6.3 (10/159)   
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Characteristic %  (r/n)
1 p-
value
2 
 Total  Male  Female   
Residency status in the UK         0.185
Indefinite leave to remain (British 
citizen, EEC member, Permanent 
resident, refugee) 
48.1 (125/260)  54.8 (57/104)  43.6 (68/156)   
Visa entry  33.5 (87/260)  27.9 (29/104)  37.2 (58/156)   
Uncertain right to remain (e.g. 
Asylum seeker, applying for visa, 
illegal) 
18.5 (48/260)  17.3 (18/104)  19.2 (30/156)   
Accommodation       0.164 
Own   9.9 (26/262)  14.4 (15/104)  6.9 (11/158)   
Rent   62.4 (164/262)  60.6 (63/104)  63.5(101/158)   
Live with friends or relatives  21.7 (57/262)  21.2 (22/104)  22.0 (35/158)   
Other (incl. Hostel, B&B)  6.1 (16/262)  3.8 (4/104)  7.5 (12/159)   
Employment status        0.007 
      Employed fulltime  35.9 (93/259)  48.1 (50/104)  27.7 (43/155)   
      Employed part time  14.3 (37/259)  12.5 (13/104)  15.5 (24/155)   
      Student (Full time)  18.5 (48/259)  12.5 (13/104)  22.6 (35/155)   
      Unemployed   31.3 (81/259)  26.9 (28/104)  34.2 (53/155)   
            Unemployed – not   
            registered for benefits 
43.2 (35/81)  50.0 (14/28)  39.6 (21/53)   
Age on arrival in the UK        0.187 
        0-29 years  55.9 (146/261)  51.0 (53/104)  59.2 (93/157)   
        30+ years  44.1 (115/261)  49.0 (51/104)  40.8 (64/157)   
Time in UK before HIV diagnosis:        0.265 
3 or more years  63.2 (165/261)  67.3 (70/104)  60.5 (95/157)   
<3 years  36.8 (96/261)  32.7(34/104)  39.5 (62/157)   
Median in years (range)  3.94(-0.7–34.6)  4.22 (0.1-31.8)  3.85 (-0.7-36.4)   
English spoken comfortably  88.2 (232/262)  94.2 (97/103)  84.9(135/159)  0.021 
Preferred language to read in        0.074 
       English  89.0 (234/263)  95.2 (99/104)  84.9 (135/159)   
       French  5.3 (14/263)  1.9 (2/104)  7.5(12/159)   
       Other (includes illiterate)  5.7 (15/263)  3.0 (3/104)  7.5 (12/159)   
Religion:       0.569 
Roman catholic  35.2 (92/261)  34.6 (36/104)  35.7 (56/157)   
Christian – non Roman Catholic  54.0 (141/261)  51.9 (54/104)  55.4 (87/157)   
Muslim   6.9 (18/261)  7.7 (8/104)  6.4 (10/157)   
Other  3.8 (10/261)  5.8 (6/104)  2.5 (4/157)   
1 Base varies due to item non-response 
2 Comparing men and women (Pearson Chi-square or Fishers Exact Test where appropriate) 
3 HIV prevalence (%) adults aged 15-49 at end of 2003 according to UNAIDS 
4 Universal HIV testing introduced in antenatal clinics in UK in 1999.  
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Sexual health and behaviour (table 6.6) 
Of the 190 respondents in a relationship when completing the questionnaire 37.4% did 
not know the HIV status of their partner, and 24.7% had HIV negative partners. 
Consistent condom use whilst in the UK was reported by 21.2% of respondents, and 
39.4% of all respondents reported two or more sexual partners in the UK prior to HIV 
diagnosis. Respondents were asked to provide details about their last two sexual 
partnerships in the UK: 69.2% (72/104) of partnerships were with African nationals, 
and 36.0% of these partnerships were concurrent. 
Travel back to Africa was reported by 38.5% of respondents. Of those travelling to 
Africa sexual intercourse with a new partner was reported to occur on their last journey 
in 25.0% (25/100) of cases, with 68% (17/25) reporting no, or inconsistent, condom use. 
Almost a quarter (23.3%) of men reported paying for sex, and 3.4% (5/147) of women 
had been paid for sex. Past history of a STI diagnosis was high with 27.2% (65/239) 
(47.7% of men & 15.2% of women, p<0.001) reporting a STI prior to moving to the 
UK. 
Significant differences between men and women existed for all the sexual health 
variables except reported condom use. Men appear more likely to know the HIV status 
of their partners, to have had more sexual partners since moving to the UK, to have 
sexual partners from Britain, and to have concurrent partners, than women. Women 
were more likely not to have had sex in the past two years, and for their last two sexual 
partners to come from Africa, than men.   
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Table 6.6 Sexual health and risk of study participants 
Characteristic %  (r/n)
1    p-value
2 
 Total  Male  Female   
Partner       0.004 
HIV positive  28.1 (72/256)  36.9 (38/103))  22.2 (34/153))   
HIV negative  18.4 (47/256))  24.3 (25/103)  14.4 (22/153)   
Untested for HIV  7.4 (19/256)  3.9 (4/103)  9.8 (15/153)   
Did not know  20.3 (52/256)  14.6 (15/103)  24.2 (37/153)   
       Did not have a partner   25.8 (66/256)  20.4 (21/103)  29.4 (45/153)   
In the last 2 years have had sex with:        <0.001 
Opposite sex only  79.1 (200/253)  78.8 (78/99))  79.2 (122/154)   
Same or both sexes   5.9 (15/253)  14.1 (14/99)  0.6 (1/154)   
Not had sex in last 2 years  15.0 (38/253)  7.1 (7/99)  20.1 (31/154)   
Median number of sexual partners 
since moving to UK
3 (range) 
2 (0-250) 
n=73 
3.0 
n=28 
2.0 
n=45 
 
Median number of new sexual partners 
since moving to UK
3 (range) 
1 (0-250) 
n=68 
2.5  (0-250) 
n=26 
1.0 (0-3) 
n=42 
 
Number of sexual partners in UK prior 
to HIV diagnosis 
   <0.001 
      0  21.2 (49/231)  15.1 (13/86)  24.8 (36/145)   
      1  39.4 (91/231)  33.7 (29/86)  42.8 (62/145)   
      2-3  22.1 (51/231)  18.6 (16/86)  24.1 (35/145)   
      4 or more  17.3 (40/231)  32.6 (28/86)  8.3 (12/145)   
      Median number (range)  1 (0-247)  2.0 (0-247)  1.0 (0-30)   
      Mean (standard deviation)  5.76 (25.88)  12.64 (41.14)  1.59 (2.83)   
Condom use in UK prior to HIV diagnosis         0.159 
        Yes, every occasion  21.2 (51/241)    27.1 (26/96) 17.2  (25/145)   
               Yes, some occasions  39.0 (94/241)  41.7 (40/96) 37.2  (54/145)   
        No, not used  18.7 (45/241)  13.5 (13/96)  22.1 (32/145)   
        Unsure   1.7 (4/241)  2.1 (2/96)  1.4 (2/145)   
        Not had sex in UK  19.5 (47/241)  15.6 (15/96)  22.1 (32/145)   
Proportion of past 2 sexual partners 
from Africa
3,4 
69.2 (72/104)  51.2 (22/43)  82.0 (50/61)   
Proportion of past 2 sexual partners 
from Britain
3,4 
17.3 (18/104)  25.6 (11/43)  11.5 (7/61)   
Last two sexual partners concurrent
3  36.0 (18/50)  58.8 (10/17)  24.2 (8/33)  0.016 
Number of sexual partners in past year        <0.001 
      0  21.4 (52/243)  15.1 (14/93)  25.3 (38/150)   
      1  53.5 (130/243)  44.1 (41/93)  59.3 (89/150)   
      2-3  16.0 (39/243)  24.7 (23/93)  10.7 (16/150)   
      4 or more  8.4 (22/243)  16.1 (15/93)  4.7 (7/150)   
      Median number (range)  1.83 (0-50)   .0 (0-30)  1.0 (0-50)   
Condom use in past year       0.192 
        Yes, every occasion  19.1 (48/251) 23.0  (23/100) 16.6  (25/151)   
               Yes, some occasions  31.9 (80/251)  35.0 (35/100) 29.8  (45/151)   
        No, not used  26.3 (66/251)  25.0 (25/100)  27.2 (41/151)   
        Unsure   1.2 (3/251)  2.0 (2/100)  0.7 (1/151)   
        Not had sex in past year  21.5 (54/251)  15.0 (15/100)  25.8 (39/151)    
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Characteristic %  (r/n)
1    p-value
2 
 Total  Male  Female   
Travelled back to Africa   38.5 (100/260)  38.5 (40/104)  38.5 (60/156)  0.971 
Median time in years since last 
visit (range) 
2.0 (0.4-19.6)  2.2 (0.6-19.6)  1.9 (0.4-13.5)   
Sexual intercourse with new 
partners on last visit 
25.0 (25/100)  47.5 (19/40)  10.0 (6/60)  <0.001 
Condom use with new partner(s) 
when last visiting Africa 
   0.798 
        Yes, every occasion  32.0 (8/25)  36.8 (7/19) 16.7  (1/6)   
               Yes, some occasions 36.0  (9/25)  31.6  (6/19) 50.0  (3/6)   
        No, not used  16.0 (4/25)  15.8 (3/19)  16.7 (1/6)   
        Unsure   16.0 (4/25) 15.8(3/19)  16.7  (1/6)   
 Ever paid for sex   10.6 (27/254)  23.3 (24/103)  2.0 (3/151)  --- 
Where paid for sex:         
     In Africa  50.0 (13/26)  52.2 (12/23)  33.3 (1/3)   
     In UK  34.6 (9/26) 39.1  (9/23) 0   
     In UK & Africa  11.5 (3/26) 8.7  (2/23)  33.3  (1/3)   
Ever been paid for sex  2.8 (7/249)  2.0 (2/102)  3.4 (5/147)  --- 
       Where been paid for sex:         
            In Africa  33.3 (2/6)  0  25.0 (1/4)   
     In UK  50.0 (3/6)  100.0 (2/2)  50.0 (2/4)   
     In UK & Africa  16.7 (1/6)  0  25.0 (1/4)   
Previous STI diagnosis         
Prior to moving to UK  27.2 (65/239)  47.7 (42/88)  15.2 (23/151)  <0.001 
              Herpes  7.6 (18/238)  12.5 (11/88)  4.7 (7/150)  0.027 
       Trichomonas vaginalis (TV)  0  0  0  - 
              Syphilis  4.2 (10/238)  10.2 (9/88)  0.7 (1/150)  <0.001 
       Gonorrhoea  9.2 (22/238)  22.7 (20/88)  1.3 (2/150)  <0.001 
       Genital warts  5.9 (14/238)  9.1 (8/88)  4.0 (6/150)  0.107 
       Non-specific urethritis  0.4 (1/238)  1.1 (1/88)  0  - 
              Chlamydia  2.1 (5/238)  2.3 (2/88)  2.0 (3/150)  0.887 
       STI of unknown name  5.0 (12/238)  5.7 (5/88)  4.7 (7/150)  0.715 
              Pelvic inflammatory disease      
              (PID)
 (women only) 
-   -  0.7 (1/150)   
Since moving to UK  29.9 (64/214)  35.3 (30/85)  26.4 (34/129)  0.145 
              Herpes  8.4 (18/214)  10.6 (9/85)  7.0 (9/129)  0.352 
       TV  0  0  0  - 
              Syphilis  6.1 (13/214)  10.6 (9/85)  3.1 (4/129)  0.025 
       Gonorrhoea  0.9 (2/214)  2.4 (2/85)  0  - 
       Genital warts  5.6 (12/214)  5.9 (5/85)  5.4 (7/129)  0.887 
       Chlamydia  5.6 (12/214)  7.1 (6/85)  4.7 (6/129)  0.454 
              Non-specific urethritis  0.9 (2/214)  2.4 (2/85)  0  - 
              STI of unknown name  2.8 (6/214)  3.6 (3/85)  2.3 (3/129)  0.591 
              BV (women only)  -  -  6.2 (8/129)   
              PID (women only)  -  -  3.1 (4/129)   
1 Base varies due to item non-response   
2 Comparing men and women 
3 Maximum base of 80       
4 Excludes those who have not had sex in the UK  
  157  
Health service utilisation (tables 6.7 and 6.8) 
Primary care use was high with 84.6% (220/260) being registered with a general 
practitioner (GP) for a median of 3 years.  In the year prior to HIV diagnosis 76.4% 
(181/237) had seen their GP, 38.3% (98/256) had attended outpatient services, and 
15.2% (39/257) inpatient services. The reasons for seeking medical attention are 
presented in table 6.8.  Whilst accessing of health services was high the majority (64.8% 
(169/261)) of participants rated their health status as excellent or very good 12 months 
prior to completion of the questionnaire. Of those attending GP services the issue of 
HIV and/or HIV testing was raised for 17.6% (31/176). 
Other than differences pertaining to pregnancy there were no significant differences in 
health and social service use prior to HIV diagnosis by gender. 
HIV awareness (table 6.9) 
Thirty seven percent (78/210) of respondents had a previous negative HIV test, of these 
32.5% (25/77) occurred within the UK.  Five percent (14/263) of participants were 
diagnosed with HIV within two years of a negative HIV test. The median time between 
last negative HIV test and testing HIV positive was 2.8 years for those who been 
previously tested. Neither the type of health service nor the number of different services 
attended was associated with either the site of (e.g. in hospital), or reason for (e.g. 
advised to by Doctor), last HIV test (data not shown).  
While most (68.4%) participants knew about medical confidentiality a lower proportion 
(28.3%) was aware that HIV testing could be freely obtained, and half of respondents 
had lived in the UK for two years or more before they knew where to obtain an HIV 
test. The most common (30.1%) source of HIV testing site information was whilst an 
inpatient, 24.7% reported being influenced by advertising in deciding to test.  
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Table 6.7 Health & social service use prior to HIV diagnosis of study participants 
Services %  (r/n)
1 p-value
2 
 Total  Male  Female   
Registered with GP  84.6 (220/260)  82.7 (86/104)  85.9 (134/156)  0.483 
Median time with GP (years)  3  3.5  3   
        
Inpatient use in past year  15.2 (39/257)  12.9 (13/101)  16.7 (26/156)  0.408 
        In UK  74.4 (29/39)  84.6 (11/13)  69.2 (18/26)  0.528 
Outpatient use in past year  38.3 (98/256)  35.0 (36/103)  40.5 (62/153)  0.368 
        In UK  86.6 (84/97)  83.3 (30/36)  88.5 (54/61)  0.468 
        
Number of GP visits in year 
before HIV diagnosis: 
    0.607 
None   33.3 (79/237)  36.4 (36/99)  31.2 (43/138)   
1  11.8 (28/237)  15.2 (15/99)  9.4 (13/138)   
2-4  43.0 (102/237)  36.4 (36/99)  47.8 (66/138)   
5 or more  11.8 (28/237)  12.0 (12/99)  11.6 (16/138)   
Median (range)  2 (0-18)  1 (0-12)  2 (0-18)   
        
Attended GP in 2 years before 
HIV diagnosis 
75.1 (193/257)  74.5 (76/102)  75.5 (117/155)  0.860 
        
HIV testing mentioned by GP 
in past year  
17.1 (31/176)  16.2 (11/68)  18.5 (20/108)  0.839 
        
Illness or accident that has 
affected health for at least 3 
months in the last 5 years (apart 
from HIV) 
 
24.5 (63/257) 
 
20.6 (21/102) 
 
27.1 (42/155) 
 
0.235 
        
Attended antenatal care in UK 
in past 5 years 
15.9 (25/157)          -- 15.9 (25/157)     na 
       Mean number of    
       pregnancies  
1.23                         ---                            1.3   
        
Attends HIV services within 
own Strategic Health Authority 
72.6 (170/234)  69.0 (69/100)  75.4 (101/134)  0.279 
        
Health 12 months ago        0.883 
Excellent or very good  64.8 (169/261)  66.3 (69/104)  63.7 (100/157)   
Fair  20.7 (54/261)  19.2 (20/104)  21.7 (34/157)   
Poor or terrible  14.6 (38/261)  14.4 (15/104)  14.6 (23/157)   
        
Health now       0.084 
Excellent or very good  51.5 (135/262)  57.7 (60/104)  47.5 (75/158)   
Fair  34.4 (90/262)  33.7 (35/104)  34.8 (55/158)   
Poor or terrible  14.1 (37/262)  8.7 (9/104)  17.7 (28/158)   
        
Length of poor health        0.539 
Not at all  56.5 (148/262)  53.8 (56/104)  58.2 (92/158)   
12 months or less  38.2 (100/262)  41.3 (43/104  36.1 (57/158)   
More than 1 year  5.3 (14/262)  4.8 (5/104)  5.7 (9/158)   
1 Base varies due to item non-response 
2 Comparing men & women   
3 Prior to HIV diagnosis  
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Table 6.8 Summary of medical care prior to HIV diagnosis. Values are numbers (percentages). 
  Attended GP in the 
two years prior to 
HIV diagnosis
1 
Attended 
outpatients in the 
year prior to 
HIVdiagnosis
1 
Inpatient stay in 
the year prior to 
HIVdiagnosis
1 
Total  193/257 (75.1)  98/256 (38.3)  39/257 (15.2) 
      
Reason for seeking care
2   n=183 n=92  n=31 
       Dermatology  42 (23.0)  6 (6.5)  - 
       Gastroenterology  3 (1.6)  3 (3.3)  1 (3.2) 
       Hypertension & Diabetes  6 (3.3)  6 (6.5)  - 
       Infectious causes       
               Fever ?cause  3 (1.6)  -  4 (12.9) 
               Flu or chest infection
3  84 (45.9)  17 (18.5)  2 (6.5) 
               TB  -  0.5 (1)  - 
               Varicella Zoster  3 (1.6)  1 (0.5)  1 (3.2) 
                    Other (e.g. hepatitis,  
                 meningitis, sinusitis, syphilis) 
3 (1.6)  11 (11.9)  3 (9.7) 
       Malaise  4 (2.2)  7 (7.6)  - 
       Neurological  7 (3.8)  1 (1.1)  - 
        Obstetrics, gynaecology & family   
        planning 
38 (20.8)  5 (5.4)  3 (9.7) 
       Psychiatric/depression  -  4 (4.3)  3 (9.7) 
       Surgical  3 (1.6)  6 (6.5)  9 (29.0) 
       Trauma/minor injury  12 (6.6)  4 (4.3)  - 
       Other  31 (16.9)  21 (22.8)  4 (12.9) 
1 Total greater than 100% as more than one reason could be listed 
2 Percentages are the proportion of those accessing that service with reason given 
3 Including pneumonia 
 
 
HIV awareness prior to HIV diagnosis appeared similar between men and women.   
Most (72.4%) knew someone with HIV prior to their own diagnosis, and many knew 
more than one (41.2% knowing 5 or more people). A difference did exist in the 
perception prior to diagnosis of the type of person who got HIV. Men were more likely 
to think ‘anybody’ could get it (72.1% vs. 57.1%, p=0.018) than women; and women 
were more likely to believe that only ‘people who sleep with lots of people’ got HIV 
(46.8% vs. 28.8%, p=0.004) than men.   
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Table 6.9 HIV awareness prior to HIV diagnosis of study participants 
HIV awareness prior to diagnosis  % (r/n)
1 p-value
2 
 Total  Male  Female   
Previous negative HIV test
3  37.1 (78/210)  36.9 (31/84)  37.3 (47/126)  0.954 
Number of previous tests        0.018 
     1  53.4 (39/73)  71.4 (20/28)  42.2 (19/45)   
     2-4  46.6 (34/73)  28.6 (8/28)  57.8 (26/45)   
Median duration from last negative  
HIV test to positive test (years)  
2.8 
n=44 
2.4 
n=19 
3.2 
n=25 
 
      
HIV diagnosis within 2 years of a 
negative HIV test 
31.8 (14/44)  47.4 (9/19)  20.0 (5/25)  0.101 
      
Site of last negative test        0.115 
In Africa  63.6 (49/77)  54.8 (17/31)  69.6 (32/46)   
In UK GUM or antenatal clinic  23.4 (18/77)  35.5 (11/31)  15.2 (7/46)   
Elsewhere in UK  13.0 (10/77)  9.7 (3/31)  15.2 (7/46)   
      
HIV mentioned in context of previous 
sexual health consultation
4 
    
In Africa   15.9 (14/88)  16.3 (7/43)  15.6 (7/45)  1.000 
In UK  51.8 (43/83)  63.6 (21/33)  44.0 (22/50)  0.116 
      
Time in UK before knowledge of where 
to have HIV test: 
    
0.388 
Less than 12 months  33.1 (83/251)  27.2 (28/103)  37.2 (55/148)   
1-2 years  17.1 (43/251)  19.4 (20/103)  15.5 (23/148)   
2-5 years  28.3 (71/251)  29.1 (30/103)  27.7 (41/148)   
>5 years  21.5 (54/251)  24.3 (25/103)  19.6 (29/148)   
      
How found out where to have HIV test:        0.008 
From a GP surgery  20.9 (52/249)  14.7 (15/102)  25.2 (37/147)   
Friends or family  17.7 (44/249)  19.6 (20/102)  16.3 (24/147)   
The media   6.0 (15/249)  9.8 (10/102)  3.4 (5/147)   
Internet  2.4 (6/249)  4.9 (5/102)  0.7 (1/147)   
Offered whilst in hospital  30.1 (75/249)  29.4 (30/102)  30.6 (45/147)   
Partner  5.6 (14/249)  8.8 (9/102)  3.4 (5/147)   
Other  17.3 (43/249)  12.7 (13/102)  20.4 (30/147)   
      
Ever try but unable to have an HIV test  11.0 (28/255)  6.9 (7/102)  13.7 (21/153)  0.103 
        Reason unable to have test:        0.888 
                Not offered by clinician  25.9 (7/27)  28.6 (2/7)  25.0 (5/20)   
                Didn’t know where to go  29.6 (8/27)  28.6 (2/7)  30.0 (6/20)   
                Other (no appointments, no   
                childcare, etc) 
44.4 (12/27)  42.9 (3/7)  45.0 (9/20)   
      
Discussed HIV with someone prior to 
diagnosis 
 
76.8 (199/259) 
 
78.8 (82/104) 
 
75.5 (117/155) 
 
0.552 
If yes who with:         
Partner  47.7 (95/199)  48.8 (40/82)  47.0 (55/117)  0.886 
Friends  63.8 (127/199)  64.6 (53/82)  63.2 (74/117)  0.882 
Health care professional  14.6 (29/199)  13.4 (11/82)  15.4 (18/117)  0.839 
Other      
      
Influenced to have HIV test by 
advertising 
24.7 (58/235)  20.2 (18/89)  27.4 (40/146)  0.275 
      
Knowledge that HIV testing would be 
free when arrived in UK 
28.3 (73/258)  32.7 (34/104)  25.3 (39/154)  0.208 
Knowledge of medical confidentiality 
prior to HIV diagnosis 
68.4 (175/256)  71.6 (73/102)  66.2 (102/154)  0.411  
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HIV awareness prior to diagnosis  % (r/n)
1 p-value
2 
 Total  Male  Female   
Perception of type of person who got 
HIV prior to HIV diagnosis
5 
    
       Anybody  62.7 (163/260)  72.1 (75/104)  57.1 (89/156)  0.018 
       Only people who have sex with lots  
       of people 
 
39.6 (103/260) 
 
28.8 (30/104) 
 
46.8 (73/156) 
 
0.004 
       Only people who have sex in Africa  2.7 (7/260)  1.9 (2/104)  3.2 (5/156)  0.706 
       Drug addicts  11.9 (31/260)  10.6 (11/104)  12.8 (20/156)  0.697 
       Gay men  13.1 (34/260)  11.5 (12/104)  14.1 (22/156)  0.579 
       People who do not believe in God  2.3 (6/260)  2.9 (3/104)  1.9 (3/156)  0.686 
       Other  3.5 (9/260)  4.8 (5/104)  2.6 (4/156)  0.491 
      
Number of people participant knew to 
have HIV prior to their diagnosis 
(excludes don’t knows): 
    
 
0.457 
No one  27.6 (63/228)  26.9 (25/93)  28.1 (38/135)   
1  10.1 (23/228)  12.9 (12/93)  8.1 (11/135)   
2-4  21.1 (48/228)  23.7 (22/93)  19.3 (26/135)   
5 or more  41.2 (94/228)  36.6 (34/93)  44.4 (60/135)   
      
Main source of HIV information prior to 
diagnosis 
    
0.385 
Health care workers  23.3 (50/215)  17.0 (15/88)  27.6 (35/127)   
HIV positive people or organisations  10.2 (22/215)  10.2 (9/88)  10.2 (13/127)   
Friends or partner  20.0 (43/215)  22.7 (20/88)  18.1 (23/127)   
The media  34.0 (73/215)  38.6 (34/88)  30.7 (39/127)   
Other  12.6 (27/215)  11.4 (10/88)  13.4 (17/127)   
      
1 Base varies due to item non-response 
2 Comparing men and women 
3 Excludes those who do not know if they have ever tested (n=37) 
4 Where a diagnosis of a previous STI, Candida or BV infection has been established. 
5 Respondents had option of more than one response so total >100% 
 
HIV testing and diagnosis (table 6.10) 
The majority of participants were diagnosed with HIV in a sexual health clinic (50.6%) 
or in hospital (34%). Only 4% (10/250) reported that they were diagnosed HIV positive 
in Africa. Advice by a hospital or clinic doctor was the main reason for the HIV test 
(33.7%).  11.9% had the test as part of a routine check up. Only 14.9% (37/258) were 
expecting the positive result whilst a further 21.3% did not know what to expect. No 
significant differences in site, of, reason for, or expectation of, HIV test were found by 
gender.  
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Table 6.10 Experiences of testing HIV positive for study participants 
HIV Testing  % (r/n)
1   p-value
2
 Total  Male  Female   
Diagnosed HIV positive in Africa  4.0 (10/250)  5.1 (5/99)  3.3 (5/151)  0.523 
      
Site of HIV diagnosis in the UK        --- 
Sexual Health Clinic  50.6 (131/259)  53.4 (55/103)  48.7 (76/156)   
GP surgery  6.2 (16/259)  4.9 (5/103)    7.1 (11/156)   
In hospital (ward or outpatients)  34.0 (88/259)  39.8 (41/103)  30.1 (47/156)   
Ante-natal clinic  6.9 (18/259)  0  11.5 (18/156)   
Other  2.3 (6/259)  1.9 (2/103)    2.9 (4/156)   
      
Main reason for last HIV test        0.438 
Advised to by hospital or clinic  
doctor 
33.7 (88/261)  37.5 (39/104)  31.2 (49/157)   
Advised to by GP  6.5 (17/261)  4.8 (5/104)  7.6 (12/157)   
Health complaints thought may be 
related to HIV 
18.4 (48/261)  17.3 (18/104)  19.1 (30/157)   
Sexual contact with someone 
known or thought to have HIV 
9.6 (25/261)  12.5 (13/104)  7.6 (12/157)   
Child tested positive  3.1 (8/261)  2.9 (3/104)  3.2 (5/157)   
Related to pregnancy of partner or 
self 
10.0 (26/261)  5.8 (6/104)  12.7 (20/157)   
Routine check up  11.9 (31/261)  13.5 (14/104)  10.8 (17/157)   
Other  6.8 (18/261)  5.8 (6/104)  7.6 (12/157)   
      
Expecting positive result  14.3 (37/258)  16.5 (17/103)  12.9 (20/155)  0.634 
        Do not know  21.3 (55/258)  22.3 (23/103)  20.6 (32/155)   
      
Perceived reason for time of infection        --- 
Sex with someone now known to  
have HIV 
15.6 (31/199)  20.5 (17/83)  12.1 (14/116)   
Sex with someone at high risk of  
HIV 
22.6 (45/199)  30.1 (25/83)  17.2 (20/116)   
Sexual assault/rape  6.5 (13/199)  0  11.2 (13/116)   
Became unwell  21.1 (42/199)  18.1 (15/83)  23.3 (27/116)   
Blood transfusion or injection  6.5 (13/199)  6.0 (5/83)  6.9 (8/116)   
Other/don’t know  27.6 (55/199)  25.3 (21/83)  29.3 (34/116)   
      
1 Base varies due to item non-response 
2 Comparing men and women 
3 Participants could select more than one reason hence total more than 100% 
 
 
Influencing factors on HIV testing (table 6.11) 
Approximately 70% (179/256) of the participants had not considered the possibility that 
they may be HIV positive. Similarly 59.1% (146/247) felt that if someone had told them 
they were at risk it would have made them test earlier. 17.8% were unaware that HIV 
could be treated and 11.7% unaware that the risk of mother to child transmission 
(MTCT) could be reduced, both factors that would have made participants test earlier.  
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Table 6.11 Factors influencing study participants timing of HIV test
1 
 
 Factor
2 Main  Factor
2 
Factors stopping participants testing for HIV earlier  n=256 n=208 
       Had not considered possibility that may be HIV+  69.9%  54.3% 
       Well so no need  51.2%  20.2% 
        Afraid of the result  28.1%  11.1% 
       Afraid of the stigma associated with HIV  28.9%  5.8% 
       Other
3 33.1%  8.6% 
    
Factors that would have made participants test for HIV 
earlier 
n=247 n=213 
       If someone had told me that I was at risk  59.1%  49.3% 
       If felt would be supported if I tested HIV positive  31.2%  8.0% 
       If there was no stigma associated with HIV  36.8%  16.4% 
       If HIV was not so linked to sex  21.9%  6.6% 
       If knew medication for HIV was available  17.8%  6.6% 
       If knew could reduce vertical transmission  11.7%  4.2% 
       Other factor  10.9%  8.9% 
    
1 Participants were asked to tick all factors that applied and to identify the single most important factor. 
2 Base varies due to item non-response 
3 Other includes not wanting to go to a Genitourinary medicine clinic, not knowing where to go, fear of 
losing a relationship, fear of influencing immigration process, the fact that some had previously tested for 
HIV so felt not applicable. 
 
The factors potentially influencing the timing of an HIV test did not significantly differ 
between men and women. 
Clinical presentation (table 6.12) 
Half (131/263) of all participants presented with late stage disease, with 20% (52/263) 
being severely immuno-compromised (CD4 counts below 50x10
6/l). In keeping with the 
immunology 46.2% (121/262) had symptomatic disease (CDC B or C) at diagnosis: 
Tuberculosis (29/74) accounted for 39.2% of all AIDS defining illnesses. Mutations 
conferring medium or high-level primary antiretroviral drug resistance were found in 
9.5% (9/95) of samples tested.  Within six months of diagnosis 63.1% (169/252) of 
participants were commenced on ART and 66.9% (113/169) had an undetectable viral 
load (<50 copies/ml).    
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Table 6.12 Clinical characteristics of study population  
Clinical Characteristics   % (r/n)
1 p-value
2 
 Total  Male  Female   
Proportion with late disease at 
diagnosis (CD4<200) 
49.8 (131/263)  52.9 (55/104)  47.8 (76/159)  0.420 
        
CD4 count at diagnosis (x10
6/l)       0.733 
      0-49  19.8 (52/263)  23.1 (24/104)  17.6 (28/159)   
      50-199  30.0 (79/263)  29.8 (31/104)  30.2 (48/159)   
      200-349  24.3 (64/263)  23.1 (24/104)  25.2 (40/159)   
      350+  25.9 (68/263)  24.0 (25/104)  27.0 (43/159)   
      Median (range)  200 (0-1333)  170 (0-1020)  202 (0-1333)   
        
HIV viral load at diagnosis (copies/ml)        <0.001 
       <10,000  25.5 (63/246)  11.6 (11/95)  34.4 (52/151)   
       10,000-<100,000  44.1 (109/246)  51.6 (49/95)  39.1 (59/151)   
       100,000+  30.4 (75/246)  36.8 (35/95)  26.5 (40/151)   
       Median  36650  51000  25864   
        
Proportion with symptomatic disease 
at diagnosis (CDC
3 B or C) 
46.2 (121/262)  51.9 (54/104)  42.4 (67/158)  0.131 
Proportion with AIDS within 6 months 
of diagnosis 
28.8(74/257)  33.3 (34/102)  25.8 (40/155)  0.192 
        
Principal AIDS defining illnesses        
       TB pulmonary  39.2 (29/74)  38.2 (13/34)  40.0 (16/40)   
       Pneumocystis carinii pneumonia  14.9 (11/74)  11.8 (4/34)  17.5 (7/40)   
       Oesophageal candidiasis  14.9 (11/74)  8.8 (3/34)  20.0 (8/40)   
        
Viral subtype (clade)        --- 
     A  4.3 (3/69)  3.3 (1/30)  5.1 (2/39)   
     B  7.2 (5/69)  16.7 (5/30)  0   
     C  52.2 (36/69)  43.3 (13/30)  60.0 (23/39)   
     D  4.3 (3/69)  0  7.7 (3/39)   
     F  2.9 (2/69)  6.6 (2/30)  0   
     G  4.3 (3/69)  3.3 (1/30)  5.1 (2/39)   
     Recombinant   23.2 (16/69)  26.7 (8/30)  20.5 (8/39)   
     Multiple   1.4 (1/69)   0  2.6 (1/39)   
        
Primary resistance found
4  9.5 (9/95)  20.0 (7/35)  3.3 (2/60)  0.011 
        
Antiretrovirals within 6 months of 
diagnosis 
63.1(169/252)  60.6 (60/99)  71.2 (109/153)  0.079 
Proportion on therapy with 
undetectable viral load (<50copies/ml) 
66.9 (113/169)  66.7 (43/60)  64.2 (70/109)  0.106 
        
CD4 count six months post diagnosis (x10
6/l)       0.478 
      0-49  5.0 (13/258)  5.9 (6/102)  4.5 (7/156)   
      50-199  26.7 (69/258)  30.4 (31/102)  24.4 (38/156)   
      200-349  31.4 (81/258)  32.4 (33/102)  30.8 (48/156)   
      350+  36.8 (95/258)  31.4 (32/102)  40.4 (63/156)   
      Median (range)  270 (1-1062)  257 (10-850)  277 (1-1062)   
        
1 Base varies due to item non-response   
2 Comparing men & women 
3 Centers for disease control and prevention classification: A=documented HIV infection, asymptomatic; 
B=symptomatic conditions not in category C; C=AIDS defining conditions; 1=CD4 >=500; 2=CD4 200-
499; 3= CD4<200. 
4 Only mutations conferring medium or high-level resistance included.  
  165  
 
Data on time on ART in relation to viral load was not collected. Very few differences 
existed by gender: men were likely to have a higher viral load at diagnosis (median of 
51,000 copies/ml vs. 25,864 copies/ml, p<0.001) and more likely to have primary 
resistance (20.0% (7/35) vs. 3.3% (2/60), p=0.011) than women.  
Post-diagnosis (table 6.13 & 6.14) 
Whilst 89.6% (233/260) trusted the staff at their HIV clinics, 39.6% (97/245) trusted the 
staff at their GP surgery. Principal concerns were lack of confidentiality (54.1%), 
behaviour and attitudes of reception staff (53.2%), discrimination (33.0%) and lack of 
knowledge about HIV (30.3%). Thirty six percent (78/214) of respondents had 
disclosed their HIV status to their GP.  
Disclosure of HIV status to current partners was reported by 58.6% (129/220), 12.6% 
had disclosed to some or all of their ex-partners, and 25.3% to a least one friend. 
Approximately half of the respondents knew people who had also HIV tested and 
32.8% believed most people would test if they thought they were at risk of HIV. 
A belief that faith alone can cure HIV was reported by 30.6%, and 4.7% believed taking 
ART implies a lack of faith in God.  These beliefs were as likely amongst people on 
ART and those with undetectable viral loads as those not on ART (data not shown). 
Very few differences existed by gender: men were more likely than women to discuss 
HIV with their partner (62.1% vs. 38.9%, p<0.001); women were more likely to believe 
that faith alone can cure HIV (37.8% vs. 19.6%, p =0.008). Fewer than 10% reported 
use of traditional or herbal medicines. More information on having a family and 
disclosing status to partners was wanted by 44.3% and 45.5% respectively. 
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Table 6.13 Post HIV diagnosis 
Since diagnosis  % (r/n)
1     p-value
2 
 Total  Male  Female   
Disclosed HIV status to someone   89.1 (228/256)  87.1 (88/101)    90.3 (140/155)       0.424 
     Who disclosed to
3:       
           Partner  58.6 (129/220)  65.6 (59/90)  53.8 (70/130)  0.083 
           GP  36.4 (78/214)  35.7 (30/84)  36.9 (48/130)  0.858 
           Friend(s) (all or some)  25.3 (56/221)  22.1 (19/86)  27.4 (37/135)  0.376 
           Ex-partners (all or some)  12.6 (26/206)  9.9 (8/81)  14.4 (18/125)  0.340 
        
Belief that faith alone can cure HIV  30.6 (79/258)  19.6 (20/102)  37.8 (59/156)  0.008 
     Do not know  18.2 (47/258)  20.6 (21/102)  16.7 (26/156)   
Belief that taking ART implies lack of 
faith in God 
 
4.7 (12/255) 
 
2.0 (2/101) 
 
6.5 (10/154) 
0.149 
     Do not know  10.2 (26/255)  12.9 (13/101)  8.4 (13/154)   
        
Used traditional or herbal medicines
4   9.7 (25/258)  8.7 (9/104)  10.3 (16/155)  0.831 
        
Trust staff at HIV clinic/hospital:        0.143 
Yes  89.6 (233/260)  88.3 (91/103)  90.4 (142/157)   
Don’t know  7.7 (20/260)  10.7 (11/103)  5.7 (9/157)   
        
Trust staff at GP surgery:        0.530 
Yes  39.6 (97/245)  39.6 (38/96)  39.6 (59/149)   
Don’t know  25.7 (63/245)  29.2 (28/96)  23.5 (35/149)   
        
Believe most people would have an 
HIV test if they thought they were at 
risk of infection 
 
32.8 (84/256) 
 
34.0 (35/103) 
 
32.0 (49/153) 
0.719 
      Don’t know  43.8 (112/256)  40.8 (42/103)  45.8 (70/153)   
        
Number of people known who have 
had an HIV test 
     0.724 
Most  6.9 (18/262)  5.8 (6/104)  7.6 (12/158)   
A few  45.4 (119/262)  42.3 (44/104)  47.5 (75/158)   
None  21.0 (55/262)  23.1 (24/104)  19.6 (31/158)   
Don’ know  26.7 (70/262)  28.8 (30/104)  25.3 (40/158)   
        
1 Base varies due to item non-response 
2 Comparing men and women 
3 Excludes those who do not have a partner, or GP etc.  Assumes no response is equivalent to no so long 
as indicated had disclosed to someone (ie. addressed the question) 
4 Traditional medicine use for any reason, not necessarily HIV related use. 
 
The principal benefits of knowing HIV positive status were: ability to take medication 
to remain healthy and alive (85.8%), and the ability to prevent onward transmission 
(76.5%), only 1.9% (5/260) reported that there were no benefits. Reasons not to know 
HIV status included fear (64.5%) and discrimination within the community (34.1%); 
despite having accessed HIV services and information 12.4% (31/251) felt nothing  
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could be done about HIV thus there was no point in knowing status.  There were no 
significant differences reported in the pros or cons of knowing HIV positive status by 
gender. 
Table 6.14 Pros and cons of knowing HIV positive status 
 
 Factor
2 Main  Factor
2 
Benefits of knowing HIV positive status:   n=260 n=177 
       It’s a weight off my shoulders  41.5%  6.8% 
       Can prevent onward transmission  76.5%  33.9% 
Can reduce likelihood of vertical transmission  37.7%  7.9% 
Can take medication to keep healthy and alive  85.8%  30.5% 
It has helped with future planning   66.9%  11.9% 
It has provided me social support  23.5%  0.6% 
       It provides me control over my health  68.8%  6.2% 
       There are no benefits  1.9%  2.3% 
    
Reasons not to know HIV positive status:   n=261 n=185 
       Discrimination within community  64.1%  31.9% 
       Discrimination at work  43.8%  2.7% 
       Difficulty in planning a family  30.7%  4.9% 
Increases likelihood of deportation  14.3%  3.8% 
Insurance and mortgage difficulties  27.5%  1.6% 
Knowing ones status makes one ill  21.5%  3.8% 
        There is no point as nothing can be done.  12.4%  2.2% 
        There is no point as God will protect me  6.8%  1.6% 
        Fear  64.5%  40.0% 
Other 12.0%  7.6% 
1 Participants were asked to tick all factors that applied and to identify the single most important factor. 
2 Base varies due to item non-response 
 
Beliefs regarding HIV and HIV services (table 6.15) 
Beliefs around HIV and HIV services appeared similar between men and women. 
Whilst the majority of participants did not subscribe to conspiracy theories 3.6% (9/250) 
disagreed and 5.6% (14/250) were unsure that HIV causes AIDS, 8.6% (21/244) 
believed HIV to be created by white people (with a further 23.4% (57/244) neither 
agreeing or disagreeing), and 5.6% (14/250) felt medicines were less effective for black 
people than white people.   
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Table 6.15 Study participants’ beliefs around HIV and HIV services 
 %  (r/n)
1     p-value
2 
 Total  Male  Female   
        
HIV causes AIDS         0.889 
     Agree or strongly agree  90.8 (227/250)  91.2 (93/102)  90.5 (134/148)   
     Neither agree or disagree  5.6 (14/250)  5.9 (6/102)  5.4 (8/148)   
     Disagree or strongly disagree  3.6 (9/250)  2.9 (3/102)  4.1 (6/148)   
        
HIV is a disease created by white 
people 
      
0.525 
     Agree or strongly agree  8.6 (21/244)  11.0 (11/100)  6.9 (10/144)   
     Neither agree or disagree  23.4 (57/244)  22.0 (22/100)  24.3 (35/144)   
     Disagree or strongly disagree  68.0 (166/244)  67.0 (67/100)  68.8 (99/144)   
        
The medicines available work just as 
well on black people as white people 
      
0.667 
     Agree or strongly agree  86.4 (216/250)  88.0 (88/100)  85.3 (128/150)   
     Neither agree or disagree  8.0 (20/250)  8.0 (8/100)  8.0 (12/150)   
     Disagree or strongly disagree  5.6 (14/250)  4.0 (4/100)  6.7 (10/150)   
        
The NHS meets the needs of African 
patients 
      
0.956 
     Agree or strongly agree  81.4 (201/247)  82.0 (82/100)  81.0 (119/147)   
     Neither agree or disagree  15.8 (39/247)  15.0 (15/100)  16.3 (24/147)   
     Disagree or strongly disagree  2.8 (7/247)  3.0 (3/100)  2.7 (4/147)   
        
The NHS treats African patients as 
fairly as other patients 
      
0.529 
     Agree or strongly agree  82.4 (206/250)  79.8 (79/99)  84.1 (127/151)   
     Neither agree or disagree  13.2 (33/250)  16.2 (16/99)  11.3 (17/151)   
     Disagree or strongly disagree  4.4 (11/250)  4.0 (4/99)  4.6 (7/151)   
        
1 Base varies due to item non-response 
2 Comparing men and women 
 
 
Reactions and attitudes to HIV (table 6.16)  
The majority of participants (66.1%, 162/245) believed partners would leave if they 
knew about the HIV; this was more evident in the women’s responses than the men’s 
(72.4% vs. 57.0%, p=0.027).  Otherwise perceptions of people’s reactions and attitudes 
to HIV did not differ by gender. 68.3% (172/252) felt families, 26.6% (65/244) believed 
friends, and 35.2% (87/247) believed the church/mosque would stand by and support 
them if they knew about the HIV.   
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Table 6.16 Participants perceptions of people’s reactions and attitudes to HIV 
 %  (r/n)
1     p-value
2 
 Total  Male  Female   
Most partners of people who are HIV+ 
would leave if they knew about the 
HIV  
 
 
 
    
 
0.027 
     Agree or strongly agree  66.1 (162/245)  57.0 (57/100)  72.4 (105/145)   
     Neither agree or disagree  19.6 (48/245)  27.0 (27/100)  14.5 (21/145)   
     Disagree or strongly disagree  14.3 (35/245)  16.0 (16/100)  13.1 (19/145)   
        
My family would stand by and support 
me if they knew about my HIV 
      
0.664 
     Agree or strongly agree  68.3 (172/252)  65.0 (65/100)  70.4 (107/152)   
     Neither agree or disagree  17.1 (43/252)  19.0 (19/100)  15.8 (24/152)   
     Disagree or strongly disagree  14.7 (37/252)  16.0 (16/100)  13.8 (21/152)   
        
My friends would stand by and 
support me if they knew about my 
HIV 
      
 
0.302 
     Agree or strongly agree  26.6 (65/244)  30.9 (30/97)  23.8 (35/147)   
     Neither agree or disagree  34.0 (83/244)  28.9 (28/97)  37.4 (55/147)   
     Disagree or strongly disagree  39.3 (96/244)  40.2 (39/97)  38.8 (57/147)   
        
HIV + people are at risk of isolation if 
their church/mosque finds out about 
their diagnosis 
      
 
0.686 
     Agree or strongly agree  39.7 (98/247)  36.7 (36/98)  41.6 (62/149)   
     Neither agree or disagree  25.1 (62/247)  27.6 (27/98)  23.5 (35/149)   
     Disagree or strongly disagree  35.2 (87/247)  35.7 (35/98)  34.9 (52/149)   
        
There is a sense of personal failure 
associated with being diagnosed HIV+ 
      
0.937 
     Agree or strongly agree  63.3 (155/245)  62.2 (61/98)  63.9 (94/147)   
     Neither agree or disagree  16.3 (40/245)  17.3 (17/98)  15.6 (23/147)   
     Disagree or strongly disagree  20.4 (50/245)  20.4 (20/98)  20.4 (30/147)   
        
Being diagnosed HIV+ is a source of 
shame for family in Africa 
      
0.189 
     Agree or strongly agree  67.8 (166/245)  61.9 (60/97)  71.6 (106/148)   
     Neither agree or disagree  9.8 (24/245)  13.4 (13/97)  7.4 (11/148)   
     Disagree or strongly disagree  22.4 (55/245)  24.7 (24/97)  20.9 (31/148)   
        
1 Base varies due to item non-response 
2 Comparing men and women 
 
6.3 Discussion  
In keeping with national Black and minority ethnic HIV statistics, 60% of SONHIA 
participants were women, 92% heterosexual, and 50% presented late to HIV services. 
Respondents predominantly defined themselves as black African (93.5%) and Christian  
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(89.2%), were well educated (43.8% having some form of tertiary education), and 
48.1% had indefinite rights to remain in the UK. However 31.3% were not in paid 
employment or full time education, and 6.1% were homeless with a further 21.7% 
reliant on friends or family for accommodation. 
High primary and secondary care use was found prior to HIV diagnosis representing 
missed opportunities for earlier HIV diagnosis. Primary care in particular was extremely 
well utilised however HIV testing was not broached by the GP in 82.4% (145/176) of 
cases. Medical attention was sought for wide ranging reasons, often not obviously 
connected to underlying HIV status. 37% had previously tested negative for HIV, 
representing a failure in HIV prevention. 
Despite the population often coming from countries of high HIV prevalence, and 
demonstrating significant risk factors, e.g. 47.7% of men having been diagnosed with a 
STI whilst in Africa and 23% of men having paid for sex, personal appreciation of risk 
was low and knowledge lacking as to the benefits of HIV testing. Confidentiality 
concerns meant trust and disclosure of HIV status to GPs was low. 
The HIV status of partners was reported as negative by 18.4% (47/256) of respondents, 
and it was unknown for a further 27.7%. Whilst it is likely that many partners with 
untested/unknown HIV status were HIV positive some will not have been. Thus many 
respondents were currently in HIV serodiscordant relationships. Of those respondents 
currently in a relationship 41.4% (91/220) had not disclosed their HIV positive status to 
their partner, and only 12.6% of respondents had informed either all or some of their ex-
partners. The median time between HIV diagnosis and questionnaire completion was 
3.5 months so it is possible that respondents were intending on informing their partners 
but had yet to do so. Assortative sexual mixing, in which people are more likely to have 
sex with people like themselves, was found with 69.2% (72/104) of reported  
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partnerships being with fellow Africans. Concurrency was also frequent, occurring in 
36.0% of partnerships. 17.3% of all respondents reported 4 or more sexual partners 
since moving to the UK, and 21.2% reported consistent condom use in the UK prior to 
diagnosis. These findings demonstrate the substantial potential for onward transmission 
of HIV in the UK. They also show a need for more effective partner notification 
strategies.  
6.3.1  Limitations 
This study had some limitations. The study design meant only those people already 
accessing care were eligible.  This could introduce selection bias, it is possible that this 
population may be more favourably disposed to and eligible for medical services than 
those not accessing services.  The 17 people who were potentially eligible but died 
before being approached may have differed in their opportunities for earlier diagnosis 
compared to the sampled population. However all of these patients died of advanced 
HIV related diseases, if any missed opportunity for earlier diagnosis did exist this 
reflects a real failing on the part of our health services. If no such opportunity had 
existed then we must ask ourselves why someone who was likely to have been unwell 
had not been or felt able to seek medical care earlier.  
Similarly of concern is the substantial proportion (15.4%) of potentially eligible patients 
who became lost to clinic follow-up. These people may also differ compared to the 
sampled population. The reasons for lost to follow up were usually not known but are 
likely to include people already known to be HIV positive and using the testing process 
as a means of disclosure to a partner, people transferring care to other centres, people 
returning to Africa, those unable to come to terms with their HIV diagnosis, and those 
who found HIV services unacceptable. Whilst getting people into HIV services earlier is 
the first step to improving clinical outcomes, this will only be achieved if people find  
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services acceptable and are able to continue to access them. The study was limited to 
London so was unable to assess if people moving away from their communities, as in 
the asylum dispersal scheme (UK Parliament, 2002), had any impact on opportunities 
for earlier diagnosis. 
People not approached to participate in the study were more likely to come from West 
Africa (a region with generally lower HIV prevalence than Southern & Eastern Africa) 
and to have higher CD4 counts than those approached.  It is possible that this selection 
bias may have influenced our findings. 
As data were collected retrospectively recall bias may have occurred, especially for 
those in whom prior accessing of health services was associated with their HIV 
diagnosis. However any effect of this is likely to have been small given that participants 
were surveyed within 12 months of HIV diagnosis (the median time between diagnosis 
and questionnaire completion was only 3.5 months) and questions around health care 
were deliberately restricted to a relatively narrow time frame.  
Gender differences may partially be attributable to reporting bias. Men and women may 
differ in what they count as ‘sex’, and social desirability bias may cause men to over-
report and women to under-report certain behaviours. 
6.3.2   Implications  
The data suggests that rather than having poor access to health services, Africans report 
higher rates of primary and secondary care attendance and HIV testing than the general 
population (Burns & Mercer, 2006).  That Africans continue to present to HIV services 
with advanced disease despite accessing health services prior to diagnosis suggests HIV 
is often missed as a differential diagnosis, or that clinicians are either reluctant to 
address HIV or are doing so ineffectively.  Similarly, that many Africans test HIV  
  173  
positive after a previous negative test, suggests these HIV prevention opportunities are 
not being used effectively. 
The age and country of origin of participants alone should guide health practitioners to 
the possibility of HIV infection, irrespective of health status.  Whilst some of the 
reasons for attending medical services may relate to HIV many do not.  The findings 
suggest a proactive approach to HIV testing, as found in the antenatal setting, is 
required to minimise these missed opportunities for earlier diagnosis. 37.1% of 
respondents reported a previous negative HIV test.  Whilst the majority of these 
occurred in Africa 32.5% had occurred in the UK.  HIV infection risks are ongoing, 
with acquisition within the UK a real phenomenon for resident Africans. The risk of 
HIV acquisition within the UK is the focus of chapter 8. 
The Centres for Disease Control and Prevention (CDC) now recommends that HIV 
screening be performed routinely in all health-care settings for 13-64 year olds (Branson 
et al., 2006). GP’s should be the first port of call for all health issues, including HIV.  
The ongoing care relationship provided by primary care services should lend itself to 
the provision of personalised ongoing HIV information and repeat screening 
opportunities. Work to address the concerns of service users around HIV and primary 
care is required.   
The National Strategy for Sexual Health and HIV (Department of Health, 2001) in 2001 
set clear targets for HIV testing and reducing undiagnosed infection. In practice these 
recommendations have yet to be realised, probably because of the low priority of sexual 
health in most primary care trusts has resulted in lack of funds.  Proposals to exclude 
overseas visitors from eligibility to free NHS primary medical service (Department of 
Health, 2004b), designed to align primary care with hospital care, will further reduce 
opportunities for earlier diagnosis.  A more positive approach would be to ensure that  
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health services that are currently well utilised by this high risk population have both the 
resources and incentives to effectively address HIV. 
Quantitative questionnaires of this nature provide crude measures that help focus 
direction, but they are unable to disentangle the complex components of a culture in 
enough depth, to guide HIV prevention interventions.  Qualitative work is required to 
gain deeper understanding of these factors and the interplay between them.  The 
findings of 26 in-depth interviews conducted to explore late presentation are presented 
in chapter 9.  
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Chapter 7: Late presentation of HIV in 
Africans in London 
Abstract 
Objective: To identify factors associated with late presentation of HIV 
in Africans resident in London. 
Methods: Analysis of data from the survey of newly diagnosed HIV 
positive Africans in London  (SONHIA).   
Results: 263 questionnaires were completed, representing an uptake rate 
of 79.5% of patients approached. 49.8% (131/263) of participants 
presented with advanced HIV disease (CD4 <200x10
6/l at diagnosis).  
Participants who defined themselves as bi or homosexual, who were 
French speakers, and who did not believe HIV causes AIDS, were less 
likely to present with advanced disease than heterosexuals (AOR 0.16, 
95%CI 0.04, 0.62), non-French speakers (AOR 0.11, 95%CI 0.02, 0.58), 
and people who believed HIV causes AIDS (AOR 0.25, 95%CI 0.08, 
0.863).  Late presentation was not significantly associated with gender, 
age, or socio-economic factors, in this study.  
Conclusion: HIV presentation patterns appear to be governed by factors 
linked to the characteristics of, and response to, the HIV epidemic 
operating within people’s sociocultural networks. Further work is 
needed to understand these factors in order to guide HIV interventions. 
 
7.0  Introduction  
This chapter seeks to identify the demographic, behavioural and social factors 
associated with delayed presentation to HIV treatment services in Africans with newly 
diagnosed HIV infection. The first section explains the conceptual framework and 
statistical approaches utilised in analysing the cross sectional survey.  The second 
explores the factors associated with late presentation, providing crude and adjusted odds 
ratios.  
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7.0.1               Aims and objectives 
This chapter aims to determine the demographic, behavioural and social factors 
independently associated with delayed presentation (CD4<200 cells/μl at time of HIV 
diagnosis) to treatment services. 
7.1  Methods 
As previously described in chapters 5 and 6. 
7.1.1    Outcome   
The principal endpoint for the survey was late presentation. Late presentation was 
defined as a CD4 count below 200 cells/µL at time of HIV diagnosis.  
7.1.2 Data editing and reduction 
When necessary continuous variables such as age were categorised into groups that 
would have statistical efficacy whilst maintaining relevance.  Similarly explanatory 
variables were re-categorised if numbers were too small for analysis and merger of 
categories was not felt to lead to loss of information.  The impact of re-categorising 
explanatory variables was tested to ensure association with the outcome variable of late 
presentation was not significantly altered. 
7.1.3   The conceptual framework 
Traditionally epidemiological studies have relied predominantly on individual risk 
factor analysis without the application of a conceptual framework.  This can make the 
interpretation of the relative importance of individual variables difficult. The need to 
understand the socioeconomic and sociocultural forces underlying population processes 
is increasingly being recognised. Conceptual frameworks that acknowledged the 
biological processes that link society to health outcomes initially developed for the  
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study of fertility and infant mortality (Mosley & Chen, 2003; Stover, 1998), have been 
adapted for HIV (Boerma & Weir, 2005; Lewis et al., 2007).  
These ‘proximate-determinant’ frameworks explain the hierarchical and non-
hierarchical associations between different variables. The frameworks have a set of 
variables, termed ‘proximate determinants’, that have behavioural and biological 
aspects that can be influenced by changes in contextual variables or by interventions 
(the ‘distal’ or ‘underlying determinants’).  
Boerma and Weir’s proximate-determinant model is concerned with the acquisition of 
HIV, thus it incorporates biological determinants that affect the reproductive number for 
infection (the average number of secondary cases that arise from any new case of 
infection (Anderson, 1992)) (Boerma et al., 2005). The focus of this study however is 
not HIV acquisition but HIV testing behaviour. Thus the framework (figure 6.1) does 
not include variables exploring efficiency of HIV transmission per contact or duration 
of infectivity.  It does include biological factors related to exposure to HIV as these 
could impact on perception of HIV risk and thus testing behaviours.  It also includes 
factors affecting exposure to health services and factors affecting HIV testing 
behaviour. Boerma and Weir included one feedback mechanism, prevalence of HIV 
infection, which is absent in this model. This is because background HIV prevalence 
has been viewed as an underlying contextual determinant that influences the more 
proximate factors. The framework is restricted to sexual transmission of HIV, the 
predominant mode of HIV transmission in this population.  
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Figure 7.1 Conceptual framework underlying analysis 
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7.1.4   Statistical analysis 
Two-way associations were examined using cross tabulations and χ
2  tests, unless 
numbers were small when Fishers exact test was used.  
Logistic regression was used for both univariate and multivariate analysis to obtain 
crude and adjusted odds ratios (OR) with 95% confidence intervals (95%CI).   
Significance was set at p<0.05, although those below 0.1 were retained for multivariate 
analysis.  
Factors potentially on the causal pathway were excluded from the multivariate model. 
These included site of HIV diagnosis, reason for last HIV test, and perception of health. 
 Several variables that were significantly associated with late presentation in univariate 
analysis measured very similar behaviours or factors, thus exhibiting high degrees of co 
linearity:  Sexuality (heterosexual or homosexual/bisexual) had substantial overlap with 
‘in the past two years had sex with: opposite sex, same or both sexes, and not had sex’; 
The ability to speak French comfortably (yes or no) was closely aligned to the preferred 
language to read in (English or other including illiterate);  and country of birth and 
country of adolescence also exhibited high co linearity. To enable multivariate analysis 
the variables ‘with whom had sex in the past two years’, ‘preferred language to read in’, 
and ‘country of adolescence’ were dropped.   
For multivariate analysis backwards-stepwise selection was used based on a simple 
conceptual framework (figure 7.1). First the association of the socio-cultural and 
economic factors with the outcome was determined. Variables were eliminated from 
this ‘distal model’ if they did not contribute significantly to the model (p<0.055).   
Gender, age and sexuality were kept in the model on a priori basis as all of these factors 
are known to be associated with late diagnosis (The UK Collaborative Group for HIV  
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and STI Surveillance, 2006). The proximate factors, which had been significantly 
associated with the outcome in bivariate analysis, were then included and the process of 
stepwise backward elimination repeated, preserving those factors that contributed 
significantly in the ‘distal model’. Several variables (when think was infected with HIV, 
why think was infected with HIV, main source of information about HIV, and previous 
negative HIV test) had appreciable missing data and were excluded from the stepwise 
analysis. Once the most parsimonious model was found logistic regression was repeated 
with all eligible cases. Those variables that had been dropped from the analysis due to 
their small base were then sequentially added back into the model and retained if they 
contributed significantly, however none did.  
The model selection (backwards stepwise) was then repeated without any hierarchy or a 
priori variables, i.e. treating all factors equally, to assess the influence of the conceptual 
framework.  
7.1.5   Effect  modifiers 
Effect modification was investigated once the final model had been determined.  To 
ensure adequate power each parameter in the final model was recoded into a binary 
variable.  
Despite this it was not possible to test for interactions between French language and any 
of the other parameters in either the hierarchal or non-hierarchal model. This was 
because characteristics inherent in this population made certain combinations of 
variables so rare there were not adequate numbers. Whilst this means this study is 
unable to definitely say whether interactions between these parameters existed, the 
occurrence would be so rare it is unlikely to be of practical importance.  No interactions 
were found between any of the other parameters.   
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7.2  Results  
7.2.1   Descriptive analysis 
Detailed description of response rates, item non-response and the socio-demographic, 
health beliefs, heath care utilisation and clinical presentation patterns of newly 
diagnosed HIV positive Africans in London and missed opportunities for earlier 
diagnosis are reported in chapter 6. 
7.2.2           Factors associated with late presentation 
Fifty percent of participants presented late to HIV services 
7.2.2.1 Univariate  analysis 
Socio-demographics (Tables 7.1)  
Gender, age, education, marital status, time in the UK, and residency status were not 
significantly associated with late presentation. Age was not associated with late 
presentation whether it was treated as a categorical or a continuous variable (data not 
shown). Participants defining themselves as bi- or homosexual were less likely to 
present late than heterosexuals (OR 0.25; 95%CI 0.08-0.77); French speakers were less 
likely to present late (OR 0.11, 95%CI 0.03-0.50) than non French speakers, and 
persons who preferred to read in a language other than English (including illiterate) 
were also less likely to present late (OR 0.41, 95%CI 0.18-0.94).   
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Table 7.1Univariate analysis of socio-demographic factors associated with late presentation (CD4 
<200 cells/µL at diagnosis) 
Characteristic %  (r/n)
1  Crude OR  95% CI  p-value 
Gender        
Male 52.9  (55/104)  1  -  - 
Female 47.8  (76/159)  0.82  0.50,  1.34  0.420 
Age (years):         
<35 48.1  (64/133)  1  -  - 
35+ 51.5  (67/130)  1.15  0.71,  1.86  0.579 
Ethnicity:          
Black African  50.8 (125/246)  1  -  - 
Other   35.3 (6/17)  0.53  0.19, 1.47  0.216 
Sexuality:        
Heterosexual 51.7  (121/234)  1  -  - 
Bi or Homosexual  21.1 (6/19)  0.25  0.08, 0.77  0.016 
Education        
High school education or below   51.9 (70/135)  1  -  - 
Higher education  48.8 (61/125)  0.89  0.54, 1.44  0.623 
Marital Status:         
Married or cohabiting  49.0 (48/98)  1  -  - 
Other   51.3 (82/160)  1.10  0.66, 1.81  0.723 
Have children         
       No  46.0 (40/87)  1  -  - 
       Yes  51.5 (89/173)  1.24  0.74, 2.09  0.405 
HIV prevalence
2 of country of birth         
       5% or higher  48.6 (107/220)  1  -   
       Low (<5%)  55.8 (24/43)  1.33  0.69, 2.57  0.390 
Time in UK before HIV diagnosis:         
3 or more years  49.7 (82/165)  1  -  - 
<3 years  51.04 (49/96)  1.07  0.65, 1.77  0.798 
Age on arrival in UK         
        0-29 years  45.9 (67/146)  1  -  - 
        30+ years  55.7 (64/115)  1.50  0.92, 2.45  0.106 
Currently:        
Living in the UK  48.5 (98/202)  1  -  - 
Other (e.g. studying, short term-
work contract, visiting) 
54.1 (33/61)  1.25  0.70, 2.22  0.445 
Residency status in the UK         
Indefinite right to remain (British 
citizen, EEC member, Permanent 
resident, refugee) 
50.4 (63/125)  1  -  - 
Other (e.g. visa entry, Asylum 
seeker, applying for visa, illegal) 
48.9 (66/135)  0.94  0.58, 1.53  0.808 
Accommodation        
Own or rent  46.8 (89/190)  1  -  - 
Other   56.9 (41/72)  1.50  0.87, 2.59  0.144 
Employment status         
      Employed fulltime  46.2 (43/93)  1  -  -  
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Characteristic %  (r/n)
1  Crude OR  95% CI  p-value 
      Other (e.g. employed part time,  
       student, unemployed) 
51.2 (85/166)  1.22  0.73, 2.03  0.443 
Speaks English comfortably         
No 43.3  (13/30)  1  -  - 
Yes 50.4  (117/232)  1.33  0.62,  2.86  0.464 
Speaks French comfortably         
       No  52.5 (128/244)  1  -  - 
       Yes  11.1 (2/18)  0.11  0.03, 0.50  0.001 
Preferred language to read in         
       English  52.1 (122/234)  1  -  - 
       Other, including illiterate  31.0 (9/29)  0.41  0.18, 0.94  0.032 
Religion:       0.898 
Roman catholic  48.9 (45/92)  1  -   
Christian – non Roman Catholic  48.9 (69/141)  1.00  0.59, 1.69   
Other (including Muslim)  53.6 (15/28)  1.21  0.52, 2.81   
1 Base varies due to missing values
 
2 HIV prevalence (%) adults aged 15-49 according to UNAIDS 2003 data 
 
 
Sexual health & behaviour (table 7.2) 
The only sexual health variable significantly associated with late presentation in 
univariate analysis related to sexual behaviour in the two years prior to diagnosis. 
Participants who had sex with the same or both sexes were less likely to present late 
(OR 0.27, 95%CI 0.07-0.97) than those who had sex with only the opposite sex. This 
would be expected given the association between sexuality and presentation (see 
above), this variable was included to measure actual behaviour rather than sexual 
identity.  
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Table 7.2 Univariate analysis of sexual health factors associated with late presentation (CD4 <200 
cells/µL at diagnosis) 
Characteristic %  (r/n)
1  Crude OR  95% CI  p-value 
Partner
2       0.739 
HIV positive  43.1 (31/72)  1  -   
HIV negative  48.9 (23/47)  1.27  0.61, 2.65   
Do not know or untested for HIV  48.7 (38/78)  1.26  0.66, 2.39   
In the last 2 years have had sex with:        0.026 
Opposite sex only  48.5 (97/200)  1  -   
Same or both sexes   20.0 (3/15)  0.27  0.07, 0.97   
Not had sex in last 2 years  63.2 (24/38)  1.82  0.89, 3.72   
Number of sexual partners in UK prior to HIV diagnosis        0.149 
      0  61.2 (30/49)  1  -   
      1  48.4 (44/91)  0.59  0.29, 1.20   
      2 or more  44.0 (40/1)  0.50  0.24, 1.01   
Consistent condom use in the UK if sex prior to 
HIV diagnosis  
      
Yes 49.0  (25/51)  1  -  - 
No or unsure  47.6 (68/148)  0.94  0.50, 1.79  0.857 
Number of sexual partners in past year        0.061 
      0  63.5 (33/52)  1  -   
      1  43.9 (57/130)  0.45  0.23, 0.87   
      2 or more  49.2 (30/61)  0.56  0.26, 1.19   
Consistent condom use if sex in past year         
Yes 47.9  (23/48)  1  -  - 
No or unsure  46.3 (69/149)  0.94  0.49, 1.80  0.846 
Travelled back to Africa since moving to UK         
No 53.4  (86/141)  1  -  - 
Yes 43.4  (43/99)  0.67  0.40,  1.11  0.118 
Sexual intercourse with new partners on last 
visit to Africa 
      
No 46.1  (35/76)  1  -  - 
Yes 37.5  (9/24)  0.70  0.27,  1.80  0.462 
 Ever paid for sex          
No 48.9  (111/227)  1  -  - 
Yes 51.9  (14/27)  1.13  0.51,  2.50  0.772 
Ever been paid for sex         
No 49.2  (119/242)  1  -  - 
Yes 57.1  (4/7)  1.38  0.30,  6.29  0.678 
STI prior to moving to UK         
       No  48.9 (85/174)  1  -  - 
 Yes  50.8 (33/65)  1.08  0.61, 1.91  0.792 
STI since moving to UK         
        No  45.6 (68/149)  1  -  - 
 Yes  48.4 (31/64)  1.12  0.62, 2.01  0.707 
1 Base varies due to item non-response 
2 Excludes those without a partner at present  
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Health & health care behaviours (table 7.3) 
Use of primary and secondary care services did not significantly differ in those 
presenting late compared to those not presenting late (primary care OR 1.22; 95%CI 
0.69-2.15; inpatient use OR 1.85; 95%CI 0.92-3.72; outpatient use OR 1.05; 95%CI 
0.64-1.74)) (Table 6.13). Similarly GPs mentioning HIV was not associated with late 
presentation (OR1.2; 95%CI 0.55-2.61).  No one reason for seeking medical care was 
found to be associated with late presentation. 
Variables likely to reflect the impact of HIV disease on health were unsurprisingly 
found to be associated with late presentation. Three or more GP visits in the past year, 
an illness or accident affecting health for greater than three months in the last five years, 
and poor or terrible health 12 months ago and currently, were all associated with 
significantly higher odds of late presentation.  Similarly testing HIV positive in a 
hospital or GP surgery had higher odds of late presentation than other testing sites (OR 
3.17, 95%CI 1.84-5.44).  
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Table 7.3 Univariate analysis of health & social service use prior to HIV diagnosis associated with 
late presentation (CD4 <200 cells/µL at diagnosis) 
Services %  (r/n)
1  Crude OR  95% CI  p-value 
Registered with GP         
      No  45.0 (18/40)  1  -  - 
      Yes  50.5 (111/220)  1.24  0.63, 2.45  0.526 
GP visits in year before HIV diagnosis:        0.025 
None   44.3 (35/79)  1  -   
1-2 41.3  (33/80)  0.88  0.47,  1.66   
3 or more  61.5 (48/78)  2.01  1.06, 3.80   
Attended GP in 2 years before HIV 
diagnosis
2 
     
      No  45.3 (29/64)  1  -  - 
      Yes  50.3 (97/193)  1.22  0.69, 2.15  0.493 
Inpatient use in year prior to HIV 
diagnosis 
     
        No  46.3 (101/218)  1  -  - 
        Yes  61.5 (24/39)  1.85  0.92, 3.72  0.080 
Outpatient use in year prior to HIV 
diagnosis 
     
        No  48.7 (77/158)  1  -  - 
        Yes  50.0 (49/98)  1.05  0.64, 1.74  0.844 
Illness or accident affecting health for 
at least 3 months in the last 5 years 
(excluding HIV) 
 
 
 
 
 
 
 
 
      No  43.8 (85/194)  1  -  - 
      Yes  65.08 (41/63)  2.39  1.32, 4.31  0.003 
Attended antenatal care in UK in past 5 
years 
     
      No  49.1 (114/232)  1  -  - 
      Yes   48.2 (13/27)  0.96  0.43, 2.13  0.922 
Child born in the UK         
      No  51.2 (105/205)  1  -  - 
      Yes  44.2 (23/52)  0.76  0.41, 1.39  0.368 
Attends HIV services within own SHA         
      No  43.8 (28/64)  1  -  - 
      Yes  50.6 (86/170)  1.32  0.74, 2.35  0.351 
Health 12 months ago        0.004 
Excellent or very good  43.2 (73/169)  1  -   
Fair 53.7  (29/54)  1.53  0.82,  2.82   
Poor or terrible  73.7 (28/38)  3.68  1.68, 8.06   
Health now       <0.001 
Excellent or very good  38.5 (52/135)  1  -   
Fair 57.8  (52/90)  2.18  1.27,  3.76   
Poor or terrible  70.3 (26/37)  3.77  1.72, 8.26   
Length of poor health         
Not at all  37.2 (55/148)  1  -  - 
Ill health present  65.8 (75/114)  3.25  1.95, 5.42  <0.001 
1 Base varies due to item non-response                                                                                                     
2 Reasons for seeing GP in the 2 years prior to HIV diagnosis not associated with late presentation  
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HIV awareness (table 7.4) 
People who had a prior negative HIV test were less likely to present late (OR 0.55; 
95%CI 0.31-0.96); this did not depend on whether the test was in the UK or abroad (OR 
0.94; 95%CI 0.35-2.49).  
Participants who found out where to have an HIV test by means other than being 
offered one whilst in hospital, and who knew about medical confidentiality prior to their 
HIV test were also less likely to present late.  
HIV knowledge, attitudes and beliefs (tables 7.5, 7.6, & 7.7) 
Participants who tested for reasons other than advice by a Doctor or being symptomatic 
were less likely to present to HIV service late. Participants who perceived the timing of 
HIV acquisition as related to high-risk sexual contact had lower odds of presenting late 
than those who associated HIV acquisition with becoming unwell (OR 0.37, 95%CI 
0.17-0.80). 
No factors related to the perception of peoples reaction and attitudes to HIV were found 
to impact significantly on presentation. However participants who disagreed or were 
ambivalent about whether HIV causes AIDS were less likely to present late (OR 0.18, 
95%CI 0.06-0.56). 
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 Table 7.4 Univariate analysis of HIV awareness factors associated with late presentation (CD4 
<200 cells/µL at diagnosis) 
HIV awareness prior to diagnosis  % (r/n)
1  Crude OR  95% CI  p-value 
Previous negative HIV test
2        
No 56.1  (74/132)  1  -  - 
Yes 41.0  (32/78)  0.55  0.31,  0.96  0.035 
Last negative test in UK         
Yes 40.0  (10/25)  1  -  - 
No 38.5  (20/52)  0.94  0.35,  2.49  0.897 
HIV testing mentioned by GP in past year          
       No  50.3 (73/145)  1  -  - 
       Yes  54.8 (17/31)  1.20  0.55, 2.61  0.650 
Time in UK before knowledge of where to 
have HIV test:  
      
 
Less than 2 years  48.4 (61/126)  1  -  - 
2 or more years  51.2 (64/125)  1.12  0.68, 1.83  0.659 
How found out where to have HIV test:        <0.001 
Offered whilst in hospital  69.3 (52/75)  1  -   
From a GP surgery   48.1 (25/52)  0.41  0.20, 0.85   
Other (e.g. partner, friends, media, internet)  39.3 (48/122)  0.29  0.16, 0.53   
Ever try but unable to have an HIV test         
        No  48.5 (110/227)  1  -  - 
        Yes  57.1 (16/28)  1.42  0.64, 3.13  0.388 
Perception of type of person who got HIV prior 
to HIV diagnosis
5 
      
       Anybody         
               No  46.9 (45/96)  1  -  - 
               Yes  51.2 (84/164)  1.19  0.72, 1.97  0.499 
       Only people who have sex with lots  
       of people 
 
 
 
 
 
 
 
 
               No  52.23 (82/157)  1  -  - 
               Yes  45.6 (47/103)  0.77  0.47, 1.26  0.298 
Number of people participant knew to have 
HIV prior to their diagnosis (excludes don’t 
knows): 
      
 
0.985 
5 or more  50.0 (47/94)  1  -   
1-4 49.3  (35/71)  0.97  0.52,  1.80   
No one  50.8 (32/63)  1.03  0.55, 1.95   
Main source of HIV information prior to diagnosis        0.144 
Health care workers  62.0 (31/50)  1  -   
Media 43.8  (32/73)  0.48  0.23,  1.0   
Other (e.g. friends, partner, organisations)  51.3 (60/117)  0.65  0.33, 1.27   
Knowledge that HIV testing would be free 
when arrived in UK 
      
       No  47.6 (88/185)  1  -  - 
       Yes  56.2 (41/73)  1.41  0.82, 2.44  0.214 
Knowledge of medical confidentiality          
       No  59.3 (48/81)  1  -  - 
       Yes  44.0 (77/175)  0.54  0.32, 0.92  0.024 
Influenced to have HIV test by advertising         
       No  49.7 (88/177)  1  -  - 
       Yes  44.8 (26/58)  0.82  0.45, 1.49  0.518 
1 Base varies due to item non-response   
2 Excludes those who do not know if they have ever tested (n=37)  
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Table 7.5 Univariate analysis of factors associated with testing HIV positive and late presentation 
(CD4 <200 cells/µL at diagnosis) 
HIV Testing  % (r/n)
1  Crude OR  95% CI  p-value 
Site of HIV diagnosis in UK        <0.001 
      Sexual Health Clinic  40.5 (53/131)  1  -   
      In hospital or GP surgery  68.3 (71/104)  3.17  1.84, 5.44   
      Other (e.g. Ante-natal clinic)  25.0 (6/24)  0.49  0.18, 1.32   
Main reason for last HIV test         
      Advised to by Doctor or health   
      complaints thought related to HIV 
 
64.7 (99/153) 
 
1 
 
- 
 
- 
      Other (e.g. pregnancy)  29.6 (32/108)  0.23  0.14, 0.39  <0.001 
Expecting positive result         
      No or did not know  47.5 (105/221)  1  -   
      Yes  62.2 (23/37)  1.81  0.89, 3.71  0.099 
Perceived reason for HIV infection        0.037 
      Became unwell  66.7 (28/42)  1  -   
      High –risk sexual contact
 2   42.7 (38/89)  0.37  0.17, 0.80   
      Other (e.g. blood transfusion)  46.3 (25/54)  0.43  0.19, 0.99   
Factors stopping earlier HIV testing         
       Had never considered may be HIV +         
            No  52.0 (40/77)  1  -  - 
            Yes  49.7 (89/179)  0.91  0.54, 1.56  0.744 
      Well so no need         
            No  47.2 (59/125)  1  -  - 
            Yes  53.4 (70/131)  1.28  0.79, 2.10  0.319 
      Afraid of the result         
            No  48.9 (90/184)  1  -  - 
            Yes  54.2 (39/72)  1.23  0.71, 2.13  0.450 
      Afraid of the stigma          
            No  48.9 (89/182)  1  -  - 
            Yes  54.1 (40/74)  1.23  0.72, 2.11  0.455 
      Fear of losing a relationship         
            No  49.8 (11/237)  1  -  - 
            Yes  57.9 (11/19)  1.39  0.54, 3.57  0.498 
Factors that would have made 
respondent test for HIV earlier 
     
 
      If had been told were at risk         
            No  43.6 (44/101)  1  -  - 
            Yes  54.8 (80/146)  1.57  0.94, 2.62  0.083 
      If felt would be supported if tested  
      HIV positive 
     
            No  52.4 (89/170)  1  -  - 
            Yes  45.5 (35/77)  0.76  0.44, 1.30  0.316 
      If no stigma attached to HIV         
            No  50.6 (79/156)  1  -  - 
            Yes  49.5 (45/91)  0.95  0.57, 1.60  0.857 
      If HIV not so linked to sex         
            No  49.7 (96/193)  1  -  - 
            Yes  51.9 (28/54)  1.09  0.59, 1.99  0.784 
      If knew could treat HIV          
            No  51.7 (105/203)  1  -  - 
            Yes  43.2 (19/44)  0.71   0.37, 1.37  0.306 
      If knew could reduce MTCT         
            No  50.0 (109/218)  1  -  - 
            Yes  51.7 (15/29)  1.07  0.49, 2.33  0.862 
User of traditional medicines ever         
      No  48.7 (114/234)  1  -  - 
      Yes  52.0 (13/25)  1.14  0.50, 2.60  0.755 
1 Base varies due to item non-response    
2 Including sexual assault/rape    MTCT= mother to child transmission  
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Table 7.6 Univariate analysis of reactions and attitudes to HIV associated with late presentation 
(CD4 <200 cells/µL at diagnosis) 
 %  (r/n)
1  Crude OR  95% CI  p-value 
Most partners of people who are HIV+ would 
leave if they knew about the HIV  
 
 
 
    
     Agree or strongly agree 45.7  (74/162)  1  -  - 
     Disagree or strongly disagree
2 56.6  (47/83)  1.55  0.91,  2.65  0.105 
        
My family would stand by and support me if 
they knew about my HIV 
      
 
     Agree or strongly agree 52.9  (91/172)  1  -  - 
     Disagree or strongly disagree
2 42.5  (34/80)  0.66  0.39,  1.12  0.124 
        
My friends would stand by and support me if 
they knew about my HIV 
      
 
 
     Agree or strongly agree  55.4 (36/65)  1  -  - 
     Disagree or strongly disagree
2  48.0  (86/179) 0.74 0.42,  1.32  0.311 
        
HIV + people are at risk of isolation if their 
church/mosque finds out about their diagnosis 
      
     Agree or strongly agree  45.9 (45/98)  1  -  - 
     Disagree or strongly disagree
2  51.0  (76/149) 1.23 0.74,  2.04  0.434 
        
There is a sense of personal failure associated 
with being diagnosed HIV+ 
      
 
     Agree or strongly agree 51.0  (79/155)  1  -  - 
     Disagree or strongly disagree
2 46.7  (42/90)  0.84  0.50,  1.42  0.516 
        
Being diagnosed HIV+ is a source of shame for 
family in Africa 
      
 
     Agree or strongly agree 50.6  (84/166)  1  -  - 
     Disagree or strongly disagree
2 48.1  (38/79)  0.91  0.53,  1.55  0.714 
        
1 Base varies due to item non-response 
2 Includes those neither agreeing or disagreeing 
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Table 7.7 Univariate analysis of beliefs around HIV and HIV services to late presentation (CD4 
<200 cells/µL at diagnosis) 
 %  (r/n)
1  Crude OR  95% CI  p-value
HIV causes AIDS          
     Agree or strongly agree  53.3 (121/227)  1  -  - 
     Disagree or strongly disagree
2 17.4  (4/23)  0.18  0.06,  0.56  0.001 
        
HIV is a disease created by white 
people 
     
 
     Agree or strongly agree  47.6 (10/21)  1  -  - 
     Disagree or strongly disagree
2 49.3  (110/223)  1.07  0.44,  2.62  0.881 
        
The medicines available work just as 
well on black people as white people 
     
 
     Agree or strongly agree  49.5 (107/216)  1  -  - 
     Disagree or strongly disagree
2 44.1  (15/34)  0.80 0.39,  1.66  0.557 
        
The NHS meets the needs of African 
patients 
     
 
     Agree or strongly agree  51.2 (103/201  1  -  - 
     Disagree or strongly disagree
2 43.5  (20/46)  0.73 0.38,  1.40  0.343 
        
The NHS treats African patients as 
fairly as other patients 
     
 
     Agree or strongly agree  49.5 (102/206)  1  -  - 
     Disagree or strongly disagree
2 50.0  (22/44)  1.02 0.53,  1.96  0.953 
        
1 Base varies due to item non-response 
2 Includes those neither agreeing or disagreeing 
 
 
7.2.2.2 Multivariate  analysis 
Hierarchal model (table 7.8) 
When incorporated into a hierarchal multivariate model four factors remained 
independently associated with late presentation. The adjusted odds of presenting late 
were lower for participants identifying as bi- or homosexual (AOR 0.16, 95%CI 0.04-
0.62) compared to those identifying as heterosexual. Participants who had one sexual 
partner in the past year had lower adjusted odds of presenting late (AOR 0.27, 95%CI 
0.12-0.62) than those who had no sexual partners. Being a French speaker was 
associated with reduced odds of late presentation (AOR 0.11, 95%CI 0.02-0.58). 
Participants expressing a belief that HIV does not cause AIDS had lower adjusted odds 
of late presentation (AOR 0.25, 95%CI 0.08-0.83) than those who believe it does.  
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Table 7.8 Multivariate analysis of factors associated with late presentation(CD4 <200 cells/µL at 
diagnosis) using hierarchal selection (n=229)
1 
Factor 
Crude OR 
Adjusted OR
2  95% CI  P value 
Gender
3        
      Male  1  1  -  - 
      Female  0.82  0.80  0.43, 1.52  0.503 
        
Age (years)
3        
    <35  1  1  -  - 
    35+  1.15  1.00  0.55, 1.82  0.995 
        
Sexuality
3        
     Heterosexual  1  1  -  - 
     Bi or homosexual  0.25  0.16  0.04, 0.62  0.009 
        
French speaker         
     No  1  1  -  - 
     Yes  0.11  0.11  0.02, 0.58  0.009 
        
Number of sexual partners in past year          
      0   1  1  -  - 
      1  0.45  0.27  0.12, 0.62  0.002 
      2 or more  0.56  0.45  0.18, 1.16  0.100 
        
Belief that HIV causes AIDS         
     Agree or strongly agree  1  1  -  - 
     Disagree or strongly disagree
4 0.18  0.25  0.08,  0.83  0.023 
        
1 Some subjects had missing values on one or more of the independent variables 
2 Adjusted for all other variables in the model  
3 Retained in model on a priori basis 
4 Includes those neither agreeing or disagreeing 
 
 
 
Non-hierarchal model (table 7.9) 
When the same variables were incorporated into a non-hierarchal selection model four 
factors still remained significantly associated with the outcome however number of 
sexual partners was replaced by knowledge of medical confidentiality. The adjusted 
odds of presenting late remained lower for participants identifying as bi- or homosexual 
(AOR 0.20, 95%CI 0.06-0.74) compared to those identifying as heterosexual.  Being a 
French speaker also remained associated with reduced odds of late presentation (AOR 
0.15, 95%CI 0.03-0.70), as did expressing a belief that HIV does not cause AIDS (AOR  
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0.23, 05%CI 0.07-0.73). Finally those participants who had knew that Doctors were 
legally obliged to respect their confidentiality and not inform others about their HIV 
infection prior to their HIV diagnosis were also less likely to present late to HIV 
services (AOR 0.54, 95%CI 0.30-0.97) than those who did not. 
 
 
Table 7.9 Multivariate analysis of factors associated with late presentation  - non hierarchal 
selection (n=239)
1 
Factor 
Crude OR 
Adjusted OR
2  95% CI  P value 
Sexuality         
      Heterosexual  1  1  -  - 
      Bi or homosexual  0.25  0.20  0.06, 0.74  0.016 
        
Belief that HIV causes AIDS         
     Agree or strongly agree  1  1  -  - 
     Disagree or strongly disagree
3 0.18  0.23  0.07,  0.73  0.012 
        
French speaker         
     No  1  1  -  - 
     Yes  0.11  0.15  0.03, 0.70  0.016 
        
Knowledge of medical confidentiality 
prior to HIV diagnosis 
      
 
       No  1  1  -  - 
       Yes  0.54  0.54  0.30, 0.97  0.04 
        
1 Some subjects had missing values on one or more of the independent variables 
2 Adjusted for all other variables in the model  
3 Includes those neither agreeing or disagreeing  
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7.3  Discussion  
Half of all respondents had advanced HIV disease at the time of their HIV diagnosis. 
Risk behaviours and risk perception were generally not found to be associated with HIV 
presentation patterns in the univariate analysis. There were two exceptions: reduced 
odds of late presentation was associated with the number of sexual partners in the past 
year (those having one compared to none, but not those having two or more (although 
there was a non-significant reduced odds in this group)); reduced odds of late 
presentation was also found in respondents who associated their HIV acquisition with a 
risk exposure, compared to respondents associating their HIV acquisition with the onset 
of ill health. Factors reflecting poor health of respondents were, unsurprisingly, found to 
be associated with increased odds of late presentation, these included number of GP 
visits, ill health in the past 5 years, and site and reason for last HIV test.  
The ability to access health information did not appear associated with late presentation, 
for example being GP registered showed no association with HIV presentation.   
Contrary to expectations respondents who’s preferred language to read in was not 
English (including those who were illiterate), and who spoke French, were less likely to 
present late.  Whilst people testing HIV positive after a previous negative test reflects 
failure in prevention messages, people who had previously tested for HIV (37.1%) were 
less likely to present to HIV services late. Knowledge of medical confidentiality prior to 
HIV diagnosis also was associated with reduced odds of late presentation. 
 
Multivariate analysis of factors associated with late presentation to HIV services 
Unlike national data where late presentation is higher in older and male populations, no 
association between age or gender and late presentation was found in this study.  This  
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may reflect sampling bias; clinicians were reluctant to deem the ante and post natal 
periods as an ‘appropriate time’ for study recruitment. The relative paucity of women 
diagnosed antenatally in the sample (9.4% of women) could influence both gender and 
age, as pregnant women tend to be younger and to present earlier (The UK 
Collaborative Group for HIV and STI Surveillance, 2006; Chadborn, 2005).  
Routine antenatal testing accounted for 15.6% (274/1761) of new HIV diagnoses in 
black African women in the UK in 2006 (The UK Collaborative Group for HIV and STI 
Surveillance, 2007). In 2004 the median CD4 count at diagnosis of women diagnosed in 
pregnancy was 340 cells/µL, compared to 259 cells/µL in non-pregnant women, and 
227 cells/µL in heterosexual men (Chadborn, 2005). Published data on late presentation 
by risk group typically merges pregnant and non-pregnant women into a ‘heterosexually 
acquired – women’ group.  If women diagnosed antenatally were separated out, 
differences in presentation patterns between men and women with heterosexually 
acquired HIV would be less marked (figure 7.2). 
Percentage of HIV infected adults diagnosed late: 
with CD4 count at HIV diagnosis less than 200 cells per mm3;
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Figure 7.2 Percentage of HIV infected adults diagnosed late (CD4 <200 cells/µL), 
England and Wales 2004  ___ Sex between men and women (Men) 
___ Sex between men and women (women) 
___ Pregnant women 
___ Men who have sex with men 
Year of HIV diagnosis 
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Participants identifying as bi or homosexual were less likely to de diagnosed with 
advanced HIV than heterosexuals. Whilst the differences in presentation and in reasons 
for HIV testing between the heterosexual and the gay community within the UK have 
been well documented (Burns et al., 2001; Boyd et al., 2005; Chadborn et al., 2006; 
Delpierre et al., 2007), little research to date has focused on explaining these differences 
(Erwin et al., 2002; Dodds, 2006), although it is assumed to relate to increased 
awareness of the benefits of testing and the increased accessing of sexual health services 
by the gay community.  
Why participants who spoke French fluently should be less likely to present late is 
unknown. The Demographic Republic of Congo, Cote d’Ivoire, and Cameroon 
accounted for 72.2% (13/18) of all French speakers in the study. French speakers did 
not differ socio demographically from non-French speakers (data not shown). French 
language ability is presumably a proxy measure for cultural difference that influences 
HIV presentation patterns.  Unfortunately the in-depth interviews (chapter 9) were 
limited to English speakers, thus cultural differences between former English and 
French colonies in knowledge, attitudes and behaviours were unable to be explored in 
this study. 
Persons reporting one sexual partner in the last 12 months were less likely to present 
late than people with no sexual partners. Respondents reporting 2 or more partners also 
had lower odds of late presentation than respondents reporting no partners however the 
difference was not significant. This association may reflect perception of risk, state of 
health, or even exposure to health services. People with advanced HIV disease are often 
assumed to be less sexually active (as a direct consequence of ill health). However no 
association between number of sexual partners in the past year and perception of health 
(ever suffered from poor health, yes, no), or consideration of the possibility of HIV was  
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found (data not shown). Participants who had 2 or more sexual partners in the past year 
were less likely to be registered with a GP but no other association with health service 
use was found. Participants reporting no, or two or more, sexual partners in the past 12 
months were also less likely to be married or cohabiting, possibly suggesting some 
association between HIV testing patterns and social support. 
The belief that HIV does not cause AIDS was associated with reduced odds of late 
presentation in both models.  How this belief influences HIV testing behaviour in this 
way is difficult to explain.  It may reflect knowledge of medication, that is, HIV no 
longer has to lead to AIDS (as suggested by a handwritten comment within the 
questionnaire ‘HIV causes AIDS if not treated’); participants not believing HIV causes 
AIDS may be less concerned about the diagnosis and thus more willing to test if the test 
was offered; or alternatively this belief may have remained in the model by chance. 
In the non-hierarchical model HIV knowledge of medical confidentiality was 
significantly associated with late presentation, whilst number of sexual partners in the 
past year was no longer associated with the outcome. It makes sense that knowledge 
that confidentiality is respected in healthcare settings would facilitate HIV testing. 
While all these variables were significantly independently associated with late 
presentation, the size of the confidence intervals reflects considerable uncertainty in the 
true magnitude of their effect. 
7.3.1 Limitations 
Several limitations of the survey have been previously discussed in chapter 6. As data 
on outcome and associated factors were collected simultaneously it is possible that the 
factors may not be relevant due to temporality, that is, the outcome (late presentation) 
may have occurred prior to the determinant, e.g. employment status, perception of  
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health.  However this is unlikely to apply to any of the factors remaining in the 
multivariate model. Retrospective data also introduces the possibility of recall bias. 
Recall is unlikely to have been different for most explanatory variables in those who 
had or had presented late. Although detailed information on many potential confounders 
was collected residual confounding both from known and unknown factors is still 
possible.   
Finally the term ‘African’ comprises an aggregation of heterogeneous population 
subgroups.  Although data were collected to explore ethnic, cultural and temporal 
diversities of this population the study may have lacked power to fully explore their 
influences on late presentation. 
The conceptual framework  
Two approaches to multivariate analysis were used deliberately to test the influence of 
the conceptual framework based on a proximate-determinant model. The factors 
associated with late presentation varied according to the model selection criteria. Whilst 
this would be expected it is difficult to explain the differences. The hierarchal model is 
designed specifically to favour the distal factors. The hierarchical framework was to 
ensure that associations of more proximate factors with the outcome could not be 
explained by the more distal factors.  The finding of significant proximate factors in the 
final model suggests there remain distal factors, such as psychological or cultural 
factors, that have not yet been identified. 
The discrepancy between the models and failure of the hierarchal model to identify 
more socio-cultural and economic variables could be explained by several factors. 
Firstly it may be entirely due to chance. Some classification may have been insufficient 
to adequately measure important distinctions within and between parameters. The  
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conceptual framework may be at fault. Proximate determinant models have traditionally 
been used for biological outcomes and using one in the context of a behavioural 
outcome has yet to be formally tested. The framework, by necessity, is an over 
simplistic model of the determinants of behaviour and residual confounding is likely to 
exist. The framework, for example, has very limited ability to explore the influence of 
psychological and cultural factors. For example ‘sense of security’ may be an influential 
factor in HIV testing behaviour yet this would be very difficult to measure in a survey 
of this nature. A further difficulty in this model was in deciding whether the knowledge 
and attitudinal variables represented underlying or proximate determinants.  It may be 
that these have been incorrectly placed.  
A difficulty in the conceptualisation of this model was that it meant to explore timing of 
HIV testing among an HIV positive population specifically, rather than factors 
associated with HIV testing per se.   Factors potentially on the causal pathway were 
excluded from multivariate analysis yet it is possible that these factors may, at some 
level, be independently associated with the outcome.  
7.3.2  Implications  
HIV presentation patterns appear to be governed by factors linked to the characteristics 
of, and response to, the HIV epidemic operating within people’s sociocultural networks. 
Sexuality and French language ability do not directly determine individual HIV testing 
behaviours rather they are proxy measures of the affected populations knowledge, 
attitudes, and culture, which in turn influence behaviour.   
Further work is needed to extricate the critical factors that determine group behaviours. 
For example, in the UK, compared to African communities the gay community has had 
more community mobilisation around HIV, it is comparatively well informed, and has  
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invested a lot of resource into reducing stigma and normalising HIV testing; are HIV 
testing behaviours influenced by one or all of these factors? It is difficult to know the 
mechanisms through which French-speaking cultures differ to non-French speaking 
cultures. HIV prevalence and hence personal contact with HIV is similar between the 
populations, however governmental or community mobilisation may differ, as may 
attitudes to sex, or perceptions of illness.   
The success of universal antenatal testing for HIV in both its uptake and its ability for 
diagnosing women with HIV earlier should be extrapolated to opportunistic testing of 
partners in the antenatal setting and to other health care settings. 
Quantitative questionnaires of this nature provide crude measures that help focus 
direction, but they are unable to disentangle the complex components of a culture in 
enough depth, to guide HIV prevention interventions.  Qualitative work is required to 
gain deeper understanding of these factors and the interplay between them.  The 
findings of 26 in-depth interviews conducted to explore late presentation are presented 
in chapter 9.  
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Chapter 8: Acquisition of HIV infection 
in Africans resident in England 
 Abstract 
Objective: To determine the extent to which United Kingdom-
resident HIV positive Africans acquired their infection in the UK. 
Methods: A cross-sectional survey of newly diagnosed HIV positive 
Africans attending 15 HIV treatment centres across London (April 
2004 to February 2006). Three independent assessors used 
information from confidential self-completed questionnaires linked 
to clinical records, in conjunction with previously developed criteria 
to attribute country of HIV acquisition. 
Results: 263 questionnaires were completed (79.5% of patients 
approached). At least one in four HIV infections appeared to be 
attributable to UK acquisition. All cases acquired abroad indicated 
Africa as the probable region of acquisition. No significant 
differences were found in the country of acquisition by gender or 
age. Persons defining themselves as homosexual or bisexual were 
more likely to have acquired HIV in the UK than persons defining 
themselves as heterosexuals (47.4%vs.24.4%, p=0.028). Of 263 
respondents, 61 (23.2%) fulfilled criteria for ‘definitely acquired 
HIV abroad’, 44 (16.7%) ‘probably abroad’, and 27 (6.1%) 
‘definitely in the UK’, leaving 142 (54%) requiring more detailed 
assessment. After independent detailed assessment UK acquisition 
ranged between 25.1% and 35.4%, whilst 60.8% to 67.3% were 
assessed as acquired abroad.  
Conclusion: Between a quarter to a third of HIV positive Africans, 
and nearly half of HIV positive African MSM, may have acquired 
their HIV in the UK, substantially higher than previously estimated.   
These estimates may increase given the increasing HIV prevalence 
and assortative sexual mixing in this community. HIV prevention 
interventions for Africans must focus on reducing transmission 
within the UK as well as addressing infections acquired abroad.  
The findings within this chapter are published in AIDS (2008) United 
Kingdom acquisition of HIV infection in African residents in 
London: more than previously thought. F Burns et al., v.23: pp 262-
266. 
 
8.0 Introduction 
In the UK the majority of HIV infection acquired through heterosexual transmission 
is in persons born in sub-Saharan Africa.  Whilst most of these infections are  
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diagnosed for the first time in the UK, acquisition is thought to have predominantly 
occurred in Africa (The UK Collaborative Group for HIV and STI Surveillance, 
2006). Previous studies suggest that people are most likely to form sexual 
partnerships with those from their own cultural and ethnic group (Ford et al., 2002; 
Barlow et al., 1997), sometimes referred to as assortative sexual mixing. As HIV 
prevalence in heterosexuals in the UK is highest in African communities (Sadler et 
al., 2007) assortative sexual mixing may place people of African origin living in the 
UK at increased risk of acquisition of HIV compared with others.  
Previous work has suggested national data may underestimate heterosexual 
transmission of HIV among African communities in the UK (Sinka et al., 2003; 
Arthur, 2006).  Underestimating the degree of transmission will undermine our 
potential for averting HIV amongst this population. An accurate understanding of 
transmission is also important for prevention interventions. An aim of the SONHIA 
study was to determine the extent to which acquisition of HIV infection in a UK 
African population may have occurred within the UK.  Description of the processes 
used and our findings are presented in this chapter. 
8.1 Methods 
8.1.1   Participants 
The study of newly diagnosed HIV infection among Africans in London (SONHIA) 
is a survey of newly diagnosed HIV positive Africans attending 15 HIV treatment 
centres across London conducted between April 2004 and February 2006.  For the 
purposes of this study Africans were defined as persons born or raised in Africa, and 
as such included persons of all racial and ethnic groups.  Participants had to be 
within 12 months of initial HIV diagnosis and aged 18 years or older. Detailed  
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description of the design and recruitment process is provided in chapter 5. All 
participants of the SONHIA study were included in this analysis.   
8.1.3   Study instruments 
As described in chapter 5 the survey consisted of a self-completed pen and paper 
questionnaire, available in English or French, linked to clinician completed clinical 
records. The confidential questionnaire collected quantitative data on socio-
demographic characteristics, behavioural and social factors, sexual health and 
behaviour, HIV testing history, and migration history, which were then matched 
with CD4 and clinical data. Established criteria
13 (Paine et al., 1997) to assess 
possible region of infection were modified to include criterion that utilised 
additional data collected in the SONHIA study (see box 8.1).  These modified 
criteria were then used to determine likely region of acquisition. Region of 
acquisition refers to either the African continent or the UK as whole, rather than 
specific countries within these, entities.   
8.1.4     Statistical analysis 
The data for all respondents was assessed according to the criteria in box 8.1 to rank 
the likelihood of HIV acquisition in the UK or abroad. Every respondent who 
fulfilled criteria for ‘definitely or probably acquired their HIV in Africa’ (categories 
1 and 2) or ‘definitely acquired their HIV in the UK’ (category 6) was classified as 
‘determinate’; all others were classified as ‘indeterminate’. Two independent 
assessors (both HIV clinicians) then repeated the process of assessing country of 
HIV acquisition using the same criteria on all indeterminate cases. This produced a 
range of estimates for region of acquisition apportionment. When there was 
                                                 
13 First used for assessing possible country of infection from clinic notes in Lambeth, Southwark and 
Lewisham (LSL), Paine 1997.  
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Box 8.1 Criteria for assessing possible country of infection  
 
based on ‘Criteria for assessing possible country of infection from clinic notes in Lambeth Southwark 
& Lewisham’(Paine et al., 1997) 
1 Those definitely infected abroad 
•  those who have never had unprotected sexual intercourse in the UK before their test 
•  those who tested positive before arrival 
•  those in the UK for less than 6 months when diagnosed with AIDS  
•  those who arrived in the UK symptomatic 
•  those who had a child born before they came who tested positive 
•  those who came less than a month before testing positive, whose test shows no 
seroconversion features 
2 Those probably infected abroad 
•  those who had a positive partner abroad and negative partner(s) here 
•  those in the UK for less than 2 years when developing AIDS 
•  those in the UK for less than 2 years with a CD4<200 at presentation 
•  those ‘visiting’ the UK (if short term visit and no features of seroconversion)* 
•  those who have had sex with commercial sex workers in high prevalence areas, and 
no other suspected HIV positive partners 
3 Those likely to have been infected abroad 
•  those in the UK for less than 5 years when developing AIDS 
•  those in the UK for less than 4 years and a CD4 count <200 at presentation 
•  those who have had unprotected sexual intercourse in high prevalence country in 
past 10 years and since then no partners in the UK from abroad  
•  those with a presumed positive partner abroad and no known positive partner in the 
UK 
•  those who received blood/blood products in high prevalence country in the past 10 
years; no other documented high risk 
•  those with a history of STI abroad and no STI diagnosed other than HIV in UK* 
4 Those likely to have been infected in the UK 
•  those with a presumed positive partner in the UK and no known positive partner 
abroad 
•  known positive partner in the UK, CD4 count <500 at presentation; no evidence of 
positive partner abroad 
5 Those probably infected in the UK 
•  known positive partner in the UK, CD4 count>500 at presentation 
•  those in the UK for at least 12 years when developing AIDS (with no unprotected 
sexual intercourse  in high prevalence country since arriving in the UK)* 
•  those with a negative test before coming to the UK (if test in same year of arriving 
in UK)* 
•  those with documented negative partner(s) abroad 
6 Those definitely infected in the UK 
•  no UPSI except in the UK 
•  documented seroconversion in UK with no travel abroad within 2 months of test 
•  prior negative HIV test in the UK and since then no overseas travel* 
7 Those with a positive partner with whom they have had sex in the UK as well 
as elsewhere 
•  this group cannot be placed 
8 Inadequate information to assess    
* Text in italics reflects modifications used in this study.  
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discordance between the assessors’ responses the data were reviewed to identify the 
degree with which disagreement occurred.  Apportionment of region of acquisition 
was also ascertained utilising a measure entirely based on CD4 band at the time of 
diagnosis (and hence estimated time from seroconversion (table 8.1)) and time in the 
UK (Satten et al., 1996). Additionally each assessor was asked to identify the 
principal criterion(s) that influenced each coding decision.   
Table 8.1 Estimated time of seroconversion based on CD4*  
CD4 band (x10
6/l) 
Median time from seroconversion to 
diagnosis 
>499 24  months 
350-499 50.4  months 
200-349 74.4  months 
<200 8.5  years 
These criteria are currently used by the HPA (Arthur, 2006). 
 
 
To enable comparative analysis the outcome measure (likelihood of HIV acquisition 
in UK or abroad) was regrouped into a binary measure of ‘acquisition of HIV in the 
UK or abroad’. When an assessor had categorised country of acquisition as 
‘inadequate information to assess’ or ‘unable to place as HIV positive partner 
potentially both in UK and elsewhere’, the case was assigned to ‘HIV acquisition 
abroad’ as acquisition within Africa is statistically more probable, and this would 
represent the most conservative estimate of acquisition within the UK.    
Data were entered onto a secure database and systematically checked for errors prior 
to statistical analysis. Summary statistics, agreement rates and kappa statistics to 
assess inter assessor reliability are presented. Analysis was performed using 
Intercooled STATA 8.0 (Stat Corp., College station, Texas, USA) and SPSS12.0 
(SPSS Inc., Chicago, Illinois, USA).  
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8.2 Results 
Detailed description of the response rate and differences between those approached 
and not approached are presented in chapter 6 
As stated in chapter 6 the median age of respondents was 34 years, 60.5% were 
women, and approximately 50% presented with late stage disease (CD4 <200x10
6/l 
at diagnosis).  The median time in the UK prior to HIV diagnosis was 3.9 years. The 
majority of respondents identified as heterosexual (92.5%) and 93.5% identified as 
black African. The socio-demographic, behavioural and clinical characteristics of 
the study population are described in chapter 6. 
Of 263 respondents, 61 (23.2%) fulfilled criteria for ‘definitely acquired HIV 
abroad’, 43 (16.3%) ‘probably abroad’, and 27 (6.1%) ‘definitely in the UK’, 
leaving 143 (54.4%) ‘indeterminate cases’ for further analysis. The proportion of 
all
14 HIV infections assessed as acquired in the UK ranged between 25.1% and 
35.4%, whilst 60.8% to 67.3% were assessed as acquired abroad. All cases acquired 
abroad indicated Africa as the region of acquisition. Utilising the CD4/time in the 
UK criteria 35.1% of HIV was acquired in the UK, and 64.9% in Africa, however it 
had only a moderate level of agreement with the more detailed assessment (kappa
15 
=0.427, n=262, p<0.001 (table 8.3)). 
No significant differences were found in the region of acquisition by gender or age. 
Age on arrival in the UK was associated with region of acquisition, persons aged 30 
or older on arrival were less likely to have acquired HIV in the UK than those aged  
                                                 
14 Derived by adding determinate cases to proportions derived by the 3 assessors for the indeterminate 
cases. 
15 Kappa determines inter assessor reliability after accounting for chance. Levels of agreement as 
determined by kappa can be grouped into <0.0 poor; 0.0-0.20 slight; 0.21-0.40 fair; 0.41-0.60 
moderate; 0.61-0.80 substantial; 0.81-1.0 almost perfect (Landis and Koch 1977, Biometrics).  
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Table 8.2 Agreement of CD4/Time in UK with assessors rating 
  Agreement Kappa  N  p-value 
Assessor 1 
      - All cases 
 
75.6% 
 
0.427 
 
262 
 
<0.001 
- Indeterminate cases only  64.8%  0.293  142  <0.001 
Assessor 2  64.1%  0.283  142  0.001 
Assessor 3  62.7%  0.252  142  0.002 
 
 
Table 8.3 Classification of region of acquisition by Assessors and CD4/time in UK criteria 
 
Place of acquisition 
 
According to criteria in box 8.1 
Measure based on 
CD4 at diagnosis 
and time in UK  
 Assessor  1 
% (n) 
Assessor 2
a 
% (n) 
Assessor 3
a 
% (n) 
 
% (n) 
 
     
Africa (total):  62.7 (165)  60.8 (160)  67.3 (177)  64.9 (170) 
     Definitely in   
     Africa 
23.2 (61)  23.2 (61)  23.2 (61)   
     Probably in  
     Africa  
16.7 (44)  17.5 (2+44=46)  18.6 (5+44=49)   
     Likely in Africa  22.8 (60) 20.2  (53) 25.5  (67)   
       
UK (total):  25.1 (66)  35.4 (93)  28.5 (75)  35.1 (92) 
     Likely in UK  6.8 (18)  20.5 (54)  13.7 (36)   
     Probably in UK  12.2 (32)  5.3 (14)  7.2 (19)   
     Definitely in UK  6.1 (16)  9.5 (9+16=25)  7.6 (4+16=20)   
       
Unable to place
b 10.3  (27) 0.4  (1) 0.4  (1)   
Inadequate information 
to assess  
1.9 (5)  3.4 (9)  3.8 (10)   
       
Total: 100  (263)  100 
(142+132=263) 
100 
(142+132=263) 
100 (262)
c 
Highlighted cells assumed to be correctly assigned given criteria requirements and thus not reassessed 
by assessors 2 & 3 however figures added to final tally for assessors 2 & 3 to enable comparison. 
a Determinate cases added to assessors tally 
b Those with an HIV positive partner but information on duration and/or location of partnership 
missing
 
c Base 262 due to missing data on time in UK  
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less than 30 years (13.0% vs. 36.8%, odds ratio OR 0.21, 95% CI 0.11-0.42, 
p<0.0001). Persons defining themselves as homosexual or bisexual were more likely 
to have UK acquired HIV than heterosexuals (47.4% vs. 24.4%, OR 2.86, 95% CI 
1.11-7.39, p=0.028), as were early compared with late presenters (35.6% vs. 14.5%, 
OR 2.87, 95% CI 1.58-5.21, p=0.001).  The association between acquisition in the 
UK and early presentation remained when adjusted for sexual orientation (Adjusted 
odds ratio (AOR) 2.66 (95%CI 1.45-4.88, p=0.002). 
The allocation of country of acquisition according to the three assessors is presented 
in table 8.3. Between 7% and 22.5% of cases were unable to be assigned, either due 
to insufficient information available or because a known HIV positive partner may 
have been a partner in both the UK or in Africa. Assessor 1 (the author) felt that if 
duration of the partnership (and hence whether it preceded migration to the UK) was 
not known then an assumption of place of acquisition could not be made. The 
principal factors influencing allocation of region of acquisition for the determinate 
cases are presented in table 8.4. 
Focusing on the case-by-case agreement of indeterminate cases:  Complete 
agreement (when all assessors agreed on the exact classification) was 38.7% 
(95%CI: 30.7-47.3%) (Table 8.5); However when assessing region of acquisition, 
rather than the degree of probability within that region, agreement was 63.0% 
(95%CI: 54.2-70.6%); this rose to 79.0% (95%CI: 71.2-85.3%) when including 
those cases where two assessors had complete agreement but the third felt unable to 
assess. In 18.9% (95%CI: 12.9-26.4%) of cases the assessors differed on country of 
acquisition.   
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Table 8.4 Major influences of factors in assessing country of acquisition –  
determinate cases (n=120) 
Influencing factors by classification  % (n) 
  
Definitely acquired in the UK (n=16):   
     Prior negative HIV test in UK and since then no overseas travel   75.0% (12/16) 
    No unprotected sexual intercourse except in the UK  
     (and no exposure to blood products abroad) 
12.5% (2/16) 
     Other  12.5% (2/16) 
  
Definitely acquired in Africa (n=61):   
     No sex in the UK  73.8% (45/61) 
     AIDS within 6 months of arrival in the UK  6.6% (4/61) 
     Symptomatic on arrival in UK  4.9% (3/61) 
     No unprotected sexual intercourse in the UK  4.9% (3/61) 
     Diagnosed prior to or within one month of arrival  (no seroconversion)  4.9% (3/61) 
     Other  4.9% (3/61) 
  
Probably acquired in Africa (n=43):   
     In the UK <2 years with CD4 <200 at presentation  30.2% (13/43) 
     In the UK <2 Years with AIDS at presentation  14.0% (6/43) 
     Sex with or as commercial sex worker in Africa and no other known    
     HIV positive partners  
18.6% (8/43) 
     Those on short term visit to the UK and no features of seroconversion  11.6% (5/43) 
     Those with an HIV + partner in Africa and negative partner here  9.3% (4/43) 
     Other (e.g. rape in Africa, probable vertical transmission)  16.3% (3/43) 
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Table 8.5 Measure of agreement of indeterminate
† cases (n=143) 
 Complete 
agreement
1 
Near 
Agreement
2 
Within country 
agreement
3 
Two complete 
agreement + one 
unable to assess
4 
Two unable to 
assess + one placed
5 
Two complete 
agreement  + one 
different country
6 
Complete 
disagreement
7 
Number  56 33  1  23  3  14  13 
Proportion (95%CI)  39.2% 
(30.7-47.3) 
23.1% 
(16.6-31.1) 
0.7% 
(0.02-3.9) 
16.1% 
10.6-23.3) 
2.1% 
(0.4-6.1) 
9.8% 
(5.5-16.0) 
9.1% 
(5.0-15.1) 
Within continent 
agreement (95%CI) 
 
63.0% (54.2-70.6) 
      
   
79.0% (71.2-85.3) 
 
21.0% (14.7-28.8) 
Assessors differed in 
specified ROA 
          
18.9% (12.9-26.4) 
 
† ‘Indeterminate’ refer only to those cases who had not definitely or probably acquired their HIV in Africa or definitely acquired their HIV in the UK. 
1  All three assessors agreed on exact classification of region of acquisition (ROA) 
2  Two assessors agreed on exact classification and third differed on degree of probability by one as long as that difference did not alter country of acquisition, e.g.  
     two assessors rated country of acquisition as 4 (likely acquired in UK) and one as 5 (probably acquired within UK).  
3  All three assessors agreed on country of acquisition but differed on degree of probability, e.g. one rated ROA as 4 (likely acquired in UK) and another   
    rated ROA as 6  (definitely acquired in UK) 
4  Two assessors had complete agreement (see footnote 1) but third assessor felt there was either insufficient information to assess or that as   
    respondent potentially had a positive partner in both Africa and the UK region of acquisition could not be placed. 
5  Two assessors felt there was either insufficient information to assess or that as respondent potentially had a positive partner in both Africa and  
    the UK region of acquisition could not be placed but third assessor felt able to assign region of acquisition. 
6  Two assessors agreed on exact classification but third assessor differed on region of acquisition 
7  All three assessors differed in their opinion (one placed ROA in Africa; one in UK; and one as unable to assess).  
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Figure 8.1 (located at end of chapter) shows the level of agreement between the 
assessors according to assigned region of acquisition for the indeterminate cases. 
The degree of complete agreement was similar according to whether HIV was 
assessed as acquired in Africa (56.1%, 95%CI: 44.1-66.6%) or the UK (50.6%, 95% 
CI: 39.3-61.9%); however agreement was substantially lower in cases felt unable to 
be assigned (9.3%, 95%CI: 3-22%). The overall measure of agreement for the 
indeterminate cases (with all cases unable to be assigned reclassified as likely 
acquired in Africa) was Kappa = 0.6 (n=142, p<0.001). 
The principal factors influencing allocation of region of acquisition for the 
determinate cases are presented in table 8.5. HIV testing history in combination with 
travel history was the most important factor in determining whether HIV had 
definitely UK acquired; 75% (12/16) of those assessed as definitely acquiring HIV 
in UK had a prior negative HIV test in the UK and no subsequent overseas travel, a 
further 12.5% reported only ever having unprotected sex in the UK and no exposure 
to blood products abroad.   Definite acquisition of HIV in Africa was most 
associated with reported sexual behaviour (no sex in the UK (73.8%)) and clinical 
factors (an AIDS diagnosis within six months of arriving, or symptomatic on arrival 
in UK (11.5%)). Time in the UK (<2 years) in relation to CD4 and AIDS defining 
illnesses were most associated with probable acquisition in Africa (44.2% (19/43)), 
followed by sex with or as a commercial sex worker in Africa with no other known 
HIV positive partners (18.6%).   
The key criteria that were informative in assigning region of acquisition for the 142 
indeterminate cases included sexual behaviour (number of partners in the UK, past 
history of STIs), time in the UK in relation to CD4 count at diagnosis, and partner 
issues (whether known HIV positive partner or not, country of origin of partner and  
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duration of partnership) (table 8.6). The influence of these three factors was 
consistent between assessors (range 78.9 to 80.5%), and for cases where the 
assessors agreed and disagreed on country of acquisition (data not shown). 
Table 8.6 Influencing factors in assessing region of acquisition
1 –indeterminate cases (n=142) 
Factor Principal  factor  Second  factor  Third factor   Overall 
Sexual behaviour /STI history  39.1%  34.2%  20.0%   34.1% 
Time in UK in relation to CD4  17.4%  22.9%  37.9%   22.9% 
HIV status of partner(s)  23.3%  23.8%  17.9%   22.6% 
HIV  testing  history  13.2% 6.1% 8.4%    9.6% 
Clinical reason  1.9%  4.8%  7.4 %  3.9% 
Travel  history  1.6% 6.5% 4.2%    3.9% 
Other/exceptional reason e.g. 
rape, blood transfusion 
3.5% 1.7% 4.2%    2.9% 
Total 100%  100%  100%  100% 
1 As identified by assessors. 
2 Allocation could be influenced by 1, 2 or 3 factors depending on the case. 
 
8.3 Discussion 
These findings suggest that the proportion of UK-resident Africans who may have 
acquired HIV in the UK is substantially higher than previously estimated.   Between 
a quarter to a third of all HIV positive Africans currently resident in the UK, and 
nearly half of HIV positive African MSM, were likely to have become HIV-infected 
in the UK. 
National surveillance data from the Health Protection Agency (HPA) reports that in 
individuals of black African ethnicity approximately 8% of newly diagnosed 
heterosexually acquired HIV infections in the UK were probably UK acquired (The 
UK Collaborative Group for HIV and STI Surveillance, 2007). No breakdown of 
probable region of acquisition is provided by country of birth.    The HPA’s region 
of HIV acquisition data are based primarily upon voluntary confidential reports by  
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clinicians, with review and follow-up of incomplete data by national surveillance 
coordinators (Dougan et al., 2005). By systematically incorporating more detailed 
demographic, behavioural and clinical information, this study is able to draw on a 
richer source of information in assessing country of acquisition, which may account 
for the differences between these findings and those of the HPA. 
The high transmission of HIV within the UK is supported by current research. There 
is a high background prevalence of HIV within African communities in the UK; 
14% of respondents tested HIV positive in Mayisha II, and 66% of these infections 
were undiagnosed (Sadler et al., 2007). HIV positive Africans in the UK are also 
more likely to present later and with advanced disease than non Africans (Burns et 
al., 2001; The UK Collaborative Group for HIV and STI Surveillance, 2006; 
Chadborn et al., 2006). Undiagnosed infection and advanced disease (via high viral 
loads) are important components in facilitating the onward transmission of the 
infection (Quinn et al., 2000; Marks et al., 2006). When considered in conjunction 
with the high HIV prevalence and known assortative mixing patterns it becomes 
evident that an African resident in the UK is at substantially higher risk of HIV 
exposure than a non-African resident. However until now, the impact of this risk in 
terms of incident cases in the UK has not been quantified. 
8.3.1    Limitations 
Limitations of the study design in terms of selection and recall bias have been 
described in chapter 5. Participants had more advanced disease, as defined by CD4 
at diagnosis, than non-participants. Acquisition of HIV in the UK was negatively 
associated with late presentation; hence our findings potentially underestimate 
infection acquired in the UK. No evidence to support a shift in HIV testing patterns 
within African communities currently exists which could account for our findings.   
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The data were not complete in that certain responses were missing. There were 
incomplete data on a number of variables that would have facilitated country of 
acquisition allocation. For example whether partners were resident in the UK, and 
country of origin and timing of last two sexual partners, were questions added after 
recruitment had commenced so data are only available for a relatively small 
proportion of respondents.  
As with other clinic based surveys, reporting bias in response to sensitive subject 
matter (migration, sexual behaviour, HIV) may have influenced the reliability and 
validity of the reported data. For example, socio-culturally prescribed behaviours 
(e.g. sexual orientation or numbers of partners) may be underreported. Recall bias 
may have influenced the degree to which risk behaviours or the locations where they 
had occurred were reported based upon individuals’ beliefs about their risks, or 
seroconversion episode. Misclassification may have occurred in ascertaining the 
likely country/region of acquisition, especially if the country with the higher HIV 
prevalence was presumed to be the country of infection. We attempted to minimise 
this by having multiple reviewers of each participant’s record and assessing for 
concordance between them. 
Criterion related to CD4 and time in the UK is located within the modified criteria 
and was second only to sexual behaviour as the most influential factor in assigning 
country of acquisition. However this data suggests that it would be insufficient to 
use this criterion in isolation as it had only fair levels of agreement with the 
modified criteria as a whole. 
The modified criteria were shown to be an acceptable though imperfect tool in 
determining likely region of acquisition; a kappa score of 0.6 reflecting moderate to 
substantial levels of agreement between the assessors. This score only relates to the  
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indeterminate cases where allocation of country of acquisition was uncertain, the 
kappa score would have been substantially higher if the determinate cases had been 
included. However the criteria is not suitable for routine clinical use. 
According to HPA data 2311 Africans were newly diagnosed with HIV in London in 
2004-2005 (Kuczawski, 2007). SONHIA participants represent approximately 11% 
of this population. Comparison between the two populations demonstrates that the 
SONHIA sample was largely representative of the London wide (and indeed the 
UK) in terms of gender, age, and ethnic group (table 8.7). The high proportion of 
African MSM who may have acquired HIV in the UK is in keeping with national 
surveillance data which reports that 72% of ethnic minority MSM were probably 
infected in the UK (The UK Collaborative Group for HIV and STI Surveillance, 
2007). The higher proportion of African MSM in SONHIA (7.5% vs 0.9%) probably 
reflects this fact and that the HPA used country of infection as a proxy marker of 
country of origin in supplying the comparative data (Kuczawski, 2007). 
Determining region of HIV acquisition proved to be difficult, individuals may have 
had multiple partners within and outside the UK, and explicit robust criteria do not 
currently exist. Even after informal discussion with the national surveillance 
coordinators it was not always evident what criterion should be given precedence, 
with respondents often having conflicting clinical, migratory and behavioural 
parameters. Whilst the three assessors used the same data and criteria, and the key 
factors in influencing their decisions were almost identical, variation still occurred in 
the output due to differing interpretations.   
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Table 8.7 Comparison between adults associated with Africa
a newly diagnosed with HIV in 
London in 2004-2005 and SONHIA participants  
Characteristic HPA  data  SONHIA   
Total 2311  263   
Gender    P=0.229 
     Men  827 (35.8%)  104 (39.5%)   
     Women  1484 (64.2%)  159 (60.5%)   
     
Age  (years)    P=0.849 
     18-24  201 (8.7%)  20 (7.6%)   
      25-34  1023 (44.3%)  113 (43.0%)   
      35-44  772 (33.4%)  94 (35.7%)   
      45+  315 (13.6%)  36 (13.7%)   
     
Exposure  category    p<0.001 
     Heterosexual  2271 (98%)  234 (92.5%)
a  
     Sex between men  20 (0.9%)  19 (7.5%)   
     
Ethnic  group    P=0.188 
     Black African   2106 (91.1%)  246 (93.5%)   
            
Region of infection/origin
a    p<0.001 
     Central  & Western Africa  697 (30.2%)  62 (23.6%)   
     East Africa  539 (23.3%)  67 (25.5%)   
     Southern & South-eastern Africa  813 (35.2%)  127 (48.3)   
     Other (including unknown)  262 (11.3%)  7 (2.7%)   
     
a  Individuals associated with Africa are defined by probable country of infection. The HPA use 
country of infection as a proxy marker for country of birth 
b Missing data for 10 (n=253)  
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8.3.2   Implications 
Our findings have implications for HIV prevention policy and practice within the 
UK. More work is now needed to develop user-friendly assessment tools to assist 
clinicians in their determination of country of acquisition for newly diagnosed HIV 
positive persons. Combining expanded clinical, demographic and behavioural 
markers can substantially improve the accuracy, reliability and validity of country of 
HIV acquisition determinations.  However, there are trade-offs between the 
comprehensiveness and utility for such assessment tools, since busy clinicians are 
unlikely to use a complex questionnaire on a routine basis. Also, even in research 
settings, more comprehensive assessment tools are susceptible to residual 
interpretive error. Consequently, these approaches should be supported by new 
technologies such as HIV-incidence testing and phylogenetic mapping, technologies 
that are not yet routinely applied to newly diagnosed HIV-infected individuals in the 
UK. Without these developments clinicians and our national HIV surveillance data 
are likely to continue overestimating the burden of imported infections. 
The dangers of continually underestimating the incidence of in-country HIV 
transmission and acquisition are multifaceted. It provides a false sense of security 
that HIV among Britain’s migrant populations solely reflects global trends and not 
ongoing endemic transmission of HIV within the UK. It falsely assumes that the UK 
is homogeneously ‘low prevalence’ despite robust evidence to suggest that the HIV 
prevalence in particular sexual networks (e.g. MSM) or geographic settings (e.g. 
central London) exceed those of many parts of the world. It also systematically 
disenfranchises HIV prevention efforts for ethnic minority communities by failing to  
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comprehensively address the syndemics
16 of HIV and sexually transmitted 
infections, assortative sexual mixing patterns, and poor access to culturally-specific 
prevention programs.  
Finally, failure to more systematically measure, track and respond to the endemic 
HIV transmission delays the urgency to develop and implement effective 
interventions earlier in the endemic phase. There are still no culturally specific 
effective behavioural interventions for migrant Africans in the UK (Prost, 2005), 
reflecting in part this broadly held assumption that acquisition has occurred abroad. 
These findings challenge this assumption and hopefully will encourage efforts to 
develop intervention programmes that support African communities to raise HIV 
awareness and reduce HIV transmission. 
Delayed diagnosis of HIV facilitates the onward transmission of the infection as well 
as leading to poorer clinical outcomes.  If the estimates of HIV acquisition within 
the UK in this study are correct it is likely that late presentation is a critical 
component. The following chapter uses qualitative methods to explore the context 
within which African migrants face HIV to help understand why late presentation 
continues to be a defining feature of HIV in this population. 
 
                                                 
16 The synergistic interaction of co-existent diseases and social conditions at the biological and 
population level (Singer et al., 2006).  
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Chapter 9: Qualitative study with     
purposively selected respondents  
 
Abstract 
Objective: To develop a contextual understanding of the factors 
contributing to late presentation to HIV services by Africans resident in 
the UK. 
Methods: 26 in-depth interviews with a purposively selected sample of 
newly diagnosed HIV positive Africans were conducted between 
February and December 2005. Analysis was undertaken using 
Framework.  
Results: The delay in HIV diagnosis appeared to be the consequence of 
interplay between stigma, perception of personal risk, lack of perceived 
benefit, and migratory and institutional factors. Stigma contributed to 
low risk perception by perpetuating the concept of ‘otherness’; HIV was 
still seen as a disease that only certain types of people were at risk of 
acquiring. HIV was typically not considered until the onset of ill health. 
The lack of benefit in knowing ones serostatus was in part related to lack 
of knowledge about effective medications and in part because of the 
continuing negative repercussions in terms of stigma and discrimination, 
and disclosure to immigration services.  The focus of people’s lives was 
on financial or immigration issues, not on health.  The narratives also 
recounted numerous missed opportunities for earlier HIV diagnosis 
within the health system itself. Improving the uptake of HIV testing was 
believed to be possible by the provision of more information utilising 
positive non-targeted images, and creating more testing opportunities. 
Conclusion: These findings highlight the central role of HIV-related 
stigma and discrimination in influencing HIV testing behaviours among 
migrant Africans in Britain. Significant cultural work is needed to break 
down the associations that accompany HIV. Similarly the medical 
profession is complicit in perpetuating the cycle of late diagnosis and 
onward disease transmission by continuing to treat HIV differently to 
other chronic health conditions. 
 
9.0 Introduction   
In the preceding chapters factors associated with late presentation have been identified, 
missed opportunities for earlier diagnosis highlighted, and the consequent impact on 
HIV transmission and acquisition within the UK presented. The aim of this chapter is to  
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develop a contextual understanding of the factors contributing to late presentation to 
HIV services. It also aims to identify future means of improving access to HIV services 
for Africans in Britain.  
The chapter begins with a detailed description of the methodology, followed by an 
overview of the sample interviewed. The findings relating to late presentation and how 
to improve access of services are then presented thematically, followed by my 
reflections on the interviews. The chapter concludes with a discussion of these findings. 
9.1 Methods 
A detailed description of the sample design and development of the topic guide is 
presented in chapter 5 (section 5.1.3).  In-depth, semi-structured interviews were 
conducted with a purposively selected sub-sample of the 263 participants of the 
SONHIA study. A quota-based sample was used to ensure diversity of gender, age, 
length of time in the UK, partnership status, region of origin, and site of care. 
Whilst originally 40 interviews were planned only 26 were conducted (table 9.1).  The 
reduced sample was primarily due to time and resource limitations. 
9.1.2   Patient identification and recruitment 
As stated in chapter 5, the key worker at each study site facilitated recruitment to the 
qualitative sub-study. The key workers ensured respondents understood the aim of the 
interview, addressed concerns regarding the subject matter and provided reassurance of 
confidentiality. Having read the patient information sheet (appendix 5), and if the 
patient consented, their name and contact number was supplied to me. All participants 
were contacted by phone to assess eligibility to the interviews. A screening 
questionnaire established if the patient fulfilled required criteria according to the quota 
matrix (appendix 7).  If eligible arrangements for the in-depth interview were made at a  
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mutually convenient and appropriate time and location.  Written informed consent was 
obtained prior to commencing any interview. Patients receiving clinical care from 
myself, the sole interviewer, were excluded from participation in the interviews.  
9.1.3   The interviews 
Exploratory, semi-structured, in-depth interviews were used to develop a contextual 
understanding of the factors that inhibit African people seeking HIV care. All 
interviews were based on a topic guide (see box 9.1 and appendix 8) that covered key 
areas for investigation. The interviews were conducted either in the patients’ own 
homes, or a private room on hospital premises depending on the wishes of the 
participant. 
Box 9.1 Key areas of exploration within interview topic guide: 
Areas to explore: 
1.  Personal circumstances: socio-demographic background and migration history 
2.  Personal & community attitudes: important influences, stigma, role of religion, 
and the role of the African community  
3.  Learning about and awareness of HIV: experiences, perceptions of risk, and 
knowledge of treatment options 
4.  Health & service history: perceptions and experiences both within the UK and 
Africa, including detailed sexual health history 
5.  Improvements to services and information: what would be effective and who 
should be targeted? 
9.1.4   Quality control measures 
A variety of quality control measures were employed throughout the study: 
1.  Prior to commencement of the study a five-day in-depth interviewing course run 
by the National Centre for Social Research was attended. This included training 
and practical sessions in the design, conduct and analysis of in-depth interviews.   
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2.  Records were kept of the interviews and observations about the interview.  
3.  An experienced qualitative researcher listened to some of the recorded interviews 
and provided feedback throughout the study. He was involved in development of 
the thematic framework, checked the coding procedures, and reviewed data 
classification.  
4.  Finally, triangulation of the research findings with other studies and with the 
quantitative component of this study, was undertaken where possible. 
9.1.5   Data collection and analysis 
Data collection was carried out between February and December 2005. The majority 
(n=19/26) of interviews were conducted in a private room located within the 
participants HIV treatment centre, four were conducted in the participant’s home and 
the remainder occurred within my office. Interviews lasted from one to three hours 
(average 80 minutes). 
All in-depth interviews were electronically recorded where possible.  On the two 
occasions where recording failed due to technical reasons extensive notes were taken 
during the interview and subsequently written up.  The recorded interviews were 
independently transcribed verbatim. The tapes and transcripts are stored in a locked 
cupboard with access limited to the research team. No identifying data, such as name or 
hospital number are kept with the transcripts. No information about the respondents has 
or will be disclosed to other institutions or authorities.  
The analysis was undertaken using ‘Framework’ (Ritchie et al., 1994). Framework (Box 
9.2), a method of qualitative data analysis, involves ordering and synthesising verbatim 
data within a thematic matrix. The themes are developed from the research question and 
from the accounts of the research participants. This method is based on grounded theory  
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(i.e. based in and driven by the accounts and observations of the people it is 
about)(Strauss & Corbin, 1990).  It allows full review of collected material, and detailed 
between and within case analysis. Data management and analysis of the transcribed 
interviews were facilitated by the use of the qualitative software MAXqda2 (VERBI 
software, Berlin, Germany).  
Box 9.2 Stages of analysis using ‘Framework’(Ritchie et al., 1994) 
1.  Familiarisation (reading transcripts/listening to tapes) 
2.  Identifying a thematic framework (and developing a coding scheme) 
3.  Indexing (codes systematically applied to the data) 
4.  Charting (rearranging data according to the thematic content to allow within and 
between case analysis) 
5.  Mapping and interpretation (defining concepts, mapping range and nature of 
phenomena, creating typologies, finding associations, providing explanations, 
developing strategies) 
 
9.1.6   Critical examination of researcher’s own role  
As a white, middleclass New Zealander extra care had to be taken in the establishment 
of trust and rapport; key factors if open and frank discussion were to occur. It was also 
vital that as I was someone who worked ‘for the establishment’ that every effort was 
made to reassure about confidentiality and to empower participants to feel able to 
answer, or not, as they felt comfortable. 
The establishment of rapport is crucial in conducting qualitative interviews, and there is 
on going debate about the importance of language and ethnic matching in establishing 
this rapport. Evidence suggests that a shared language is crucial in conducting 
interviews, with language matching influencing data collection and the nature of the 
data collected (Grewal & Ritchie, 2006).  As solely an English speaker and the sole  
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interviewer, only people fluent in English were eligible for inclusion in this component 
of the study.   
It was obviously not possible for me to be ethnically matched to the Africans 
interviewed. It makes intuitive sense that ethnic matching may facilitate rapport through 
fostering a sense of mutual experience, however strong evidence to support this 
assumption is lacking. Being an ‘outsider’ can be a benefit when disclosure to own 
communities is a prime concern (Grewal et al., 2006), indeed this was mentioned during 
piloting. Being an outsider can also help with objectivity as it distances the interviewer 
from some of the biases that might come from over familiarity. For example if 
colloquial language is used it has to be un-packed as it is not a familiar concept to the 
outsider; ‘insider’ researchers may assume to know the intended meaning and yet the 
nuances of local meaning and local dialect may make this assumption incorrect.  
As with all researchers involved in any research, and qualitative research in particular, it 
is important to be aware how social and cultural characteristics of the interviewer 
(myself) and context of the interviews may impact on the data.  I have not attempted to 
remove these ‘interviewer effects’ but have attempted to account for them and explain 
them within my findings, a process referred to as ‘reflexivity’ (Nazroo, 2006). In order 
to increase reliability and validity I have paid close attention to unusual cases (‘the norm 
is often explained or illuminated by the exceptional’(Kellehear, 1998)); used my 
supervisors to help code and develop themes; provided simple counts of frequency; 
deliberately tested emerging themes; and triangulated findings with other studies and 
the quantitative component of this study whenever possible and appropriate. 
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9.2 Results 
9.2.1    Overview of sample 
Of the 26 participants all were Black African and 15 were women. Of the men, 10 were 
heterosexual and one bisexual. Ages ranged from 21 to 62 years with the majority in 
their thirties (see table 9.1). Seven were university educated, 8 had completed secondary 
education and 10 had been educated to a GCSE equivalent. The interviewees came from 
10 countries. Zimbabwe was the most represented (n=6), followed by Uganda (n=4), 
and seven interviewees came from West Africa. Time in the UK ranged between 4 
months and 35 years (mean 5.2 years). 
 
Table 9.1 Characteristics of interviewees (n=26) 
  Male Female 
Age    
     18-24  1  1 
     25-34  4  8 
     35+  6  6 
Partnership status     
     Single  3  5 
     Partner – not co habiting  3  5 
     Partner  - co habiting  6  4 
Region of origin
a    
     Lower HIV prevalence (<5%)  1  2 
     Medium prevalence  2  3 
     High prevalence (>15%)  8  10 
CD4 at diagnosis      
     <50  7 
     50-199  9 
     200-350  6 
     >350  4 
Residence in UK     
   <5 years  15 
    5+ years  11 
Recruitment site   
     Central London teaching   7 
     District General  19 
a According to UNAIDS data 2003  
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When asked why they had migrated to the UK seven participants mentioned political 
reasons, seven to seek a ‘better life’/for economic reasons, four to study, five to join 
family or loved ones (chain migration), two ‘to start afresh’ after failed relationships, 
and one specifically to have an HIV test (although not to access care as she was 
unaware of ART). All seven who migrated for political asylum spoke with real fear for 
personal safety at the prospect of returning home. One woman provided a horrifying 
account of torture, murder and multiple rape at the hands of guerrilla and national 
armies. 
Twelve of the participants were employed fulltime, three were fulltime students, and 10 
were unemployed, 5 being unable to register for benefits. One woman worked as a sex 
worker in the UK and another had been employed in the sex industry in Africa. One 
man had also sold sex within the UK. The majority (n=11) were renting their 
accommodation, three owned their own homes, three were homeless, living in hostels or 
Bed and Breakfasts, and nine were living with friends or family. 
Nine of the 26 interviewees had secured indefinite residential rights to remain in the 
UK, although one person’s documents were ‘unofficial’. Of the remaining 17 all bar 
two now wanted to remain in the UK. Whilst access to health services and ART in 
particular had not influenced decisions to migrate to the UK, residency in Britain was 
now felt imperative in order to guarantee access to ART; the two exceptions to this were 
in wealthy women who knew they would be able to afford medications in their home 
countries. Seven people were currently applying for leave to remain in the UK and six 
were seeking asylum (4 of which were within the appeal process).  
Only two of the 26 were not registered with a GP, both these women entering the 
country ‘underground’.  They also both happened to be, or had been, sex workers.  
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Disrupted relationships, known to be a consequence of migration, were evident in the 
stories of the interviewees. Whilst the majority of interviewees (n=16/26) were within a 
relationship at the time of the interviews, in five instances this involved a spouse who 
was still living abroad.  Two men with spouses abroad also had long-term partners in 
the UK. Four women were aware of their partners having other long-term relationships 
whilst married to them. Two respondents were widowed, one to probable HIV and 
another to political violence. Half of the interviewees had disclosed their HIV status to 
their current or ex partners; seven knew their partners to be HIV positive and three had 
HIV negative partners.   
Most (n=19) of the respondents had children, although only 5 had their children living 
with them in the UK. Extended family in Africa provided most of the ongoing care for 
children, some as young as 3 months when left behind. Three respondents had 
experienced the death of a child, two known to be HIV related (both occurring in the 
UK), and one presumed (in Africa). Another two respondents had sick children, one 
known to be HIV related and another assumed by the mother to be HIV related. The 
HIV status was unknown for many of the children still in Africa. The three respondents 
(two women and one man) who had known HIV infected children (alive or dead) had all 
declined antenatal testing. One woman was pregnant at the time of interview, and the 
birth of his first child was imminently awaited for one man. Three of the women and 
one of the men interviewed had been diagnosed HIV positive as a consequence of 
antenatal screening.  
This study draws upon the experiences of these recently diagnosed HIV positive men 
and women to contextualise the reality of HIV testing for migrant Africans in Britain.  
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9.2.2   Late presentation 
The delay in HIV diagnosis appeared to be the consequence of interplay between 
stigma, perception of personal risk, lack of perceived benefit, and migratory and 
institutional factors. Each of these factors are discussed:  
9.2.2.1   HIV/AIDS related stigma and discrimination 
All of the respondents who came from countries with a high HIV prevalence had 
witnessed the consequences of HIV first hand.  Many (n=17) had lost friends or family, 
yet despite this the association of HIV as an ‘inferior’ or ‘dirty’ disease remained.  
 
‘Well, it's a disease which people look upon you as somebody - it's an 
inferiority disease, do you know what I mean, it's a disease which 
community does not accept.’  
37 year-old Zambian woman. 
 
‘And people, they find like it's a laughing thing if you've got HIV, they 
feel like maybe you're the most dirtiest person, you know. It's not like 
it's just proper sex, they think maybe you've been sleeping with so many 
man, that's the way they put it.’  
34 year-old Malawian woman. 
 
 
People with HIV continue to be socially excluded, predominantly in Africa but people 
were fearful of that within the UK as well.   
The discrimination is grounded in a culture of blame (where the HIV infected person is 
perceived to have brought this upon themselves by their promiscuity) and also of fear. 
Being HIV positive was likened to a criminal offence: 
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‘The way they're saying it, it feels like it's your fault [that you are HIV 
positive], it feels like it's a crime that you committed, it feels like it's 
something that you did, you feel like a thief, you feel like you've 
committed a crime, you don't feel like a victim which is what you are 
really. I hate to be looked upon as a victim but - I'm not a victim, that's 
why I said I'm not a victim but you're treated as if you've done 
something wrong, as if you've stolen, as if you're a burglar, as if you're a 
killer, you're just basically whispered about.’  
34 year-old Cameroonian woman. 
 
 
The ‘crime’ being the importation of HIV into the community and subsequent risk for 
others. Whilst people knew rationally that HIV is spread sexually irrational fear about 
non-sexual (aerosol or fomite) transmission remained prevalent, often justified by the 
association of HIV with TB. 
 
‘They'll say, oh my God, she's HIV, now she's coming to my house, 
she's using my bed sheets, she's using the same things we are using, she's 
sitting on my sofa, she's just using my bed. You know.’  
31year-old Zimbabwean woman. 
 
‘He had TB, most people with TB have HIV. 
How do others react to them? 
People become isolated. People are scared of TB patients, scared that 
they may contract it. And in those days people did not know how HIV 
contracted.’  
37 year-old Zambian man. 
 
 
Several respondents referred to the importance of community and communal 
responsibility evident in African communities.  This was reflected in the narratives by 
the near universal practice of sending money home to extended family, descriptions of 
childcare and family responsibilities, the influence of social networks, and the  
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importance of keeping up appearances. As a consequence several respondents felt 
Africans, more than Europeans, experienced a lot of pressure to conform socially. 
 
‘… the Europeans of course are much more relaxed, they don't care 
much, we [Africans] sometimes seem to care about things that are 
almost, er, useless to us… I have to look good, I have to have this, I 
have to have these clothes and everything, blah-blah-blah, whatever. 
You don't live well, you don't have any source of good income and you 
still have to, have to squeeze everything that you look better whatever. 
… you know, things like that, you know, so the mentality is completely 
different. 
There's greater pressure for you to conform to an image back 
home? 
Oh yes. Oh yes, of course, yeah, yeah…’  
40year-old South African man. 
 
 
The association with sexual acquisition was the rationale given by many for stigma that 
accompanied an HIV diagnosis, although other STIs were not stigmatising   in the same 
way, presumably because they are not associated with death and suffering. 
 
‘What about other infections from sex like gonorrhoea or syphilis? 
Do people have the same attitude? 
No, that one's completely different. That one, they wouldn't look at that 
way but HIV is just something different. I don't know why. People, I 
think we don't, people, they still don't understand how HIV, how you get 
HIV. 
So they're frightened?  
Yes’  
34 year-old Malawian woman. 
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Only two men, both university educated professionals from high prevalence countries, 
felt that people with HIV were no longer socially isolated and that there was now a 
general acceptance that anyone could get it. 
 
‘A lot of people now see it as it's only a matter of time before you fall 
sick as well so people really don't, you know there is no - 
People aren't isolated any more? 
No, they aren't isolated, … - I mean it is, it's like probably a country at 
war where somebody dying does not make news any more and people 
just get on with it and you don't know when the next bullet is going to 
hit you. So yes people have kind of accepted the fact that it could be 
anyone.’  
30 year-old Zimbabwean man. 
 
 
Neither man, despite purporting an acceptance of HIV, had disclosed his HIV status to 
anyone other than his spouse.  
Those not from high prevalence countries were less likely to have experienced HIV 
directly but had still witnessed the consequent social isolation and suffering experienced 
by people with HIV in their home countries. 
 
‘But I had seen people with AIDS at the hospitals. They are isolated, no 
one talks to them, and they go home and within a few weeks they die.’  
19 year-old Cameroonian woman. 
 
 
Despite many respondents recounting examples of how they had reacted supportively to 
friends and family with HIV, few interviewed trusted that they would receive similar 
support should they disclose their HIV status. However, almost all of the respondents 
who had disclosed to friends and family (n=10) had positive experiences of both the  
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process and its consequences. The exception to this was a woman disclosing to her 
sexual partner; he left her as a consequence.  
Stigma is sometimes divided into ‘felt’ and ‘enacted’: the former referring to people’s 
feelings and expectations of others reactions in relation to the condition, whilst the latter 
refers to peoples actual experience of stigma and discrimination (Jacoby, 1994). The 
HIV-related stigma, both felt and enacted, discussed in the narratives was 
predominantly set in the African context but it was with these eyes that the respondents 
continued to look at HIV. There was almost no imagery (good, bad or indifferent) of 
HIV within the UK to replace the African experience. 
 
‘I wouldn't think that there is HIV in this country. It's totally different. 
You wouldn't think, and I've never came across a person who I'd say I 
suspect, no. I don't want to lie, I don't think. Maybe because people have 
the thing because of the medication, the food, everything, their lives, 
whatever, you won't think.’   
38 year-old Malawian woman. 
 
 
Even for those respondents who thought they would test negative, or who had not 
considered themselves to be at risk of HIV, the very process of presenting for an HIV 
test was a frightening proposition.  People expressed fear that to test for HIV exposed 
oneself to the same promiscuous label as for those testing HIV positive. This was 
because the perception was that only people at risk of HIV would or need to consider 
testing.   
There was also the fear that if people saw you attend HIV testing services they would 
assume you were HIV positive, and hence you become the subject of stigma and 
discrimination, regardless of the outcome or of what you said was the outcome.  
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‘Even if you go [for a test] and you're negative they can't believe it. 
They say, ah, she’s been there, she’s happy, that means that she's lying. 
As long as you come here they want to know.’  
33 year-old Zimbabwean woman. 
 
Stigma and discrimination made people extremely fearful of the consequences of HIV 
testing, both in accessing the service itself and in the possibility of a positive diagnosis; 
it also fundamentally altered people’s self-perceived risk of HIV. 
9.2.2.2  Perception of risk 
Despite the proximity of HIV in many of the respondents’ lives relatively few (n=6) 
perceived themselves to be at risk of the infection prior to diagnosis.  This appeared to 
be related in part to the invincibility of youth and in part to the concept of ‘otherness’ – 
HIV is something that only happens to other people, not you and not your associates.  
 
‘Because HIV from - it's like it's the kind of thing you think happens to 
everybody and not to you, it's like death, you think everyone else dies, 
not you, so it's like something you think happens to everyone else but 
you and people around you.’  
34 year-old Cameroonian woman. 
 
People trusted their perception of their partners past and present as it reflected their own 
judgement, thus it was as difficult to perceive sexual partners as at risk of HIV as it was 
of them self.  
The association of HIV with Africa, and with certain risk groups also influenced risk 
perception: 
‘Well, it [HIV testing] was just something I looked like at - [pause] - just 
a waste of time, do you know what I mean? Something I shouldn't just 
bother to go through. I didn't know the importance of it. To me the 
disease was not - it was for homosexuals, sorry about that, that's what I 
thought, drug users and all that. Somebody with a straight life how they 
get it?’                                                          37 year-old Zambian woman.  
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‘It's more something here because back home we never discuss about 
until I went to South Africa, but South Africa it's not gay people that get 
it, it's heterosexual people. But when I got here I realised it's a gay thing. 
So did you - you didn't know that before that? 
Not until here, because the information is right here.’  
39 year-old Ghanaian. man (MSM). 
 
‘I thought I was too young to have HIV’  
19 year-old Cameroonian woman. 
 
 
The West Africans interviewed all associated HIV as a regional rather than pan sub 
Saharan African issue, with Southern and Eastern Africa as the regions affected.  Their 
awareness of HIV generally and self perceived risk of HIV infection tended to be lower 
then the other interviewees. The following quote demonstrates how stigma and risk 
perception are interconnected. 
 
‘In Ghana we are not very promiscuous. South Africa, Botswana, they 
are promiscuous because I have been there, I know how the places, how 
they are.’ 
39 year-old Ghanaian man 
 
 
Sex, and sex education, were not considered suitable topics for conversation at home or 
by peers; knowledge about sex and HIV often coming from direct experience or from 
outside agencies such as schools or the church. The silence around discussing sex 
generally probably contributes to the notion that sexual practices outside the norm are 
required to put oneself at risk of HIV. 
Since being diagnosed HIV positive the disease has become all-consuming for most of 
the respondents yet prior to diagnosis it had simply not entered their consciousness.  
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That is, it was not only about absence of perception of risk but absence of any thought 
to the matter of HIV testing at all, and if HIV testing did cross their minds, it would 
often do so fleetingly. 
 
‘I know it is existing and it is a very nasty disease but I never take it to 
be so serious for sure. 
You never felt at risk? 
Never. Never thought about it.’  
31 year-old Ugandan man. 
 
 
‘And after the heat of the moment? 
Then you realise you did a mistake, a big mistake, then you start 
worrying for a couple of days. Then something has come to your mind 
then that it's gone.’ 
 39 year-old Ghanaian man. 
 
 
Whilst all respondents rationally knew people could appear physically well and have 
HIV, the physical health of themselves and their partners was often used as a means to 
account for the lack of perceived exposure to HIV.  The use of visual clues in ascribing 
HIV status to an individual was repeatedly mentioned.  
‘When people fall, fell sick for a long time, they may begin saying he 
was bewitching, this and this and this. They come to realise like, like 
when, sometimes they happen to realise it's AIDS depending on which 
symptoms someone gets. One may say, no, that's not AIDS because the 
patient has no rashes. You get what I mean?’  
35 year-old Ugandan woman. 
 
‘But now when I'm looking at myself I can see some changes on my 
body, that's when I can say this person has got like - my hair, I can look 
at someone and say she's got hair like mine, red lips, you know, that's 
when I'll say she might be.’  
31 year-old Zimbabwean woman 
  
  237
‘And in 1999 did they offer you HIV testing in pregnancy? 
At that time they did offer me but I was very healthy. And that was the 
last thing on my mind. You know, sometimes you think you hear of 
something and you always think, oh, it cannot happen to me, not 
knowing it's on your back yet. It was something which was not even 
close to my mind because I was healthy, I was carrying out my normal 
duties, everything was normal.’   
37 year-old Zambian woman. 
 
Indeed HIV infection was typically not considered until the onset of ill health; this 
appeared especially true of men. None of the 11 men interviewed had actively sought 
HIV testing, although three had previously tested.  Eight of the men tested on the advice 
of a clinician after becoming unwell. Only one of these men was expecting a positive 
HIV result despite all of them having advanced HIV disease (CD4<200) at the time of 
diagnosis, half were symptomatic with HIV related conditions and half had an AIDS 
defining illness. The man expecting the result had been advised by his GP four months 
prior to diagnosis he may have HIV, whilst not believing himself to be at risk he had 
tested at this time but had failed to collect his result; Only when he collapsed on the 
street did he accept he probably had HIV.  
The other three men tested because their partner or child had been diagnosed HIV 
positive. As a consequence all were expecting a positive result at the time of testing All 
3 men were asymptomatic and had a good CD4 count at the time of diagnosis. 
In comparison, six of the women had recognised that they may be at risk of HIV and 
had either suggested to the GP that they should be tested or presented to sexual health 
services for the test. This recognition was precipitated by physical stigmata of HIV in 
self, or illness/death of a child or a concurrent or previous sexual partner of their spouse.  
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‘Now I realised my health was not going on very well, I visited my GP 
several times. She was doing all her best but I was getting - I wasn't 
getting any better and I was paying for my prescriptions. … I suggested 
to my GP that I think I should have thorough check-up so that she gets to 
treat what she understands better and she said to me like what do you 
want me to examine you exactly? I said, I said, I said to her that I may 
be HIV positive and she wanted to know why I suspected myself to be in 
that kind of situation. And I told her my background while back home 
which was my husband while with me got another woman and had 3 
children with the woman and now the woman's dead and one of the 
children is dead.’  
35 year-old Ugandan woman. 
 
One woman had experienced acute STIs within her marriage and consequently 
anticipated a positive HIV result. Another woman sought an HIV test because of 
multiple rape experiences in Uganda.  
 
‘I was worried about HIV as you can’t have sex with more than 100 men 
and not think about HIV.’  
31 year-old Ugandan woman. 
 
 
However the one interviewee who had engaged in sex work in Africa, often without a 
condom, had not perceived herself to be at risk of HIV.  This was probably due to her 
youth and lack of awareness/knowledge about HIV generally. 
Married women often did not perceive themselves to be at risk of HIV: 
 
‘I was just like, oh no, I can't test that thing, it's not for me. I'm OK with 
what I am, I'm OK with me, I'm OK just because I'm married.’  
38 year-old Malawian woman. 
 
Five women had previously had an HIV test, two antenatally, one on request because of 
her husband’s infidelities, and two as part of routine check-ups. Prior testing was  
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associated with lack of perceived risk at the time of HIV diagnosis. Twelve of the 15 
women interviewed were asymptomatic when diagnosed with HIV.  
Men like women associated HIV risk with sexual behaviour. No men or women felt 
their behaviour put them at risk yet women often felt at risk by recognising risk in the 
sexual behaviour of their partners. Denial of HIV risk was evident in accounts from 
both men and women, but particularly the men. For example one man’s wife had tested 
HIV positive six months earlier however he could not accept he may be positive and 
waited until he developed TB before presenting to services. Another of the men had 
witnessed his 18 months old child die three years earlier, despite coming from a high 
HIV prevalence community he attributed this to ‘bewitching’. 
‘Even though you know you might be you live your life as if you’re not ’  
30 year-old Zimbabwean man. 
 
‘Occasionally you'd think about it but then you want to be, you want to 
brush it off your mind and you say, oh no, not me, it's someone else have 
it, not you. No, you are careful but you are not because sometimes you 
have unprotected sex as well.’  
39 year-old Ghanaian man. 
 
‘the first time I looked at the mirror before I even came to hospital I'd 
lost weight and I looked, because all those cheeks had gone, I had a 
flashback of someone who was dying of AIDS who I'd seen a long time 
ago at home and that's why, that's why I decided to come to hospital as 
well. 
So did you think about getting an HIV test when you had that 
thought? 
No, I didn't think as, I said to myself if I go to hospital and then we have 
to talk to my GP, … I mean because I'm just concentrating on the 
weakness of my - of my leg, I didn't - I looked at that side. The other 
thing was like I wasn't eating properly and the stresses hit me so that's 
why I'm like this. 
You're finding other reasons? 
Yeah, yeah, I'm trying to run away.’  
32 year-old Zimbabwean man. 
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The only interviewee who routinely tested for HIV and other STIs never actually 
perceived herself at risk of HIV. She did feel at risk of other STIs such as Chlamydia 
(hence the accessing of sexual health services) and tested for HIV solely as it was 
offered as part of the screening package.   
HIV testing was in itself perceived by some to be a risky practice due to fears around 
inadequate sterilisation of needles. 
Several respondents mentioned witchcraft during the course of the interviews. A strong 
belief in the power of witchcraft remains among many African communities (Middleton 
& Winter, 2004). It was used to account for ill health but was no longer used or believed 
in as a means of treating HIV. The impact of witchcraft on HIV testing was in reducing 
perceived risk by offering an alternative explanation for ill health.  
 
‘I wasn’t feeling very well, and my menses still hadn’t come, I had 
fevers and my skin was no good. I was worried that maybe it was 
witchcraft from Africa that was causing me no menses.  The King is a 
powerful man and could get someone to do that.’  
19 year-old Cameroonian woman. 
 
All respondents denied that traditional therapies would be accessed in lieu of 
conventional medicine, primarily because it was evident from the number of deaths that 
traditional therapies did not work for HIV. Conspiracy theories as to the origin of HIV, 
whilst not common were evident in the accounts of some respondents. Unlike the belief 
in witchcraft, beliefs as to the origin of HIV did not appear to impact on health seeking 
behaviour.  
Death was not feared as much as ill health.  The narratives suggested that whilst 
undiagnosed HIV may kill you, ill health was associated with diagnosed HIV.   
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9.2.2.3   Perceived benefit of HIV testing 
HAART has been freely available in the UK since 1996 yet respondents’ knowledge as 
to its availability and/or effectiveness was either lacking or incomplete. In Africa the 
focus is on condoms and avoidance of HIV, it is not on HIV testing to access 
medications. Consequently there was little to counteract the negative associations of 
HIV testing, or tilt the balance in favour of knowing ones HIV status regardless of 
perceived personal risk.  
 
‘Maybe here but back home I don't think most people know about the 
treatments because once you're diagnosed and the next is you wait for 
death to come. And the talk and the humiliation, the stigma and 
everything else.’  
31 year-old Nigerian woman. 
 
‘I knew of course about the disease and I - sometimes I used to think 
maybe, maybe it’s necessary to test because it’s positive, I mean it’s 
possible I could be positive, maybe I need to test but then I didn’t have 
enough motivation to - [laughs] - and courage.’  
38 year-old Zambian man. 
 
‘What do you know about HIV? 
That it is incurable. All I know is that I will die.’  
19 year-old Cameroonian woman. 
 
 
The lack of perceived benefit in HIV testing was compounded by the perceived risks of 
testing. 
‘I feel, people feel to have a test to find out the results costs you more 
stress, damage and things. … you don't check because people say when 
they check it puts up their stress and makes them get worried and fall 
sick, you know.’  
39 year-old Ghanaian man. 
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‘People will always hold back for their own self-esteem, you know what 
I mean, they always, they're always going to be - because you know that, 
OK, right now I'm enjoying life, I don't have to worry about anything 
except maybe normal things like credits or whatever, things that can be 
rectified in months and then be better so. But once you come into 
knowledge that you are like this, it's for a long time this thing so it's 
going to hurt you almost for the rest of your - no-one want to really, you 
know…’  
40 year-old South African man. 
 
 
The association most respondents had was of HIV testing followed by rapid decline and 
death.  This was often seen as a direct consequence of knowing your status definitively 
(‘it is the thinking about it that kills you’) and the subsequent social exclusion. 
 
‘What destroys people at home, they feel shunned, abandoned, you 
know, no-one comes near anymore. What's the point of living? I think 
this is the main thing that really kills people.’  
40 year-old South African man. 
 
‘He say, ah no, me, I'm dying [because he had been diagnosed with 
HIV], I have to just say bye-bye to everyone. So he just woke up dead 
because of the brain, he wasn't sick.’  
33 year-old Zimbabwean woman. 
 
An asylum seeker expressed concern that testing HIV positive may lead him to be 
incarcerated with other HIV positive asylum seekers and that all his future health 
complaints would be taken in this context denying him proper care. So whilst he did not 
consider himself likely to be HIV positive he was not prepared to take this risk when 
offered HIV testing by his GP. 
The impact of HIV testing extended beyond the individual. The desire to protect parents 
in particular from the expectation of death that accompanies an HIV diagnosis was 
widely recounted.  
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The lack of accessible effective medication within the African home countries meant the 
alternative reality of a newly diagnosed HIV positive person moving from unwell to 
healthy was not often experienced.  In the UK there are thousands of HIV positive 
Africans accessing care (The UK Collaborative Group for HIV and STI Surveillance, 
2007) and living ‘almost normal lives’, but because of the fear of discrimination there 
remains relative silence and a lack of role models. 
Two women considered themselves to be HIV positive but deliberately avoided HIV 
testing.  This related to fear of stigma and discrimination and the lack of perceived 
benefit in having their HIV status confirmed.   
A couple of respondents did have knowledge as to the effectiveness of medications. 
Ironically in this instance they were too optimistic, suggesting that it was safe to delay 
diagnosis as long as possible as medication would make everything all right. There was 
not much awareness that delayed diagnosis, even with access to HIV medications, is 
still associated with high morbidity and mortality. Knowledge of medication was not in 
itself enough of a precipitant to test, an additional factor such as ill health of self or an 
associate appeared to be required - A dammed if they do and dammed if they don’t 
scenario. 
 
‘Even if they think about it, if you are well you are well, you can't have 
this. You look at people and it's so funny because you get people talking 
about somebody, or somebody has died of AIDS, say, well, they 
shouldn't have, they shouldn't have, you know, blah-blah-blah, to say a 
lot of things that they shouldn't, how can you be here and still die of this 
illness when you could have got tested. Then you think to yourself, well, 
have you been tested - [laughs]’  
30 year-old Zimbabwean man. 
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‘Every Black African knows [about HIV testing] but they will never 
come. They'll come when they're sick and when they are really sick, 
that's when they'll come.’  
33 year-old Zimbabwean woman. 
 
Three respondents had declined antenatal testing, all subsequently testing because their 
children had been diagnosed with or died due to HIV.  One woman declined because 
she had previously tested and could not see the point, the other two because they did not 
perceive themselves at risk.  The narratives would suggest that when antenatal testing 
was declined no attempt was made to make the parents aware of the benefits of testing 
in this scenario or the lack of harm in taking the test. 
 
‘It's nobody to blame in that sense. You know, in other ways we should 
have done it, in other ways she [the midwife] should have explained, she 
should have found out why are you not taking that test, you know, and 
because it's really when to find out in later stages that pregnant mothers 
nowadays you don't ever go without that test. If you say no, they say 
yes, do it. You know.’  
26 year-old Zimbabwean man. 
 
‘Well, when they offered, the thing is when they offered me the test, 
partly I blame it on my GP because she didn't really emphasise, you 
know what I mean, like as I said, explaining, you know, sometimes 
things need to be explained to people to understand them properly.’  
37 year-old Zambian woman. 
 
9.2.2.4   Structural factors 
Structural factors refer to institutional or societal factors that influence individual 
agency and hence impact on health and health seeking behaviours (Farmer, Nizeye, 
Stulac, & Keshavjee, 2006); immigration policies, gender inequalities, and quality of 
health services are examples.   
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Most respondents were well educated and from the African middle class, yet most were 
experiencing economic hardship within the UK. Less then a quarter of respondents were 
working in the UK at an equivalent level to their African experience within their chosen 
profession. Prior to diagnosis half were either not working or employed in jobs that fell 
far short of their experience and qualifications, for example a businessman working as a 
street cleaner, or teachers employed in domestic work.  All bar one of the interviewees 
who did not have official rights to remain were employed on a cash-in-hand basis.  
Asylum seekers were not allowed to work despite their qualifications and desperate 
desire to be employed. 
How this change in socioeconomic position impacted on health seeking behaviour was 
difficult to disentangle. Respondents spoke of the pressure to work, not only to support 
families in the UK but also many had families back in Africa still dependent on them 
financially. The focus of people’s lives was on financial or immigration issues, not on 
health.   
‘They're not thinking about this disease because they know it's there but 
they still have, it's my family back home, have they eaten today? 
Other issues more high up? 
Yes, they're thinking of have they eaten today and to have enough 
money to send them back home. What's going to happen to me here? If 
the Government says to me go back to Zimbabwe today what's going to 
happen if I go to Zimbabwe right now…’  
32 year-old Zimbabwean man. 
 
 
Several respondents spoke of the time it took to get a check up, time that could have 
been spent earning, and how this dissuaded others from attending health services. 
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‘you want an HIV test, you are not sure whether you are HIV or not but 
you have got to go there, queue for, I don't know, 4 hours sometimes and 
wait. A lot of people are just going to say, well - and most people are 
being paid per hour in this country and they aren't going to, you know, 
wait for 4 hours because that's about half-a-day's wage they're going to 
lose in there.’  
30 year-old Zimbabwean man. 
 
Respondents typically had friends from a range of cultural groups although the majority 
had close relationships only with other African nationals. Social networks were 
generally small. A lack of trust of other Africans was evident in many narratives, this 
revolved around gossip and fear of deportation, even in those with secure residency 
rights.    
‘There's a lot of suspicion about each other. Mainly stemming from the 
immigration issue. A lot of people are very sceptical about, wary about 
who is looking into their affairs and people will only interact socially in 
a social gathering and it probably ends there. Because, yes, it's - no, 
there's no trust, no. I think it's even worse here than back in Zimbabwe.’  
30 year-old Zimbabwean man. 
 
 
Consequently disclosure of HIV in order to help redress HIV-related stigma and 
discrimination was not seen as a viable option for most. 
Racism was not reported as widely encountered although here I wondered if this was 
partly out of respect to me. The socio economic position of the respondents could 
suggest that it was operating at some level. 
‘And then being a Black person when you go for interviews, not that I 
have specifics but I just feel that sometimes because you talk different, 
because probably you approach things differently it's harder for you to 
get a job because it took me quite a while after I graduated, you know, 
and even though it was all over the place that they needed youth 
workers, well, I was out for about more than a year without a youth - 
you know, without a job in youth so I just think being a Black woman 
didn't help.’  
34 year-old Cameroonian woman.   
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None of the interviewees were aware of media reports linking African migrants with 
loss of job opportunities for British nationals and the ‘HIV plague’.  
Gender inequalities influenced women’s ability to control the risk of HIV exposure; it 
also impacted some women’s ability to access HIV services. 
‘…because [when I] explained to her what it was, we have been never at 
any point ill, never been admitted, because that's what they ask you, 
have you been admitted within the last 3 month or 4 months, say, oh, 
we've never been to the hospital. And with this she says she has never 
taken any medication. 
So she thought there's no point? 
It was not up to her, there was no point.’  
26year old Zimbabwean man on wife being offered antenatal testing and 
why it was declined. 
 
‘And could a woman ask a man to have an HIV test?  
It's difficult to in our culture, for really approaching, say, your husband 
and telling him that we should go for an HIV test is really difficult. I 
don't lie to you, it's difficult. Because most of the time we see men as the 
head of the house and then the women are still like subordinates, yes. 
You can be educated, you have a nice house, have money but still the 
men will always be on top, that's how it is in our culture.’  
29 year-old South African woman. 
 
 
 
Many narratives unwittingly highlighted the subjugated position of women.  Examples 
included lack of autonomy, the accepted practice of polygamy for men, that 
transactional sex was a necessary commodity for many women, domestic violence, and 
the frequency and value ascribed to rape. A couple of the men held women responsible 
for the spread of HIV; perceiving them as deliberately deceitful and promiscuous 
vectors of the disease. 
Most (n=20) of the respondents had visited a GP in the 2 years prior to HIV diagnosis. 
Knowledge of how to register with a GP tended to come via friends and family with  
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little official information on the NHS readily available (unless already within services). 
For a significant minority access was delayed due to fears around disclosure of self to 
immigration services. The perception was that health services and the home office were 
linked, principally because of the need to provide your address when registering with a 
GP. 
‘There are people who are living here illegally … that person can never 
get tested. They would even fall sick and still not get tested until they are 
actually helpless themselves and they have got to be taken to hospital 
because they are so much afraid of the law. Of the consequences of 
being sent back …’  
30 year-old Zimbabwean man. 
 
 
‘So to get the medicine I tried the pharmacy, they say we can't, they can't 
give me tablets, I have to go for the GP and I tried and the GPs, the GPs 
I went, oh, we check documents and because of that I just say, ah, let me 
go to the walk-in, that's when I came here.’  
33 year-old Zimbabwean woman. 
 
Attitudes and experiences of primary and secondary care were mixed. Within primary 
care the appointment system, short consultations, and reception staff were criticised; 
whilst hospitals were perceived as unclean and the nurses too open with patient details 
during handover. The tendency for reception staff to discuss and disclose patient 
information was a particular concern for many. 
 
‘I trust my GP but I don't trust those, the ladies, those young girls who 
work at the reception. Yes. You can see that they are young, they talk all 
the time. You can hear, they talk, they check somebody's file and then 
they start talking about the patients which is not good.’  
33 year-old Zimbabwean woman. 
 
All respondents were extremely satisfied with the HIV care they had received, and no 
concerns regarding confidentiality were expressed.  
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Unfortunately the narratives recounted numerous missed opportunities for earlier HIV 
diagnosis within the health system itself, predominantly within primary care. As one 
could argue that health professionals should have identified HIV as a potential risk for 
this population, the widespread failure to discuss HIV or HIV testing represents a 
systematic or structural failing.  
 
‘Did your GP know you had been raped in Africa?  
Yes, I told him everything. 
Did he ever mention HIV testing or a sexual health screen?  
No never.’  
31 year-old Ugandan woman. 
   
 
Particularly concerning were the occasions when the respondent had identified HIV as 
part of the differential diagnosis but the GP had dismissed their fears without testing. 
 
‘Like the very first day when I went to see [the GP], I told her I've got 
some rashes that I don't know where they're coming from and I heard 
some people with HIV they do develop some symptoms, then she goes, 
ah, I don't think it's that. So that's what made me think I was ok … that.’  
27 year-old Zimbabwean woman. 
 
 
Two men recounted how they had considered HIV when they had acquired shingles but 
again been reassured by the GP failing to raise the issue. In one instance the GP appears 
to have considered HIV too but rather than suggest testing he tells the man to collect 
some condoms on the way out: 
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‘People do know because I think shingles develops as a sign of your 
immune system weakening which could be a result of stress, which 
could be a result of your HIV status and, yes, people do know. 
Did it make you think about HIV?  
Well, I did but then I sort of got the comfort from the fact that the doctor 
that I was seeing was of the strong opinion that Chickenpox was 
responsible.’  
30 year-old Zimbabwean man. 
 
 
‘The only thing what happened was - it's quite funny really, I got 
shingles.…. And I went to see my GP and he looked at me and says, 
don't worry, it's just shingles, and he said to me are you living by 
yourself? I said, at the moment yes. He says to me, when you go out ask 
the nurse for some condoms…  He didn't mention getting tested or 
anything. I still remember that day because we joked when I was on the 
door, he says ask the nurse if she can give you some condoms. …It was 
like does he know I've got AIDS or - you know - when somebody says 
something to you they might not really like tell you what's going on but I 
said to myself probably when, because he didn't explain everything or 
something, the GP, so I thought does he mean that I have to protect for 
HIV or something, does he know that probably I've got HIV, maybe I 
don't have HIV, so it was a problem. It was in a joking way that I have 
to be careful of this so he told to me that condoms obvious protection 
from sexual diseases and I just walked out and I saw the nurse and asked 
the nurse and she gave me condoms.’  
32 year-old Zimbabwean man. 
 
 
Although there were examples of people declining HIV tests, most felt they would have 
accepted a test earlier if offered. Declining a test predominantly related to the 
combination of lack of perceived risk of HIV and lack of perceived benefit in having the 
test.  
‘Would there have been anything 3 years ago that someone might 
have said to you that would have made you have an HIV test? 
Well, of course I wouldn't listen to that person at that time. I wouldn't, I 
wouldn't listen to him then because that I would have thought HIV, it's 
beyond me.’   
40 year-old Nigerian man. 
 
  
  251
Testing for HIV predominantly occurred in GUM clinics, the exception to this being 
antenatal testing. Whilst GUM clinics had been the initial point of access for a few 
respondents in most cases they were accessed only after referral from other services.  
This complicated pathway to access HIV testing is another example of a structural 
barrier.  
Several respondents had been referred to sexual health services (for management of 
syphilis and infertility) by their GP without mention of HIV. Whether the GP had 
considered HIV when referring is unknown. The process of onward referral to sexual 
health services was a barrier due to the stigma attached to accessing these services, and 
the logistics of having to attend another service. In all instances it delayed diagnosis. 
 
‘I think people here, right, are not, they don't mind going to the GU 
centres, you know, but for people from Africa or from Zimbabwe, from 
my own point of view, it's a big thing to walk in there, someone would 
feel everybody's staring at me. I've seen people like back home, people 
would rather have a friend who is a nurse, a pharmacist or a doctor to 
come privately, look at them and then go and bring some tablets for 
them because people don't want to go through this whole process of, you 
know, getting to the, you know, GU centre, you know, which still for 
HIV even makes it worse because this person is not even, feels they are 
not part of that kind of community.’  
30 year-old Zimbabwean man. 
 
‘It takes a lot of courage to walk-in and a have a test. It took me, it took 
me, umm, four months from when the GP mentioned it before I went to 
[the GUM clinic]’  
37 year-old Zambian man. 
 
The circumstances behind previous negative HIV tests offer some insight into how to 
get people to test before they become unwell.  Six of the seven prior negative tests 
occurred opportunistically; two antenatally, three as part of a sexual health screen, and 
one as a visa requirement. In all of these instances the respondent had not considered or  
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been seeking an HIV test, however one was offered (or required) routinely and the offer 
was accepted.  
‘So when I came here I talked to the doctor, then he told me do you feel 
if at all you have HIV testing as well. Well, it wasn't in my mind to have 
that test but after I said OK, it's better if I get it and to know my status, 
how am I standing. But I never expected it.’  
39 year-old Ugandan man. 
 
The remaining test occurred due to fear of HIV as a consequence of ill health in a 
concurrent partner of their spouse.  
Over half of respondents had solicitors, usually involved in processing visa or asylum 
applications. Despite solicitors being privy to personal information such as rape and 
torture in no instances did a solicitor suggest accessing health services, or provide 
information to assist in this endeavour. Criminalisation of HIV was not a factor 
influencing HIV testing patterns for any of the respondents; several believed it had the 
potential to further dissuade people from testing, whilst others felt it would help control 
the spread of infection.  
9.2.3   Improving the system 
Improving the uptake of HIV testing was believed to be important and possible.  The 
provision of more information was the most fundamental element identified. The 
information needed to highlight the positive benefits of accessing therapy so as to live a 
healthy life with HIV. The negative imagery of people dying due to HIV was 
recognised as fuelling stigma, and needed to be replaced with a ‘before and after’ image 
demonstrating that testing made a positive difference. The importance of timely access 
to medication needs to be made clear and the images used need to be of people that 
others want to identify with.  
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Clear unambiguous statements on HIV in the era of effective ART were needed. The 
mixed messages inherent in HIV literature – for example that clinicians say that the 
medications are effective yet mortgage and insurance companies continue not to cover 
HIV positive people; or that adverts say ‘you don’t need to die of HIV – use a condom’ 
not mentioning that you don’t need to die of HIV even if you are already infected - 
made people mistrust the information that was provided. 
Most felt that more positive role models of people successfully living with HIV would 
help break down stigma. The disclosure by Chris Smith, cabinet minister, of his long-
standing HIV status was repeatedly identified as a good example. The disclosure by 
Nelson Mandela that his son had died of HIV/AIDS was seen as positive but not as 
influential as Chris Smith’s disclosure because he was not successfully living with HIV. 
The need for more information on entitlement and access to health services, 
confidentiality, and that health care is free was frequently mentioned. 
 
‘I did see some leaflets in his surgery, which told me about HIV testing 
and the fact treatments were available and that they were free.  That was 
what made me ask him for the test.  I didn’t know there were treatments 
or that it was free until then.’  
31 year-old Ugandan woman. 
 
Information on HIV and health services was available once people were accessing 
services.  Other than television news items no reference to HIV information could be 
identified by any of the respondents. All felt that more information and prevention 
messages, such as occurs within Africa, was needed. 
Respondents felt strongly that HIV prevention and testing messages should be universal 
and not targeted at African communities. Targeting would simply fuel stigma and 
discrimination towards Africans generally, and be ‘insulting’.  
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‘HIV is HIV. Don’t look at it as ‘African’ or ‘European’. HIV is just 
there. HIV has no age, colour…so I think the message has to be 
general.’  
37 year-old Zambian man. 
 
 
‘If your GP says to you, you know, you're from Malawi or 
Zimbabwe, there's a lot more HIV, I'd recommend you have an HIV 
test? 
Ah, but then that would be an insult to me. 
That would be an insult? 
Yeah, it would be an insult really, that's because I expect that disease to 
be everywhere. … I would just want someone simply saying would you 
mind to go for it without mentioning that, oh, Africa has got that. Yeah, 
I wouldn't mind.’  
38 year-old Malawian woman. 
 
 
‘I don’t know how they would need to package it to target it at a certain 
group of people because some people would feel offended, to say, look, 
why do you think, why are you targeting this information at us and not 
everybody else? So it’s a little bit of mystery ... to see how, how to 
package it really. If there is, for instance, a grouping of maybe African 
people, I don’t know, they meet somewhere and that kind of thing, 
maybe such groups need to be targeted to take it on board. The groups 
can take it on board but if it is seen to be, to be specifically targeted from 
a very high level like government level, it would seen to be even racial 
or all kinds of things. And in that case I think you may not achieve the 
right - the right result.’  
38 year-old Zambian man. 
 
However community mobilisation and support would be beneficial. Youths were 
identified as being particularly at risk with calls for more information in schools, youth 
groups, and health services.  
Access to medication was not necessarily enough of a carrot and further incentives to 
test would be beneficial. The right to remain in the UK was identified, though half-
heartedly, as possibly being that incentive. Whilst not likely to impact on HIV testing  
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directly the ability to work was identified as the single thing that would most improve 
the lives of asylum seekers living with diagnosed HIV. 
Health services need to expand HIV testing opportunities; in particular GPs were 
identified as the preferred venue for HIV testing.  
 
‘How do you think we could improve health services? 
I think GPs are the key.  Everyone goes to the GP.  You only go the 
hospital if you are really sick. People are scared to come to this place 
[Sexual Health Clinic].’  
31 year-old Ugandan woman. 
 
 
‘Probably through the GPs, yes, that is one way because they need to be 
made more aware and much more active in this work. I think they need 
to talk about it more, more openly with their patients.’  
38 year-old Zambian man. 
 
It was acknowledged that GPs might not be comfortable with this recommendation and 
that further training may be required: 
 
‘But I think also it's not just for the people but it's also for the GP, GPs 
to be comfortable. I don't think it's something that they're comfortable 
offering to patients, they might say, well, if I offer it she might think 
what I'm making of her, you see. But it's just something that they have to 
train to tell people in a way that doesn't seem like they're judging you 
but it's just like something they're offering to anybody because who 
knows, if they offered it more…’  
34 year-old Cameroonian woman. 
 
Similarly addressing concerns regarding confidentiality and reception staff would be 
beneficial. 
Walk-in centres, where official documentation to register is not required, were 
identified as suitable venues for HIV testing.  The concept of ‘high street clinics’  
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specifically for HIV VCT were not widely popular, principally because they, like GUM 
clinics, would be too associated with HIV and hence disclosing to the wider community. 
Whilst information on HIV/STIs and condoms should be widely available, religious 
institutions and social venues were not thought appropriate for VCT.  
Provision of services and information are only effective if people choose to make use of 
these resources and opportunities.  However most migrants do access health services 
and most of the interviewees reported that had an HIV test been offered in an 
appropriate manner earlier they would have accepted.  
Opportunistic HIV testing was widely supported.  Those who had been diagnosed in 
this way were thankful to know their status and all acknowledged they would not have 
requested testing if it had not been offered. The two respondents who had HIV testing 
discussed in their partners presence felt this had significantly eased the disclosure 
process, and facilitated testing of both parties. Both felt couple counselling and testing, 
especially in the antenatal setting, should be encouraged. A man with an HIV positive 
child felt antenatal testing should be made compulsory. 
9.2.4    Personal reflections on interviews 
Conducting these interviews was a rewarding and humbling experience. Interviewees 
expressed a sense of release in the opportunity to tell their story.  They all hoped, and 
some believed, it would help make a difference. 
‘No it was good to talk. It’s not often one gets to talk and it’s like, it’s 
like …a release. ….. To know people care. People, like yourself, are 
interested and taking time to find out how to fix things. It makes me feel 
more positive towards the future….’  
38 year-old Zambian woman. 
 
Although the respondents appreciated the opportunity to talk for many the interviews 
were a painful experience reliving distressing life events. At times I felt inhibited in  
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delving deeper due to the obvious emotional pain the subject matter was evoking, for 
example discussing declining antenatal testing in someone who has subsequently lost 
their child to HIV.  Occasionally feelings were too raw or respondents too depressed/ 
shocked at their HIV diagnosis to enable full exploration of factors.  At these times the 
interviews felt more like therapy sessions in which a person ‘unloads’ than an interview.  
During these occasions I was aware that my different hats, clinician, researcher, mother, 
and ‘friend’, could all influence the direction the interview might take. 
I became very aware of how important social realities were in influencing perception of 
HIV and what it means, mine as a physician practising HIV medicine in the UK with no 
personal experience of HIV within my home (New Zealand) country could not have 
been more at odds with theirs.  
As a relatively new mother expecting my second child I found it difficult to understand 
the apparently very common practice of leaving one’s children with relatives to raise; 
especially as this did not always seem to be driven by extreme hardship.  For me it 
reflected a fundamental cultural difference - the individualistic British versus the 
communal African societies. 
Unfortunately the interviews also made me very sad. Whilst having immense respect for 
the individuals I spoke to, I was repeatedly disappointed in how people interact and 
behave with each other, men in particular.  The medical incompetence reported, usually 
within the UK, was equally shocking and disappointing. Fortunately the personal 
strength, dignity and gratitude with which the respondents went about their often very 
hard lives compensated for the reported behaviour of others. 
‘I thank God that I am alive in 2005, I am blessed.’ 
31 year-old Ugandan woman who had experienced multiple rape and 
torture.  
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9.3 Discussion 
These findings highlight the central role of HIV-related stigma and discrimination in 
influencing HIV testing behaviours among migrant Africans in Britain. By creating a 
culture of ‘otherness’ people do not identify themselves at risk. The secrecy and silence 
with which HIV positive individuals live their lives further perpetuates the myth that it 
is an illness of others. People do not realise that HIV is all around them, in people much 
like themselves, in people who appear well.  
For those aware of the possibility of HIV infection the negative repercussions of 
knowing their serostatus are often perceived to outweigh any potential benefits. This is 
exacerbated by the context with which migrant Africans experience and view HIV. 
Migrant Africans approach HIV testing with substantially more experience of HIV and 
preconceptions of the consequences of both testing and diagnosis than the majority of 
the British population.   Few have witnessed the benefits of ART directly yet all have 
seen the suffering and dying of people infected with HIV. For those with insecure 
residency rights there is no guarantee that diagnosis will result in access to medications; 
either because of entitlement regulations or via deportation. 
Fear of non-sexual HIV acquisition was often the rationale for HIV-related stigma and 
discrimination. If people truly believed in incidental transmission then one would 
expect a higher perception of HIV risk, and similarly there to be less stigma. Given 
neither of these occur the fear of transmission may be a means of rationalising the social 
isolation of HIV positive people. The inconsistencies in the basis for HIV-related stigma 
and discrimination reinforced my interpretation that stigma and consequent 
discrimination provides a coping mechanism for many African communities.  It  
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physically and emotionally distances people from those affected/infected, making it 
(theoretically) easier to cope when they die, something seen as inevitable.   
Stigma, in African communities, may be a more powerful influence on testing 
behaviours than it would be within a more individualistic society. The communal 
culture of African communities may make operating outside common practice, for 
example being socially inclusive of people with HIV, more difficult. HIV/AIDS related 
stigma and discrimination in this context could be seen as a form of self-protection – it 
helps define group identity and offers a mechanism of addressing irrational fears.  
The stigma accompanying an HIV diagnosis within African communities in the UK has 
been widely reported (Doyal et al., 2005; Flowers et al., 2006; Dodds et al., 2004; 
Anderson et al., 2004) however there is a paucity of literature exploring how stigma 
directly impacts on service utilisation in this population (Burns, Imrie, Nazroo, Johnson, 
& Fenton, 2007). Aggleton (2005) and Busza (1999) have modelled the impact of HIV-
related stigma and discrimination on accessing HIV services, uptake of care, and 
prevention in resource limited settings (Aggleton, Wood, Malcolm, & Parker, 2005; 
Busza, 1999), these findings suggest that stigma and discrimination plays a pivotal role 
in vulnerable populations wherever the setting.  
The themes arising from this work show considerable consistency to those identified in 
the key informant interviews (chapter 4, (Burns et al., 2007)). Both studies identified the 
high awareness but low perception of personal risk of HIV, the central role of stigma, 
and the structural barriers to HIV testing. The failure of primary care clinicians to 
address HIV effectively is also supported by both the key informant interviews and the 
SONHIA survey data (Burns et al., 2008). Similarly the fear of disclosure to 
immigration services has been previously identified as a barrier to accessing health 
services (Erwin et al., 1999).  
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9.3.1    Limitations 
A limitation of this study is that only involves Africans newly diagnosed with HIV, and 
as such is a retrospective study of the factors influencing access to care. As with all 
studies of this nature it may be subject to recall bias. For example, the circumstances 
around testing HIV positive may influence people’s recall of events leading up to the 
diagnosis. Similarly, knowing you are HIV positive may influence how feelings and 
attitudes towards HIV are reported or discussed.   
Migrant Africans comprise a heterogeneous aggregation of population sub-groups. 
Group analyses may falsely construct homogeneity and the reduction of complexity. By 
employing purposive sampling techniques this study deliberately ensured relative 
diversity in the sample. By using Framework, which allows for within and between case 
analyses, the analysis should be sensitive to important distinctions between sub-
populations. The study also focuses on individual experience, providing a voice for the 
participants. 
9.3.2   Implications 
The narratives of newly diagnosed HIV positive Africans in the UK have not been heard 
before.  By understanding the contextual issues related to delayed presentation within 
this population more culturally appropriate interventions may now be developed. It is 
unrealistic to believe that simply providing information on HIV testing and medication 
will be sufficient to change behaviours in this context.  Significant cultural work is 
needed to break down the stereotypes and associations that accompany HIV before a 
change in the attitudes of migrant Africans towards accessing HIV services can be 
expected.  
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Similarly the medical profession continues to treat HIV differently to other chronic 
health conditions and is complicit in perpetuating the cycle of late diagnosis and onward 
disease transmission within the UK. If a test is not offered it is unlikely to be sought 
when perceived risk is low, especially when the testing process itself is seen to have 
negative consequences.  Services could and should be adapted to reduce the potential 
for stigmatisation.  The release of national guidelines on HIV testing (British HIV 
Association, British Association of Sexual Health and HIV, & British Infection Society, 
2008) will hopefully stimulate initiatives to address this issue. All medical practitioners 
should consider HIV testing routinely on a regular basis among higher-risk populations. 
In November 2008 the Department of Health issued a call for proposals to reduce the 
proportion of undiagnosed HIV, African communities being specifically identified as a 
group at need of targeting (Orton, 2008). As highlighted in this study encouraging 
Africans to access HIV services does raise important ethical considerations about 
entitlement to care and residency rights. To be diagnosed HIV positive in the UK but 
not have entitlement to antiretroviral therapy could be considered inhumane, as could 
the deportation of HIV infected persons back to countries where access to therapy is 
unlikely. 
By placing these findings within the wider body of work undertaken within SONHIA 
and the literature generally a more holistic understanding of HIV service utilisation by 
African migrants resident in London should emerge; This will be the focus of the 
concluding chapter. 
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Chapter 10: Discussion of findings and 
future work 
10.0   Introduction 
This final chapter summarizes and contextualises the key findings with work done by 
other investigators and the current socio-political climate. It further explores limitations 
of the research, outlines work in progress arising from this thesis, and discusses the 
public health and policy implications of this research. 
10.1 Key findings 
In this thesis I set out to explore the factors contributing to the continuing late diagnosis 
of HIV among Africans living in London, and UK acquisition of HIV in this population. 
Three pieces of preparatory work (a literature review (chapter 2), an analysis of a 
national probability sample of black Africans on the factors associated with HIV testing 
(chapter 3), and a qualitative study of specialists working in the field of HIV and 
African communities (chapter 4)) helped frame the research objectives and formulate 
the design of the main focus of the thesis, the ‘study of newly diagnosed HIV among 
Africans in London’ (the SONHIA study) (chapters 5-9).  
The key findings are summarised in the following text and in box 10.1. 
10.1.1   The importance of context 
The literature review (chapter 2) provided context in which to set the research questions. 
It highlighted how historical links and past experience shape attitudes and the HIV 
epidemic within the UK. Internal and external factors influence health care access, be 
they social, political or cultural. HIV exceptionalism has unwittingly become a barrier  
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to care for many people affected by HIV and work to normalise HIV within the medical 
establishment as well as the wider community is required. 
10.1.2   HIV testing 
An analysis of a national probability sample of black Africans on the factors associated 
with HIV testing (chapter 3) found that approximately 40% of Black Africans have ever 
tested for HIV, compared to the 12-13% tested in the general UK population 
(McGarrigle et al., 2005). No association between testing and risk perception was found 
and almost half (48.9%) of the men and 71% of the women perceived themselves ‘not at 
all at risk of HIV’. 
10.1.3   Expert opinion 
Considerable agreement about the major issues influencing uptake of HIV services by 
African communities in the UK existed amongst the key informants (chapter 4). 
Informants believed there was high HIV awareness within African communities in 
Britain but this did not translate into perception of individual risk. Home country 
experience and community mobilisation was highly influential on HIV awareness, 
appreciation of risk, and attitudes to health services. All informants identified 
confidentiality, stigma and migration issues as major influences on uptake of HIV 
services. The interviewees highlighted the role of NHS service structures in 
perpetuating poor access for migrant Africans, in particular the failure of primary care 
to address HIV effectively. 
10.1.4 Missed  opportunities  for earlier HIV diagnosis 
In chapter 6 I identify missed opportunities for earlier HIV diagnosis in Africans in the 
UK. Africans were accessing health services yet these opportunities for earlier diagnosis 
of HIV were not being utilised. Primary care services in particular were identified as  
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failing to meet the needs of these communities regarding HIV prevention and care.  
Opportunities for HIV testing remain restricted to certain settings, creating barriers for 
clinicians and patients alike. A need to normalise HIV, including the testing process, 
was frequently cited. Routine opportunistic testing, when offered, had been well 
received.  
Entitlement to care concerns and fear of disclosure to immigration services was reported 
as influencing care-seeking behaviours for many Africans, regardless of residency 
status. 
10.1.5  Late presentation to HIV services 
In London many Africans with HIV infection continue to present late to HIV services. 
Half of people participating in SONHIA had a CD4 count below 200 cells/µL at the 
time of diagnosis representing advanced disease, and three quarters (74.1%) had a count 
below 350 cells/µL – the level at which initiation of HAART is now recommended in 
the UK (Gazzard, 2008). Despite high awareness and knowledge of HIV, personal 
perception of risk was often low. Late presentation was not found to be associated with 
access to services, risk behaviours, or most socio-demographic variables (chapter 7). 
Gay men, French speakers, and persons not believing HIV causes AIDS (perhaps 
representing knowledge about the benefit of medication) were the only groups found to 
be consistently associated with reduced odds of late presentation. 
10.1.6  UK acquisition of HIV  
As discussed in chapter 8 the proportion of HIV acquired in the UK among Africans 
was higher than currently reflected in national surveillance statistics. A quarter to a third 
of SONHIA participants may have acquired their HIV in the UK. The proportion 
acquiring HIV whilst resident in the UK would be even higher; 6.5% (17/263) of all  
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participants had unprotected sex with a new partner on their last visit to Africa and 
hence acquisition is placed within Africa, although residence at the time of acquisition 
was the UK. 
UK acquisition was supported by findings of high-risk sexual behaviours in African 
men, assortative and concurrent sexual mixing patterns, and high rates of previous 
sexually transmitted infections.  
10.1.7  HIV-related stigma and discrimination  
The central role of stigma in influencing HIV testing behaviours, and attitudes to HIV, 
was highlighted in the literature review, the key informant interviews, and in both the 
quantitative and qualitative components of SONHIA. Stigma and discrimination are 
discussed in detail in chapter 9. 
The culturally embedded associations of HIV with sexual promiscuity, sin, and death 
mean Africans either often do not identify themselves at risk, or for those aware of the 
possibility of HIV infection the negative repercussions may be perceived to outweigh 
any potential benefits of knowing their serostatus. The association of AIDS with the 
‘heterosexually promiscuous population’(Serwadda et al., 1985) and commercial sex 
workers was identified, and reported on from the very beginning of the HIV/AIDS 
epidemic in Africa (Piot et al., 1984; Piot et al., 1984; Kreiss et al., 1986; Serwadda et 
al., 1985; Quinn et al., 1986). And commercial sex workers continue to be the focus of 
much HIV research and intervention work in Africa (Cowan et al., 2005; Morris & 
Ferguson, 2006; Kaul et al., 2004; Schwandt, Morris, Ferguson, Ngugi, & Moses, 
2006). It may well be that this focus has unwittingly helped create the stereotype which 
the HIV community is now trying to dispel.  
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Significant work is needed to break down the stereotypes and associations that 
accompany HIV before a change in the attitudes of migrant Africans towards accessing 
HIV services can be expected. 
Box 10.1 Key messages arising from this thesis 
Key messages: 
1.  Low appreciation of personal risk and lack of perceived ill health within the African 
communities means clinicians need to be more proactive in addressing HIV for this 
population. 
2.  Africans are accessing health services but clinicians are failing to use these 
opportunities effectively for preventive and diagnostic purposes with regards to HIV 
infection.  
3.  Africans continue to present with advanced HIV disease with consequent high 
morbidity, mortality and probable onward transmission of infection. 
4.  A quarter to a third of HIV in Africans resident in the UK may have been acquired 
in the UK. 
5.  Stigma and discrimination continue to hinder HIV prevention efforts. 
6.  Taking a more holistic approach and addressing immigration issues, entitlement to 
health services, gender inequalities, and lack of access to antiretroviral medication 
in Africa may be required to effectively tackle HIV in African communities within 
the UK. 
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10.2 Limitations 
Most of the studies’ limitations have been discussed in the preceding chapters 3-9. 
Ideally the thesis would have included detailed investigation of African people who had 
tested HIV negative and people who had never HIV tested. However, I was able to 
explore demographic, behavioural and attitudinal associations in those who presented 
late compared to early. The median time between HIV diagnosis and questionnaire 
completion was 3.5 months. The short time period hopefully minimised recall bias as to 
the factors influencing decisions to test.  
The potential downside of a short interval between testing and questionnaire completion 
may lie in the psychological consequences of receiving an HIV diagnosis. Most people 
go through an adjustment reaction of some kind on receiving an HIV diagnosis, for 
many this involves free floating anxiety or reactive depression (Miller & Riccio, 1990). 
Whilst it is probable that responses will be influenced by the affective state of the 
respondent, the barriers and fears identified in this thesis, in particular the stigma and 
discrimination, are in keeping with findings from other UK studies involving HIV 
positive Africans (Anderson et al., 2004; Doyal et al., 2005; Dodds, 2006; Erwin et al., 
1999; Flowers et al., 2006).  
Throughout the thesis it has been acknowledged that reducing all migrant African 
subpopulations into the composite variable ‘African’ may falsely construct homogeneity 
and the reduction of complexity. The concept of ethnicity is also controversial as an 
epidemiological variable. Research focusing on ethnicity can be perceived as ’racist’ 
(Bhopal, 1997), however the exclusion of such information in research and surveillance 
data can effectively hide health inequalities between ethnic groups (De Cock & Low, 
1997). Ethnicity remains one of the most effective concepts in demonstrating population  
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variations in disease (Bhopal, 2001). This work was conducted in order to reduce health 
inequalities; it is in no way intended to serve as a vehicle to further alienate migrant 
African populations. The African community reference group was involved in design, 
implementation and interpretation of findings within this work specifically to minimise 
this potential and ensure cultural acceptability. 
Despite these limitations this thesis is able to compare and contrast the findings of a 
national probability survey, key informant interviews, and quantitative and qualitative 
investigation of Africans with newly diagnosed HIV infection. This ability to 
triangulate findings from a variety of data sources and research methodologies provides 
a means of validating the work and enables a comprehensive overview of the factors 
associated with HIV presentation in Africans resident in the UK.   
10.3 Policy, practice and research implications 
The findings within this programme of work highlight the need for further investment in 
research and intervention development with African communities. Areas for future 
research and practice, some of which are already works in progress, are discussed 
below.  
10.3.1  HIV testing and missed opportunities  
Compared to the general UK population black Africans living in the UK are more likely 
to test for HIV (40% vs. 13%) (McGarrigle et al., 2005). However the figure of 40% 
ever tested is low compared to the 50 to 75% of MSM in the UK who have ever tested 
(Williamson, Dodds, Mercey, Johnson, & Hart, 2006). Even the highest UK testing 
figures for MSM, the group most at risk of HIV exposure in the UK, are low compared 
to those found in Australia and the USA where over 90% of MSM have ever tested for 
HIV (Prestage et al., 2008; Branson et al., 2006).  There also appears to be less of a  
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culture of regular screening in the UK. Of those MSM ever tested for HIV 35% had 
tested in the last year in the UK compared to over 60% of MSM in Australia (Dodds, 
Mercer, Mercey, Copas, & Johnson, 2006; Prestage et al., 2008).  Frequency of HIV 
testing has not been investigated among the UK migrant African population. In this 
work we found that 37.1% of newly diagnosed HIV positive Africans had previously 
tested negative for HIV, the median time between last negative HIV test and testing 
HIV positive was 2.8 years. Africans may not frequently access services where HIV 
testing is routinely offered. However, if they do uptake of HIV testing appears higher 
than for UK-born individuals (The UK Collaborative Group for HIV and STI 
Surveillance, 2007), a finding supported by the narratives in chapter 9 in which most 
people reported that they would have tested earlier if offered the opportunity. 
Targeted or risk-based testing policies are affected by access to care issues as well as 
the potential for individuals to be unaware of their risk, or unwilling to admit to 
potentially stigmatising risk behaviours – factors all identified within the findings of 
this work.    
The cost-effectiveness of routine HIV screening in the USA, even in populations with 
relatively low prevalence, is comparable to other commonly accepted interventions 
(Sanders et al., 2005). Routine HIV testing in a range of health care settings has been 
recommended in the USA for several years (Branson et al., 2006). In September 2008 
UK national guidelines for HIV testing were published. Universal HIV testing is 
recommended at GUM, antenatal, pregnancy termination, drug dependency, and TB, 
lymphoma, and hepatitis clinics. In addition the guidelines state that consideration 
should be given to offering HIV testing to all general medical admissions and to all men 
and women registering in general practice in areas where the prevalence of diagnosed 
HIV infections is greater than two per 1,000 (British HIV Association et al., 2008). The  
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guidelines also favour a more targeted approach in some settings such as patients 
presenting for healthcare where HIV enters the differential diagnosis.   
These developments are welcome but do not fully address the issue. The UK guidelines 
may increase one off opportunities to be offered an HIV test but they do not promote a 
culture of regular screening. Also a testing programme based around medical 
admissions, i.e. once an individual is already unwell, fails to address the importance of 
earlier diagnosis.  
Transmission during primary HIV infection may account for up to 25-49% of incident 
infections (Pao et al., 2005; Brenner et al., 2007; Lewis, Hughes, Rambaut, Pozniak, & 
Leigh Brown, 2008; Wawer et al., 2005). Whilst the guidelines may decrease the period 
of undiagnosed infection they are unlikely to help detect incident infections, for this 
promotion of highly sensitive tests such as pooled nucleic acid amplification is required 
(Pilcher et al., 2005). Research and funding are also required to guide service 
development as to the most effective, acceptable or efficient model to improve HIV testing 
within general medical settings, especially given the trust and confidentiality concerns 
expressed in SONHIA regarding primary care services, and the anxiety expressed by GPs in 
offering HIV tests (Kellock et al., 1998). 
For African communities expanding HIV testing into non-sexual health settings should 
improve access to services, however this will only occur if these opportunities are 
delivered in a non-stigmatising way. Normalisation of testing can occur through ‘opt-
out’ strategies where an HIV test is seen as routine care. Such strategies have increased 
testing in sexual health and antenatal health care settings (Simpson et al., 1998; The UK 
Collaborative Group for HIV and STI Surveillance, 2007) and successful roll out of 
such a strategy into primary care could have a major impact on reducing late  
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presentation and the proportion of undiagnosed HIV infection in the African 
communities within the UK.  
The continuing care relationship inherent in general practice provides an ideal context 
for ongoing HIV prevention messages.  Primary care is also well placed to address 
issues pertaining to risk perception as it provides a setting for personalised and targeted 
health information. Advice from doctors, be they primary or secondary care based, is 
influential with 40.2% of SONHIA respondents testing for HIV specifically because of 
clinician recommendation. Section 10.3.5.2 below provides some recommendations to 
improve service provision of HIV testing outside of GUM settings. 
The higher level of sexual risk among African men in particular suggests that reducing 
levels of undiagnosed HIV may not in itself be enough to stop new infections. 
Prevention strategies should include risk reduction behavioural interventions  - in those 
diagnosed, undiagnosed and at risk of acquiring HIV, as well as frequent HIV testing. 
10.3.2  Modelling the impact of earlier diagnosis 
Data from SONHIA are now being used in collaboration with Imperial College to 
develop a mathematical model to explore the impact earlier diagnosis would have on 
HIV transmission and clinical progression. The stochastic individual based 
mathematical model will estimate the impact late diagnosis in heterosexual Africans in 
the UK has on the potential for onward transmission of HIV within the UK. This model 
will enable calculation of the potentially preventable transmission events should HIV 
diagnosis have been made earlier.  The model will also be able to contribute to 
calculations of the cost effectiveness of different HIV testing models by providing data 
on transmission and clinical events averted with earlier diagnosis.    
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A recent paper using a similar model has controversially suggested that regular 
universal HIV testing and initiation of antiretroviral therapy regardless of CD4 count 
could eliminate HIV in high prevalence settings (Granich, Gilks, Dye, De Cock, & 
Williams, 2009; Garnett & Baggaley, 2009).  This model will inform current debate on 
the utility of earlier diagnosis and treatment as a prevention tool. 
10.3.3  Disease progression and viral subtypes 
Chapter 8 assessed the proportion of newly diagnosed HIV positive Africans who may 
have acquired HIV within the UK using predefined criteria. It was not always evident 
what criterion should be given precedence, with respondents often having conflicting 
clinical, migratory and behavioural parameters. It was apparent that on several 
occasions when HIV was classified as ‘definitely acquired within the UK’ based on 
HIV testing history and risk exposure, the CD4 count was lower than would be expected 
given the time in the UK data. 
Previous work reports that once accessing care HIV positive Africans in the UK have 
the same progression to AIDS and survival once adjusted for gender, age, and clinical 
stage and CD4 count at diagnosis (Del Amo et al., 1998). This work also looked at the 
rate of CD4 decline between Africans and non-Africans and found no difference. 
However this later conclusion was based on a comparatively small proportion of the 
cohort (34%, n=697) and no data is presented as to what viral subtypes or clades the 
cohort contained, although at the time clades A and C were the most prevalent clades in 
black Africans and clade B in UK-born individuals (Clewley, Arnold, Barlow, Grant, & 
Parry, 1996; Arnold, Barlow, Parry, & Clewley, 1995). As study participants were 
enrolled at the time of diagnosis, not at seroconversion, and required five or more CD4 
counts to be included in this component of the analysis, the data will be subject to 
survival bias.  
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There is accumulating evidence that viral subtype may influence the rate of CD4 decline 
and disease progression. Three seroconverter studies from across Africa have now 
demonstrated faster CD4 decline, progression to AIDS and higher mortality in non A 
HIV-1 subtypes compared to subtype A (Kanki et al., 1999; Kiwanuka et al., 2008; 
Baeten et al., 2007). In particular individuals with recombinant types, multiple subtypes 
and subtype D appear to have more rapid progression (Baeten et al., 2007; Kiwanuka et 
al., 2008). Data from Cascade, a European seroconverter cohort, also appears to support 
more rapid CD4 decline in individuals with non-B compared to B clade infections 
(Porter, 2009). Figure 10.1 shows the diverse geographical distribution of HIV-1 clades.  
Viral subtype data was only available for 26% (69/263) of all SONHIA respondents: 
4% (3/69) had subtype A; 4% subtype D; 23% had recombinant subtypes; and 52% 
subtype C (table 6.12).  Viral subtype data was available for 7 men who defined 
themselves as MSM, 57% (4/7) were subtype B in keeping with the dominant subtype 
among UK MSM and supporting the high proportion of HIV acquired in the UK in this 
population as described in chapter 8. 
Figure 10.1 Geographical distribution of HIV-1 clades 
 
 
Letters indicate the predominant HIV-1 clade circulating in selected countries. A/B, B/E and B/F 
indicate co-circulation of two dominant clades; AE and AG indicate circulating recombinant forms. 
Reprinted with permission (Wainberg, 2004)  
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The diversity of viral subtypes found in SONHIA and the mounting evidence of 
differing disease progression and CD4 decline according to viral subtype suggests that 
further work is required to investigate the relationship between viral clade and clinical 
progression in the UK.  Differences in rate of CD4 decline may in part explain the high 
proportion of Africans with advanced HIV disease at diagnosis and further emphasises 
the need for increasing opportunities for earlier diagnosis and care. A clear 
understanding of the relationship between clade and CD4 decline is important in 
guiding individual clinical decisions on when to initiate HAART, and in surveillance of 
acquisition in the UK; especially as the HPA is considering moving to an estimate 
primarily based on CD4 count at diagnosis in relation to time in the UK and country of 
origin for black Africans (Rice, 2009). 
10.3.4  Surveillance 
The SONHIA data suggests that the proportion of HIV acquired in the UK by African 
migrants is substantially higher than currently acknowledged in national statistics. 
These findings have been presented to the HPA Centre for Infections. The HPA is 
currently refining its systems for recording probable country of infection, and 
preliminary analyses suggest that in London at least the proportion of HIV acquired in 
the UK is indeed higher than previously reported (Pebody, 2009). 
Currently if a heterosexual resident in the UK travelled to Africa and had sex in both the 
UK and Africa, and was subsequently found to be HIV positive, this would be classified 
by the HPA as HIV acquired in Africa. However country of residence, and not travel 
history, takes precedence in surveillance of HIV acquisition in MSM, and if the same 
scenario occurred for a gay man this would be categorised as HIV acquired in the UK 
(Rice, 2009).  This could be interpreted as inconsistent classification; Despite the 
background HIV prevalence being similar in UK MSM and black African populations  
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(Health Protection Agency, 2008c; Health Protection Agency, 2008b) the implications 
and  responsibility of the infection are located within the UK for MSM but not for 
heterosexuals.  
Surveillance of HIV incidence, sexual behaviour, and prevalence of HIV, in migrant 
African communities would enhance the ability to systematically measure, track and 
respond to endemic HIV transmission. 
10.3.4.1 Incidence  testing 
When the original proposal for SONHIA was written it included serological testing 
algorithm for recent HIV seroconversion (STARHS) (Janssen et al., 1998; McFarland et 
al., 1999). STARHS works by testing a single anti-HIV positive specimen in two 
enzyme immunoassays: a sensitive screening assay and a modified or ‘detuned’ assay to 
make it relatively less sensitive.  The sensitive assay will be positive for any HIV 
positive individual but the modified assay will only be positive in those with a fully 
developed antibody response. If the sensitive assay is positive but the detuned assay is 
not the specimen is considered to have come from an individual recently infected 
(within 129 days). At the time STARHS was not validated for non-B clade HIV-1 and 
there was concern that a proportion of non-B infections may give rise to greatly 
extended window periods.  Reviewers also felt that as the vast majority of HIV in the 
UK African population had acquired their HIV abroad the cost of this component could 
not be justified. In view of the uncertainty concerning interpretation of incidence when 
applied to the African population, and the reticence to fund this component, STARHS 
was dropped from the proposal. 
More recently the HPA has been evaluating an avidity test to measure incident HIV 
infections (Chawla et al., 2007). Avidity tests measure the strength of binding between  
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IgG antibodies and the corresponding antigen, a process that increases over a period of 
months in newly acquired infections (Thomas et al., 1996). Whilst false positive results 
do occur with advanced disease (hence need to interpret results in context with clinical 
presentation), they do not appear to be influenced by viral clade (Chawla et al., 2007). 
Currently the HPA conducts incidence testing on all tests found to be HIV positive 
through unlinked anonymous testing when the sample is identified as from a man who 
has sex with men; it is not routine practice to conduct incidence testing on samples from 
other populations (Parry, 2007). 
My work found that between a quarter to a third of HIV-positive Africans, and nearly 
half of HIV-positive African MSM, may have acquired their HIV in the UK (chapter 8), 
substantially higher than the national estimate of 8% for heterosexually acquired HIV 
among black Africans (The UK Collaborative Group for HIV and STI Surveillance, 
2007).  HIV acquisition in the UK was also associated with earlier presentation to HIV 
services. Identification of newly acquired HIV infection can provide information on 
transmission networks, epidemic dynamics, patterns of drug resistance, and guide public 
health intervention programmes (Brown et al., 2009; Fisher et al., 2007; Pao et al., 
2005). The large amount of HIV acquired in the UK among Africans in this work, 
coupled with the availability of a validated measure, supports the introduction of 
incidence testing on all HIV positive samples, regardless of risk group.  
Whilst incidence testing in conjunction with travel history would help monitor HIV 
transmission within Africans in the UK, given that many Africans have advanced 
disease at the time of diagnosis, it would only be able to detect a small fraction of new 
HIV infections and hence be unable to provide an accurate measure of incidence in this 
population. The exception to this is HIV diagnosis among women as a consequence of 
antenatal screening. Incidence testing in this latter population, in conjunction with the  
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unlinked anonymous HIV testing of pregnant women (Health Protection Agency, 2009), 
may provide a suitably large unbiased sample to determine HIV incidence rates for 
heterosexual communities. 
10.3.4.2  Sexual behaviour  
Sexual behaviour is a major determinant of sexual health, and population patterns of 
sexual behaviour are major determinants of STI and HIV transmission (Johnson et al., 
2001).  High-risk behaviours were frequently reported by African men in both the 
Natsal sample (chapter 3) and the SONHIA sample (chapter 6); these included: high 
rates of new partner acquisition, concurrency, paying for sex, and sexual partners from 
outside the UK. Almost half the men in SONHIA, and 17% of black African men in 
Natsal reported a previously diagnosed STI. 
The SONHIA findings are in keeping with those from Natsal and Mayisha II (Fenton et 
al., 2005; MAYISHA II Collaborative Group, 2005).  Compared to the white British 
population black African men have been found to have higher numbers of lifetime 
sexual partnerships, higher rates of concurrency, and are more likely to have had a 
previously diagnosed STI (Fenton et al., 2005). As may be expected in an HIV positive 
sample SONHIA found higher concurrency (58.8% vs. 34.5%), more exposure to 
commercial sex work (23.3% vs. 14.9%), and higher reporting of a previous STI 
(47.7%
17 vs. 16.2%) than in the general black African population sample (Fenton et al., 
2005; Burns et al., 2005). These differences relate to male respondents, there was little 
difference in previous STI diagnosis between black African women in the SONHIA or 
Natsal sample; concurrency was more frequently reported by women in the SONHIA 
sample (24.4% vs. 7%). 
                                                 
17 Data relates only to STIs diagnosed prior to UK due to routing error in questionnaire and lack of clarity 
as to whether STI diagnosis in UK preceded or accompanied HIV diagnosis.   
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These findings highlight the importance of understanding sexual behaviour patterns. 
The identification of high-risk behaviours within populations enables appropriate 
targeting of behavioural interventions and health promotion messages.  Although 
Africans are the second largest group affected by HIV in the UK, compared to the gay 
community there is relatively little data on the sexual attitudes and lifestyles within UK 
African communities. There is currently no regular survey of black Africans knowledge, 
attitudes or behaviours associated with diagnosed or undiagnosed HIV infection.    
10.3.4.3    HIV prevalence 
In 2007 black Africans accounted for 40% of all new HIV diagnoses in the UK, the 
majority being acquired heterosexually. An estimated 3.7% of black Africans aged 15-
59 living in England are living with diagnosed HIV compared to just 0.09% of white 
people the same age (Health Protection Agency, 2008c).  The HPA also estimates that 
32% (6300/19550) of HIV positive Africans are living with undiagnosed HIV (Health 
Protection Agency, 2008a). These estimates of the diagnosed and undiagnosed fraction 
are derived by the HPA through a range of methods including unlinked anonymous 
surveillance and the annual survey of HIV-infected persons accessing care (The UK 
Collaborative Group for HIV and STI Surveillance, 2007).  
Unlinked anonymous HIV antibody surveys are carried out in a variety of settings: 
GUM clinics, neonatal dried blood spots, pregnancy termination services, antenatal 
clinics, and specialist services for injecting drug users (The UK Collaborative Group for 
HIV and STI Surveillance, 2007; Nicoll et al., 2000). By incorporating a variety of 
services the aim is to capture those individuals at higher behavioural risk (GUM clinic 
attendees and injecting drug users) and those at lower or general risk (antenatal, 
termination and neonatal sampling). Thus the derived estimates of the prevalence of  
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undiagnosed HIV rely to a degree on how representative the users of these services are 
to the populations they represent. 
Whilst between 18 to 40% of MSM have attended a GUM clinic in the past year (Dodds 
et al., 2006), only ~20% of black Africans have attended a GUM clinic ever (Burns et 
al., 2005). In the general population the proportion of black African women utilising 
antenatal services in the past five years was 57.5% (chapter 3) however this data does 
not capture whether these services were abroad or in the UK; amongst newly diagnosed 
HIV positive African women only 15.9% had accessed antenatal services in the UK in 
the past five years, yet 69% had children (chapter 6). It is therefore possible that current 
unlinked anonymous screening may not adequately capture a representative sample of 
the migrant black African population. 
Mayisha II, the largest community-based survey of sexual attitudes and lifestyles of 
African communities in England, found an HIV prevalence of 14% using unlinked 
anonymous testing of oral fluid, with 66% of infections undiagnosed (Sadler et al., 
2007); both substantially higher than current HPA estimates. The differences may arise 
from possible over-sampling of Africans from high prevalence communities (47.0% of 
participants were from South Eastern or Eastern Africa compared to 12.8% from West 
Africa), and from over sampling of HIV positive black Africans, suggested by the high 
proportion who had ever attended a GUM clinic (42.4%) (MAYISHA II Collaborative 
Group, 2005). However, the markedly higher undiagnosed fraction suggests that there 
needs to be further research to establish with certainty the true HIV prevalence and 
undiagnosed fraction in this population.  
Providing a summary composite measure for ‘black Africans’ will mask the diversity of 
behaviours and HIV prevalences within the African communities in the UK. This is 
probably essential to minimise further stigmatisation and discrimination of those  
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communities most at risk, and to prevent a false sense of security in African 
communities at lower risk by generating a sense of ‘otherness’ (HIV is something that 
affects ‘other people’ not me or those around me). 
10.3.4.4 New migrant communities 
Despite awareness of the high prevalence of HIV in sub-Saharan Africa and increasing 
immigration from this region, UK health services were relatively unprepared for the 
impact of this population on the epidemiology of HIV within the UK. Even now 
research and effective interventions for these communities are sparse (Prost, Elford, 
Imrie, Petticrew, & Hart, 2008). Health care providers and policy makers need to be 
attuned to the prevailing international disease epidemiology, and migrant communities 
are increasingly a feature of HIV cohorts throughout Europe (Hamers et al., 2004).  
The importance of the health and welfare of migrant communities, and the impact these 
communities can have on HIV and STI epidemiology is now widely recognised.  I have 
extended my work to focus on new migrant communities and the Medical Research 
Council has funded a study on the sexual attitudes and lifestyles of London’s Eastern 
Europeans (the SALLEE project) in which I am the principal investigator (UCL News, 
2007). This study will explore the sexual and reproductive attitudes, knowledge and 
behaviours of Central and Eastern European migrants to inform policy and service 
development.  
10.3.5 Interventions 
10.3.5.1  Community level interventions 
The Department of Health has responded to the HIV epidemic among Africans in the 
UK by funding and sponsoring the National African HIV Prevention Programme 
(NAHIP) (Department of Health, 2005), and in 2008/9 the programme received  
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approximately £500,000. The African HIV Policy Network (AHPN), an alliance of 
African community-based organisations, manages NAHIP. 
NAHIP has developed a multi-agency collaborative health promotion network to take 
charge of delivering a series of national (England-wide) HIV prevention education 
campaigns and interventions (Fakoya, Atim, & Imrie, 2007). Currently very little exists 
in the way of evaluation of these campaigns and interventions, and estimates of 
intervention efficacy, impact and cost-effectiveness are derived primarily from process 
evaluations.  Evidence exists that behavioural interventions can significantly reduce risk 
behaviours in many populations.(Elwy, Hart, Hawkes, & Petticrew, 2002; Johnson et 
al., 2008; Sangani et al., 2004) To date there has not been a single rigorous evaluation 
of a HIV prevention intervention with Africans living in the UK (Ellis et al., 2003; Prost 
et al., 2008).    
With the increasing number of infections among Africans that are occurring within the 
UK, there is an urgent need to develop or adapt suitable evidence-based group and 
community level behavioural prevention interventions for effectiveness trials in the UK. 
The majority of HIV prevention interventions for African communities have focused on 
secondary prevention, with detection and intervention to control disease being the 
principal objective (NAHIP, 2009).  Both primary (the protection of health) and tertiary 
(reducing the impact of chronic disease) prevention interventions are also required.  
Care must be taken in the delivery of these programmes to ensure they are culturally 
acceptable.  The narratives of those interviewed clearly stated that HIV prevention and 
testing messages should be universal and not targeted at African communities. This 
does not mean that interventions directed at African communities should be abolished, 
rather more sophisticated and innovative audience segmentation and targeting strategies 
need to be adopted to avoid and ameliorate feelings of discrimination.   
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10.3.5.2  Interventions at the service provider level 
Since 2000 there has been a 179% increase in the number of heterosexual men and 
women seen for HIV care in the UK, the majority of whom are African (The UK 
Collaborative Group for HIV and STI Surveillance, 2005). High uptake of HIV testing 
(Fenton et al., 2002; Burns et al., 2005) and  primary care services (McMunn et al., 
1998) by African communities have been known for some time, and Sullivan et al. 
(Sullivan, Curtis, Sabin, & Johnson, 2005) reported that 17% of  newly diagnosed HIV 
positive patients had sought medical care with symptoms suggestive of HIV in the 12 
months preceding diagnosis.  
Given that Africans may not perceive themselves at risk of HIV and are unlikely to 
actively seek HIV testing it is imperative that clinicians take a more proactive approach 
on HIV.  Primary care, as discussed above, is ideally placed to more effectively screen 
for HIV, much as it does for other health conditions. Primary care clinicians can 
currently attend short training courses such as the Sexual Health in Practice (SHIP) 
(Matthews, Mullineux, Quinn, & Kelly, 2004) or the British Association of Sexual 
Health & HIV STI Foundation course.  Whilst these have been shown to increase STI 
knowledge and screening for chlamydial infections no increase in HIV testing has yet 
been demonstrated; and as attendance is voluntary and costly only those with a special 
interest in this area are likely to attend (Bailey, Dean, Hankins, & Fisher, 2008).  
Whilst improved health service research would assist in our understanding of how best 
to address clinician concerns and increase HIV testing in non specialist settings, 
financial incentives (or penalties) may also be required if the UK is to see a change in 
current practice.  Recent work has demonstrated that point of care testing for HIV at GP 
surgeries is feasible and acceptable (Prost, Wright, Anderson, Griffiths, & Hart, 2008).  
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It remains to be seen if the recent call from the Department of HIV for proposals to 
reduce undiagnosed HIV will deliver successful pilots from which to build on. 
The education and training of medical undergraduates provides an ideal forum to 
normalise HIV diagnosis and care for future clinicians of all specialities. Ideally 
medical undergraduates should observe, and potentially offer, HIV testing in a variety 
of medical settings, not just within GUM clinics.  Demystifying HIV testing for medical 
undergraduates could rapidly impact on HIV testing practices given that junior medical 
staff initiate the majority of baseline investigations in hospital settings. 
Diagnosis of HIV is a critical step in secondary and tertiary HIV prevention. However 
keeping HIV positive people engaged with services is also imperative. The SONHIA 
study found 17% (120/711) of all eligible patients were lost to follow up 12 months 
after initial diagnosis.  As discussed in chapter 6 people are lost to clinic follow up for 
multiple reasons including transferring care to other centres, dispersal/emigration, those 
unable to come to terms with their HIV diagnosis, and those who found HIV services 
unacceptable. HIV services need to develop systems to monitor and address this 
phenomenon. The NHS electronic patient record system (House of Commons Health 
Committee, 2007) currently in development may assist in delineating those retesting at 
another site (as a means of personal confirmation or disclosure), and those people 
transferring care to other centres. Other more innovative interventions will be required 
to tackle lost to follow up for other reasons. 
10.3.6 Immigration law 
Migrants with HIV generally do not seek health care for several years after arrival and 
often have advanced disease at the time of HIV diagnosis (House of Commons Health 
Committee, 2005; The UK Collaborative Group for HIV and STI Surveillance, 2007).  
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Findings supported by the SONHIA data where the average time respondents had lived 
in the UK prior to HIV diagnosis was 3.9 years, and 50% had advanced disease at 
diagnosis.  This is not consistent with ‘health tourism’ (migration specifically to access 
health services). In December 2003 the government announced plans for overseas 
visitors and failed asylum seekers to have to pay in advance for NHS services, 
specifically to discourage health tourism (BBC News, 2003). This serves as an 
additional barrier to accessing HIV services and fuels stigma and discrimination in 
already vulnerable populations.   
The Health Select Committee in 2004 found no evidence of health tourism occurring 
with regard to HIV treatment and care, and acknowledged the clear threat of untreated 
and undiagnosed HIV infection to public health (House of Commons Health 
Committee, 2005). Hence they argued that all people, irrespective of immigration status, 
should be entitled to free NHS treatment for HIV.  The findings within this thesis 
strongly support this recommendation, and it could be argued that there is a moral and 
ethical duty to provide HIV treatment to all members of our population. 
Allowing asylum seekers to work whilst awaiting immigration decisions could 
significantly improve the lives of many people.  Asylum seekers constitute some of the 
UK most vulnerable and disadvantaged groups and health inequalities, especially in 
mental health, are widely acknowledged (British Medical Association Board of Science 
and Education, 2002). Work within this thesis demonstrates the importance of placing 
health in the broader context of people’s lives.  The ability to work could help foster 
self-esteem, reduce stigma and discrimination, and may save public finance expenses on 
benefits.  
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10.4 Conclusions 
There are now almost 25,000 black Africans estimated to be living with HIV in the UK, 
significant proportions remain unaware of their HIV infection, and no reduction in late 
presentation has yet been seen (Health Protection Agency, 2008a; Health Protection 
Agency, 2008c). However, the incentive to diagnose and treat people with HIV earlier 
has never been greater: Cohort studies are consistently reporting improved life 
expectancy in HIV positive individuals accessing treatment and care (Fang et al., 2007; 
Lohse et al., 2007; Lewden et al., 2007), and for those with a CD4 count greater than 
500 cells/µl it is approaching that of the general population (Bhaskaran et al., 2008). 
Also individuals with undiagnosed infection are now believed to have a 
disproportionately large impact on onward disease transmission (Marks et al., 2006).  
This thesis presents a programme of work designed to explore newly diagnosed HIV 
infection in Africans living in London. The results of the studies presented in this thesis 
can be applied to clinical practice, surveillance methods and health promotion 
strategies.  They have been referenced in calls to reduce late presentation and the roll 
out of HIV testing to non-specialist settings; they feed into the current review of country 
of acquisition surveillance at the HPA; and have been used by NAHIP in designing 
prevention interventions.  
The key recommendations arising from this work are presented in box 10.2 
When conducting such a broad piece of work it is easy to concentrate on specific 
biomedical aspects such as HIV testing.  This reductionism enables focus on 
components amenable to intervention by clinicians and policy makers alike. However, it 
would be naïve to forget that without also making social, economic, and structural  
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changes both in the UK and abroad we are unlikely to greatly improve the lives of many 
Africans affected by HIV. 
The recently proposed Equality Bill for the first time gives public bodies, including 
health and education authorities in England and Wales, a “social economic duty” to 
consider inequalities in their service provision (Government Equalities Office, 2009; 
BBC News, 2009).  Whilst not specifically designed to meet the needs of migrant 
communities this Bill has the potential to impact on structural elements in society that 
contribute to health inequalities and help perpetuate stigma and discrimination. Other 
measures should include full entitlement to HIV treatment and care in the UK 
irrespective of residency status in keeping with other infectious diseases of public health 
importance, allowing migrants to work whilst awaiting immigration decisions, and 
continuing financial and technical support in the roll out of antiretroviral programmes 
throughout Africa. 
 
 
 
 
 
 
 
 
 
  
  287
Box 10.2 Key recommendation arising from this thesis 
Key recommendations: 
1.  Routine HIV screening in primary and secondary care setting where HIV prevalence 
exceeds 0.05 per cent. 
2.  Funding to enable full evaluation of HIV testing pilots to guide service 
development. 
3.  Normalising HIV testing through training of medical undergraduates, junior doctors 
and general practitioners.  
4.  Financial incentives to increase HIV testing.  
5.  Develop or adapt evidence based risk reduction interventions for effectiveness trials 
in African communities in the UK. 
6.  Develop systems to monitor and address loss to follow up of HIV infected 
individuals. 
7.  Fund research into impact of viral clades on drug resistance and disease progression. 
8.  Develop clear guidelines on determining country of acquisition of HIV. 
9.  Enhance current surveillance with incidence testing. 
10. Regular surveys of the sexual attitudes and lifestyles of high-risk communities, and 
further research into how to establish the true prevalence of HIV and the 
undiagnosed fraction in hidden populations. 
11.  Full entitlement to HIV treatment and care in the UK irrespective of residency 
status. 
12. Allowing migrants to work whilst awaiting immigration decisions.  
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  328Appendix 2: Topic Guide for Key Informant 
Interviews 
 
1. Introduction. 
 
•  ‘SONHIA’ is about how African people living in London view HIV, their 
experiences with health services and how this influences when people test 
for HIV.  
•  This study will help determine the factors associated with late presentation 
of HIV disease so that in the future we can target resources to better meet 
the African communities health needs. 
•  Brief outline of purpose of interview –i.e. identify the key issues facing 
health service access for African communities affected by HIV so as to be 
able to generate topic guide and questionnaire for future study.  
 
Explain: Timing 
  Confidentiality 
 
2.  Key informant particulars. 
 
• Occupation 
•  How long working in this field? 
•  How much contact with African communities in London? 
 
3. Community  Attitudes. 
 
I would like to start by asking you about what you believe are the important factors 
operating at a community level. 
 
•  What do you believe are the important influences on learning and attitudes 
about HIV amongst African communities in London? 
•  Perception of risk amongst the African communities in London? 
•  How aware of symptoms and signs of HIV prior to diagnosis do you believe the 
African communities to be? 
•  Influences on learning and attitudes health care access 
 
4.  Health Services & Service History 
 
Now I would like to focus on how the health care system itself impacts on HIV testing. 
 
•  What do you believe to be the barriers to health care access 
•  What are the success stories in terms of improving health care access for these 
communities 
•  Utilisation of Services within the UK 
-  Prior hospitalisation  
-  Primary Health Care  
-  HIV testing: barriers to uptake 
 
 
 
 
  3295.  HIV Treatment options 
 
•  Extent to which treatment options have influenced HIV presentation 
-     decision making – factor in testing decision 
-  perception in the community 
- antenatal 
•  Belief in and utilisation of other forms of therapies/healing: traditional; herbal; 
faith 
 
6.  Improvements to Services and Information 
 
Finally I would like to get your opinion on how we can improve the services and 
information available on HIV and HIV testing 
 
•  Effective forms of encouragement – to test. 
•  Improvement to information available on HIV – form and content 
•  Improvement to Services available – type, location, availability. 
•  Who should be targeted – age, type required. 
  
 
Thank interviewee 
Provide contact details  
Obtain address so as to be able to send future findings etc. 
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CONFIDENTIAL 
 
 
STUDY OF NEWLY DIAGNOSED HIV INFECTION 
AMONGST AFRICANS IN LONDON 
 
 
What is this study about? 
         This is a study about what African people living with HIV 
infection think about health services in the UK, what they think 
about HIV, and how we could improve services in the future.  
 
Confidentiality 
  The questions in this booklet are mostly personal.  Your answers will be 
treated in strict confidence; the person who gave you this questionnaire  
does not need to see them. 
 
         When you have finished, put the booklet in the envelope provided and seal 
it.  Your name will not be on the booklet or envelope. 
 
How to answer 
         Just put a tick in the box opposite the appropriate answer like this D, OR 
write in the box provided like this  
1987  
 
        Not all the questions will apply to you; follow arrows and instructions. 
         Please ask for help or explanations if you are not sure. 
 
Importance 
  It is very important to the whole study that you answer these questions 
completely honestly and as accurately as you can. 
 
  Some things may be hard to remember, so please take your time 
 
 
Unique Serial Number: 
 
 
 
 
Date:  
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Please read these notes before answering the questions. 
 
They are just to make sure everyone applies the same meaning to certain terms we 
use. 
 
 
  
Partners (sexual partners) 
 People who have had sex together – whether just once, or a few times,  
or a regular partner, or as married partners. 
 
Sexual intercourse, or ‘having sex’. 
 This includes vaginal, oral and anal sexual intercourse
1. 
 
GP (General practitioner) 
These are family or student health doctors in the UK.  They are not the 
doctors who you see when you attend Accident and Emergency, or 
hospital. 
 
 
 
 
 
 
 
 
                                                 
1 Vaginal sexual intercourse: A man’s penis in a women’s vagina. (This is what people most 
usually think of as ‘having sex’ or ‘sexual intercourse’) 
Oral sex (oral sexual intercourse): A man’s or a women’s mouth on a partner’s genital area. 
Anal sex: A man’s penis in a partner’s anus (rectum or back passage) 
  332Section A:This first section includes general questions about you, your health, 
and your family 
 
1.  Are you male or female?        Male   1  Female   2  
 
 
2.  How old are you?   PLEASE WRITE IN NUMBER     YEARS OLD   
   
  
3.  What is your nationality?        PLEASE WRITE YOUR ANSWER IN THE BOX 
 
 
4.  Which languages do you feel comfortable talking in?     Tick all that apply 
An African Language (e.g. Shona, Swahili, Yoruba)  1
   English       2
   French      3
   A r a b i c         4
   O t h e r       555 
  
  5.  What is your preferred language to read in? 
PLEASE WRITE IN BOX  
  
  6.         What is your country of birth?   
PLEASE WRITE IN BOX 
 
7.         What country(s) were you living in when you were between 10-16 years of age?  
 
                                     PLEASE WRITE IN BOX 
 
 
8.          What term best describes your racial/ethnic background? 
Black African   1 
Black Caribbean   2 
Black British    3 
Black Other    4 
Mixed     5 
White     6 
Arab     7 
Asian     8 
Other  (PLEASE WRITE IN BOX)  555 
 
   
 
 
9.  Currently are you:          Tick one only 
   Living in the UK     1 
Visiting the UK   2 
Studying in the UK   3 
  333In the UK on short term work contract  4    
Other (PLEASE WRITE IN BOX)  555
  
    
      
 
 
10.  What best describes you?   
(Remember all the information you provide is confidential and will NOT be passed on to others) 
                Tick one only 
UK Citizen       1
        E E C   M e m b e r        2
        Permanent  resident      3
                  Visa entry to UK     4 
Currently applying for a visa    5 
Asylum seeker     6 
Refugee       7 
Other        555  
 
         PLEASE WRITE IN THE BOX 
 
 
 
11.   Who do/did you rely on most for immigration advice?   Tick one only 
Solicitor     1 
Refugee Council   2 
Friends/family    3 
Citizens Advice Bureau  4 
Terrence Higgins Trust  5 
Other      555 
 
            PLEASE WRITE IN THE BOX 
 
Not relevant     888 
No one      0 
 
 
12.  When did you first begin living in the UK? (month and year)   
 
Don’t know/can’t remember    999
 Not  applicable        888
  
 
 
13.  Which of these descriptions applies to you?         
Full time college/school/training     1 
Employed full time         2 
Employed part time        3
 Unemployed/registered  for  benefits    4 
  334Unemployed/not registered for benefits  5 
        Unable to work (long-term sickness or disability)  6 
  Voluntary  work     7 
Home/family  caring      8 
 
 
 
14.  If you are employed, please write your job title in the box below. 
 
     
15.   What is your highest educational qualification?          Tick one only 
I have no formal educational qualifications        1 
O-levels/GCSEs/CSEs or equivalent  (left school at age 15/16)  2 
A-levels or equivalent (left school at age 17/18)      3 
University  Degree  or  higher        4 
555  Other, such as vocational or professional qualifications   
PLEASE SAY WHAT IN BOX  
 
 
 
 
16.   Do you own or rent the place where you currently live?     Tick one only 
Own – outright or with a mortgage / loan    1 
Rent – housing association/council      2 
Rent – private landlord        3 
Tied to your job          4 
Live with friends and/or relatives      5 
Bed and breakfast /hostels/homeless     6 
Not  applicable        888 
Other   (PLEASE WRITE IN BOX BELOW)     555 
 
 
 
 
17.   What is first part of your postcode?       
            (Example: for SW3 5BP write SW3) 
Don’t know    999 
Not applicable   888 
 
 
18a.   Do you have a solicitor?   Yes  1  No  0 
           
 
GO TO Q19
 
 
b.   If yes, for how long have you had a solicitor?     MONTHS  OR     YEARS 
 
 
 
 
  33519a.   Do you have a GP (family doctor) in the UK?   
Yes  1 No  0 
           
 
b.   If yes, for how long have you had a GP?        MONTHS  OR              YEARS 
GO TO Q20 
 
 
 
 
20a.   Do you attend any community or sports groups? 
        Y e s   1 No   0     GO TO Q21
 
    
b.  If yes, which one(s)?    
     PLEASE WRITE IN BOX 
 
 
 
21a.    What  is  your  religion?        Tick one only 
None        1 
Christian –   Roman Catholic    2 
Church of England/Anglican      3 
B a p t i s t         4 
Protestant       5 
Other  Christian     6 
Islam/Muslim       7 
     O t h e r     ( PLEASE WRITE IN BOX BELOW)    555 
 
 
 
b.   How important is your faith/religion to you?     Tick one only 
Very important     1 
Important       2 
Neither important nor unimportant  3 
Not at all important    4 
 
 
 
 
c.   Apart from special occasions (eg. weddings, funerals) how often do you attend 
s e r v i c e s ?                   Tick one only 
Once a week or more   1 
Once a month or more  2 
Twice a year      3 
Once a year      4 
Never/practically never  0 
 
 
GO TO Q23 
  33622a.   Do you use the Internet?   Yes  1 No  0 
 
 
b.   If yes, how often do you use the internet?        Tick one only 
      M o s t   d a y s       1
      At  least  once  a  week     2 
      Several  times  a  month   3 
      Monthly  or  less  often       4  
  
23.    At  present  are  you…        Tick one only 
Married (and living with your (wife/husband))  1 
Living with your partner as a couple    2 
In a relationship, but living apart    3 
Widowed       4 
Divorced       5 
Separated       6 
Single and never been married    7
   
 
Remember all the information you provide is confidential and will NOT be passed on to other 
people. 
 
24.   Is your partner (boyfriend/girlfriend/wife/husband) HIV….?      Tick one only 
           Positive   1 
           Negative    2 
           U n t e s t e d     3 
           D o n ’ t   k n o w     999 
              I do not have a partner at present  0 
 
 
25a.   Do you have, or have you had, any children of your own that you are the natural 
parent of? Please include any who don’t now, or never did, live with you as part of your household. 
         
GO TO Q26  Yes  1 No  0 
 
 
 
b.   If yes, how many children have you had?        Please include any stillbirths or  
                       children who may  have died  
 
 
c.  In what year and country were your children born?  
 
Child  Year of birth  Please tick 
if born in UK
Child  Year of birth  Please tick if 
born in UK 
1     4     
2     5     
3     6     
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26.   In general would you say that your health 12 months ago was?  Tick one only 
       Excellent     1 
       Very  good     2
       F a i r       3 
       P o o r       4 
       T e r r i b l e     5 
 
27.   In general would you say your health now is?      Tick one only 
      E x c e l l e n t       1 
      Very  good      2
      F a i r        3 
      P o o r        4 
      T e r r i b l e      5 
 
 
 
28.   If you suffer from poor health now, how long have you suffered poor health (if at 
a l l ) ?                     Tick one only 
      More  than  5  years     1 
      1 -   5   y e a r s       2 
      6  -  12  months      3 
      Less  than  6  months       4 
      N o t   a t   a l l               0 
 
 
29a.   In the two years before you were diagnosed with HIV did you visit a GP 
(family doctor)?     
Yes  1 No  0    GO TO Q30 
 
 
 
b.   If yes, why did you visit a GP?              Tick ALL that apply
   
For contraception or pregnancy  1 
The flu or chest infection    2 
Skin  condition      3 
Minor  Injury      4 
Child vaccination or child unwell  5 
Other (PLEASE WRITE IN BOX BELOW)  555 
    
 
 
 
 
 
 
 
  33830a.   In the last five years or so, have you had any illness or accident (apart from 
HIV) that has affected your health for at least 3 months?    
   
     Y e s   1 No  0   GO TO Q31 
 
  
b.   If yes, what illnesses or accidents have you had?   PLEASE WRITE IN BOX BELOW 
 
 
 
 
31a.   In the year before you were diagnosed with HIV did you visit a hospital 
outpatient department/centre? (APART FROM STRAIGHTFORWARD ANTE- OR 
POSTNATAL VISITS) 
 
     Y e s   1 No  0   
GO TO Q32 
   
   
 
b.   If yes, why did you visit the hospital outpatient department/centre?  
PLEASE WRITE IN BOX 
   
 
 
c.   Where did you visit hospital outpatient centres in the past year?  Tick all that apply 
 UK     1 
Africa     2 
Elsewhere   3 
32a.   In the year before you were diagnosed with HIV were you ever admitted  
(overnight or longer) to a hospital? EXCLUDE VISITS FOR PREGNANCY    
     Y e s   1 No  0   GO TO Q33 
 
 
b.   If yes, why were you admitted to hospital?  (PLEASE WRITE ANSWER IN BOX BELOW) 
 
 
 
c.   Where were you admitted to hospital?          Tick all that apply 
  U K      1 
Africa     2 
           E l s e w h e r e    3 
 
33a.   In the last five years have you attended an ante-natal clinic or ante-natal 
service at a hospital or at your GP’s (family doctor) in the UK because you were 
pregnant? 
     Yes  1 No  0    GO TO Q34 
 
 
b.   If yes, for how many pregnancies? 
  339 
34.   In the last 2 years who have you had sex with?      Tick one only 
       M e n       1 
       W o m e n     2 
       B o t h   m e n   a n d   w o m e n     3 
       Not  had  sex  in  last  2  years  0 
 
 
35.  How do you describe your sexuality?                 
Tick one only 
Heterosexual (person who prefers sex with someone of the opposite sex)  1 
Homosexual  (person who prefers sex with someone of the same sex)  2 
Bisexual (person who likes sex with people of either sex)      3 
O t h e r               555 
 
 
  340Section B: These questions are about you BEFORE you were diagnosed HIV 
positive. 
 
1a.  Have you ever had a negative  H I V   t e s t ?        
        Yes  1  No           0 
          D o n ’ t   k n o w   999    
 
b.   If yes,  how many negative tests have you had?       TIMES 
 
 
c.   When was your last negative HIV test?   (month and year) 
 
d. Where was your last negative HIV test? 
      I n   A f r i c a        1 
          In a UK sexual health (GUM or STD) clinic  2 
     In a UK antenatal clinic      3 
     Elsewhere  in  the  UK      4 
     E l s e w h e r e        5 
 
 
2a.   How often did you see a GP (family doctor) in the 12 months before your HIV 
diagnosis?  
      TIMES OR NONE  0 
GO TO Q3
GO TO Q2 
 
 
b.   Did the GP (family doctor) ever mention HIV testing?     
  
Yes      1 
No      0 
Don’t know      999 
        
  
 
3.   How long had you been in the UK before you knew where to go to have an HIV 
test?  
          Tick one only 
     Less  than  6  months    1 
     6  to  12  months   2 
     Between  1  and  2  years  3 
     Between  2  and  5  years  4 
     More  than  5  years    5 
                       
     
4.   In the UK how did you find out where to have an HIV test?    Tick one only 
     From  a  GP  (family  doctor)     1 
     The  Media  (radio,  magazines,  newspapers)  2
     I n t e r n e t       3
  
  341     P a r t n e r ( s )        4
     Friends  or  family      5
     HIV  organisations  (THT,  IVO)     6 
     Pastor/Religious  minister/Church    7 
          It was offered to me whilst in hospital    8
     O t h e r   (PLEASE WRITE IN THE BOX BELOW)   555
  
      
        
 
 
5a.   Before your HIV diagnosis did you ever try but were unable to have an HIV 
test? 
        Y e s   1  No           0 
GO TO Q6 
          D o n ’ t   k n o w   999    
 
 
b.  If yes why were you not able to have an HIV test?       
        Tick ALL that apply 
The doctor did not offer it      1 
No appointments available      2 
I did not know where to go      3 
I was unable to get to the clinic     4 
No one was able to look after my children  5 
The clinic was not open when I could go  6 
Other   (PLEASE SPECIFY  IN BOX)     555 
   
 
 
 
 
6.  Before  you tested HIV positive what type of person did you think got HIV?  
         Tick ALL that apply 
     Anybody       1 
          People who do not believe in God    2 
          Only people who sleep with lots of people  3 
          Only people who have sex in Africa    4 
     Drug  addicts         5 
     G a y   m e n        6 
     O t h e r     (PLEASE WRITE IN THE BOX BELOW)   555
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7a.   Before being HIV positive can you remember discussing HIV with anyone?  
  
GO TO 8 
Yes  1   No  0   
 
 
b.    If  yes,  who?                Tick ALL that apply 
My partner/husband/wife      1 
HIV positive people/friends      2 
Friends      3 
Health care professional      4 
Counsellor       5 
I don’t like to talk about HIV issues    6 
Internet / Chatlines        7 
Advice  Helplines      8 
Don’t  know       999 
Other  (PLEASE WRITE ANSWER IN BOX BELOW)  555 
   
 
8.   Before testing HIV positive how many people did you know that were HIV 
p o s i t i v e ?           Tick ONE only 
0     1 
1     2 
2-4     3 
5 or more    0 
Don’t know    999 
  
 
9.   In the UK what were your sources of information about HIV, before testing HIV 
positive?                                 Tick ALL that apply 
     Health  Care  Workers  (e.g.  doctor/nurse) 1  
HIV positive friends        2 
     Other  friends       3 
     T h e   M e d i a        4
     HIV positive press        5 
     I n t e r n e t       6 
     P a r t n e r ( s )        7
     HIV  organisations  (THT,  OPAM)    8
    Pastor/Religious  minister/Church/Mosque    9
     Other  (PLEASE WRITE IN BOX BELOW)    555
     None        0
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your MAIN source of information about HIV? 
Tick ONE only 
     Health  Care  Workers  (e.g.  doctor/nurse) 1  
HIV positive people/friends      2 
     Other  friends       3 
     The  Media       4
     HIV  positive  press      5 
     I n t e r n e t       6 
     P a r t n e r ( s )        7
     HIV  organisations  (THT,  OPAM)    8
    Pastor/Religious  minister/Church/Mosque    9
     O t h e r   (PLEASE WRITE IN BOX BELOW)   555 
     None        0 
 
 
 
11.  Did you know that HIV testing would be free in the UK when you first arrived in 
the  UK?       Yes  1 No  0 
 
 
12.   Did you know that Doctors are legally obliged to respect your confidentiality and 
not inform others of your HIV infection before your HIV test?  
Yes  1 No  0 
 
13.   How important were each of the following reasons in preventing YOU 
from testing earlier. 
 
PLEASE ANSWER (a)-(g) BY TICKING 
ONE BOX ON EACH LINE 
 
Very 
important 
 
Important 
Neither 
important or 
unimportant 
Probably 
not 
important 
Definitely 
not 
important 
a. Distance to health services  1  2  3  4  5 
b. Personal financial resources  1  2  3  4  5 
c. Level of knowledge about      
HIV/AIDS in the community 
 
1 
 
2 
 
3 
 
4 
 
5 
d. Stigma or shame within the        
African community in the UK 
 
1 
 
2 
 
3 
 
4 
 
5 
e. Lack of employment 
opportunities for HIV positive 
people 
 
1 
 
2 
 
3 
 
4 
 
5 
f. Having to go to a sexual health 
clinic  
1  2  3  4  5 
g. The assumption that all HIV is 
spread sexually.  
 
1 
 
2 
 
3 
 
4 
 
5 
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The next few questions are about your sexual health. Some of the questions are 
quite personal but remember this questionnaire is completely confidential. Again 
these questions relate to the time BEFORE you tested HIV positive. 
  
14a.   Since moving to the UK and before being diagnosed HIV positive have you 
returned to Africa? 
     Y e s   1 No  0   
GO TO Q15 
 
 
b.   If yes, in what year did you last visit?      YEAR   
 
c.   Which country(s) did you visit? 
   
 
d.   Thinking of this time when you visited Africa did you have sexual intercourse  
with any  people for the first time whilst you were there? 
Yes  1 No  0    GO TO Q15
 
e.   Did you use a condom with these new sexual partners? 
    Yes,  used  on  every  occasion    1 
Yes, used on some occasions  2 
No, not used        3 
     N o t   s u r e         4 
 
15a.   Now thinking of the time since you moved to the UK and before being 
diagnosed HIV positive how many people did you had sexual intercourse with 
in the UK?           
  
 
b.   Was a condom used?   Yes, used on every occasion   1 
Yes, used on some occasions  2 
No, not used        3 
     N o t   s u r e         4 
Not had sex since moving to UK  0 
 
16.  In the past year how many people have you had sexual intercourse with?  
 
 
b.   Was a condom used? 
    Yes,  used  on  every  occasion    1 
Yes, used on some occasions  2 
No, not used        3 
     N o t   s u r e         4 
Not had sex in past year    0 
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17a.  Have you ever paid (or given gifts) for sex? 
             Yes  1 No  0   
GO TO Q18 
 
 
b.   Where was this?    Tick ALL that apply 
In the UK    1 
In Africa    2 
Elsewhere   3 
 
18a.   Have you ever been paid (or received gifts) for sex?   
    Yes  1 No 0    GO TO Q19 
 
 
b.   Where was this?    Tick ALL that apply 
In the UK    1 
In Africa    2 
Elsewhere   3 
19a.   Before moving to the UK, had you ever been told by a doctor that you had any 
of the following? (Please tick each that applies, or tick none (the last box))   
          b) When was  
a)Tick if     the last time? 
    ‘ YES ‘           (year) 
  
Herpes (genital herpes)      1               
Trichomonas (Trich, TV)      2               
Gonorrhoea       3             
Syphilis      4             
C h l a m y d i a        5             
NSU (non specific urethritis)      6             
Genital warts (veneral warts,  HPV)    7             
Thrush (Candia, yeast infection)    8             
Women only:  
Pelvic inflammatory disease (PID)     9                 
Bacterial vaginosis (BV)      10             
A sexually transmitted infection  
but cannot remember it’s name     11             
None  of  these       0     GO TO Q20 
 
b.   Was HIV or HIV testing mentioned at the time you were told you had the above 
infection(s)?    Yes  1 No  0    Don’t know  999 
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20a.   Since moving to the UK, had you ever been told by a doctor that you had any 
of the following? (Please tick each that applies, or tick none (the last box))    
       b) When was  
a)Tick if     the last time? 
    ‘ YES ‘           (year)   
Herpes (genital herpes)      1               
Trichomonas (Trich, TV)      2             
Gonorrhoea       3             
Syphilis      4             
C h l a m y d i a        5             
NSU (non specific urethritis)      6             
Genital warts (veneral warts,  HPV)    7             
Thrush (Candia, yeast infection)    8             
Women only:  
Pelvic inflammatory disease (PID)     9               
Bacterial vaginosis (BV)      10             
A sexually transmitted infection  
but cannot remember it’s name     11             
None  of  these       0     GO TO Q21 
 
 
b.   Where were you treated for this condition(s)?          Tick ALL that apply 
                           At a GP surgery  1 
At a Sexually Transmitted Disease clinic (STD or GUM clinic)  2 
Somewhere else  3 
 
 
c.   Was HIV or HIV testing mentioned at the time you were told you had the above 
infection(s)?    Yes  1 No  0      Don’t know  999 
 
 
 
21a.  Did any advertising influence your decision to have a HIV test? 
Yes  1 No  0      Don’t know  999 
 
b.  If yes, in what form was this advertising? 
Radio       1 
Magazine      2 
Health or HIV publication    3 
Leaflet       4 
P o s t e r        5 
T V        6 
Other  (PLEASE SPECIFY IN BOX BELOW)  555 
 
  347Section C: This section is about your experiences of BEING diagnosed HIV 
positive. 
 
1.  When, if ever, were you first diagnosed HIV positive in Africa? 
  
       YEAR     OR      I was not diagnosed with HIV in Africa  0 
 
 
2.  When were you first diagnosed HIV positive in the UK?     
    (month and year)            
  Don’t  know  999 
 
 
3.   Where were you first diagnosed with HIV in the UK?     Tick ONE only 
      In a Sexual Health Clinic (GUM/STD/HIV clinic)      1 
     At  a  GP  (family  doctor)        2 
      In hospital (on a ward or outpatient clinic)        3 
  In  an  ante-natal  clinic         4 
  Other/None  of  the  above  (PLEASE SAY WHERE IN BOX BELOW)  555 
 
 
 
 
4.   What was the main reason for you having your last HIV test?   Tick ONE only 
A hospital or clinic doctor advised me to test       1 
I had health complaints that I thought may be related to HIV    2 
I was advised to by my GP (family doctor)      3 
I had sexual contact with someone known or thought to have HIV  4 
My child tested HIV positive        5 
It was related to pregnancy of my partner or myself     6 
It was part of a routine check up       7 
It was part of insurance, mortgage, or visa requirements    8 
   Other  (PLEASE WRITE IN BOX BELOW)        555 
 
5.   Were you expecting the positive result?   
        Y e s   1 No  0 Don’t  know  999 
 
6a.   When did you first think you became HIV positive?                YEAR 
 
 
 
 
 
 
 
  348b.   Why do you think this is when you became HIV positive?     
      I had sex with someone now known to be HIV positive  1 
      I had sex with someone at high risk of HIV      2 
   I  was  raped/sexually  assaulted      3 
   I  started  being  unwell        4 
   I  had  a  blood  transfusion       5 
      I was given an injection or vaccination      6 
      Other   (PLEASE WRITE IN BOX BELOW)      555 
 
 
 
    
 
  7.  What stopped you testing for HIV earlier? 
                           Single most              
                           important   
                       r e a s o n  
         Tick ALL        Tick ONE  
         that apply               only 
  I had not considered the possibility that I may be HIV positive  1   1 
  I was well so no need                1   2 
            I did not know where to go for a test         1   3 
            I was afraid of the result          1   4 
            I was afraid of the stigma associated with HIV         1   5 
            I was afraid it might influence my immigration application       1   6 
            Fear of losing a relationship             1   7 
            I did not want to ask my GP (family doctor)         1   8 
            I did not want to attend a sexual health centre         1   9 
            Other reason (PLEASE WRITE IN THE BOX BELOW)           1   555 
 
 
 
 
 
 
 
8.  What would have made you test for HIV earlier?  
                                Single most        
                               important  
                                reason 
         Tick ALL        Tick ONE  
         that apply               only 
If someone had told me that I was at risk    1   1 
If I felt that I would be supported if I tested positive  1   2 
If there was no stigma associated with HIV    1   3 
If HIV was not so linked to sex        1   4 
If I had known there were medicines available    1   5 
If I had known you could make it less likely  
for babies to become infected    1   6 
        Other reason (PLEASE WRITE IN THE BOX)     1   555 
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positive. 
1.   Who have you told that you are HIV positive? (TICK ONCE ON EACH LINE)   
          YES NO  NOT  RELEVANT 
            A S   I   D O   N O T   H A V E   O N E  
      Your  partner     1  0  888 
        Your GP (family doctor)  1  0  888 
      Your  mother     1  0  888 
      Your  father     1  0  888 
      My  solicitor     1  0  888 
      Social  services   1  0  888 
          ALL SOME  NONE  NOT  RELEVANT 
      Your  children     1  2  0  888 
      Your  brothers/sisters    1  2  0  888 
      Your  friends     1  2  0  888 
      Your  work  colleagues    1  2  0  888 
      Your  ex  partners    1  2  0  888 
 
 
2.   With whom are you most likely to talk about HIV issues?           Tick ALL that apply 
My partner/husband/wife      1 
HIV positive friends        2 
Other  friends       3 
Health care professional      4 
Counsellor       5 
I don’t like to talk about HIV issues    6 
Anyone who cares to listen      7 
Internet / Chatlines        8 
Advice  Helplines      9 
Don’t  know       999 
Other  (PLEASE WRITE ANSWER IN BOX BELOW)  555 
 
 
 
 
3.  Do you think the internet would be a good place to obtain information about HIV 
services in the UK?       
Yes  1         No 0     Don’t know  999 
 
4.  If you knew HIV testing was free and confidential at sexual health clinics would 
you have tested earlier?  
Yes  1         No 0     Don’t know  999
  
 
5.   If you knew HIV testing was free and confidential at sites other than sexual 
health clinics would you have tested earlier?  
Yes  1         No 0     Don’t know  999 
  3506.   If you had known that anti-HIV medicines may stop you getting sick or of dying 
from HIV/AIDS would you have tested earlier?    
Yes  1         No 0     Don’t know  999 
 
7.   If there was a cure for HIV would you have tested earlier? 
Yes  1         No 0     Don’t know  999 
 
 
7.  Would most people you know have an HIV test if they thought they  
were at risk of HIV? 
Yes  1         No 0     Don’t know  999 
 
 
9.   How many people that you know have had an HIV test?    Tick ONE only 
Most   1 
A few    2 
None   3 
Don’t know  999 
 
 
10.   What do you see as the benefits of knowing your HIV status?    
               Which of these  
               i s   t h e   s i n g l e      
 most  important  
 benefit 
         Tick ALL        Tick ONE  
         that apply               only 
  It’s a weight off my shoulders         1   1 
I can prevent spreading HIV to others      1   2 
I could take medicines to reduce the chance of my baby  
becoming infected with HIV        1   3 
I can take medicines to keep me healthy and alive longer  1   4 
It has provided me social support        1   5 
It helps with future planning for myself and family    1   6 
It gives me control over my own health      1   7 
None          1   8 
O t h e r           1   555 
  PLEASE WRITE IN THE BOX 
   
 
 
 
11.   What do you see as the main reasons not to have an HIV test? 
Which of these 
is the single  
most  important 
reason 
         Tick ALL         Tick ONE  
         that apply         only 
Discrimination within my community      1   1 
Discrimination in my job        1   2 
Makes it difficult to plan a family      1   3 
  351More likely to be deported        1   4 
Insurance and mortgage difficulties      1   5 
No point as nothing can be done about HIV    1   6 
No point as God will protect me      1   7 
Knowing makes you ill        1   8 
Fear         1   9 
O t h e r          1   555
  
 
PLEASE WRITE IN THE BOX 
 
 
12.   Do you access any HIV support groups (eg. Body & Soul, IVO)? 
Yes  1         No 0     Don’t know  999 
 
 
13a.   Do you use any traditional or herbal medicines to improve your health?   
      Y e s   1 No  0  GO TO Q14 
 
 
b.   If yes, what for? (PLEASE WRITE ANSWER IN BOX BELOW) 
 
 
c.   When was the last time you used traditional or herbal medicines?    Tick 
one only 
     In  the  last  7  days?      1 
          Between 7 days and 4 weeks ago    2 
     Between  4  weeks  and  1  year  ago    3 
Longer than 1 year ago      4 
 
d.   For how long have you used traditional or herbal medicines? 
(PLEASE WRITE ANSWER IN BOX)   
   
 
 
 
14a.   Do you believe that faith alone can  cure  HIV?      
Yes  1         No 0     Don’t know  999 
 
 
b.  Do you believe that taking anti-HIV medicines implies a lack of faith in God? 
Yes  1         No 0     Don’t know  999
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Section E: These questions are about the future. This is the final section. 
1a.   Do you feel you can trust the staff at your HIV clinic/hospital?    
    Y e s   1         No 0     Don’t know  999 
 
b.  If not, what are your main concerns?  
 
Links with other government departments (e.g. immigration)  1 
Lack of confidentiality (e.g. in the clinic, misdirected mail)    2 
Disclosure of HIV status to others          3 
Discrimination          4 
Lack of knowledge about HIV           5 
Behaviour and attitudes of reception staff        6 
Other      (PLEASE WRITE IN THE BOX BELOW)      555 
       
   
 
 
 
 
2a.   Do you feel you can trust the staff at your GP (family doctor) surgery? 
  
    Y e s   1         No 0     Don’t know  999 
 
b.  If not, what are your main concerns?  
Links with other government departments (e.g. immigration)  1 
Lack of confidentiality (e.g. in the clinic, misdirected mail)    2 
Disclosure of HIV status to others          3 
Discrimination          4 
Lack of knowledge about HIV           5 
Behaviour and attitudes of reception staff        6 
Other      (PLEASE WRITE IN THE BOX BELOW)      555 
       
   
 
 
 
3.   Who else, if anyone, do you feel you can trust?  (PLEASE WRITE ANSWER IN BOX 
BELOW) 
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4.   These next few questions are about people’s reactions and attitudes to HIV. 
 
 
PLEASE ANSWER (a)-(f) BY TICKING ONE  
BOX ON EACH LINE 
 
Strongly 
agree 
 
 
Agree 
 
Neither 
agree nor 
disagree 
 
 
Disagree 
 
Strongly 
disagree 
a. Most partners of people who are 
HIV+ would leave if they knew about 
the HIV 
 
1 
 
2 
 
3 
 
4 
 
5 
b. If my family knew about my HIV they 
would stand by me and support me 
 
1 
 
2 
 
3 
 
4 
 
5 
c. If my friends knew about my HIV 
they would stand by me and support 
me 
 
1 
 
2 
 
3 
 
4 
 
5 
d. People who are HIV+ are at risk of 
isolation if their church/mosque finds 
out about their diagnosis 
 
1 
 
2 
 
3 
 
4 
 
5 
e. There is a sense of personal failure 
associated with being diagnosed HIV+ 
 
1 
 
2 
 
3 
 
4 
 
5 
f. Being diagnosed HIV+ is a source of 
shame for family in Africa 
 
1 
 
2 
 
3 
 
4 
 
5 
 
 
 
5.   Please assess how much you agree with the following statements. 
 
 
PLEASE ANSWER (a)-(e) BY TICKING ONE  
BOX ON EACH LINE 
 
Strongly 
agree 
 
 
Agree 
Neither 
agree nor 
disagree 
 
 
Disagree 
 
Strongly 
disagree 
a. HIV causes AIDS  1  2  3  4  5 
b. HIV is a disease created by white 
people 
1  2  3  4  5 
c. The medicines available work just as 
well on black people as on white 
people 
 
1 
 
2 
 
3 
 
4 
 
5 
d. The NHS meets the needs of African 
patients 
 
1 
 
2 
 
3 
 
4 
 
5 
e. The NHS system treats African 
patients as fairly as other patients 
 
1 
 
2 
 
3 
 
4 
 
5 
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Other comments  
 
Did you feel able to answer all the questions honestly? 
Yes  1 No  0 
 
If not which questions were difficult to answer honestly? 
 
 
 
 
We are very interested in your thoughts about this questionnaire.  If you have any 
comments on particular questions asked, the way the questionnaire was written, or 
anything else about the questionnaire, then please write them in the box below. 
 
   
 
 
 
 
 
 
 
If there is anything else you would like to tell us about your experiences of HIV or 
health services in the UK please do so here. 
 
   
 
 
 
 
 
 
 
 
 
 
THANK YOU VERY MUCH FOR YOUR HELP 
Please check you have answered all the questions that apply to you and then 
put this questionnaire back in the envelope provided. 
 
Results of this study will be published and made available at your clinic. As the study is 
recruiting new patients until June 2005 the results will not be available until after this 
date.   
If you would like to know more about the study or to find out about the results  
please contact Dr Fiona Burns on 0207 387 9300 ext. 8970. 
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        SONHIA 
       Study Of Newly diagnosed HIV Infection amongst  
Africans in London  
 
   CLINICAL DATA FORM 
 
NOT TO BE GIVEN TO RESPONDENT 
 
To be completed using patient database and case records. 
 
 
Unique Serial Number: 
(Attach sticker) 
 
 
Date:      Clinic  Number 
     (or  attach  clinic  label) 
  
 
a.  DOB:  / /   
   
b.  Gender: Male           Female    
 
c.  Country of birth: _______________________________ 
 
Information from time of first diagnosis: 
 
d.  Date HIV diagnosis:  / /  
 
e.  CDC Classification at time of HIV diagnosis:   (see classification below) 
 
f.  CD4 at time of HIV diagnosis:  x 10
6 
 
g.  Viral load at time of HIV diagnosis: ____________ copies/ml 
 
h.  Was a primary resistance test taken around the time of first diagnosis? 
Yes       No      Don’t know   
 
i.  If yes, was primary resistance detected? Yes       No      Don’t know   
 
i.  Was there evidence that this patient was seroconverting or had incident infection  
      (a positive detuned assay) at the time of diagnosis?  
           Y e s         No      Don’t know   
  356Complete at six months post diagnosis*: 
 
a.  CDC Classification at 6 months:            Not applicable      
 
b.  CD4 count at 6 months*:      x 10
6           Not applicable      
 
c.  Viral load at 6 months*: ___________ copies/ml           Not applicable      
 
*Please provide results from bloods taken as close to 6 months post diagnosis as 
possible and give date bloods taken here       / /  
 
d.  Has viral typing been performed on this patient? 
Yes       No      Don’t know    
e.   If yes, what was the result? __________________ 
 
f.  Date first AIDS diagnosis:  / /        Not applicable   
 
g.  Please list all AIDS defining illnesses (ADI) within first 6 months:   
         Not applicable    ADI (see below for code) 
 
 
 
 
 
h.  Has the patient taken any anti-retrovirals since diagnosis?    Yes      No   
i.  Date of death:  / /               Not applicable   
 
Codes for AIDS Defining Illnesses 
1=Recurrent Bacterial pneumonia   11=CMV retinitis    21=Other  
2=Lymphoma     12=CMV  other 
3=Oeso.  Candida    13=Toxoplasmosis    
4=PCP      14=TB  pulmonary 
5=PML      15=TB  disseminated   
6=Cryptococcosis    16=HSV 
7=Crptosporidiosis/Isoporiasis   17=Wasting  Disease   
8=Mycobacteriosis    18=KS  mucocutaneous 
9=Cervical  cancer    19=KS  visceral    
10=Salmonella septicaemia    20=HIV encephalopathy/ADC 
CDC Classification  List as A1, B2 etc. 
Category A – documented HIV infection, asymptomatic –  includes PGL and acute seroconversion. 
Category B – symptomatic, conditions not in category C 
Includes: recurrent thrush (oral and vulvovaginal), mod to severe cervical dysplasia, fever (38.5) or 
diarrhoea greater than 1 month, OHL, herpes zoster (shingles) greater then 1 episode or more than 1 
dermatome, ITP (thrombocytopenia), PID and peripheral neuropathy. 
Category C – AIDS defining conditions  
Category 1 – CD4+ greater or equal to 500 or 29% 
Category 2 – CD4+ equal to 200 – 499, or 14-28% 
Category 3 – CD4+ less than 200, or 14% 
 
Thank you 
Please keep these forms on site and notify Dr Fiona Burns, ph. 02073879300, 
email: fburns@gum.ucl.ac.uk, to come and collect. 
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Key informant interviews 
 
University College London 
13/06/03 
 
SONHIA : 
Study of Newly diagnosed HIV Infection amongst Africans in London. 
 
Information Sheet 
 
As an individual with extensive experience in the area of HIV and sexual health, 
working with African communities, or in health service access, we are asking you to 
help in the development of a research study’s instruments. The study is to find out more 
about African people who are diagnosed with HIV. Before you decide it is important for 
you to understand why the research is being done and what it will involve.  Please take 
the time to read the following information carefully. If there is anything that is not clear 
or if you would like more information on, please ask.  Take time to decide whether or 
not you wish to take part. Thank you for reading this. 
What is the purpose of the study? 
HIV/AIDS among Britain’s African communities is a major public health concern, yet 
to date relatively little research has focused on this group. Africans with HIV often have 
delayed presentation and poor uptake of health services compared to non-Africans. This 
can result in poorer health, both physical and psychological, as well as greater economic 
costs to the health service. Many opportunities for earlier diagnosis and treatment of 
HIV/AIDS among Africans are missed. The study aims to describe the health beliefs, 
heath care utilisation and clinical presentation patterns of newly diagnosed HIV positive 
Africans in London. We hope to use this information to identify ways to prevent 
progression to AIDS in the future, as well as in the development of culturally 
appropriate health promotion and disease prevention initiatives.  Recruitment to the 
study will run for 18 months starting in October 2003. 
The specific aims and objectives of the study are: To describe the health beliefs, heath 
care utilisation and presentation patterns of newly diagnosed HIV positive Africans in 
London in order to inform the development of culturally appropriate HIV prevention 
interventions.   
Specific objectives:  
To describe the demographic characteristics, migration history, HIV/sexual health history, 
patterns of service utilisation and  levels of psycho-social support among this group.  
To determine the extent to which acquisition of their infection may have occurred within the 
UK, and in so doing, determine opportunities for earlier diagnosis of their HIV disease.  
To determine the factors associated with delayed presentation (CD4<200) to treatment services 
  358To explore in a qualitative study, the contextual, social and economic factors, which influence 
timely access to and uptake of HIV prevention and treatment. 
 
Why have I been chosen? 
Because you are an individual with extensive experience in the area of HIV and sexual 
health, working with African communities, epidemiology, or in health service access.    
Do I have to take part? 
No. It is up to you to decide whether or not to take part.  
 
What do I have to do? 
An informal face to face interview will be requested and if granted conducted at the 
venue of your choice. The semi-structured interview will be used to identify the key 
issues facing health service access for African communities affected by HIV. Clinical 
practice, other than how policy and the structure of health services affect it, will not be 
discussed.  
 
Will my taking part in this study be kept confidential? 
Yes. All information which is collected during the course of the research will be kept 
strictly confidential. The information you provide will be used to help develop the topic 
guide and questionnaire. 
 
What will happen to the results of the study? 
You have the option of reviewing the instruments (topic guide and questionnaire) once 
they have been developed and will be fully informed of the studies findings. Results of 
the study will be published in leaflets that will be available in the clinics.  They will also 
be written up for publication in journals, and relevant information fed back to the 
African communities and relevant organisations.  Preliminary results should be 
available in June 2004, and final results by October 2005.  
 
Who is organising and funding this research? 
This research is funded by a Wellcome Training Fellowship grant.  Dr Fiona Burns is 
the person organising the study and is responsible for all the data.  Ethical approval for 
this study has been attained from both the Multi-centre and your local Research Ethics 
Committee. 
 
Thank you very much for taking the time to help. 
 
Contacts for further information: 
Dr Fiona Burns    Ph. 0207 3879300 ext.8970 
 
Research Team:   Dr Fiona Burns, Dept. of STDs, UCL 
Dr Kevin Fenton, Dept. of STDs, UCL 
Dr James Nazroo, Dept. of Epidemiology & Public Health, UCL 
Prof. Anne Johnson, Dept. of Primary Health Care & Population  
Sciences, RFUCMS, UCL 
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      SONHIA 
                     Study Of Newly diagnosed HIV Infection amongst Africans in London 
 
Information Sheet for Questionnaire 
 
We are asking you to be involved in a research study to find out more about African 
people who are diagnosed with HIV in the UK and how we can improve health services 
for them. Before you take part it is important to understand why this work is being 
done.  Please take the time to read the following information and discuss it with others 
if you wish. Please ask us if anything is unclear or you have any concerns.  Take time to 
decide if you want to take part or not.  
 
What is the purpose of the study? 
 
HIV/AIDS is an important health problem among Britain’s African communities. 
Africans with HIV tend to wait a long time before they seek help from the NHS. This 
often means they are too unwell to benefit from all the new treatments and services 
available for people with HIV. We know that earlier diagnosis and treatment helps 
people with HIV live longer and healthier lives, as well as help stop the spread of HIV. 
The aim of this study is to understand how we can improve opportunities for earlier 
diagnosis and treatment of HIV among Africans. Using this information in collaboration 
with African organisations we hope to develop a more effective and acceptable HIV 
prevention strategy.  
 
Why have I been chosen? 
 
The study is being undertaken at HIV treatment centres throughout London.  All people 
born or raised in Africa and diagnosed HIV positive during the study period will be 
asked to participate in the study. We are hoping to get at least 330 people involved in 
the study.  Recruitment to the study will run for 18 months beginning in January 2004. 
 
Do I have to take part? 
 
It is up to you whether or not to take part.  If you decide to take part you will be given 
this information sheet to keep and a consent form to sign.  You will also be given a copy 
of the consent form to keep.  If you decide to take part you are still free to withdraw at 
any time and without giving a reason. A decision not to take part, or to withdraw at any 
time, will not affect the care you receive in any way.  
 
What would I have to do? 
 
You would have to fill-in a questionnaire. The questionnaire should take approximately 
45 minutes to complete, and would be at a time and place convenient for you.  A small 
token of £10 will be provided to cover your expenses. The questionnaire is available in 
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languages if this is required. 
 
If for any reason you do not want to complete the questionnaire, we would be grateful if 
you would give us permission to take some basic details from your patient records, that 
is your age, gender, country of birth, length of time in the UK, CD4 count and CDC 
stage.  We would remove your name and any identification from this information before 
using it in our study. The reason we would like to collect this information is so that we 
can find out if the people who do not complete the questionnaire are similar to the 
people that do complete the questionnaire.  
 
Will my taking part in this study be kept confidential? 
 
Yes. All information will be kept strictly confidential.  We will remove all identifying 
data, such as name, address or clinic number, so that you will not be recognised. We 
will keep all the information under lock and key at UCL. The completed questionnaires 
will be kept until all analyses are complete and then destroyed. We realise that some of 
the questions are very personal but your co-operation and help will be greatly 
appreciated. Any question that you really do not wish to answer, or feel unable to 
answer, can be missed out. All the information you provide will be extremely useful in 
developing better services. 
 
If you have difficulty with any of the questions the clinic staff will be pleased to help 
you.  If you would like to speak to someone about issues raised by this study please feel 
free to approach a health advisor, doctor, nurse or member of the research team. 
 
What will happen to the results of the study? 
 
The results will be shared with all the participating clinics, African communities and 
relevant organisations. Leaflets detailing the important findings and recommendations 
will be available in the clinic.  They will also be written up for publication in journals. 
The first results should be available in January 2005, and final results by December 
2005.  If you are interested copies of the results will be available from the research 
team. 
 
Who is organising and funding this research? 
 
This research is funded by a Wellcome Training Fellowship grant.  Dr Fiona Burns is 
the person responsible for the study and all the data.  Ethical approval for this study has 
been attained from both the Multi-centre and your local Research Ethics Committee. 
 
Thank you very much for taking the time to consider taking part in this study. 
 
Contacts for further information: 
   
Dr Fiona Burns          Ph. 020 7387 9300 ext.8970 
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      Version 3 11.11.03 
    SONHIA  
              Study Of Newly diagnosed HIV Infection amongst Africans in London 
 
Information Sheet for In-depth Interviews 
 
We are asking you to be involved in a research study to find out more about African 
people who are diagnosed with HIV in the UK and how we can improve health services 
for them. Before you take part it is important to understand why this work is being 
done.  Please take the time to read the following information and discuss it with others 
if you wish. Please ask us if anything is unclear or you have any concerns.  Take time to 
decide if you want to take part or not.  
 
What is the purpose of the study? 
 
HIV/AIDS is an important health problem among Britain’s African communities. 
Africans with HIV tend to wait a long time before they seek help from the NHS. This 
often means they are too unwell to benefit from all the new treatments and services 
available for people with HIV. We know that earlier diagnosis and treatment helps 
people with HIV live longer and healthier lives, as well as help stop the spread of HIV. 
The aim of this study is to understand how we can improve opportunities for earlier 
diagnosis and treatment of HIV among Africans. Using this information in collaboration 
with African organisations we hope to develop a more effective and acceptable HIV 
prevention strategy.  
 
Why have I been chosen? 
 
The study is being undertaken at HIV treatment centres throughout London.  All people 
born or raised in Africa and diagnosed HIV positive during the study period will be 
asked to participate in the study. We are hoping to get at least 40 people involved in this 
part of the study.  Recruitment to this part of the study will run for 6 months beginning 
in February 2005. 
 
Do I have to take part? 
 
It is up to you whether or not to take part.  If you decide to take part you will be given 
this information sheet to keep and a consent form to sign.  You will also be given a copy 
of the consent form to keep.  If you decide to take part you are still free to withdraw at 
any time and without giving a reason. A decision not to take part, or to withdraw at any 
time, will not affect the care you receive in any way.  
 
What would I have to do? 
 
It would involve an ‘in-depth’ interview with a qualified interviewer.  The interview 
will be about you and your experiences and thoughts around HIV.  The interviews 
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and place convenient to you.  A token of £20 will be given to you to cover any expenses 
and in appreciation of the time the interviews take.  All the interviews will be conducted 
in English. The interviews will also be tape-recorded and transcribed by qualified 
personnel.  No identifying data, such as your name, will be kept with the transcripts and 
only people on the research team will have access to them.  We record and transcribe 
the interviews to ensure we do not forget or miss important information that you tell us. 
The tapes will be destroyed as soon as all analyses are complete. If you really do not 
want to be tape-recorded you have the option to opt-out from this. 
 
Will my taking part in this study be kept confidential? 
 
Yes. All information will be kept strictly confidential.  We will remove all identifying 
data, such as name, address or clinic number, so that you will not be recognised. We 
will keep all the information under lock and key at UCL. Data collected as part of this 
study will be kept for a maximum of 5 years or until all analyses are complete. We 
realise that some of the questions are very personal but your co-operation and help will 
be greatly appreciated.  The information you provide will be extremely useful in 
developing better services.  
 
If you have difficulty with any of the questions the clinic staff will be pleased to help 
you.  If you would like to speak to someone about issues raised by this study please feel 
free to approach a health advisor, doctor, nurse or member of the research team. 
 
What will happen to the results of the study? 
 
The results will be shared with all the participating clinics, African communities and 
relevant organisations. Leaflets detailing the important findings and recommendations 
will be available in the clinic.  They will also be written up for publication in journals. 
The first results should be available in November 2004, and final results by October 
2005.  If you are interested, copies of the results will be available from the research 
team. 
 
Who is organising and funding this research? 
 
This research is funded by a Wellcome Training Fellowship grant.  Dr Fiona Burns is 
the person responsible for the study and all the data.  Ethical approval for this study has 
been attained from both the Multi-centre and your local Research Ethics Committee. 
 
Thank you very much for taking the time to consider taking part in this study. 
 
Contacts for further information: 
 
Dr Fiona Burns          Ph. 020 7380 9300 ext. 8970 
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Headed paper 
Version 3 28/11/03 
      SONHIA 
                  Study Of Newly diagnosed HIV Infection amongst Africans in London 
Consent Form 
Questionnaire 
 
Patient unique serial number for this study (attach sticker): 
 
 
 
Researchers:  Dr Fiona Burns    Prof. James Nazroo 
    Dr Kevin Fenton    Prof. Anne Johnson 
     
I confirm that I have read and understand the information sheet for the above study and 
have had the opportunity to ask questions. 
I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason, without my medical care or legal rights being affected. 
I understand that sections of my medical notes may be looked at by responsible          
individuals where it is relevant to my taking part in this study. These individuals would only 
access information which is relevant to this study.  I give permission for these individuals 
to have access to my records. 
I agree to take part in the above study   
 
_________________________  _______________    ___________________ 
Name  of  Patient     Date    Signature 
 
_________________________ _____________ __________________ 
Researcher      Date    Signature 
 
 
I decline to take part in this study but I have no objection to the researchers collecting data 
about my age, gender, country of birth, time in the UK, CD4 count or CDC stage from my 
records, removing my name and identification from it before adding it to study data.                        
Agree/Disagree 
 
_________________________ _____________ ___________________ 
Name  of  Patient     Date    Signature 
 
_________________________ _____________ ___________________ 
Researcher      Date    Signature 
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In-depth Interviews 
 
CONSENT FORM 
 
Researchers:  Dr Fiona Burns 
  Dr  Kevin  Fenton 
  Dr  James  Nazroo 
  Prof.  Anne  Johnson 
 
Unique serial number for this study (attach sticker): 
 
 
 
 
I confirm that I have read and understand the information sheet for the above study and 
have had the opportunity to ask questions. 
 
I understand that my participation is voluntary and that I am free to withdraw at any time,  
without giving any reason, without my medical care or legal rights being affected. 
 
I do / do not agree to the interview being tape-recorded and transcribed. 
 
I agree to take part in the above study  
 
 
_________________________ _____________ _____________________ 
Name  of  Patient     Date    Signature 
 
 
_________________________ _____________ _____________________ 
Researcher      Date    Signature 
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Appendix 7: Quota matrix for in-depth interviews 
 
Primary quotas 
Age  Male  Female  Total 
18-24 1-3  1-3  2-6 
25-34 5-7  5-7  10-14 
35-45 5-7  5-7  10-14 
45+ 5-7  5-7  10-14 
Residence in 
UK 
     
<5 years  15-25  20-24 
5+ years  15-25  20-24 
 
Secondary quotas 
Partnership  Male  Female  Total 
Partner – not living together  5-8  5-8  10-16 
Partner – living together  5-8  5-8  10-16 
No current partner  5-8  5-8  10-16 
Region of origin 
     
Lower prevalence (<5%) 
Northern                   Horn of Africa 
Benin                        Madagascar 
Chad                         Mali 
DR Congo (Zaire)    Senegal 
Ghana                      Sudan 
 
 
 
5-8 
 
 
5-8 
 
 
10-16 
Higher prevalence (>15%) 
Namibia                     
Botswana                    
Zambia 
Zimbabwe                   
Mozambique 
South Africa 
 
 
5-8 
 
 
5-8 
 
 
10-16 
Medium prevalence 
Ethiopia                 
Nigeria                 Rep of Congo      
Burkina Faso       Tanzania               
Uganda               Cote d’Ivorie         
Kenya                         
 
 
5-8 
 
 
5-8 
 
 
10-16 
Recruitment site 
     
Central London teaching   5-10  5-10 
District General  5-10  5-10 
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Primary quota controls 
Sex and age 
 Male  18-24   
 Female  18-24    
 
 Male  25-34   
 Female  25-34     
 
  Male 35 +   
 Female  35+    
Residence 
Under 5 years     
 
5 years and over      
 
Secondary quota controls 
Partnership status 
  Male – single           
  Female – single         
 
  Male – Partner (co-habiting)       
  Female – Partner (co-habiting )   
 
  Male – Partner non co-habiting    
  Female- Partner non co-habiting  
 
Region of Origin 
  Male - Lower prevalence       
  Female - Lower prevalence       
Male - Higher prevalence        
Female - Higher prevalence       
 
Male -Increasing prevalence         
Female -Increasing prevalence    
 
Recruitment site 
Central London teaching            
District General                   
 Appendix 8: Topic Guide for in-depth interviews
 
2.  Introduction. 
•  This study, named ‘SONHIA’, is about how African people 
living in London view HIV, their experiences with health 
services and how this influences when people test for HIV. 
It is also hoped that it will help with understanding where 
and when African people in the UK are acquiring their HIV. 
Very little is currently known on this topic. 
•  This study will help determine the factors associated with 
late presentation of HIV disease so that in the future we 
can target resources to better meet the African 
communities health needs. 
•  Brief outline of interview  
 
Explain:  Timing (anticipating 90 minutes) 
 Confidentiality 
Tape recording – not compulsory, obtain verbal consent 
(written consent already obtained)  
Check if any questions before begin 
 
8. Personal  Circumstances. 
Could we start by you telling me a bit about yourself? 
- age 
-  who lives with respondent (relationship), children 
-  employment/ last occupation or other activities/and 
partners 
-  how long lived at current residence/ owned or rented 
•  Time spent living in the UK and other countries 
-  How long lived in UK 
- Where  born 
-  Other countries lived/ went to school 
-  Parents: occupation/ migration history 
-  Siblings: ages/ differences in migration history 
 
9.  Personal and Community Attitudes. 
Now I would like to ask you about what or who motivates you and 
important influences in your life.  
 
•  What do you hold most dear/important? 
•  What do you most fear? 
•  What, or who, provides your support network 
•  Who do you trust 
•  Your experiences of living in the UK – authority/ racism  
•  Role of religion – influence on illness; HIV testing; attitude of 
church to HIV 
•  Role of the African community – support; attitudes to HIV; how 
people react when someone diagnosed HIV positive; differences 
between the UK and home 
• Immigration   
-  Visa - issues outstanding/ attitudes of those encountered/ 
stress involved/ HIV status and immigration – influence on 
testing? 
-  Solicitor/immigration advisor – experience/ advice given 
 
10. Learning about HIV. 
We have spoken a little about what influences and motivates you.  Now 
I would like to focus on HIV and your experiences in learning about it. 
 
•  How first found out about HIV 
- Age 
- What  learnt/discovered 
-  Views and feelings at the time/of the experience 
 
•  What sort of things were learnt 
- Context 
- Timing 
- Most  important 
•  Other sources of information on HIV/AIDS 
•  What was learnt about HIV/AIDS 
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•  Influence on attitude within your community by being an STD 
•  Who did you tell when you were diagnosed HIV positive   
- their  response 
-  attitudes and behaviours of people you told – family; 
friends; partner. 
 
11. Awareness of HIV 
There is a lot of attention on HIV in Africa. I am interested in knowing 
your views on how much awareness there is about HIV in your 
community here in the UK. 
 
•  Perception of risk amongst your friends; partners 
•  Experiences: own; partners; others  
-  explore risk behaviours/practices  
-  cultural practices that may help transmission 
-     condom use, prevention measures 
•  Awareness of symptoms and signs of HIV prior to diagnosis. 
•  Sources of treatment 
-  Knowledge of different places/services available/ who runs 
them 
-  Awareness of sources of treatment/testing/advice and 
information 
- Experiences/past  use 
-  Preferences – testing; care (specialist; hospital; GP; other) 
 
12. Health Services & Service History 
Thinking about your own experiences with health services – both here 
in the UK and abroad - I would now like to find out about your 
perceptions of these services.  
• Perception 
• Access 
• Referral  process 
•  Utilisation of services prior to the UK 
-  Prior hospitalisation – where/when/experience 
-  Primary Health Care – experience/ referral process 
-   HIV testing raised? 
•  Utilisation of Services within the UK 
-  Prior hospitalisation – where/when/experience/maternity 
-  Primary Health Care – experience/how long had GP in 
UK/referral process 
-  HIV testing:  issue raised / barriers to uptake 
•  Sexual health history – prior sexually transmitted infections, 
where treated. 
•  Testing  - prior test/ why then/ experience/ peers 
13. HIV Treatment options 
There are various treatments now available for HIV.  I would now like to 
focus on these.  I’ll start by asking have you ever heard of HAART or 
combination therapy? 
•  Understanding and awareness of HAART/combination therapy 
-  ever heard of it prior to testing 
-  what does it mean or suggest 
•  Extent to which treatment options have influenced HIV 
presentation 
-     decision making – factor in testing decision 
-  perception in the community 
- ante-natal 
•  Belief in and utilisation of other forms of therapies/healing: 
traditional; herbal; faith 
14. Improvements to Services and Information 
Finally I would like to get your opinion on how we can improve the 
services and information available on HIV and HIV testing 
•  Effective forms of encouragement – to test. 
•  Improvement to information available on HIV – form and 
content 
•  Improvement to Services available – type, location, availability. 
•  Who should be targeted – age, type required. 
Thank interviewee – check if any questions or issues raised by 
interview. 
Reassure re confidentiality 
Provide contact details 
Invite them to be sent summary of research findings and inform how the 
results of the study will be disseminated.
  369 Appendix 9: Collaborators & key workers 
 
The study of newly diagnosed HIV infection among Africans in London was possible 
due to the collaboration and generous assistance of the following people. 
Archway Sexual Health Clinic   Dr Eva Jungmann 
     Denise  Thorburn 
     Johanna  Baruah 
Patricia Whyte 
 
Central Middlesex Hospital    Dr Gary Brook 
     Munyaradzi  Chikohora 
 
Charing Cross Hospital    Dr John Wright 
 
Chelsea & Westminster Hospital  Dr Anton Pozniak 
     Dr  Ann  Sullivan 
     R i c h a r d   S t a c k  
 
Homerton University Hospital  Dr Jane Anderson 
     N i c k y   H i c k e y  
     L o r r a i n e   M u r o m b a  
 
Mortimer Market Centre    Dr Patrick French 
     Nina  Panahmand 
     Elizabeth  Kirkpatrick 
 
Newham University Hospital   Dr Ade Fakoya 
     Cheryl  Tawana 
 
North Middlesex Hospital    Dr Jonathan Ainsworth 
     A n e l e   W a t e r s  
     Fiona  Young 
 
St. Bartholomew’s & Royal London Hospital     
Dr Chloe Orkin 
James Hand 
     S a r a h   M a n n e y  
 
St. Georges Hospital      Dr Tariq Sadiq  
     S i m o n e   G h o s h  
 
St. Mary’s Hospital      Dr Harpal Lamba 
     Andy  Hughes 
 
University College Hospital    Dr Rob Miller 
     P e t e r   M c K e n z i e  
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Victoria  Clinic     Dr  Nneka  Nwokolo 
     Anthony  Kerley 
      
 
Watford District General Hospital  Dr Pat Munday 
     M i c h e l l e   S l i n n  
 
 